gene,snp,snippet
AANAT,Rs3760138,autism
AANAT,Rs3760138,autism
ABCA1,Rs2230808,brain changes
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2230808,CSF cholesterol levels
ABCA1,Rs2230808,cerebrospinal fluid
ABCA1,Rs2230808,ischaemic stroke
ABCA1,Rs2230808,HDL cholesterol levels
ABCA1,Rs2230808,dementia
ABCA1,Rs2230808,schizophrenia
ABCA1,Rs2230808,brain changes
ABCA1,Rs2297404,Alzheimer's disease
ABCA1,Rs2297404,rs2297404
ABCA1,Rs2297404,rs2230808
ABCA1,Rs2297404,rs2020927 
ABCA1,Rs2297404,haplotype1 
ABCA1,Rs2297404,TGG
ABCA1,Rs4149268,0.82mg/dl increase in HDL cholesterol
ABCA1,Rs4149268,increase in HDL cholesterol
ABCA1,Rs4149268,good cholesterol
ABCA1,Rs2230808,schizophrenia 
ABCA1,Rs2230808,dementia
ABCA1,Rs2230808,ABCA1 polymorphisms
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs1800977,polymorphism
ABCA1,Rs1800977,therothrombotic cerebral infarction
ABCA1,Rs2020927,Alzheimer's disease
ABCA1,Rs2020927,atherogenic dyslipidaemia
ABCA1,Rs2230808,ischaemic stroke
ABCA1,Rs2230806,coronary artery disease
ABCA1,Rs2230806,HDL-C
ABCA1,Rs2230806,coronary artery disease 
ABCA1,Rs2230806,Alzheimer's disease
ABCA1,Rs2020927,Type 2 diabetes
ABCA1,Rs2230806,Alzheimer's disease
ABCA1,Rs2230806,ischaemic stroke
ABCA1,Rs2230806,dementia
ABCA1,Rs2230806,postprandial lipoproteins
ABCA1,Rs2230806,hyperlipidemic 
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2230808,ABCA1 polymorphisms
ABCA1,Rs2230806,Alzheimer's disease
ABCA12,Rs28940271,congenital Lamellar ichthyosis
ABCA12,Rs28940271,skin condition
ABCA12,Rs28940271,Lamellar ichthyosis
ABCA12,Rs28940271,recessive SNP
ABCA12,Rs28940271,skin condition
ABCA12,Rs28940568,recessive SNP
ABCA12,Rs28940568,skin condition
ABCA12,Rs28940568,Lamellar ichthyosis
ABCA12,Rs28940568,skin condition
ABCA12,Rs28940270,skin condition
ABCA12,Rs28940568,congenital Lamellar ichthyosis
ABCA12,Rs28940270,recessive SNP
ABCA12,Rs28940268,Lamellar ichthyosis
ABCA12,Rs28940270,skin condition
ABCA12,Rs28940270,congenital Lamellar ichthyosis
ABCA12,Rs28940269,skin condition
ABCA12,Rs28940269,recessive SNP
ABCA12,Rs28940269,Lamellar ichthyosis
ABCA12,Rs28940269,skin condition
ABCA12,Rs28940269,congenital Lamellar ichthyosis
ABCA12,Rs28940268,skin condition
ABCA12,Rs28940268,recessive SNP
ABCA12,Rs28940268,skin condition
ABCA12,Rs28940268,congenital Lamellar ichthyosis
ABCA12,Rs28940270,Lamellar ichthyosis
ABCA7,Rs3764650,Alzheimer's 
ABCA7,Rs3764650,disease 
ABCA7,Rs200538373,late-onset Alzheimer's disease
ABCA7,Rs3764650,Alzheimer's disease
ABCA7,Rs200538373,loss-of-function ABCA7 mutations
ABCA7,Rs200538373,late-onset Alzheimer's disease 
ABCA7,Rs200538373,Alzheimer's disease
ABCA7,Rs200538373,Alzheimer's disease
ABCB1,Rs1128503,allogeneic hematopoietic stem cell transplantation
ABCB1,Rs1128503,myeloid leukemia
ABCB1,Rs1128503,functional polymorphism (C3435T) of the gene encoding P-glycoprotein
ABCB1,Rs1128503,major depressive disorder
ABCB1,Rs2032582,lung cancer
ABCB1,Rs2032582,squamous cell carcinoma
ABCB1,Rs2235035,colorectal cancers
ABCB1,Rs2235035,Crohn disease
ABCB1,Rs2235035,ulcerative colitis
ABCB1,Rs2235035,colorectal cancers
ABCB1,Rs2235035,refractory Crohn disease
ABCB1,Rs2235035,ulcerative colitis
ABCB1,Rs1128503,cancer
ABCB1,Rs2032582,Crohn's disease
ABCB1,Rs1128503,nephrotic syndrome
ABCB1,Rs1128503,major depressive disorder
ABCB1,Rs1128503,Pazopanib-induced hyperbilirubinemia
ABCB1,Rs1128503,Gilbert's syndrome
ABCB1,Rs1128503,opiate dependence
ABCB1,Rs1128503,requiring the 'higher' methadone dose
ABCB1,Rs1128503,dementia
ABCB1,Rs1128503,age-matched non-demented control patients
ABCB1,Rs1128503,addictive diseases
ABCB1,Rs1128503,childhood acute lymphoblastic leukemia
ABCB1,Rs1128503,ABCB1 polymorphisms
ABCB1,Rs1128503,liver transplant
ABCB1,Rs1128503,major depression
ABCB1,Rs1128503,antidepressant response
ABCB1,Rs1128503,ciclosporin exposure
ABCB1,Rs1128503,drug-refractory epilepsy
ABCB4,Rs45575636,cholestasis of pregnancy
ABCB4,Rs58238559,atrial fibrillation/flutter
ABCC2,Rs717620,nonalcoholic fatty liver disease
ABCC2,Rs717620,intrahepatic cholestasis
ABCC2,Rs3740065,invasive breast cancer
ABCC2,Rs2273697,epilepsy
ABCC2,Rs2273697,neurological adverse drug reactions
ABCC2,Rs2273697,reduced carbamazepine transport across the cell membrane.
ABCC4,Rs11568658,myocardial infarction
ABCC4,Rs9561778,ADR
ABCC4,Rs9561778,ed that
ABCC6,Rs63749823,pseudoxanthoma elasticum
ABCC6,Rs63749823,ABCC6 mutations
ABCC6,Rs63749823,pseudoxanthoma elasticum
ABCC8,Rs151344624,somatic loss
ABCC8,Rs151344624,pregnancy 
ABCC8,Rs151344624,mutation 
ABCC8,Rs151344623,somatic loss of heterozygosity
ABCC8,Rs151344623,compound heterozygosity
ABCC8,Rs151344623,pregnancy
ABCC8,Rs1048095,permanent neonatal diabetes mellitus
ABCC8,Rs1048095,permanent neonatal diabetes mellitus (PNDM)
ABCC8,I5012558,Familial Hyperinsulinism
ABCC8,I5012556,Familial Hyperinsulinism
ABCC8,I5008233,Familial Hyperinsulinism
ABCC8,Rs151344623, homozygosity
ABCC9,Rs4148649,postural changes in blood pressure
ABCC9,Rs4148649,postural changes in blood pressure
ABCC9,Rs4148649,postural changes in blood pressure
ABCC9,Rs4148649,blood pressure
ABCC9,Rs4148649,blood pressure
ABCC9,Rs4762865,blood pressure
ABCC9,Rs4762865,postural changes in blood pressure
ABCC9,Rs4762865,postural changes in 
ABCC9,Rs4762865,postural changes in blood pressure
ABCC9,Rs4762865,postural changes in blood pressure
ABCC9,Rs4762865,blood pressure
ABCC9,Rs4762865,blood pressure
ABCC9,Rs4762865,postural changes in blood pressure
ABCC9,Rs4148649,postural changes in 
ABCC9,Rs4148649,blood pressure
ABCC9,Rs2955503,haplotype
ABCC9,Rs2900492,postural changes in blood pressure.
ABCC9,Rs2900492,postural changes in blood pressure
ABCC9,Rs2900492,postural changes in blood pressure
ABCC9,Rs11046232,blood pressure
ABCC9,Rs11046232,blood pressure
ABCC9,Rs11046232,postural changes in blood pressure
ABCC9,Rs11046232,postural changes in blood pressure
ABCC9,Rs11046232,postural changes in blood pressure
ABCC9,Rs11046232,postural changes in 
ABCC9,Rs11046232,postural changes in blood pressure
ABCC9,Rs11046232,blood pressure
ABCC9,Rs4148649,postural changes in blood pressure
ABCD1,Rs398123109,pathogenic for adrenoleukodystrophy (ALD)
ABCD1,Rs398123109,pathogenic for adrenoleukodystrophy (ALD)
ABCD1,Rs398123109,adrenoleukodystrophy
ABCD1,Rs398123109,adrenoleukodystrophy (ALD)
ABCD1,Rs398123104,pathogenic for adrenoleukodystrophy
ABCD1,Rs1131691743,adrenoleukodystrophy
ABCD1,Rs1057518721,"deafness, dystonia, and cerebral hypomyelination"
ABCD1,Rs398123109,adrenoleukodystrophy
ABCG2,Rs3114018,gout
ABCG2,Rs3114018,gout
ABCG2,Rs3114018,haplotype blocks
ABCG2,Rs3114018,gout
ABCG2,Rs2231142,diarrhea 
ABCG2,Rs2231142,lung cancer
ABCG2,Rs2231142,Atherosclerosis
ABCG2,Rs2231142,"rs2231142, also known as Q141K and C421A, is a SNP in the ABCG2 gene, indicating a missense variant. ""Our data indicate that at least 10% of all gout cases in whites are attributable to this causal variant.""A is the risk allele. A large study totaling 7,699 participants in the Framingham cohort and 4,148 participants in the Rotterdam cohort was conducted, with genome-wide significant SNPs then replicated in 11,000+ Caucasian and ~4,000 African-American individuals who took part in the study of Atherosclerosi"
ABCG2,Rs2231142,"4,000 African-American individuals who took part in the study of Atherosclerosis Risk in Communities"
ABCG2,Rs2231142,Atherosclerosis Risk
ABCG2,Rs3114018,gout
ABCG2,Rs2231137,ischemic stroke
ABCG2,Rs2231137,black
ABCG2,Rs2231137,white
ABCG2,Rs2231137,stroke
ABCG2,Rs2231137,allele homozygotes
ABCG2,Rs2231137,ischemic stroke
ABCG2,Rs2231137,stroke
ABCG2,Rs2231137,ischemic stroke
ABCG2,Rs1481012,colorectal cancer
ABCG2,Rs2231142,heterozygotes
ABCG8,Rs6756629,gallstone disease
ABCG8,Rs6756629,increased HDL cholesterol levels
ABCG8,Rs6756629,decreased LDL levels
ABCG8,Rs6756629,decreased triglyceride levels
ABCG8,Rs41360247,Gallstone disease
ABCG8,Rs11887534,"p=1.4x10-14), "
ABCG8,Rs41360247,increases susceptibility to Gallstone disease
ABO,Rs8176747,ABO Blood Type
ABO,Rs8176719,blood group type O
ABO,Rs8176719,blood group type O
ABO,Rs8176719,blood type A
ABO,Rs8176719,blood type B
ABO,Rs8176719,"blood type A, B, or AB"
ABO,Rs8176719,type O
ABO,Rs8176741,blood group type
ABO,Rs8176743,ABO Blood Type
ABO,Rs8176746,G/T
ABO,Rs8176746,A/C
ABO,Rs8176719,blood group type A or type B
ABO,Rs8176719,"blood group types A, B, and AB"
ABO,Rs8176719,blood group type O status
ABO,Rs657152,ABO blood group
ABO,Rs657152,men and women
ABO,Rs41302905,may influence ABO blood group see gs129ABO Blood Type
ABO,Rs505922,pancreatic cancer
ABO,Rs505922,pancreatic cancer
ABO,Rs507666,histo-blood
ABO,Rs7853989,ABO Blood Type
ABO,Rs507666,histo
ABO,Rs507666,blood 
ABO,Rs657152,pancreatic cancer
ABO,Rs657152,pancreatic cancer
ABO,Rs657152,ABO histo-blood
ABO,Rs657152,women
ABO,Rs657152,thyroid
ABO,Rs56392308,A2 ABO blood
ABP1,Rs2268999,single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activities
ABP1,Rs2052129,selective hypersensitivity to ibuprofen
ABP1,Rs2052129,selective NSAID hypersensitivity 
ABP1,Rs2052129,HIT
ABP1,Rs2052129,NSAID hypersensitivity 
ABP1,Rs2052129,hypersensitivity to ibuprofen
ABP1,Rs2052129,Caucasian
ABP1,Rs10156191,hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs)
ABP1,Rs2052129,"histamine intolerance (HIT), "
ACADM,I5003116,Dehydrogenase Deficiency
ACADM,I5003117,Medium-Chain
ACADM,Rs121434280,temperature-sensitive mutation
ACE,Rs4359,anti-hypertensive drug ramipril
ACE,Rs4359,SNP 
ACE,Rs4353,late-onset Alzheimer disease
ACE,Rs4343,diabetic nephropathy
ACE,Rs4311,diabetic nephropathy.
ACE,Rs4293,Alzheimer's disease
ACE,Rs4293,SNP 
ACE,Rs4293,Alzheimer's disease
ACE,Rs4293,Alzheimer's disease.
ACE,Rs4311,diabetic nephropath
ACKR1,Rs2814778,Malaria Resistance
ACKR1,Rs2814778,Plasmodium vivax malaria
ACKR1,Rs2814778,Malaria
ACKR1,Rs2814778,Plasmodium vivax malaria 
ACKR1,Rs2814778,Malaria
ACKR1,Rs2814778,malaria
ACKR1,Rs12075,blood group antigen system
ACKR1,Rs2814778,Duffy blood group antigen
ACTA2,Rs1926203,lung cancer
ACTA2,Rs121434528,transient ischemic attacks
ACTA2,Rs121434528,ministrokes
ACTA2,Rs121434528,Strokes
ACTA2,Rs1926203, lung cancer risk
ACTA2,Rs121434528,"Moyamoya,"
ACTA2,Rs121434528,moyamoya-like cerebrovascular disease
ACTA2,Rs121434528,familial thoracic aortic aneurysm and dissection (TAAD)
ACTA2,Rs121434528,arteries at the base of the brain are blocked
ACTC1,Rs193922680,eft ventricular noncompaction
ACTC1,Rs193922680,pathogenic/likely pathogenic
ACTC1,Rs193922680,amilial hypertrophic cardiomyopathy
ACTG1,Rs28999111,deafness
ACTG1,Rs28999111,deafness
ACTG1,Rs28999112,deafness
ACTG1,Rs28999112,deafness
ACTN3,Rs1815739,SNPs 
ACTN3,Rs1815739,athletic status
ACTN3,Rs1815739,life course physical capability
ACTN3,Rs1815739,leg muscle power
ACTN3,Rs1815739,endurance ability
ACTN3,Rs1815739, power/sprint performance
ACTN3,Rs1815739,performance phenotypes i
ACTN3,Rs1815739,polymorphism
ACTN3,Rs1815739,endurance ability
ACTN3,Rs1815739,explosive leg muscle power
ACTN3,Rs1815739,muscle performance
ACTN4,Rs121908415,Focal segmental glomerulosclerosis
ACTN4,Rs121908416,Focal segmental glomerulosclerosis
ACTN4,Rs121908417,Focal segmental glomerulosclerosis
ADA,Rs121908739,adenosine deaminase deficiency
ADA,Rs121908739,adenosine deaminase deficiency.
ADA,Rs121908738,adenosine deaminase deficiency
ADA,Rs121908738,adenosine deaminase deficiency.
ADA,Rs121908735,SCID
ADA,Rs121908736,adenosine deaminase deficiency.
ADA,Rs121908735,ADA
ADA,Rs121908736,adenosine deaminase deficiency
ADAM10,Rs145518263,Alzheimer's disease
ADAM10,Rs61751103,Alzheimer's disease
ADAM10,I6006818,Alzheimer's disease
ADAM10,I6006817,Alzheimer's disease
ADAM10,I6006817,Alzheimer's disease
ADAM10,I6006818,Alzheimer's disease assocation
ADAM19,Rs1422795,lung cancer
ADAM19,Rs1422795,COPD
ADAM33,Rs574174, bronchial hyperresponsiveness
ADAM33,Rs574174,asthma
ADAM33,Rs574174,COPD
ADAM33,Rs574174,psoriasis
ADAM33,Rs574174,asthma
ADAM33,Rs574174,immune-mediated diseases
ADAM33,Rs574174,type 1 diabetes
ADAM33,Rs512625,psoriasis
ADAM33,Rs512625,psoriasis
ADAM33,Rs44707,bronchial hyperresponsiveness.
ADAM33,Rs44707,asthma 
ADAM33,Rs3918396,chronic obstructive pulmonary disease (COPD)
ADAM33,Rs2853209,atopic dermatitis
ADAM33,Rs2853209,atopic dermatitis
ADAM33,Rs574174,asthma and bronchial hyperresponsiveness
ADAM33,Rs574174,type 1 diabetes
ADAM33,Rs574174,polymorphisms
ADAM33,Rs574174,disintegrin
ADAM33,Rs2787094,Japanese women
ADAM33,Rs628977,rhinoconjunctivitis
ADAM33,Rs628977,smoking
ADAM33,Rs628977,genetic polymorphisms
ADAM33,Rs628977,atopic dermatitis
ADAM33,Rs628977,polymorphisms
ADAM33,Rs574174,immune-mediated diseases
ADAM33,Rs628977,psoriasis susceptibility
ADAM33,Rs628977,psoriasis
ADAM33,Rs628977,early-onset psoriasis
ADAM33,Rs574174,polymorphisms
ADAM33,Rs574174,lung function
ADAM33,Rs574174,asthma
ADAM33,Rs574174,metalloprotease
ADAM33,Rs628977,atopic dermatitis
ADAM33,Rs2787094,rhinoconjunctivitis
ADAM33,Rs2787094,Chinese Han population
ADAM33,Rs2787094,psoriasis
ADAM33,Rs2787094,asthma
ADAM33,Rs2787094,rhinoconjunctivitis
ADAM33,Rs2787094,allergy and asthma 
ADAM33,Rs2787094,asthma
ADAM33,Rs2787094,atopic dermatitis
ADAM33,Rs2787094,rhinitis
ADAM33,Rs2787094,bronchial hyperresponsiveness
ADAM33,Rs2787094,adult allergic asthma
ADAM33,Rs2787094,immune-mediated diseases
ADAM33,Rs2787094,type 1 diabetes
ADAM33,Rs2787094,bronchial hyperresponsiveness
ADAM33,Rs2787094,asthma
ADAM33,Rs2280089,bronchial hyperresponsiveness
ADAM33,Rs2280089,asthma
ADAM33,Rs2787094,asthma 
ADAM33,Rs2787094,type 1 diabetes
ADAM33,Rs2787094,Han population of northeastern China
ADAM33,Rs2787094,asthma
ADAM33,Rs2787094,African American urban population
ADAM33,Rs2787094,childhood allergy and asthma
ADAM33,Rs2787094,asthma
ADAM33,Rs2787094,psoriasis
ADAM33,Rs2787094,tobacco smokers
ADAM33,Rs2787094,lung function
ADAM33,Rs2787094,Indian children
ADAM33,Rs2787094,atopic dermatitis
ADAM33,Rs2787094,immune-mediated diseases
ADAM33,Rs2787094,rhinitis
ADAM33,Rs2787094,adult allergic asthma
ADAM33,Rs2787094,psoriasis
ADAM33,Rs2787094,German populations
ADAM33,Rs2787094,Japanese children
ADAMTS13,Rs28647808,50% higher risk for renal complications
ADAMTS13,Rs28647808,higher renal or cardiavascular complications
ADAMTS13,Rs28647808,type-2 diabetes
ADCY2,Rs13166360,Bipolar Disorder
ADCY2,Rs13166360,Bipolar Disorder
ADCY2,Rs13166360,Bipolar Disorder
ADCY2,Rs13166360,Major Mood Disorders
ADCY2,Rs13166360,Schizophrenia
ADCY2,Rs13166360,bipolar disorder
ADCY2,Rs13166360,bipolar disorder
ADCY2,Rs13166360,BD
ADCY2,Rs13166360,Bipolar Disorders
ADCY2,Rs13166360,bipolar disorder
ADCY2,Rs13166360,Bipolar Disorder (BD)
ADCY2,Rs13166360,"those suffering from bipolar disorder are at a higher risk of suicide, anxiety disorders, and substance abuse"
ADCY2,Rs13166360,BD
ADCY2,Rs13166360,BD
ADCY2,Rs13166360,recurrent episodes of depression and mania
ADCY3,Rs541941351,obesity
ADCY5,Rs796065306,dyskinesia disorder
ADCY5,Rs796065306,facial myokymia
ADCY5,Rs796065306,dyskinesia disorder
ADCY5,Rs796065306,autosomal dominant familial dyskinesia
ADCY5,Rs796065306,facial myokymia
ADCY5,Rs11708067,glucose and insulin responses
ADH1B,Rs6413413,Spaniards
ADH1C,Rs283413,affect alcohol metabolism
ADH1C,Rs283413,Parkinson's disease (PD)
ADH1C,Rs283413,PD
ADH1C,Rs283413,alcohol metabolism
ADH1C,Rs283413,Parkinson's disease
ADH1C,Rs283413,"y the gs211 genoset. Note that the effects of alcohol are higher in individuals who break down (basically, detoxify) ethanol more slowly"
ADH1C,Rs283413,neurodegenerative diseases
ADIPOQ,Rs182052,type 2 diabetes
ADIPOQ,Rs182052,ischemic stroke
ADIPOQ,Rs822393, Adipokine
ADIPOQ,Rs822396,ischemic stroke
ADIPOQ,Rs822395,breast cancer
ADIPOQ,Rs822395,colorectal cancer
ADIPOQ,Rs822395,overweight and obesity.
ADIPOQ,Rs822396,coronary heart disease
ADIPOQ,Rs822396,breast cancer risk
ADIPOQ,Rs822396,type 2 diabetes
ADIPOQ,Rs822396,colorectal cancer
ADIPOQ,Rs182052,polymorphisms
ADIPOQ,Rs822396,incident myocardial infarction and ischemic stroke
ADIPOQ,Rs182052,birth weight
ADIPOQ,Rs822395,Single nucleotide polymorphisms
ADIPOQ,Rs182052,prostate cance
ADIPOQ,Rs182052,insulin sensitivity
ADIPOQ,Rs17300539,increased risk of insulin resistance
ADIPOQ,Rs17300539,obesity
ADIPOQ,Rs17300539,insulin resistance
ADIPOQ,Rs17300539,weight regain
ADIPOQ,Rs17300539,SNP
ADIPOQ,Rs17300539,diabetes risk
ADIPOQ,Rs182052,type 2 diabetes
ADIPOQ,Rs17300539,risk of insulin resistance
ADIPOQ,Rs182052,incident myocardial infarction
ADIPOQ,Rs182052, ischemic stroke
ADIPOQ,Rs182052,plasma adiponectin levels
ADIPOQ,Rs182052,diabetes-related quantitative traits
ADIPOQ,Rs17300539,diabetes
ADORA2A,Rs5751876,Parkinson's disease
ADRA2A,Rs1800544,clonidine treatment of Irritable bowel syndrome
ADRA2A,Rs1800544,depression
ADRA2A,Rs1800544, treatment
ADRA2B,Rs2229169,Koreans 
ADRA2B,Rs2229169,cardiac heart disease
ADRA2B,Rs2229169,prolonged acute chest pain
ADRA2B,Rs2229169,myocardial infarction
ADRA2B,Rs2229169,"Association of the deletion genotype with small-vessel disease was the main contributor to the risk. In a study of more than 400 young Swiss adults, the carriers of del301–303 polymorphism had about 20% better memory for emotional photographs, both positive and negative"
ADRA2B,Rs2229169,Chinese 
ADRA2B,Rs2229169,This may result in both negative cardiovascular consequences and positive cognitive effects
ADRA2B,Rs2229169,Alpha-2B adrenergic receptors contribute to norepinephrine stimulation in the brain and to peripheral vasoconstriction.
ADRA2B,Rs2229169,deletion polymorphism
ADRA2B,Rs2229169,This is a good proxy for alpha-2B-adrenergic receptor gene
ADRA2B,Rs2229169,"Associations with the number of sudden cardiac deaths and overall cardiac heart disease mortality were also observed, but they would not be significant after correcting for multiple comparisons."
ADRB2,Rs1042714,obesity
ADRB2,Rs1042714,type-2 diabetes
ADRB2,Rs1042714,hypertension
ADRB2,Rs1042713,asthma
ADRB2,Rs1042713,asthma
AFG3L2,Rs151344523,spinocerebellar ataxia-28
AGT,Rs4762,diabetic retinopathy.
AGT,Rs5051,essential hypertension
AGT,Rs4762,Alzheimer disease
AGT,Rs4762,coronary artery disease
AGT,Rs4762,pre-eclampsia
AGT,Rs4762,pre-eclampsia
AGT,Rs4762,diabetic retinopathy
AGT,Rs4762,coronary artery disease
AGT,Rs4762,heart failure
AGT,Rs4762,Alzheimer disease
AGT,Rs3889728,pre-eclampsia
AGT,Rs387906578,OMIM
AGT,Rs3889728,"pre-eclampsia,"
AGT,Rs4762,pre-eclampsia
AGTR1,Rs5182,reduced risk of heart attack
AHCY,Rs819134,methylations
AHCY,Rs819147,regulation of biologic methylations
AHCY,Rs819171,regulation of biologic methylations
AHSG,Rs4917,body fat levels
AHSG,Rs4917,increased risk for leanness
AHSG,Rs4917,lower body fat concentrations
AHSG,Rs4917,reduced plasma lipid levels
AHSG,Rs4917,insulin sensitivity
AHSG,Rs2518136,Caucasians
AHSG,Rs2518136,type-2 diabetes
AHSG,Rs2518136,Caucasians
AHSG,Rs2518136,type-2 diabetes
AHSG,Rs2518136,type-2 diabetes
AHSG,Rs4917,obesity 
AKT1,Rs3730358,Korean population
AKT1,Rs3730358,Obstetric Complications
AKT1,Rs3730358,schizophrenia
AKT1,Rs3730358,schizophrenia
AKT1,Rs3730358, cell lung cancer
AKT1,Rs3730358, no
AKT1,Rs3730358, associations with schizophrenia: meta-analyses of 12 candidate genes. Absence of AKT1 mutations in glioblastoma. No association betwee
AKT1,Rs3730358,non-small cell lung cancer.
AKT1,Rs3730358,lung cancer
AKT1,Rs3730358,polymorphism
AKT1,Rs3730358,Taiwanese population
AKT1,Rs3730358,schizophrenia
AKT1,Rs2494732,psychotic disorde
AKT1,Rs2494732,mind-altering symptoms
AKT1,Rs2494732,once-a-month cannabis users
AKT1,Rs2494732,cannabis-related psychosis
AKT1,Rs2494732,"drug-related psychoses,"
AKT1,Rs2494732,", schizophrenia"
AKT1,Rs3730358,glioblastoma
ALB,Rs79744198,abnormality of albumin
ALB,Rs79228041,melanoma
ALB,Rs78784172,splicing mutation
ALB,Rs78784172,Analbuminemia
ALB,Rs78340021,Novel nonsense mutation
ALB,Rs78340021,analbuminemia
ALB,Rs77050410,Mutations in genetic variants of human serum albumin found in Italy.
ALB,Rs76593094,alloalbumins
ALB,Rs76483862,alloalbumins
ALB,Rs75152012,acute glomerulonephritis
ALB,Rs75152012,teroid-sensitive idiopathic nephrotic syndrome
ALB,Rs75152012,analbuminemia
ALB,Rs1800580,truncated albumin variant
ALB,Rs1800580,Albumin Rugby Park
ALDH3A2,Rs1800870,oral cancer
ALDH3A2,Rs1800870,interleukin-10 gene
ALDH3A2,Rs1800870,oral cancer
ALDH5A1,Rs3765310,SSADH deficiency
ALDH5A1,Rs3765310,succinate semialdehyde dehydrogenase
ALDH5A1,Rs2760118,ccin
ALDH5A1,Rs2760118,United 
ALDH5A1,Rs2760118,Reduc
ALDH5A1,Rs2760118,he suc
ALDH5A1,Rs2760118,mutatio
ALDH5A1,Rs2760118,e a
ALDH5A1,Rs2760118,tive 
ALDH5A1,Rs2760118,King
ALDH5A1,Rs2760118,with S
ALDH5A1,Rs2760118, accumulation 
ALDH5A1,Rs2760118,dyslexia
ALDH7A1,Rs121912707,pyridoxine-dependent epilepsy
ALDH7A1,Rs121912707,pyridoxine-dependent epilepsy
ALDH7A1,Rs121912707,pyridoxine-dependent epilepsy
ALDOB,Rs1800546,avoidance of fructose-containing foods
ALDOB,Rs1800546,food aversion to fructose-rich foods
ALDOB,Rs1800546,liver failure and death
ALDOB,Rs1800546,"bloating, abdominal pain, diarrhea, hypoglycemia, hyperuricemia, mental depression, jaundice, and cirrhosis"
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,phosphate sink
ALDOB,Rs1800546,autosomal recessive
ALDOB,Rs1800546,severe hypoglycemia
ALDOB,Rs1800546,halt of gluconeogenesis and glycogenolysis
ALDOB,Rs1800546,"altered consciousness, diaphoresis, and seizures"
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,Italian patients
ALDOB,Rs1800546,European ancestry
ALDOB,Rs1800546,American
ALDOB,Rs1800546,Italians
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,Chronic Diarrhea
ALDOB,Rs1800546,hereditary fructose intolerance
ALDOB,Rs76917243,ALDOB gene mutation
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,death
ALDOB,Rs1800546,HFI
ALDOB,I5012665,Hereditary fructose intolerancers
ALDOB,I5012665,Hereditary fructose intolerance
ALDOB,I5012665,fructose intolerance
ALDOB,Rs1800546,=CLINICAL OVERVIEW:=
ALDOB,Rs1800546,hereditary fructosuria
ALDOB,Rs1800546,"bloating, abdominal pain, diarrhea, hypoglycemia, hyperuricemia, mental depression, jaundice, and cirrhosis that can lead to liver failure and death."
ALDOB,Rs1800546,severe hypoglycemia
ALDOB,Rs1800546,diaphoresis
ALDOB,Rs1800546,altered consciousness
ALDOB,Rs1800546,seizures
ALDOB,I5008215,Hereditary Fructose Intolerance
ALDOB,Rs1800546,loss of function of aldolase B
ALDOB,Rs1800546,death
ALDOB,Rs1800546,fructose intolerance
ALDOB,Rs1800546,hereditary fructosuria
ALDOB,Rs1800546,hypoglycemia
ALDOB,Rs1800546,European ancestry
ALDOB,Rs1800546,mental depression
ALDOB,Rs1800546,"altered consciousness, diaphoresis, and seizures, sometimes resulting in death."
ALDOB,Rs1800546,"bloating, abdominal pain, diarrhea, hypoglycemia, hyperuricemia, mental depression, jaundice, and cirrhosis that can lead to liver failure and death"
ALDOB,Rs1800546,inability of the body to break down fructose into byproducts for human consumption
ALDOB,Rs1800546,cirrhosis
ALOX5AP,Rs4076128,breast cancer
ALOX5AP,Rs4076128,ethnicity 
ALOX5AP,Rs4076128,women 
ALOX5AP,Rs4076128,east cancer
ALOX5AP,Rs4076128,higher breast cancer risk
ALOX5AP,Rs4769874,haplotype
ALOX5AP,Rs4769874,myocardial infarction
ALOX5AP,Rs4769874,ischemic stroke
ALOX5AP,Rs4769874,myocardial infarction or ischemic stroke
ALOX5AP,Rs9315050,myocardial infarction
ALOX5AP,Rs4769874,ischemic stroke
ALOX5AP,Rs9315050,ischemic stroke
ALOX5AP,Rs9315050,myocardial infarction
ALOX5AP,Rs9551963,myocardial infarction
ALOX5AP,Rs9551963,ischemic stroke
ALOX5AP,Rs9551963,atherosclerosis
ALOX5AP,Rs9551963,hypercholesterolemia
ALOX5AP,Rs9551963,atherothrombotic cardiovascular disease
ALOX5AP,Rs17222814,ischemic stroke
ALOX5AP,Rs4769874,myocardial infarction
ALOX5AP,Rs9315050,ischemic stroke
ALOX5AP,Rs17222814,myocardial infarction
ALOX5AP,Rs17222814,bifurcation intima-media thickness
ALOX5AP,Rs17222814,alcohol consumption
ALOX5AP,Rs10507391,myocardial infarction
ALOX5AP,Rs10507391,ischemic stroke
ALOX5AP,Rs10507391,ischemic stroke
ALOX5AP,Rs10507391,cardiovascular disease
ALOX5AP,Rs10507391,atherosclerosis
ALOX5AP,Rs10507391,diabetes
ALOX5AP,Rs10507391,augmentation of bronchodilator responsiveness
ALOX5AP,Rs10507391,myocardial infarction
ALOX5AP,Rs10507391,atherosclerosis
ALOX5AP,Rs10507391,cardiovascular disease
ALOX5AP,Rs10507391,atherosclerosis
ALOX5AP,Rs10507391,diabetes
ALOX5AP,Rs10507391,myocardial infarction
ALOX5AP,Rs10507391,ischemic stroke
ALOX5AP,Rs10507391,significant (only) in males
ALOX5AP,Rs10507391,leukotriene biosynthesis pathway and association with atherosclerosis
ALOX5AP,Rs10507391,Genetic effects in the
ALOX5AP,Rs10507391,ischemic stroke
ALOX5AP,Rs17222814,myocardial infarction or ischemic stroke
ALPL,I6006951,perinatal form of hypophosphatasia
ALPL,I6006948,hypophosphatasia
ALPL,I6006946,hypophosphatasia.
ALPL,I6006946,rare/minor allele
ALPL,I6006933,hypophosphatasia
ALPL,I6006940,hypophosphatasia
ALPL,I6006940,hypophosphatasia
ALPL,I6006951,pathogenic for the perinatal form of hypophosphatasia.
ALPL,I6006940,rare/minor allele
ALPL,I6006953,hypophosphatasia
ALPL,I6007032,erinatal form of hypophosphatasia
ALPL,I6006956,infantile form
ALPL,I6006956,pathogenic 
ALPL,I6006969,perinatal form of hypophosphatasia
ALPL,I6006989,hypophosphatasia
ALPL,I6006989,pathogenic 
ALPL,I6006996,hypophosphatasia
ALPL,I6006996,hypophosphatasia.
ALPL,I6007029,infantile form of hypophosphatasia
ALPL,I6007029,hypophosphatasia
ALPL,I6006927,childhood form of hypophosphatasia
ALPL,I6006956,hypophosphatasia
ALPL,I6006927,childhood form of hypophosphatasia.
ALPL,I6006940,pathogenic 
ALPL,I6006921,hypophosphatasia
ALPL,I5002756,perinatal form of hypophosphatasia
ALPL,I5002757,hypophosphatasia
ALPL,I5002765,hypophosphatasia
ALPL,I5002766,hypophosphatasia
ALPL,I5002771,hypophosphatasia
ALPL,I5002772,hypophosphatasia
ALPL,I5002773,hypophosphatasia
ALPL,I5002774,infantile form of hypophosphatasia
ALPL,I5012683,hypophosphatasia
ALPL,I5012683,"i5012683, also known as c.1133A>T or p.D378V, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the infan"
ALPL,I5002756,ypophosphatasia
ALPL,I5012683,infantile form of hypophosphatasia
ALPL,I5012684,.Based on the ALPL gene mutations
ALPL,I5900451,hypophosphatasia.
ALPL,I6006888,hypophosphatasia
ALPL,I6006897,hypophosphatasia
ALPL,I6006926,hypophosphatasia
ALPL,I6006897,rare/minor allele
ALPL,I6006897,hypophosphatasia.
ALPL,I6006912,hypophosphatasia
ALPL,I6006921,childhood
ALPL,I5012683,"i5012683, also known as c.1133A>T or p.D378V, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the infan"
AMPD1,Rs35859650,recessively inherited mutation
AMPD1,Rs35859650,muscle AMP deaminase deficiency
ANG,Rs17114699,Polish
ANG,Rs17114699,Swedish
ANG,Rs17114699,amyotrophic lateral sclerosis
ANG,Rs17114699,Irish
ANGPTL3,Rs267606655,coron
ANGPTL3,Rs267606655, artery disease
ANGPTL3,Rs267606655,minor allele
ANGPTL3,Rs267606655,coronary artery disease
ANGPTL3,Rs267606655,coronary artery disease.
ANGPTL3,Rs398122987,ANGPTL3
ANK3,Rs10994336,times compared
ANK3,Rs4948418,bipolar disorder
ANK3,Rs4948418,bipolar disorder
ANK3,Rs10994336,SNPs|
ANK3,Rs10994336,NutraHacke
ANK3,Rs10994336,one
ANK3,Rs10994336,CC genotype
ANK3,Rs10994336,disorder
ANK3,Rs10994336,his
ANK3,Rs10994336,developing
ANK3,Rs10994336,odds
ANK3,Rs10994336,increased
ANK3,Rs10994336,bipolar
ANK3,Rs10994336,Each T 
ANK3,Rs10994336,rs10994336
ANK3,Rs10994336,blog
ANK3,Rs10994336,23andMe
ANO5,Rs137854529,limb-girdle muscular dystrophy
ANO5,Rs137854529,muscular dystrophies
ANO5,Rs137854529,limb-girdle muscular dystrophy
ANO5,Rs137854523,dystrophies
ANO5,Rs137854523,muscular 
ANO5,Rs137854521,limb-girdle muscular dystrophy
ANO5,Rs137854523,muscular dystrophies
ANO5,Rs137854521,muscular dystrophies
ANO5,Rs137854521,limb-girdle muscular dystrophy
ANO5,Rs137854523,chloride 
AOC1,Rs2052129,NSAID hypersensitivity 
AOC1,Rs2268999,single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activities
AOC1,Rs2052129,selective NSAID hypersensitivity 
AOC1,Rs2052129,HIT
AOC1,Rs2052129,selective hypersensitivity to ibuprofen
AOC1,Rs2052129,hypersensitivity to ibuprofen
AOC1,Rs2052129,Caucasian
AOC1,Rs10156191,hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs)
AOC1,Rs2052129,"histamine intolerance (HIT), "
AP4E1,Rs760021635,stuttering
AP4E1,Rs760021635,The minor (A) allele
AP4E1,Rs760021635,mutation 
AP4E1,Rs556450190,AP4E1 gene
AP4E1,Rs760021635,stuttering
APC,Rs587782557,attentuated familial polyposis
APOA2,Rs5085,type-2 diabetes
APOA2,Rs6413453,type-2 diabetes
APOA2,Rs6413453,type-2 diabetes
APOA2,Rs5085,APOA2 SNPs
APOA2,Rs5085,type-2 diabetes
APOA2,Rs6413453,APOA2 SNPs
APOA2,Rs5082,"ages 4, 7 and 10"
APOA2,Rs5082,Body Mass Index 
APOA2,Rs5082,heart disease 
APOA2,Rs5082,obesity
APOA2,Rs5082,heart disease
APOA2,Rs5082,obesity
APOA2,Rs3813627,severity of coronary atherosclerosis
APOA2,Rs5082,fat 
APOA5,Rs662799,heart attack
APOA5,Rs662799,hypertriglyceridemia
APOA5,Rs662799,SNP 
APOA5,Rs662799,heart attack
APOA5,Rs662799,SNP 
APOA5,Rs662799,higher triglyceride levels
APOA5,Rs662799,SNP
APOA5,Rs2075291,severe hypertriglyceridemia
APOA5,Rs2075291,doubling of triglyceride levels
APOA5,Rs2075291,risk for hypertriglyceridemia
APOA5,Rs662799,myocardial infarction
APOB,Rs693,and LDL-Cholesterol
APOB,Rs693,Elevated Apolipoprotein B
APOB,Rs673548,coronary heart disease risk
APOB,Rs673548,risk of biliary tract cancers and stones
APOB,Rs673548,coronary heart disease
APOB,Rs673548,biliary tract cancers and stones
APOB,Rs12714264,cardiovascular genetic risk score
APOB,Rs12714264,SNP
APOB,Rs12714264,cardiovascular genetic
APOB,Rs12714264,cardiovascular genetic risk
APOB,I4000339,Hypercholesterolemia
APOC3,Rs2542052,longevity
APOC3,Rs147210663,coronary artery disease
APOC3,Rs147210663,loss of function mutations
APOC3,Rs147210663,coronary artery disease
APOC3,Rs147210663,>40% lower average triglyceride level
APOC3,Rs140621530,coronary artery disease
APOC3,Rs140621530,loss of function mutations
APOC3,Rs138326449,coronary artery disease
APOC3,Rs138326449,corresponding decrease
APOC3,Rs138326449,lower average triglyceride level
APOE,Rs7412,Alzheimer's disease
APOE,Rs7412,obstructive sleep apnea in children
APOE,Rs7412,Filipino systemic lupus erythematosus families
APOE,Rs7412,Subarachnoid hemorrhage
APOE,Rs7412,coronary artery disease
APOE,Rs7412,polymorphisms and menopausal status
APOE,Rs440446,gallbladder cancer
APOE,Rs7412,Atherosclerosis
APOE,Rs7412,sporadic amyotrophic lateral sclerosis
APOE,Rs7412,female reproductive disorders
APOE,Rs7412,Polycystic ovary syndrome and ovarian response
APOE,Rs7412,Alzheimer's disease
APOE,Rs7412,cardiovascular disease
APOE,Rs7412,cardiovascular mortality
APOE,Rs769455,Subarachnoid hemorrhage
APOE,Rs7412,Alzheimer's disease
APOE,Rs440446,osteoporosis
APOE,Rs7412,obesity
APOE,Rs440446,bile duct cancer
APOE,Rs440446,ampullary cancer
APOE,Rs440446,obesity
APOE,Rs7412,Alzheimer's disease
APOE,Rs440446,Subarachnoid hemorrhage
APOE,Rs440446,Alzheimer disease
APOE,Rs7412,osteoporosis
APOE,Rs440446,Alzheimer's disease
APOE,Rs440446,osteoporosis
APOE,Rs449647,Alzheimer's disease
APOE,Rs449647,Alzheimer's disease
APOE,Rs449647,Alzheimer's disease
APOE,Rs449647,Alzheimer's disease
APOE,Rs7412,Alzheimer's disease
APOE,Rs440446,cardiovascular disease
APOE,Rs7412,Alzheimer's Disease Family
APOE,Rs7412,antipsychotic recipients
APOE,Rs7412,Alzheimer disease
APOE,Rs769455,obstructive sleep apnea
APOE,Rs769455,Subarachnoid hemorrhage
APOE,Rs769455,obstructive sleep apnea
APOE,Rs769455,Subarachnoid hemorrhage
APOE,Rs769455,obstructive sleep apnea
APOE,Rs7412,Central Italy population
APOE,Rs7412,Taiwanese population
APOE,Rs7412,diabetic nephropathy
APOE,Rs7412,Alzheimer's disease
APOE,Rs7412,cancer
APOE,Rs7412,children
APOE,Rs7412,Alzheimer disease
APOE,Rs7412,postmenopausal women of Northwest India
APOE,Rs7412,osteoporosis
APOE,Rs7412,Alzheimer's Disease
APOE,Rs7412,Chilean women
APOE,Rs7412,gallbladder cancer
APOE,Rs7412,ischemic stroke
APOE,Rs7412,Alzheimer's disease
APOE,Rs7412,Spanish APOE 4 carriers
APOE,Rs7412,venous thromboembolism
APOE,Rs7412,plasma lipoprotein traits
APOE,Rs7412,multiethnic sample
APOE,Rs7412,natural menopause in Caucasian females
APOE,Rs7412,coronary heart disease risk
APOE,Rs7412,Brazilian individuals
APOE,Rs7412,cardiovascular risk
APOE,Rs7412,Alzheimer's disease
APOE,Rs7412,white women
APOE,Rs7412,dyslipidemia
APOE,Rs7412,carotid artery disease
APOE,Rs7412,colorectal cancer
APOE,Rs440446,gallstone disease
APOE,Rs429358,early-onset disease
APOE,Rs440446,gallstones
APOE,Rs2373115,Alzheimer's disease
APOE,Rs2373115,Alzheimer
APOE,Rs2373115, late-onset Alzheimer's disease
APOE,Rs2373115,Alzheimer's
APOE,Rs2373115,increased risk for Alzheimer's disease among ApoE4 carriers
APOE,Rs2373115,odds ratio of 4.06 
APOE,Rs2373115,risk of Alzheimer's disease
APOE,Rs2373115,risk (OR 4.1) of late-onset Alzheimer's disease
APOE,Rs2373115,Alzheimer's risk.
APOE,Rs199768005,type 3 hyperlipoproteinemia
APOE,Rs199768005,AD
APOE,Rs199768005,AD
APOE,Rs199768005,AD
APOE,Rs199768005,AD
APOE,Rs199768005,AD
APOE,Rs199768005,AD
APOE,Rs199768005,AD
APOE,Rs440446,biliary tract conditions
APOE,I5000217,familial hyperlipoproteinemia
APOE,I5000217,hyperlipoproteinemia
APOE,I6007504,familial hyperlipoproteinemia
APOE,I6007504,hyperlipoproteinemia
APOE,Rs121918393,"ApoE-ε2, ApoE-ε3, and ApoE-ε4"
APOE,Rs2373115,Alzheimer's
APOE,Rs121918393,type III hyperlipoproteinemia
APOE,Rs121918393,Alzheimer's disease
APOE,Rs121918393,Alzheimer's disease
APOE,Rs121918393, Alzheimer's disease
APOE,Rs121918393,Alzheimer's disease
APOE,Rs121918393,Alzheimer's disease
APOE,Rs121918393,Alzheimer's disease
APOE,Rs121918393,Alzheimer's disease
APOE,Rs267606664,hypertriglyceridemia
APOE,Rs2373115,Alzheimer's disease
APOE,Rs387906567,autosomal dominant manner
APOE,Rs440446,bile duct cancer
APOE,Rs440446,ampullary cancer 
APOE,Rs387906567,"hyperlipoproteinemia, type III"
APOE,Rs440446,osteoporosis
APOE,Rs440446,disequilibrium 
APOE,Rs440446,Alzheimer 
APOE,Rs440446, gallbladder cancer 
APOE,Rs440446,Alzheimer's 
APOE,Rs440446,cardiovascular 
APOE,Rs440446,disease
APOE,Rs440446,Singaporean Chinese
APOE,Rs440446,polymorphisms 
APOE,Rs440446,insulin resistance
APOE,Rs440446,cancer
APOE,Rs440446,disease 
APOE,Rs440446,gallstone disease
APOE,Rs440446,obesity 
APOE,Rs429358,heart disease
APOE,Rs387906567,defective lipoprotein binding
APOE,Rs405509,Alzheimer's disease
APOE,Rs440446,cancer and gallstones
APOE,Rs405509,obstructive sleep apnea
APOE,Rs429358, Alzheimer's disease
APOE,Rs429358,ethnicity
APOE,Rs429358,sex
APOE,Rs429358,increased risk for heart disease
APOE,Rs429358,Alzheimer's disease
APOE,Rs429358,ethnicity
APOE,Rs429358,late-onset Alzheimer's
APOE,Rs429358,early-onset disease
APOE,Rs429358,increased risk
APOE,Rs429358,late-onset Alzheimer's
APOL1,Rs60910145,kidney disease
APOL1,Rs4419330,C allele
APOL1,Rs4419330,allele G1
APOL1,Rs60910145,Trypanosoma brucei rhodesiense
APOL1,Rs4419330,alleles G1 and G2 of APOL1
APOL1,Rs71785313,Trypanosoma brucei rhodesiense. 
APOL1,Rs73885319,kidney disease
APOL1,Rs73885319,Trypanosoma brucei rhodesiense
APOL1,Rs71785313,kidney disease
APOL1,Rs4419330,T allele
APOL1,Rs136175,A allele 
APOL1,Rs136176,allele G1
APOL1,Rs136176,C allele
APOL1,Rs136176,alleles G1 and G2 of APOL1
APOL1,Rs136176,T allele
APOL1,Rs136176,A allele 
APOL1,Rs136175,allele G1
APOL1,Rs136175,C allele
APOL1,Rs136175,alleles G1 and G2 of APOL1
APOL1,Rs136175,T allele
APOL1,Rs4419330,A allele 
APOM,Rs3117582,lung cancer
APOM,Rs3117582,lung cancer 
APOM,Rs3117582,lung cancer
APP,Rs63750847,Alzheimer's disease
APP,Rs63750671,cerebral amyloid angiopathy
APP,Rs63750671,Alzheimer's disease
APP,Rs63750671,Presenile dementia 
APP,Rs63750671,cerebral haemorrhage 
APP,Rs63750671,Alzheimer dementia 
APP,Rs63750671,Alzheimer's disease.
APP,Rs63750847,myocardial infarction
APP,Rs63750921,cerebral amyloid angiopathy
APP,Rs63750851,early-onset Alzheimer's disease
APP,Rs63750868,Alzheimer's disease
APP,Rs63750868,rare mutation
APP,Rs63750868,Alzheimer's disease
APP,Rs63750671,Alzheimer's disease
APP,Rs63750921,cerebral amyloid angiopathy
APP,Rs63750973,Alzheimer's disease
APP,Rs63751039,Alzheimer's disease
APP,Rs63751039,Alzheimer's disease
APP,Rs63750847,Alzheimer's disease
APP,Rs63750671,Flemish mutation
APP,Rs63750671,Presenile dementia
APP,Rs63750671,Presenile Alzheimer dementia
APP,Rs145564988,Alzheimer's disease
APP,Rs145564988,Alzheimer's disease
APP,Rs281865161,Alzheimer's disease
APP,Rs281865161,Alzheimer's disease
APP,Rs63750064,Alzheimer's disease
APP,Rs63750671,Alzheimer's disease
APP,Rs63750066,cerebral amyloid angiopathy
APP,Rs63750066,early-onset Alzheimer's disease
APP,Rs63750066,Alzheimer's disease
APP,Rs63750399,Alzheimer's disease
APP,Rs63750579,pathogenic for cerebral amyloid angiopathy
APP,Rs63750579,cerebral amyloid angiopathy
APP,Rs63750579,cerebral amyloid angiopathy
APP,Rs63750671,Alzheimer's disease
APP,Rs63750671,cerebral amyloid angiopathy
APP,Rs63750671,Alzheimer's disease
APP,Rs63750671,cerebral haemorrhage
APP,Rs63750399,pathogenic
AQP4,Rs9951307,severe brain edema
AQP4,Rs9951307,severe brain edema
AQP4,Rs9951307,middle cerebral artery occlusion 
AQP4,Rs9951307,ischemic stroke
AQP4,Rs9951307,brain edema
AQP4,Rs9951307,brain edema
AQP4,Rs9951307,middle cerebral artery occlusion
AQP4,Rs9951307,ischemic stroke
AQP4,Rs9951307,brain edema
AQP4,Rs9951307,severe brain edema
AQP4,Rs9951307,main water channel in the brain and is implicated
AQP4,Rs9951307,brain edema
AR,Rs137852591,2 cm shorter than non-carriers
ARG1,Rs2781659,bronchodilator response
ARG1,Rs2781659,Asthma
ARG1,Rs2781659,lower BDR compared to the homozygous major allele
ARHGAP24,Rs7660702,Genome-wide association
ARHGAP24,Rs7692808,Genome-wide association
ARID5B,Rs10994982,childhood B-cell acute lymphoblastic leukemia.
ARID5B,Rs10994982,childhood B-cell acute lymphoblastic leukemia.
ARID5B,Rs10994982,childhood B-cell acute lymphoblastic leukemia
ARID5B,Rs10994982,childhood B-cell acute lymphoblastic leukemia
ARMS2,Rs3750848,polypoidal choroidal vasculopathy
ARMS2,Rs3750848,age-related macular degeneration
ARMS2,Rs3750848,age-related macular degeneration
ARMS2,Rs3750848,age-related macular degeneration
ARMS2,Rs3750848,macular degeneration
ARMS2,Rs3750848,macular degeneration
ARMS2,Rs3750847,macular degeneration
ARMS2,Rs3750847,macular degeneration
ARMS2,Rs3750847,macular degeneration
ARMS2,Rs3750847,macular degeneration
ARMS2,Rs3750847,maculopathy
ARMS2,Rs3750847,macular degeneration
ARMS2,Rs3750847,"association with ARMD Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-relate"
ARMS2,Rs3750847,OC387715 in age-related macular degeneration. Genome-wide as
ARMS2,Rs3750847,LOC387715 
ARMS2,Rs10490924,Alzheimer's disease
ARMS2,Rs10490924,polypoidal choroidal vasculopathy
ARMS2,Rs10490924,CFH
ARMS2,Rs10490924,polypoidal choroidal vasculopathy
ARMS2,Rs10490924,neovascular AMD
ARMS2,Rs10490924,geographic atrophy
ARMS2,Rs10490924,choroidal neovascularization
ARMS2,Rs10490924,macular degeneration
ARSA,Rs74315455,Gly101Asp
ARSA,Rs74315455,Gly101Val
ARSA,I6007566,sulfatase A deficiency
ASAP1,Rs3057,perfect pitch
ASL,Rs769960006,argininosuccinate lyase deficiency
ASL,Rs143793815,argininosuccinate lyase deficiency
ASL,Rs143793815,pathogenic allele
ASL,Rs145138923,R12Q
ASL,Rs145138923,Arg12Gln
ASL,Rs202142867,pathogenic for argininosuccinate lyase deficiency
ASL,Rs202142867,argininosuccinate lyase deficiency
ASL,Rs367543006,Gln116Ter
ASL,Rs749788626,argininosuccinate lyase deficiency
ASL,Rs752100894,argininosuccinate lyase deficiency
ASL,Rs752100894,argininosuccinate lyase deficiency
ASPA,Rs28940574,Canavan disease
ASPA,Rs12948217,Canavan disease
ASS1,Rs35269064,AncestryDNA
ASS1,Rs35269064,benign
ASTN2,Rs4838255,schizophrenic
ASTN2,Rs4838255,result of perphenazine
ASTN2,Rs4838255,schizophrenics
ASXL1,Rs373145711,Bohring-Opitz syndrome
ASXL1,Rs373145711,Bohring-Opitz syndrome
ASXL1,Rs373145711,somatic mosaicism
ASXL1,Rs373145711,Bohring-Opitz syndrome
ASXL1,Rs373145711,Bohring-Opitz syndrome
ASXL1,Rs373145711,mutation
ASXL1,Rs373145711,mutation
ASXL1,Rs373145711,somatic mosaicism
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn disease
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Celiac Diseasers
ATG16L1,Rs2241880,Inflammatory Bowel Diseases
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880, ileal disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,inflammation
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,NOD2-induced hyperinflammation.
ATG16L1,Rs2241880,disease 
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,autoimmune
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,inflammatory bowel diseases
ATG16L1,Rs2241880,celiac disease.
ATG16L1,Rs2241880, inflammatory
ATG16L1,Rs2241880,Crohn's disease 
ATG16L1,Rs2241880,Crohn disease
ATG16L1,Rs2241880,type 2 diabetes
ATG16L1,Rs2241880,autoimmune and inflammatory diseases
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,sclerosing cholangitis and primary biliary cirrhosis
ATG16L1,Rs2241880,disease 
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,hyperinflammation
ATG16L1,Rs2241880,inflammatory bowel disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn disease
ATG16L1,Rs2241880,inflammatory bowel disease
ATG16L1,Rs2241880,Asians
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Celiac Disease
ATG16L1,Rs2241880,Inflammatory Bowel Diseases
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,ileal disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241879,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,polymorphism 
ATG16L1,Rs2241880,inflammatory bowel diseases
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,polymorphism 
ATG16L1,Rs2241880,nflammatory bowel disease
ATG16L1,Rs2241880,polymorphism 
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,inflammatory bowel disease
ATG16L1,Rs2241880,inflammatory bowel disease
ATG16L1,Rs2241880,polymorphisms 
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn disease
ATG16L1,Rs2241880,type 2 diabetes
ATG16L1,Rs2241880,autoimmune and inflammatory diseases
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,cirrhosis 
ATG16L1,Rs2241880,sclerosing cholangitis
ATG16L1,Rs2241880,celiac disease
ATIC,Rs4673993,polymorphisms 
ATIC,Rs4673993,rheumatoid arthritis
ATM,Rs28904921,cancers 
ATM,Rs28904921,breast cancer
ATM,Rs28904921,breast cancer
ATM,Rs1800058,contralateral breast cancer
ATM,Rs1800058,breast tumour 
ATM,Rs1800057,breast cancer susceptibility
ATM,Rs1800058,Breast Cancer
ATM,Rs1800058,breast tumour 
ATM,Rs1800058,breast cancer
ATM,Rs1800058,breast cancer
ATM,Rs28904921,breast cancer
ATM,Rs1800058, breast cancer
ATM,Rs4987945,breast cancer
ATM,Rs3218695,increased risk
ATM,Rs28904921,cancers
ATM,Rs28904921,breast cancer
ATM,Rs28904921,breast cancer
ATM,Rs3218695,breast cancer
ATM,Rs3218695,breast cancer entry
ATM,Rs3218695,breast cancer
ATM,Rs3218695,risk for breast cancer
ATM,Rs3218695,breast cancer
ATM,Rs3218695,breast cancer
ATM,Rs3218695,breast cancer
ATM,Rs4987945,breast cancer
ATM,Rs4987945,breast cancer
ATM,Rs28904921,breast cancer
ATM,Rs1800057,breast tumour
ATM,Rs1800056,increased risk
ATM,Rs1800057,risk for breast cancer
ATM,Rs1800057,Breast Cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,increased risk for breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast tumour
ATM,Rs1800056,breast cancer
ATM,Rs1800056,contralateral breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast tumour
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800057,radiotolerant prostate brachytherapy
ATM,Rs1800057,post-lumpectomy
ATM,Rs1800057,radio-sensitivity
ATM,Rs1800056,breast cancer
ATM,Rs1800056,contralateral breast cancer
ATM,Rs1800056,reduced risk
ATM,Rs1800057,breast cancer.
ATM,Rs1800056,Breast Cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast tumour
ATP7A,Rs2227291,prone to epigenetic alterations
ATP7A,Rs2227291,X-inactivation in female human embryonic stem cells
ATP7A,Rs2227291,X-inactivation in female human embryonic stem cells
ATP7A,Rs2227291,epigenetic alterations
ATP7A,Rs2227291,X-inactivation in female human embryonic stem cells
ATP7B,Rs137853280,Wilson's disease
ATP7B,Rs137853280,pathogenic mutations 
ATP7B,Rs28942074,Wilson's disease
ATP7B,Rs137853280,Wilson's disease
ATP7B,Rs1061472,Wilson disease
ATP7B,Rs137853280,Wilson's disease
ATR,Rs2227928,pancreatic cancer
ATR,Rs2227928,pancreatic cancer
ATR,Rs2227928,pancreatic cancer
ATXN2,Rs7137828,longevity
ATXN2,Rs7137828,longevity
ATXN2,Rs653178, blood pressure
ATXN2,Rs653178,risk of hypertension
ATXN2,Rs653178,celiac disease
ATXN2,Rs653178,celiac disease
ATXN2,Rs653178,SNP 
ATXN2,Rs7137828,longevity
ATXN2,Rs653178,hypertension
ATXN2,Rs653178,celiac disease
ATXN2,Rs653178,hypertension
AURKA,Rs8173,prostate cancer
AURKA,Rs8173,Bladder cancer
AURKA,Rs8173,prostate cancer risk
AURKA,Rs8173,Bladder cancer
BAAT,Rs1572983,Genetic polymorphism
BAAT,Rs1572983,Japanese individuals
BACE1,Rs4938369,Alzheimer's disease
BACE1,Rs4938369,sporadic Alzheimer's disease
BACE1,Rs638405,increased risk for late-onset Alzheimer's disease
BACE1,Rs638405,late-onset Alzheimer's disease
BACE1,Rs638405,increased risk for Alzheimer's disease appear to be seen in individuals who are also ApoE4 carriers
BAK1,Rs5745582,autoimmune rheumatic diseases
BAK1,Rs5745582,rheumatic diseases
BAK1,Rs513349,autoimmune rheumatic diseases
BAK1,Rs513349,rheumatic diseases
BANK1,Rs17266594,systemic lupus erythematosus genetic associations
BANK1,Rs17266594,systemic lupus erythematosus
BANK1,Rs17266594,systemic lupus erythematosus
BANK1,Rs17266594,rheumatoid arthritis
BANK1,Rs17266594,odds ratio observed was 1.22
BANK1,Rs17266594,systemic lupus erythematosus
BANK1,Rs17266594,systemic lupus erythematosus susceptibility and autoantibody production
BANK1,Rs17266594,autoantibody production
BANK1,Rs17266594,rheumatoid arthritis
BANK1,Rs17266594,BANK1 gene
BANK1,Rs17266594,systemic lupus
BANK1,Rs10516487,systemic lupus erythematosus
BANK1,Rs10516487,lupus
BANK1,Rs10516487,SLE
BANK1,Rs17266594,systemic lupus erythematosus
BANK1,Rs10516487,lupus
BANK1,Rs17266594,lupus erythematosus
BANK1,Rs10516487,systemic lupus erythematosus
BARD1,Rs6435862,aggressive neuroblastoma
BCAM,Rs1135062,Auberger blood group
BCAM,Rs1135062,Lutheran blood group
BCAR1,Rs7190458,pancreatic cancer
BCAR1,Rs7190458,breast cancer
BCAR1,Rs7190458,Pancreatic cancer
BCHE,Rs28933389,Pseudocholinesterase Deficiency
BCKDHA,Rs398123489,Urine Disease
BCKDHA,Rs398123489,Maple Syrup Urine Disease
BCKDHA,Rs398123489,mutation
BCKDHA,Rs137852870,Maple Syrup Urine Disease
BCKDHA,Rs137852870,Old Order Mennonites 
BCKDHB,I4000422,Maple Syrup Urine Disease Type 1
BCKDHB,I4000422, Maple Syrup Urine Disease
BCKDHB,I4000422,Maple Syrup Urine Disease
BCKDHB,Rs28934895,"Maple Syrup Urine Disease,"
BCKDHB,I3002808,Urine Disease
BCKDHB,I4000422,Maple Syrup Urine Disease
BCKDHB,I3002808,"Maple Syrup Urine Disease, Type 1B"
BCL2,Rs1801018,Chronic myeloid leukemia
BCL2,Rs1801018,cancer 
BCL2,Rs1801018,azoospermia 
BCL2,Rs956572,The Bcl-2 gene polymorphism
BCL2,Rs956572,bipolar disorder
BCL2,Rs956572,bipolar disorder
BCR,Rs3761418,increased risk for depression
BCR,Rs2267015,depression
BCR,Rs2267015,increased risk for depression
BCR,Rs131690,Japanese patients.
BCR,Rs131690,bipolar disorder.
BCR,Rs131690,bipolar disorder
BDKRB2,Rs945032,associated with panic disorder
BDKRB2,Rs945032,bipolar disorder
BDKRB2,Rs945032,drug abuse|substance abuse
BDNF,Rs7103411,schizophrenia
BDNF,Rs7103411,schizoaffective disorder
BDNF,Rs7103411,Brain-derived neurotrophic factor
BDNF,Rs7103411,attention-deficit/hyperactivity disorde
BDNF,Rs7103411,Huntington's disease
BDNF,Rs6265,thinking skills
BDNF,Rs6265,suicidal behaviour
BDNF,Rs6265,lost memory
BDNF,Rs6265,depression 
BDNF,Rs6265,short-term motor learning
BDNF,Rs6265,brain-derived neurotrophic
BDNF,Rs6265,lower body mass
BDNF,Rs7103411,bipolar disorder
BDNF,Rs7124442,bulimia
BDNF,Rs7124442,anorexia
BDNF,Rs7124442,elderly population.
BDNF,Rs7124442,Altered brain-derived neurotrophic factor blood levels
BDNF,Rs7124442,anorexia
BDNF,Rs7124442,bulimia
BDNF,Rs7124442,depressive symptoms
BDNF,Rs7124442,depressive symptoms
BDNF,Rs7124442,anorexia
BDNF,Rs7124442,bulimia
BDNF,Rs7124442,anorexia 
BDNF,Rs7124442,bulimia
BDNF,Rs7124442,asthmatic 
BDNF,Rs6265, Alzheimer's disease
BDNF,Rs7103411,childhood IgA nephropathy
BDNF,Rs6265,A allele
BDNF,Rs12291063,Hispanic 
BDNF,Rs2030324,schizophrenia
BDNF,Rs6265,G allele
BDNF,Rs12291063,Brain-Derived Neurotrophic Factor
BDNF,Rs12291063,Human Obesity
BDNF,Rs12291063,higher BMI
BDNF,Rs12291063,adiposity
BDNF,Rs12291063,Human Obesity
BDNF,Rs12291063,Hispanic
BDNF,Rs12291063,African-American
BDNF,Rs12291063,obesity 
BDNF,Rs2030324,nicotine dependence association
BDNF,Rs2030324,schizophrenia
BDNF,Rs2030324,brain-derived neurotrophic factor
BDNF,Rs2030324,bipolar disorder
BDNF,Rs12291063,in vivo
BDNF,Rs2030324,bipolar
BDNF,Rs2030324,multiple sclerosis
BDNF,Rs2030324,major depression
BDNF,Rs2030324,ipolar disorder
BDNF,Rs2030324,schizophrenia.
BDNF,Rs2030324,schizophrenia
BDNF,Rs2030324,bipolar disorde
BDNF,Rs2030324,bipolar
BDNF,Rs2030324,asthmatic
BDNF,Rs2030324,multiple sclerosis
BDNF,Rs2030324,major depression
BDNF,Rs2030324,bipolar disorder
BDNF,Rs2030324,prophylactic lithium response
BHMT,Rs617219,ADHD
BHMT,Rs617219,ADD
BHMT,Rs617219,patient's attention levels.
BHMT,Rs3733890,neural tube defects
BLM,I4000396,Bloom syndrome
BLM,Rs2380165,breast cancer
BLOC1S3,Rs2159324,cholesterol
BLOC1S3,Rs2159324,cholesterol
BLOC1S3,Rs2159324,LDL 
BMP2,Rs15705,skeletal Class I
BMP2,Rs235754,bone density
BMP2,Rs235754,bone fractures or osteoporosis
BMP2,Rs235754,osteoporosis
BMP2,Rs235754,ultrasound parameters speed of sound and stiffness.
BNC2,Rs10810635,freckles.
BNC2,Rs10810635,freckles
BNC2,Rs2153271,freckling
BRAF,Rs121913355,cancers
BRAF,Rs121913355,rasopathy
BRCA1,Rs80357688,breast cancer
BRCA1,Rs80357688,breast cancer
BRCA1,Rs80357711,breast cancer
BRCA1,Rs80357714,BRCA
BRCA1,Rs80357714,breast cancer
BRCA1,Rs80357714,breast cancer 
BRCA1,Rs80357717,breast cancer
BRCA1,Rs80357717,breast cancer 
BRCA1,Rs80357729,breast
BRCA1,Rs80357669,deletion variant in the BRCA1 gene
BRCA1,Rs80357808,breast cancer
BRCA1,Rs80357729,pathogenic for breast cancer
BRCA1,Rs80357747,breast cancer
BRCA1,Rs80357783,breast cancer
BRCA1,Rs80357786,breast cancer
BRCA1,Rs80357786,BRCA1 gene
BRCA1,Rs80357801,breast cancer
BRCA1,Rs80357801,breast cancer
BRCA1,Rs80357804,pathogenic for breast cance
BRCA1,Rs80357804,breast cancer
BRCA1,Rs80357729,also known as 3746insA
BRCA1,Rs80357729,cancer
BRCA1,Rs80357654,breast cancer
BRCA1,Rs80357641,breast cancer
BRCA1,Rs80357596,BRCA1 gene
BRCA1,Rs80357596,breast cancer
BRCA1,Rs80357597,breast cancer
BRCA1,Rs80357597,breast cancer
BRCA1,Rs80357600,breast cancer
BRCA1,Rs80357604,BRCA1 gene
BRCA1,Rs80357604,breast cancer
BRCA1,Rs80357609,BRCA1 gene
BRCA1,Rs80357609,breast cancer
BRCA1,Rs80357641,pathogenic 
BRCA1,Rs80357612,breast cancer
BRCA1,Rs80357612,BRCA1 gene
BRCA1,Rs80357623,breast cancer
BRCA1,Rs80357624,breast cancer
BRCA1,Rs80357635,breast cancer
BRCA1,Rs80357641,breast
BRCA1,Rs80357641,cancer 
BRCA1,Rs80357641,4868delAG
BRCA1,Rs80357641,rs80357641
BRCA1,Rs80357641,BRCA1 gene
BRCA1,Rs80357612,breast cancer
BRCA1,Rs80357823,breast cancer
BRCA1,Rs80357906,breast cancer
BRCA1,Rs80357829,breast cancer
BRCA1,Rs80357969,BRCA1 gene
BRCA1,Rs80357969, breast cancer
BRCA1,Rs80357969,breast cancer
BRCA1,Rs80357970,breast cancer
BRCA1,Rs80357971,pathogenic
BRCA1,Rs80357971,breast cancer
BRCA1,Rs80357971,breast cancer
BRCA1,Rs80357971,breast cancer
BRCA1,Rs80357975,breast cancer
BRCA1,Rs80357945,breast cancer
BRCA1,Rs80357977,breast cancer
BRCA1,Rs80357980,cancer 
BRCA1,Rs80357980,pathogenic
BRCA1,Rs80357980,breast cancer
BRCA1,Rs80357980,breast cancer
BRCA1,Rs80357981,pathogenic for breast cancer
BRCA1,Rs80357981,pathogenic
BRCA1,Rs80357981,breast cancer
BRCA1,Rs80357993,breast cancer
BRCA1,Rs80359874,breast cancer
BRCA1,Rs80357980,breast 
BRCA1,Rs80357941,breast cancer
BRCA1,Rs80357941, breast cancer
BRCA1,Rs80357569,breast cancer
BRCA1,Rs80357829,breast cancer
BRCA1,Rs80357829,BRCA1 gene
BRCA1,Rs80357844,breast cancer
BRCA1,Rs80357846,breast cancer
BRCA1,Rs80357848,breast cancer
BRCA1,Rs80357853,breast cancer
BRCA1,Rs80357862,breast cancer
BRCA1,Rs80357868,pathogenic 
BRCA1,Rs80357868,breast cancer
BRCA1,Rs80357880,breast cancer
BRCA1,Rs80357880, breast cancer 
BRCA1,Rs80357887,breast cancer
BRCA1,Rs80357887,breast cancer
BRCA1,Rs80357888,breast cancer
BRCA1,Rs80357888,breast cancer
BRCA1,Rs80357889,BRCA1 gene
BRCA1,Rs80357889,breast cancer in ClinVar
BRCA1,Rs80357889,breast cancer
BRCA1,Rs80357902,breast cancer
BRCA1,Rs80357902,breast cancer
BRCA1,Rs80357903,breast cancer
BRCA1,Rs80357823,breast cancer
BRCA1,Rs80357558,breast cancer
BRCA1,Rs80357612,breast cancer
BRCA1,Rs80357558,pathogenic for breast cancer
BRCA1,Rs1799966,breast cancer
BRCA1,Rs1799966,breast cancer 
BRCA1,Rs2227945,breast cancer
BRCA1,Rs2227945,breast cancer
BRCA1,Rs2227945,breast cancer 
BRCA1,Rs273897659,breast cancer 
BRCA1,Rs273900730,breast cancer
BRCA1,Rs386833395,breast cancer in
BRCA1,Rs386833395,Ashkenazi Jews
BRCA1,Rs1799966,breast cancer
BRCA1,Rs4986850,breast cancer
BRCA1,Rs4986850,breast cancer
BRCA1,Rs4986850,breast cancer
BRCA1,Rs4986850,"breast cancer,"
BRCA1,Rs4986850,breast cancer
BRCA1,Rs55770810,"breast cancer,"
BRCA1,Rs55770810,breast cancer
BRCA1,Rs62625308,breast cancer
BRCA1,Rs80356875,pathogenic 
BRCA1,Rs80356875,breast cancer
BRCA1,Rs4986850,breast cancer
BRCA1,Rs1799950,breast cancer
BRCA1,Rs1799950,breast cancer
BRCA1,Rs1799950,breast cancer
BRCA1,I4000377,ovarian cancer
BRCA1,I4000377,breast cancer
BRCA1,I4000377,breast cancer
BRCA1,I4000377,ovarian cancer
BRCA1,I4000378,breast cancer and ovarian cancer.
BRCA1,I4000459,breast cancer
BRCA1,I4000459,breast cancer
BRCA1,I4000459,breast cancer
BRCA1,I5009493,breast cancer
BRCA1,I5009511,breast cancer
BRCA1,I5009526,breast cancer
BRCA1,I5009536,breast cancer
BRCA1,Rs80357558,breast cancer
BRCA1,I5009546,breast cancer
BRCA1,I5009553,breast cancer
BRCA1,I5009558,breast cancer
BRCA1,Rs1799950,"along with the two methods used to calculate overall risk estimates for breast cancer, refer to the SNPedia breast cancer entry"
BRCA1,Rs1799950,breast cancer
BRCA1,Rs1799950,breast cancer
BRCA1,Rs1799950,breast cancer
BRCA1,Rs1799950,breast cancer
BRCA1,Rs80356925,breast cancer
BRCA1,Rs80356925,breast cancer
BRCA1,I5009541,breast cancer
BRCA1,Rs80357035,breast cancer
BRCA1,Rs80357347,breast cancer
BRCA1,Rs80357355,breast cancer
BRCA1,Rs80357355,breast cancer
BRCA1,Rs80357382,breast cancer
BRCA1,Rs80357405,pathogenic for breast cancer
BRCA1,Rs80357405,breast cancer
BRCA1,Rs80357433,breast cancer
BRCA1,Rs80357433,BRCA1 gene
BRCA1,Rs80357508,breast cancer
BRCA1,Rs80357347,breast cancer
BRCA1,Rs80357509,breast 
BRCA1,Rs80357509,3485_3485delA 
BRCA1,Rs80357509,breast cancer
BRCA1,Rs80357511,breast cancer
BRCA1,Rs80357511,breast cancer
BRCA1,Rs80357520,3878delTA
BRCA1,Rs80357520,rs80357520
BRCA1,Rs80357520,cancer 
BRCA1,Rs80357520,breast 
BRCA1,Rs80357010,breast cancer 
BRCA1,Rs80357509,cancer 
BRCA1,Rs80357347,pathogenic
BRCA1,Rs80357509,breast cancer
BRCA1,Rs80357318,breast cancer
BRCA1,Rs80357035,BRCA1 gene 
BRCA1,Rs80357318,pathogenic for breast cancer
BRCA1,Rs80357035,breast cancer
BRCA1,Rs80357071,breast cancer
BRCA1,Rs80357071,breast cancer
BRCA1,Rs80357071,breast cancer
BRCA1,Rs80357115,pathogenic
BRCA1,Rs80357115,breast cancer
BRCA1,Rs80357115,breast cancer
BRCA1,Rs80357115,breast cancer
BRCA1,Rs80357131,breast cancer
BRCA1,Rs80357071,pathogenic 
BRCA1,Rs80357161,breast cancer
BRCA1,Rs80357161,BRCA1 gene
BRCA1,Rs80357284,breast cancer
BRCA1,Rs80357161,breast cancer in ClinVar.
BRCA1,Rs80357162,breast cancer
BRCA1,Rs80357259,breast cancer
BRCA1,Rs80357284,breast 
BRCA1,Rs80357284,cancer 
BRCA1,Rs80357284,rs80357284
BRCA1,Rs80357284,W1782X
BRCA2,Rs28897756,breast cancer
BRCA2,Rs28897756,Dutch families
BRCA2,Rs28897756,risk for breast cancer
BRCA2,Rs28897756,breast cancer
BRCA2,Rs28897756,pathogenic
BRCA2,Rs28897756,breast cancer
BRCA2,Rs28897756,breast cancer
BRCA2,Rs28897756,breast cancer
BRCA2,Rs1799954,breast cancer
BRCA2,Rs1801426,breast cancer
BRCA2,Rs1801426,breast cancer
BRCA2,Rs4987047,increased risk for breast cancer
BRCA2,Rs1801426,breast cancer
BRCA2,Rs28897756,breast cancer
BRCA2,Rs4987047,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,calculate overall risk estimates for breast cancer
BRCA2,Rs80359550,breast cancer
BRCA2,Rs1799954,increased risk for breast cancer
BRCA2,Rs80359550,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,increased risk for breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,BRCA2 gene
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,BRCA2 gene
BRCA2,Rs11571833,breast cancer
BRCA2,I5005578,breast cancer
BRCA2,Rs11571746,breast cancer
BRCA2,I4000379,breast cancer
BRCA2,I4000466,breast cancer
BRCA2,I4000466,breast cancer
BRCA2,I5005576,breast cancer
BRCA2,I5005576,mutations
BRCA2,I5005576,breast cancer
BRCA2,I5005576,causal/pathogenic
BRCA2,I5005576,breast cancer
BRCA2,I5005578,breast cancer
BRCA2,I5005578,mutations
BRCA2,I5005578,breast cancer
BRCA2,I5005578,causal/pathogenic
BRCA2,Rs11571833,increased risk for breast cancer
BRCA2,I5005579,mutations
BRCA2,I5005579,breast cancer
BRCA2,I5005579,breast cancer
BRCA2,I5005579,breast cancer
BRCA2,Rs11571746,breast cancer
BRCA2,Rs11571746,breast cancer
BRCA2,Rs11571746,breast cancer
BRCA2,I5005579,causal/pathogenic
BRCA2,I5009091,causal/pathogenic
BRCA2,I5009091,breast cancer
BRCA2,I5009091,breast cancer
BRCA2,I5009091,breast cancer
BRCA2,I5009090,breast cancer
BRCA2,I5009090,causal/pathogenic
BRCA2,I5009090,breast cancer
BRCA2,I5009090,mutations
BRCA2,I5009090,breast cancer
BRCA2,I5009091,mutations
BRIP1,Rs587778134,Icelanders
BRIP1,Rs587778134,reduced average lifespan
BRIP1,Rs587778134,cancer
BRIP1,Rs587778134,ovarian cancer
BRIP1,Rs587778134,ovarian cancer
BRIP1,Rs587778134,cancer
BRIP1,Rs587778134,ovarian cancer
BRIP1,Rs587778134,ovarian cancer
BRIP1,Rs4986764,Kazakhstan.
BRIP1,Rs4986764,prostate cancer.
BRIP1,Rs4986764,breast cancer
BRIP1,Rs4986764,prostate cancer
BRIP1,Rs4986764,familial breast cancer risk
BTBD9,Rs9296249,restless legs syndrome
BTBD9,Rs4714156,sleep disorder
BTBD9,Rs4714156,restless legs syndrome
BTBD9,Rs4714156,restless legs syndrome
BTBD9,Rs4714156,SNP 
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTD,Rs13078881,symptomatic children
BTD,Rs35034250,pathogenic
BTD,Rs35034250,benign
BTD,Rs13078881,biotinidase deficienc
BTD,Rs13078881,biotinidase deficiency.
BTD,Rs13078881,biotinidase deficiency
BTD,Rs13078881,biotinidase deficiency
BTD,Rs13078881,biotinidase deficiency
C21orf91,Rs2824499,cold sore
C21orf91,Rs2824499,cold sore
C21orf91,Rs2824499,labialis
C21orf91,Rs2824499,herpes simplex
C21orf91,Rs2824495,cold sore
C21orf91,Rs2824495,cold sore
C21orf91,Rs2824495,herpes simplex
C21orf91,Rs1047978,cold sore
C21orf91,Rs1047978,cold sore
C21orf91,Rs1047978,labialis
C21orf91,Rs1047978,herpes simplex
C21orf91,Rs2824495,labialis
C3,Rs2230201,systemic lupus erythematosus
C3,Rs7951,level of the C3 protein was lower
C3,Rs7951,systemic lupus erythematosus (SLE)
C3,Rs2230201,higher risk for systemic lupus erythematosus (SLE)
C3,Rs2230201,systemic lupus erythematosus (SLE)
C3,Rs1047286,ARMD
C3,Rs2230199,ARMD
C3,Rs11569562,bronchial asthma
C3,Rs1047286,ARMD 
C3,Rs1047286,SNP 
C3,Rs2230199,ARMD
C5,Rs10985112,Rheumatoid Arthritis
C5,Rs7026551,Rheumatoid Arthritis
C5,Rs7026551,Rheumatoid Arthritis
C6orf10,Rs910049,sclerosis
C6orf10,Rs910049,coronary artery disease
C6orf10,Rs910049,multiple sclerosis
C6orf10,Rs910049,type-1 diabetes
C6orf10,Rs910049,type-2 diabetes
C6orf10,Rs3129934,type 1 diabetes
C6orf10,Rs3129934, type 1 diabetes
C6orf10,Rs3129934,type-1 diabetes
C6orf10,Rs3129934,type 1 diabetes
C6orf10,Rs3129934,MS
C6orf10,Rs3129934,multiple sclerosis
C6orf10,Rs3129934,multiple sclerosis
C6orf10,Rs3129934, autoimmune diseases
C6orf10,Rs3129900, This new pain medication was approved in Europe in late 2006
C6orf10,Rs3129900,liver injury
C6orf10,Rs3129900,liver injury
C6orf10,Rs3129934,type-1 diabetes
CACNA1A,Rs121908236,Clinical spectrum of episodic ataxia type 2.
CACNA1C,Rs2159100,schizophrenia
CACNA1C,Rs80315385,arrhythmia disorder
CACNA1C,Rs80315385,arrhythmia disorder
CACNA1C,Rs80315385,cardiac L-type calcium channel mutations
CACNA1C,Rs80315385,cardiac L-type calcium channel mutations
CACNA1C,Rs80315385,cardiac L-type calcium channel mutations
CACNA1C,Rs80315385,arrhythmia disorder
CACNA1C,Rs2159100,bipolar disorder
CACNA1C,Rs80315385,arrhythmia disorder
CACNA1C,Rs2159100,schizophrenia
CACNA1C,Rs121912776,J-wave syndromes
CACNA1C,Rs2159100,schizophrenia
CACNA1C,Rs1006737,decreased outflow of information from medial frontal gyrus
CACNA1C,Rs121912776,Loss-of-function
CACNA1C,Rs121912776,sudden cardiac death
CACNA1C,Rs1006737,medial frontal gyrus
CACNA1C,Rs2159100,bipolar disorder
CACNA1C,Rs2159100,schizophrenia
CACNA1C,Rs2159100,bipolar disorder
CACNA1C,Rs2159100,bipolar disorder
CACNA1D,Rs3774426,blood pressure
CACNA1D,Rs312481,hypertension
CACNA1D,Rs312481,systolic and diastolic blood pressure
CACNA1D,Rs3774426,hypertension with L-type dCCBs (calcium channel blockers)
CACNA1D,Rs3774426,lowered systolic and diastolic blood pressure
CACNA1D,Rs3774426,hypertension
CACNA1D,Rs3774426,lowered systolic and diastolic blood pressure
CACNA1D,Rs3774426,hypertension 
CACNA1D,Rs3774426,hypertension
CACNA1G,Rs12603112,autism
CACNA1S,Rs1800559,hyperthermia
CACNA1S,Rs80338779,Early onset of hypokalaemic periodic paralysis caused by a novel mutation of the CACNA1S gene.
CACNA1S,Rs80338779,hypokalaemic periodic
CACNA1S,Rs80338779,CACNA1S gene
CACNA1S,Rs80338779,hypokalaemic periodic paralysis
CACNA1S,Rs28930069,"hypokalemic periodic paralysis, type 1"
CACNA1S,Rs80338779,paralysis
CACNA1S,Rs1800559,malignant hyperthermia
CACNA1S,Rs1800559,malignant hyperthermia
CACNA1S,Rs1800559,Malignant-hyperthermia
CACNA1S,Rs1800559,malignant hyperthermia
CACNA1S,Rs28930068,"hypokalemic periodic paralysis, type 1"
CACNB2,Rs2799573,bipolar disorder
CACNB2,Rs2799573,major depressive disorder
CACNB2,Rs2799573,schizophrenia
CACNB2,Rs2799573,bipolar disorder
CACNB2,Rs2799573,bipolar disorder
CACNB2,Rs2799573,schizophrenia
CACNB2,Rs2799573,bipolar disorder
CACNB2,Rs2799573,major depressive disorder
CACNB2,Rs2799573,ADHD
CACNB2,Rs2799573,autism spectrum disorder
CACNB2,Rs2799573,psychiatric disorders
CACNB2,Rs11014166,blood pressure
CACNB2,Rs2799573,schizophrenia
CALHM1,Rs2986017,late-onset Alzheimer's disease
CALHM1,Rs2986017,Alzheimer's disease
CALR3,Rs142951029,Familial hypertrophic cardiomyopathy
CALU,Rs339097,Caucasians
CALU,Rs339097,African Americans
CAMK1,Rs2304277,mutation 
CAMK1,Rs2304277,cancer 
CAMK1,Rs1052133,lung cancer
CAMK1,Rs1052133,lung cancer
CAMK1,Rs1052133,gallbladder cancer
CAMK1,Rs2304277,risk of ovarian cancer
CAMK1,Rs1052133,bladder cancer
CAMK1,Rs1052133,lung cancer
CAMK1,Rs1052133,gallbladder cancer
CAMK1,Rs1052133,bladder cancer
CAMK1,Rs1052133,lung cancer
CAMK1,Rs1052133,lung cancer
CAMK1,Rs1052133,gallbladder cancer
CAMK1,Rs1052133,lung cancer
CARD14,Rs281875215,psoriasis
CARD14,Rs281875212,gain-of-function mutation
CARD14,Rs281875212,autosomal dominantly inherited psoriasis
CARD14,Rs281875214,autosomal dominantly inherited psoriasis
CARD14,Rs281875214,autosomal dominantly inherited psoriasis
CARD14,Rs281875215,dominantly inherited psoriasis
CARD14,Rs281875215,autosomal dominantly inherited
CARD9,Rs4077515,ulcerative colitis
CARD9,Rs4077515,Crohn's disease
CASP3,Rs1049216,significantly decrease the Non-Hodgkin Lymphoma.
CASP3,Rs1049216,Non-Hodgkin Lymphoma.
CASP3,Rs6948,non-Hodgkin lymphoma
CASP3,Rs6948,multiple myeloma
CASP3,Rs6948,squamous cell carcinoma
CASP3,Rs6948,susceptibility to non-Hodgkin lymphoma
CASP3,Rs6948,susceptibility to multiple myeloma
CASP3,Rs6948,risk of squamous cell carcinoma of the head and neck
CASP8,Rs13113,lymphoma
CASP9,Rs1052576,colon cancer
CASP9,Rs1052576,lung cancer
CASP9,Rs1052576,lymphoma
CASP9,Rs1052576,gastric cancer
CASP9,Rs1052576,cancer
CASP9,Rs1052576,DNA fragmentation and apoptosis
CASP9,Rs1052576,nuclear membrane breakdown
CASP9,Rs1052576,multiple myeloma
CASP9,Rs1052576,cancers
CASP9,Rs1052576,non-Hodgkin lymphoma
CASP9,Rs1052576,non-small cell lung cancer
CASP9,Rs1052576,myeloma
CASP9,Rs1052576,general cancer risk
CASP9,Rs1052576,ADHD
CASP9,Rs1052576,Multiple myeloma
CASP9,Rs1052576,cellular transformation
CASP9,Rs1052576,liver cancer
CASP9,Rs1052576,multiple myeloma
CASP9,Rs1052576,bladder cancer
CASP9,Rs4645978,multiple myeloma
CASP9,Rs4645978,Koreans
CASP9,Rs4645978,lung cancer
CASP9,Rs4645978,myeloma
CASP9,Rs4645978,SNP
CASP9,Rs4645978,lung cancer
CASP9,Rs1052576,Multiple myeloma
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,Non-Hodgkin Lymphoma
CASP9,Rs1052576,chronic lymphocytic leukemia
CASP9,Rs1052576,Non-Hodgkin’s lymphomas
CASP9,Rs1052576,Non-Hodgkin Lymphoma
CASP9,Rs1052576,multiple myeloma
CASP9,Rs1052576,Non-Hodgkin Lymphoma
CASP9,Rs1052576,increased risk of death
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,dose dependent effect
CASP9,Rs1052576,cancer 
CASP9,Rs1052576,cancer
CASP9,Rs1052576,B cell chronic lymphocytic leukemia
CASP9,Rs1052576,lung cancer
CASP9,Rs1052576,gastric cancer
CASP9,Rs1052576,cancer 
CASP9,Rs1052576,apoptosis
CASP9,Rs1052576,DNA fragmentation
CASP9,Rs1052576,nuclear membrane breakdown
CASP9,Rs1052576,revention of cellular transformation
CASP9,Rs1052576,immune response
CASP9,Rs1052576,development
CASP9,Rs1052576,cancers
CASP9,Rs1052576,non-Hodgkin lymphoma
CASP9,Rs1052576,non-small cell lung cancer
CASP9,Rs1052576,multiple myeloma
CASP9,Rs1052576,cancer
CASP9,Rs1052576,follicular lymphoma
CASP9,Rs1052576,colon cancer
CASP9,Rs1052576,myeloma 
CASP9,Rs1052576,lymphoma
CASP9,Rs1052576,cancer
CASP9,Rs1052576,marginal zone lymphoma
CASP9,Rs1052576,Follicular lymphoma
CASP9,Rs1052576,Diffuse large B cell lymphoma
CASP9,Rs1052576,B-cell lymphomas
CASP9,Rs1052576,T cell lymphomas
CASP9,Rs1052576,B-cell lymphomas
CASP9,Rs1052576,liver cancer
CASP9,Rs1052576,B-cell lymphomas
CASP9,Rs1052576,B-lymphocytes
CASP9,Rs1052576,Non-Hodgkin Lymphoma
CASP9,Rs1052576,multiple myeloma
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,multiple myeloma
CAV3,Rs72546667,hyper-CK-emia
CAV3,Rs116840785,rippling muscle disease
CAV3,Rs72546667,muscular dystrophy.
CAV3,Rs116840798,skeletal muscle
CAV3,Rs116840788,CAV3 
CAV3,Rs116840788,CAV3 
CAV3,Rs116840785,rippling muscle disease
CAV3,Rs116840785,rippling muscle disease
CAV3,Rs28936685,rippling muscle disease
CAV3,Rs116840782,rippling muscle
CAV3,Rs116840782,muscular dystrophy genes
CAV3,Rs116840782,novel caveolin-3 mutation
CAV3,Rs116840782,rippling muscle
CAV3,Rs116840782,muscular dystrophy
CAV3,Rs116840776,sudden infant death syndrome.
CAV3,Rs116840776,muscular dystrophy
CAV3,Rs116840785,rippling muscle disease.
CBLB,Rs3087243,type 1 diabetes odds ratio 1.37 and 1.28
CBLB,Rs3087243,acute rejection development
CBLB,Rs3087243,acute rejection
CBLB,Rs3087243,risk factor for developing rheumatoid arthritis (RA)
CBLB,Rs3087243,type-1 diabetes
CBLB,Rs3087243,type-1 diabetes
CBLB,Rs3087243,autoimmune thyroid disease
CBLB,Rs3087243,1.5 fold increased risk of type-1 diabetes
CBLB,Rs3087243,autoimmune thyroid disease
CBLB,Rs3087243,1.3 fold increased risk of autoimmune thyroid disease
CBLB,Rs3087243,autoimmune thyroid disease
CBS,Rs5742905,conotruncal heart defects
CBS,Rs5742905,blood pressure
CBS,Rs5742905,conotruncal heart defects
CBS,Rs5742905,spina bifida
CBS,Rs5742905, hypertension
CBS,Rs5742905,spina bifida
CBS,Rs5742905,Homocystinuria
CBS,Rs5742905,blood pressure progression
CBS,Rs5742905,glaucoma
CBS,Rs5742905,pseudoexfoliation syndrome
CBS,Rs5742905,Homocystinuria
CBS,Rs234706,Ehlers-Danlos syndrome
CBS,Rs121964972,Homocystinuria
CBS,Rs5742905,incident hypertension
CCDC122,Rs3088362,increased susceptibility to leprosy 
CCDC174,Rs869025342,infantile hypotonia
CCDC174,Rs869025342,psychomotor retardation
CCL2,Rs4586,Polygenic
CCL2,Rs4586,Sickle Cell Disease
CCL2,Rs4586,carotid atherosclerosis
CCL2,Rs4586,MCP-1 promoter variant -362C associated with protection
CCL2,Rs4586,pulmonary tuberculosis
CCL2,Rs4586,knee osteoarthritis
CCL2,Rs3917887,nephropathy
CCL2,Rs3917887,chemotactic 
CCL2,Rs3917887,Monocyte 
CCL2,Rs3917887,cytokine 
CCL2,Rs3917887,inflammatory 
CCL2,Rs3917887,polymyositis/dermatomyositis
CCL26,Rs2302009,"eosinophilic esophagitis,"
CCL26,Rs2302009,esophagitis
CCL26,Rs2302009,gastroesophageal reflux disease
CCL26,Rs2302009,eosinophilic esophagitis
CCR2,Rs1799864,recurrent venous thromboembolism
CCR2,Rs1799864,AIDS 
CCR2,Rs1799864,HIV
CCR2,Rs1799864,AIDS 
CCR5,Rs333,type 1 diabetes
CCR5,Rs333,HIV
CCR5,Rs333,abdominal aortic aneurysm
CCR5,Rs2856758,coronary heart disease among US women
CCR5,Rs333,aneurysms
CCR5,Rs2856758,resistance to HIV infection
CCR5,Rs2856758,resistance to HIV
CCR5,Rs1800452,hay-fever
CCR5,Rs1800452,hay-fever
CCR5,Rs2856758,selection pressure from plague (Black Death) or smallpox
CD14,Rs2569190,cerebrovascular diseases
CD14,Rs2569190,elevated IgE levels
CD14,Rs5744455,pylori infection
CD14,Rs2569190,smokers 
CD14,Rs2569190,stroke 
CD14,Rs2569190,non-smokers
CD2AP,Rs9349407,Alzheimer
CD33,Rs3865444,Alzheimer's disease
CD33,Rs3865444,Alzheimer's disease
CD40,Rs4810485,Europeans
CD40,Rs4810485, rheumatoid arthritis (RA)
CD40,Rs4810485,autoimmune disease
CD40,Rs4810485,European ancestry
CD40,Rs4810485,Korean ancestry
CD40,Rs4810485,orean ancestry
CD40,Rs4810485,RA 
CD40,Rs4810485,Korean
CD44,Rs353644,vaccine-induced immunity to HBV infection
CD58,Rs12044852,multiple sclerosis
CD58,Rs2300747,multiple sclerosis
CD58,Rs2300747,protective
CD59,Rs397514767,hemolytic anemia and immune-mediated polyneuropathy
CDH1,Rs587780784,diffuse gastric cancer
CDH1,Rs587780784,hereditary diffuse gastric cancer
CDH1,Rs587780787,pathogenic rare mutation
CDH1,Rs587780787,hereditary diffuse gastric cancer
CDH1,Rs587780787,gastric cancer
CDH1,Rs587783047,gastric cancer 
CDH1,Rs587783047,R63X
CDH1,Rs587783047,gastric cancer in ClinVar
CDH1,Rs786201045,hereditary diffuse gastric cancer
CDH1,Rs587780784,pathogenic 
CDH1,Rs786201045,hereditary diffuse gastric cancer
CDH1,Rs786202033,gastric cancer
CDH1,Rs786203752,hereditary diffuse gastric cancer
CDH1,Rs863224505,hereditary diffuse gastric cancer
CDH1,Rs864622655,gastric cancer
CDH1,Rs876660771,cancer 
CDH1,Rs876660771,gastric 
CDH1,Rs786201045,gastric cancer
CDH1,Rs587780784,hereditary diffuse gastric cancer
CDH1,Rs587776398,gastric cancer
CDH1,Rs587780784,hereditary diffuse gastric cancer
CDH1,I5004969,gastric cancer
CDH1,I5004970,gastric cancer
CDH1,I5004970,gastric cancer
CDH1,I5004971,gastric cancer
CDH1,I5004971,gastric cancer
CDH1,I5004974,gastric cancer
CDH1,I5004975,gastric cancer
CDH1,Rs587780784,pathogenic rare mutation
CDH1,Rs121964875,hereditary diffuse gastric cancer
CDH1,Rs13689,arsenic-related skin lesions
CDH1,Rs13689,arsenic-related skin
CDH1,Rs13689,E-cadherin polymorphisms
CDH1,Rs1862748,colorectal cancer
CDH1,Rs1862748,rsenic-related skin lesions
CDH1,Rs1862748,"West Bengal, India"
CDH1,Rs587780113,gastric cancer
CDH1,Rs13689,E-cadherin polymorphisms
CDH13,Rs6565113,attention deficit/hyperactivity disorder
CDH13,Rs6565113,autism spectrum disorder
CDH13,Rs6565113,autism spectrum disorder.
CDH13,Rs6565113,attention-deficit/hyperactivity disorder
CDH13,Rs6565113,attention deficit hyperactivity disorder
CDH13,Rs6565113,attention-deficit/hyperactivity disorder
CDH23,Rs111033271,Usher syndrome and nonsyndromic deafness.
CDH23,Rs111033271,hearing loss
CDH23,Rs111033271,Usher syndrome
CDH23,Rs111033271,nonsyndromic deafness
CDH23,Rs372388344,pathogenic variant
CDKAL1,Rs4712523,type 1 diabetes
CDKAL1,Rs4712523,type 2 diabetes
CDKAL1,Rs7754840,type-2 diabetes
CDKAL1,Rs7754840,type-2 diabetes
CDKAL1,Rs7754840,type-2 diabetes
CDKAL1,Rs7754840,higher glucose
CDKAL1,Rs7754840,type-2 diabetes
CDKAL1,Rs4712523,type 2 diabetes
CDKAL1,Rs7754840,type-2 diabetes
CDKAL1,Rs4712523, type-2 diabetes
CDKAL1,Rs4712523,type 2 diabetes
CDKAL1,Rs4712523,glycated hemoglobin
CDKAL1,Rs4712523,ype-2 diabetes 
CDKAL1,Rs4712523,type 2 diabetes
CDKAL1,Rs4712523,type 1 diabetes
CDKAL1,Rs4712523,type-2 diabetes
CDKAL1,Rs10946398,Type II Diabetes
CDKAL1,Rs4712523,type 2 diabetes
CDKAL1,Rs4712523,type 2 diabetes
CDKAL1,Rs4712523,related quantitative traits
CDKAL1,Rs4712523,type 2 diabetes
CDKN1A,Rs1801270,cancer
CDKN1A,Rs3176336,breast cancer
CDKN1A,Rs3176336,breast cancer
CDKN1A,Rs2395655,leukemia
CDKN1A,Rs2395655,early-onset disorders
CDKN1A,Rs2395655,breast cance
CDKN1A,Rs1801270,"chronic obstructive pulmonary disease (COPD),"
CDKN1A,Rs1801270,lung cancer
CDKN1A,Rs1801270,increased tumor susceptibility 
CDKN1A,Rs2395655,ovarian cancer
CDKN1A,Rs1059234,sporadic colorectal cancer
CDKN1A,Rs1059234,breast cancer
CDKN1A,Rs1059234,Bladder cancer
CDKN1A,Rs1059234,squamous cell carcinoma of the head and neck
CDKN1A,Rs1059234,sporadic colorectal cancer
CDKN1A,Rs1059234,breast cancer 
CDKN1A,Rs1059234,Bladder cance
CDKN1A,Rs1059234,squamous cell carcinoma of the head and neck
CDKN1A,Rs1059234,ovarian cancer
CDKN1B,Rs34330,breast cancer
CDKN1B,Rs34330,prostate cancer
CDKN1B,Rs34330, endometrial cancer
CDKN1B,Rs34330,prostate cancer
CDKN1B,Rs34330,endometrial cancer
CDKN1B,Rs34330,endometrial cancer
CDKN1B,Rs34330,prostate cancer 
CDKN1B,Rs34330,breast cancer
CDKN1B,Rs34330,breast cancer
CDKN2A,Rs1800586,"malignant melanoma,"
CDKN2A,Rs1800586,cancer.
CDKN2A,Rs1800586,malignant melanoma
CDKN2A,Rs3731239,breast cancer
CDKN2A,Rs3731239,ovarian cancer
CDKN2A,Rs3731239,breast cancer
CDKN2B,Rs3217992,ovarian cancer risk
CDKN2B,Rs3217992,British population
CDKN2B,Rs3217992,breast cancer
CDKN2B,Rs3217992,single-nucleotide polymorphisms 
CDKN2B,Rs3217992,older people
CDKN2B,Rs3217992,cell cycle single-nucleotide polymorphisms
CDKN2B,Rs3217992,Han Chinese
CDKN2B,Rs3217992,male 
CDKN2B,Rs3217992,myocardial infarctions
CDKN2B,Rs3217992,breast cancer
CDKN2B,Rs3217992,ovarian cancer
CDKN2B,Rs3217992,myocardial infarctions
CDKN2B,Rs3217992,Multiple Disease Phenotypes Correlate with ANRIL Expression
CDKN2B-AS1,Rs564398,Korean population
CDKN2B-AS1,Rs564398,Western
CDKN2B-AS1,Rs564398,Chinese Han population
CDKN2B-AS1,Rs564398,Asians
CDKN2B-AS1,Rs564398,obesity
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,French Europids
CDKN2B-AS1,Rs496892,Japanese patients
CDKN2B-AS1,Rs4977574,Coronary artery disease
CDKN2B-AS1,Rs564398,gestational diabetes mellitus
CDKN2B-AS1,Rs496892,intracranial aneurysms
CDKN2B-AS1,Rs496892,atherosclerotic stroke
CDKN2B-AS1,Rs496892,periodontitis
CDKN2B-AS1,Rs496892,coronary heart disease
CDKN2B-AS1,Rs496892,coronary artery disease
CDKN2B-AS1,Rs496892,familial and sporadic intracranial aneurysms
CDKN2B-AS1,Rs4977574,myocardial infarction
CDKN2B-AS1,Rs564398,Han Chinese
CDKN2B-AS1,Rs564398,type 1 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs496892,atherosclerotic stroke
CDKN2B-AS1,Rs564398,type 2 diabetes 
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,atherosclerotic stroke
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,gestational diabetes mellitus
CDKN2B-AS1,Rs564398,Type 2 diabetes-associated genetic variants
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs496892,periodontitis
CDKN2B-AS1,Rs3217992,Han Chinese
CDKN2B-AS1,Rs496892,coronary artery disease
CDKN2B-AS1,Rs2891168,glioma
CDKN2B-AS1,Rs2891168,periodontitis
CDKN2B-AS1,Rs2891168,coronary heart disease
CDKN2B-AS1,Rs2891168,atherosclerosis
CDKN2B-AS1,Rs2891168,Coronary artery disease
CDKN2B-AS1,Rs2157719,high-grade glioma susceptibility
CDKN2B-AS1,Rs2157719,RTEL1
CDKN2B-AS1,Rs2891168,myocardial infarction
CDKN2B-AS1,Rs2157719,CDKN2B
CDKN2B-AS1,Rs1556516,longevity
CDKN2B-AS1,Rs1556516,longevity
CDKN2B-AS1,Rs1556516,longevity
CDKN2B-AS1,Rs1537375,myocardial infarction
CDKN2B-AS1,Rs1011970,breast 
CDKN2B-AS1,Rs1011970,cancer 
CDKN2B-AS1,Rs1011970,breast cancer
CDKN2B-AS1,Rs17756311,childhood acute lymphoblastic leukemia
CDKN2B-AS1,Rs3217992,myocardial infarctions
CDKN2B-AS1,Rs2891168,type 2 diabetes
CDKN2B-AS1,Rs3217992,British population
CDKN2B-AS1,Rs3218005,polymorphisms 
CDKN2B-AS1,Rs3218005,breast cancer
CDKN2B-AS1,Rs3218005,association with breast cancer
CDKN2B-AS1,Rs3218005,ovarian cancer
CDKN2B-AS1,Rs3218005,breast cancer
CDKN2B-AS1,Rs3217992,older people
CDKN2B-AS1,Rs3217992,ovarian cancer
CDKN2B-AS1,Rs3218005,ovarian cancer
CDKN2B-AS1,Rs3217992,breast cancer
CDKN2B-AS1,Rs3217992,ovarian cancer risk
CDKN2B-AS1,Rs3217992,cell cycle single-nucleotide polymorphisms
CDKN2B-AS1,Rs3217992,Multiple Disease Phenotypes Correlate with ANRIL Expression
CDKN2B-AS1,Rs3217992,male 
CDKN2B-AS1,Rs3217992,myocardial infarctions
CDKN2B-AS1,Rs496892,coronary heart disease
CDKN2B-AS1,Rs3217992,breast cancer
CDKN2B-AS1,Rs3217992,single-nucleotide polymorphisms 
CELSR1,Rs9615362,retracted
CEP290,Rs62638180,inherited disease.
CEP290,Rs752197734,Blueprint Genetics Retinal dystrophy
CEP290,Rs62638180,recessively inherited disease
CEP290,Rs752197734,Blueprint Genetics Retinal dystrophy
CEP290,Rs281865192,congenital blindness
CEP290,Rs281865192,Leber Congenital Amaurosis
CEP290,Rs281865192,Retinal dystrophy
CETP,Rs7499892,decreased HDL cholesterol levels
CETP,Rs708272,had a reduced risk (odds ratio 0.21) for CHD in intermediate vs low drinkers
CETP,Rs708272,reduced coronary heart disease risk in those drinking alcohol
CETP,Rs708272,protect individuals from coronary artery disease
CETP,Rs708272,coronary heart disease
CETP,Rs708272,myocardial infarction
CETP,Rs708272,myocardial infarction
CETP,Rs708272,cardiovascular risk
CETP,Rs708272,coronary artery disease
CETP,Rs708272,lead to higher HDL levels
CETP,Rs5882,dementia
CETP,Rs5882,Alzheimer's disease
CETP,Rs708272,high cardiovascular risk
CETP,Rs2303790,ischemic stroke
CETP,Rs2303790,candidate gene polymorphisms
CETP,Rs1532624,dyslipidemia
CETP,Rs1532624,carotid artery disease
CETP,Rs1532624,Polymorphism
CETP,Rs1532624,HDL cholesterol
CETP,Rs1532624,cholesterol levels
CETP,Rs183130,lipoprotein 
CETP,Rs183130,independent 
CETP,Rs183130,population 
CETP,Rs2303790,ischemic stroke
CETP,Rs1532624,myocardial infarction
CFAP43,Rs376788209,pathogenic variant
CFH,Rs3753396,atypical haemolytic uremic syndrome
CFH,Rs3753394,age-related macular degeneration
CFH,Rs3753396,macular degeneration
CFH,Rs3753396, Neovascular age-related macular degeneration
CFH,Rs3753396,haemolytic uremic syndrome
CFH,Rs3753396,hemolytic uremic syndrome.
CFH,Rs3753396,age related macular degeneration
CFH,Rs3753396,Neovascular age-related macular degeneration
CFH,Rs3753396,atypical hemolytic uremic syndrome
CFH,Rs800292,polypoidal choroidal vasculopathy
CFH,Rs800292,macular degeneration
CFH,Rs800292,polypoidal choroidal vasculopathy
CFH,Rs800292,macular degeneration
CFH,Rs800292,coronary heart disease
CFH,Rs800292,retinopathy
CFH,Rs800292,retinitis pigmentosa
CFH,Rs800292,hemolytic uremic syndrome
CFH,Rs3753394,age-related macular degeneration 
CFH,Rs800292,blindness
CFH,Rs3753394,polypoidal choroidal vasculopathy
CFH,Rs1061147,age related macular degeneration
CFH,Rs3753394,polypoidal choroidal vasculopathy
CFH,Rs1061147,macular degeneration (damage to the eye with ageing)
CFH,Rs1061147,macular degeneration
CFH,Rs1061147,age related macular degeneration
CFH,Rs1061147,damage to the eye with ageing
CFH,Rs1061170,Some SNPs in other genes (like C7 and MBL2) may protect individuals with
CFH,Rs1061170,degeneration
CFH,Rs1065489,meningococcal disease.
CFH,Rs3753394,blindness 
CFH,Rs1061147,macular degeneration
CFH,Rs3753394,AMD 
CFH,Rs3753394,exudative AMD
CFH,Rs3753394,age-related macular degeneration
CFH,Rs3753394,polypoidal choroidal vasculopathy
CFH,Rs3753394,age-related macular degeneration
CFH,Rs3753394,atypical hemolytic uremic syndrome
CFH,Rs3753394,ARMD 
CFH,Rs3753394,exudative AMDCFH variations 
CFH,Rs3753394,atypical haemolytic uremic syndrome
CFI,Rs10033900,age-related macular degeneration
CFI,Rs10033900,wet-type age-related macular degeneration
CFI,Rs10033900,polypoidal choroidal vasculopathy
CFTR,I4000321,ystic Fibrosisr
CFTR,I4000324,Cystic Fibrosis
CFTR,I4000322,Cystic Fibrosisrs
CFTR,I4000321,Fibrosis
CFTR,I4000321,Cystic
CFTR,I4000324,Cystic Fibrosis
CFTR,I4000320,Cystic Fibrosis
CFTR,I4000320,better anthropometric and lung function measure
CFTR,I4000320,higher frequency of pancreatic sufficiency
CFTR,I4000320,milder disease
CFTR,I4000320,most common autosomal recessive disorder in populations with European ancestry
CFTR,I4000320,Cystic fibrosis
CFTR,I5006050,Cystic Fibrosis
CFTR,I4000320,and lower infection susceptibility
CFTR,I5006053,Cystic Fibrosis
CFTR,I5006072,Cystic Fibrosisrs
CFTR,I5006054,Cystic Fibrosis
CFTR,I4000320,cystic fibrosis
CFTR,I5006080,Cystic Fibrosis
CFTR,I5006076,Cystic Fibrosis
CFTR,I5006075,Cystic Fibrosis
CFTR,I5006074,Cystic Fibrosis
CFTR,I5006072,Fibrosisrs121909013
CFTR,I5006083,Cystic Fibrosis
CFTR,I5006071,Cystic Fibrosis
CFTR,I5006063,Cystic Fibrosisrs
CFTR,I5006062,Cystic Fibrosis
CFTR,I5006056,cystic
CFTR,I5006056,fibrosis
CFTR,I5006055,Cystic Fibrosisrs
CFTR,I5006054,Cystic Fibrosis
CFTR,I5006070,Cystic Fibrosis
CFTR,I4000320,lower infection susceptibility
CFTR,I4000311,Cystic Fibrosis
CFTR,I4000320, higher frequency of pancreatic sufficiency
CFTR,I4000320,better anthropometric and lung function measure
CFTR,I3000001,Cystic Fibrosis
CFTR,I3002449,Cystic Fibrosis
CFTR,I3002449,Cystic Fibrosis
CFTR,I4000291,Cystic Fibrosis
CFTR,I4000292,Cystic Fibrosis
CFTR,I4000292,no mutations
CFTR,I4000294,Cystic Fibrosis
CFTR,I4000294,Cystic Fibrosis
CFTR,I4000296,Cystic Fibrosis
CFTR,I4000299,Cystic Fibrosis
CFTR,I4000301,Cystic Fibrosis
CFTR,I4000305,cystic fibrosis
CFTR,I4000306,Cystic Fibrosisrs
CFTR,I4000308,Cystic Fibrosis
CFTR,I4000308,Cystic Fibrosisrs
CFTR,I4000316,Cystic Fibrosis
CFTR,I4000320,cystic fibrosis
CFTR,I4000320,cystic fibrosis
CFTR,I4000320,Cystic Fibrosis
CFTR,I4000320,cystic fibrosis
CFTR,I4000320,pancreatic insufficiency
CFTR,I4000320,European 
CFTR,I4000316,Cystic Fibrosisrs
CFTR,I4000320,autosomal recessive disorder
CFTR,I4000320,pancreatic insufficiency
CFTR,I4000320,respiratory infections
CFTR,I4000320,raised sweat chloride
CFTR,I4000320,Cystic fibrosis
CFTR,I4000320,autosomal recessive
CFTR,I4000317,Fibrosisrs76713772
CFTR,I4000320,Cystic fibrosis
CHAMP1,Rs863225076,mental retardation
CHAMP1,Rs879255261,autosomal dominant mental retardation
CHAMP1,Rs863225077,autosomal dominant mental retardation
CHAMP1,Rs863225076,mental retardation
CHAMP1,Rs863225076,pathogenic
CHAMP1,Rs863225074,autosomal dominant mental retardation.
CHAMP1,Rs797044963,autosomal dominant mental retardation
CHAMP1,Rs797044961,autosomal dominant mental retardation
CHAMP1,Rs200070245,form of autosomal dominant mental retardation
CHAMP1,Rs1131691845,autosomal dominant mental retardation
CHCHD10,Rs730880031,okela type of spinal muscular atrophy
CHCHD10,Rs730880031,Late-onset spinal motor neuronopathy
CHEK2,Rs28909982,breast cancer
CHEK2,Rs1805129,silent polymorphism
CHEK2,Rs17879961,lung cancer
CHEK2,Rs17879961,breast cancer
CHEK2,Rs17879961,breast cancer
CHEK2,Rs17879961,breast cancer
CHEK2,Rs17879961,lung cancer
CHEK2,Rs17879961,breast cancer
CHEK2,Rs17879961,breast cancer
CHEK2,Rs17879961,breast cancer
CHI3L1,Rs6691378,polymorphisms
CHI3L1,Rs6691378,lung function
CHI3L1,Rs10399931,coronary artery disease
CHI3L1,Rs6691378,atopy
CHI3L1,Rs6691378,risk of asthma
CHI3L1,Rs6691378,asthma
CHI3L1,Rs6691378,schizophrenia
CHI3L1,Rs10399931,rheumatoid arthritis.
CHI3L1,Rs10399931,coronary heart disease
CHI3L1,Rs10399931,rheumatoid arthritis
CHI3L1,Rs10399931, coronary heart disease
CHI3L1,Rs10399931,Genetic polymorphisms
CHI3L1,Rs6691378,asthma-susceptibility
CHRM3,Rs2165870,post-operative nausea
CHRM3,Rs2165870,higher risk for nausea
CHRM3,Rs2165870,post-operative nausea
CHRNA3,Rs1051730,alcohol abuse
CHRNA3,Rs578776,nicotine dependence
CHRNA3,Rs1051730,PAD
CHRNA3,Rs578776,lung cancer
CHRNA3,Rs8042374,lung cancer
CHRNA3,Rs578776,nicotine dependence
CHRNA3,Rs1051730,peripheral arterial disease
CHRNA3,Rs1051730,lung cancer
CHRNA3,Rs1051730,lung cancer
CHRNA3,Rs1051730,lung cancer
CHRNA3,Rs1051730,lung cancer
CHRNA3,Rs1051730,Artery Disease
CHRNA3,Rs1051730,lung cancer
CHRNA3,Rs1051730,lung cancer
CHRNA4,Rs3787137,nicotine addiction
CHRNA4,Rs3787137,nicotine dependence
CHRNA4,Rs3787137,nicotine dependence
CHRNA4,Rs3787137,nicotine dependence
CHRNA5,Rs684513,COPD
CHRNA5,Rs684513,lung cancer
CHRNA5,Rs684513,cognitive performance
CHRNA5,Rs684513,nicotine dependence 
CHRNA5,Rs684513,smoking quantity
CHRNA5,Rs684513,lung cancer
CHRNA5,Rs951266, subunit
CHRNA5,Rs684513,lung cancer
CHRNA5,Rs951266,Lung cancer
CHRNA5,Rs951266,Age-Dependent Nicotine Addiction
CHRNA5,Rs951266,Peripheral arterial disease
CHRNA5,Rs951266,Substance dependence
CHRNA5,Rs951266,Substance dependence
CHRNA5,Rs684513,susceptibility to heavy smoking
CHRNA5,Rs951266,bipolar disorder
CHRNA5,Rs951266,age-dependent nicotine addiction
CHRNA5,Rs951266,nicotine dependence
CHRNA5,Rs951266,lung cancer
CHRNA5,Rs951266,Lung cancer
CHRNA5,Rs684513,nicotine addiction
CHRNA5,Rs684513,multiple substance dependence phenotypes
CHRNA5,Rs684513,bipolar disorder
CHRNA5,Rs16969968,smoking
CHRNA5,Rs16969968,lung cancer
CHRNA5,Rs684513,nicotine dependence
CHRNA5,Rs16969968,decreased response to a nicotine agonist
CHRNA5,Rs16969968,nicotine dependence
CHRNA5,Rs16969968,cocaine dependence
CHRNA5,Rs16969968,nicotine dependence
CHRNA5,Rs16969968,enhanced pleasurable responses
CHRNA5,Rs16969968,chronic obstructive pulmonary disease
CHRNA5,Rs16969968,chronic obstructive pulmonary disease
CHRNA5,Rs16969968,Age-Dependent Nicotine Addiction
CHRNA5,Rs17486278,nicotine addiction
CHRNA5,Rs17486278,lung cancer
CHRNA5,Rs17486278,nicotine dependence
CHRNA5,Rs17486278,Risk for nicotine dependence
CHRNA5,Rs17486278,lung cancer
CHRNA5,Rs6495306,Substance dependence
CHRNA5,Rs16969968,Substance dependence
CHRNA5,Rs6495306,Alcohol
CHRNA7,Rs6494223,delusions
CHRNA7,Rs6494223,Alzheimer's disease
CHRNA7,Rs6494223,delusions
CHRNA7,Rs6494223,Alzheimer's disease
CLCN1,I5003259,Myotonia congenitars
CLCN1,I5003260,Myotonia
CLCN1,Rs121912810,Thomsen's myotonia congenita
CLCN1,Rs121912810,Thomsen's myotonia congenita
CLCN1,Rs80356690,Thomsen's myotonia congenita
CLCN1,Rs80356690,Myotonia levior
CLCN1,Rs80356694,dominant myotonia congenita
CLCN1,Rs80356694,Decrement of compound muscle action
CLDN14,Rs219781,Kidney Stones
CLDN14,Rs219780,kidney stones
CLDN14,Rs219780,decreased bone mineral density
CLDN14,Rs368027306,deafness
CLDN14,Rs219778,risk of developing kidney stones
CLDN14,Rs368027306,SNP
CLDN14,Rs368027306,OMIM
CLDN14,Rs368027306,ClinVar
CLDN14,Rs368027306,deafness
CLDN14,Rs219781,Kidney Stones
CLDN14,Rs219778,kidney stones
CLDN14,Rs143797113,homozygous minor
CLDN14,Rs143797113,deafness 
CLDN14,Rs143797113,recessively
CLDN14,Rs143797113,CLDN14 gene
CLDN14,Rs143797113,minor
CLDN14,Rs143797113,deafness
CLDN14,Rs143797113,deafness
CLDN14,Rs143797113,heterozgyote form
CLDN14,Rs143797113,pathogenic 
CLDN14,Rs143797113,childhood
CLDN14,Rs143797113,ecessively
CLDN16,Rs765256758,OMIM
CLDN16,Rs765256758,pathogenic variant
CLDN16,Rs765256758,Ala139Val
CLEC16A,Rs725613,multiple sclerosis
CLEC16A,Rs725613,multiple sclerosis
CLEC16A,Rs725613,type 1 diabetes
CLEC16A,Rs725613,T1D
CLEC16A,Rs725613,type-1 diabetes 
CLEC16A,Rs725613,"10e-3) but also with multiple sclerosis (odds ratio = 1.21, p = 6.7 x 10e-5). rs"
CLEC16A,Rs725613,type-1 diabetes
CLEC16A,Rs725613,type-1 diabetes
CLEC16A,Rs2903692,type 1 diabetes
CLEC16A,Rs725613,multiple sclerosis
CLN3,Rs386833721,Blueprint Genetics Retinal dystrophy
CLN3,Rs386833721,Blueprint Genetics Retinal dystrophy
CLOCK,Rs4864548,obesity
CLOCK,Rs1554483,obesity
CLOCK,Rs1554483,overweight
CLOCK,Rs4864548,overweight
CLRN1,Rs111033258,Usher Syndrome Type III
CLRN1,Rs111033258,Usher Syndrome Type III
CLTCL1,Rs1061325,insulin resistance on modern diets.
CMAS,Rs2955503,haplotype
CNGB3,Rs3735967,visual phenotype
CNGB3,Rs121918344,colorblindness
CNGB3,Rs121918344,photophobia
CNGB3,Rs121918344,nystagmus
CNGB3,Rs121918344,20/200 visual acuity
CNGB3,Rs35365413,achromatopsia
CNGB3,Rs35365413,macular degeneration
CNGB3,Rs3735967,Achromatopsia
CNGB3,Rs397515360,achromatopsia
CNGB3,Rs397515360, achromatopsia
CNNM1,Rs6584273,alcohol metabolism
CNNM1,Rs6584273,genetic variation in pathways that metabolize
CNNM1,Rs6584273,May Affect Diabetes Risk
CNR1,Rs806377,cannabis dependence
CNR1,Rs806377,cannabis dependence
CNR1,Rs806377,cocaine dependence
CNR1,Rs806377,European Americans
CNR1,Rs806377,adolescents and young adults
CNR1,Rs806377,happy faces
CNR1,Rs806377,cannabis dependence
CNR1,Rs806378,irritable bowel syndrome-diarrhea
CNR1,Rs806378,fasting colonic motility
CNR1,Rs806378,nonconstipated irritable bowel syndrome
CNR1,Rs806378,overweight
CNR1,Rs806378,obesity
CNR1,Rs806378,nonconstipated irritable bowel syndrome
CNR1,Rs806377,happy faces
CNR1,Rs806377,adolescents
CNR1,Rs806378,obesity
CNR1,Rs806377,males
CNR1,Rs2023239,cannabis dependence
CNR1,Rs6454674,ADHD
CNR1,Rs6454674,schizophrenia
CNR1,Rs6454674,obesity
CNR1,Rs6454674,European
CNR1,Rs806377,females
CNR1,Rs6454674,nicotine dependence
CNR1,Rs6454674,metabolic syndrome in postmenopausal Polish women
CNR1,Rs6454674,cocaine addiction
CNR1,Rs806377,ADHD
CNR1,Rs806377,ADHD
CNR1,Rs806377,ADHD
CNR1,Rs806377,ADHD
CNR1,Rs6454674,obesity
CNTNAP2,Rs7794745,autism
CNTNAP2,Rs7794745,autism
CNTNAP2,Rs4431523,nonsense-word repetition
CNTNAP2,Rs7794745,autistic children
CNTNAP2,Rs4431523,inability of children with typical specific language impairment
CNTNAP2,Rs371642222,pathogenic variant
CNTNAP2,Rs2538991,autism
CNTNAP2,Rs4431523,Speech development 
COCH,Rs1045644,Meniere's disease
COCH,Rs1045644,Meniere's disease
COCH,Rs28938175,deafness
COCH,Rs28938175,deafness
COL11A1,Rs587782990,Blueprint Genetics Retinal dystrophy
COL11A1,Rs587782990,Blueprint Genetics Retinal dystrophy
COL11A1,Rs1676486,LDH
COL11A1,Rs1676486,Japanese
COL11A1,Rs1676486,Lumbar disc herniation (LDH)
COL11A1,Rs1676486,musculoskeletal diseases
COL1A1,Rs1107946,Bone mineral density
COL1A1,Rs1107946,postmenopausal osteoporosis in India
COL1A1,Rs1107946, osteoporosis
COL1A1,Rs1107946,osteoporosis
COL1A1,Rs1107946,reduced bone quality and hip fracture
COL1A1,Rs1107946,osteoporotic fractures
COL1A1,Rs1107946,bone mineral density
COL1A1,Rs1107946,fracture risk
COL1A1,Rs1107946,bone mass and geometry
COL1A1,Rs1107946,high myopia susceptibility in Japanese
COL1A1,Rs1107946,Caucasian and Chinese nuclear families
COL1A1,Rs1107946,femoral neck bone geometric parameters
COL1A1,Rs1107946,bone mineral density in women
COL1A1,Rs1107946,osteoporosis
COL1A1,Rs1107946,obesity 
COL1A1,Rs1107946, osteoporosis
COL1A2,Rs42524,intracranial aneurysms
COL2A1,Rs121912880,mutations
COL2A1,Rs121912880,pathogenic for Spondylometaphyseal dysplasia
COL2A1,Rs121912880,Stickler syndrome type I
COL3A1,Rs1057521106,vascular Ehlers-Danlos syndrome
COL3A1,Rs1057521106,sudden cardiac death patient
COL3A1,Rs1800255,associated with pelvic organ prolapse
COL3A1,Rs1800255,risk for pelvic organ prolapse
COL4A3,Rs121912827,Mutations
COL4A3,Rs121912827,familial benign hematuria.
COL4A3,Rs121912826,Mutations
COL4A3,Rs121912826,familial benign hematuria.
COL5A1,Rs61735045,EDS
COL5A1,Rs61735045,EDS
COL5A1,Rs61735045,causative mutation
COL5A1,Rs61735045,EDS
COL5A1,Rs12722,COL5A1 
COL5A1,Rs12722,Achilles 
COL5A1,Rs12722,tendinopathy
COL5A1,Rs61735045,Ehlers-Danlos syndrome(EDS)
COL9A3,Rs35908728,lumbar disc disease.
COL9A3,Rs35908728,lumbar disc disease
COL9A3,Rs61734651,lumbar disc disease
COMT,Rs165631,breast cancer
COMT,Rs9332377,Cisplatin
COMT,Rs9332377,hearing loss
COMT,Rs4633,endometrial cancer
COMT,Rs4633,Schizophrenia Susceptibility Genetic
COMT,Rs165688,rs165688
COMT,Rs165631,breast cancer
COMT,Rs165631,breast cancer
COMT,Rs165631,breast cancer
COMT,Rs165631,breast cancer
COMT,Rs165631,breast cancer
COMT,Rs165599,bipolar disorder 
COMT,Rs165599,schizophrenia
COMT,Rs165599,schizophreniapart
COMT,Rs165599,anxiety-related personality traits
CPED1,Rs148771817,increase in bone density
CPED1,Rs148771817,increase in bone density
CPED1,Rs148771817,increase in bone density
CPED1,Rs190543052,femoral fracture
CREBBP,Rs3025684,autism-susceptibility
CREBRF,Rs373863828,considered insufficient to lead to obesity
CREBRF,Rs373863828,35 per cent higher chance of obesity 
CRH,Rs28364015,self-protection behaviors
CRH,Rs28364015,orphaned
CRP,Rs3091244,Crohn disease
CRP,Rs3091244,psoriasis
CRP,Rs3091244,inflammation
CRP,Rs3091244,C-reactive protein levels and body mass index
CRP,Rs3091244,risk of psoriasis
CRP,Rs3093059,Japanese subjects
CRP,Rs3093059,cardiovascular risk
CRP,Rs3093059,type 2 diabetes mellitus
CRP,Rs3093059,Filipino systemic lupus erythematosus families
CRP,Rs3093059,metabolic-syndrome pathways
CRP,Rs3093061,lupus erythematosus
CRP,Rs3093059,risk of systemic lupus erythematosus
CRP,Rs3093059,ischemic stroke
CRP,Rs3093059,hemorrhagic stroke
CRP,Rs3093059,Chinese Han population
CRP,Rs3093059,coronary artery bypass surgery
CRP,Rs3093061,lupus erythematosus
CRP,Rs3091244,susceptibility to Plasmodium falciparum malaria
CRP,Rs3093062,functional haplotypes containing
CRP,Rs3093062,which is associated with SLE
CRP,Rs3093059,neovascular age-related macular degeneration
CRP,Rs3091244,risk of coronary heart disease
CRP,Rs3093059,age-related macular degeneration
CRP,Rs3091244,CRP levels and hypertension
CRP,Rs3091244,marker of metastatic prostate cancer
CRP,Rs1800947,SLE
CRP,Rs1800947,systemic lupus erythematosus
CRP,Rs1800947,"autoimmune disorder SLE,"
CRP,Rs1800947,ystemic lupus erythematosus.
CRP,Rs1800947,autoimmune disorder SLE
CRP,Rs3091244,risk of abdominal aortic aneurysm (AAA)
CRP,Rs3091244,cardiovascular risk
CRP,Rs3091244,prevalent coronary heart disease
CRP,Rs3091244,severe hand osteoarthritis
CRP,Rs3091244,variability in serum C-reactive protein level
CRP,Rs1800947,systemic lupus erythematosus
CRP,Rs3091244,Neovascular age-related macular degeneration risk
CRP,Rs3091244,linked to coronary heart disease risk
CRP,Rs3091244,risk of incident coronary heart diseas
CRP,Rs3091244,systemic lupus erythematosus
CRP,Rs3091244,neovascular age-related macular degeneration
CRP,Rs3091244,coronary heart disease
CRP,Rs3091244,risk of systemic lupus erythematosus
CRP,Rs3091244,susceptibility to ischemic stroke and hemorrhagic stroke
CRP,Rs3091244,COPD risk and systemic inflammation
CRP,Rs3091244,risk of age-related macular degeneration
CRYM,Rs28929490,deafness
CRYM,Rs28929490,deafness
CSF2RB,Rs11705394,schizophrenia.
CSF2RB,Rs11705394,schizophrenia
CSF2RB,Rs2072707,schizophrenia.
CSF2RB,Rs2072707,schizophrenia
CSNK1D,Rs397514693,migraine
CSNK1D,Rs397514693,Familial Advanced Sleep Phase syndrome 2
CSNK1D,Rs397514693,sleep disorder
CSNK1D,Rs104894561,Familial Advanced Sleep Phase syndrome 2
CSNK1D,Rs104894561,sleep disorder
CSNK1D,Rs104894561,autosomal dominant
CSNK1D,Rs104894561,sleep disorder
CSNK1D,Rs104894561,sleep disorder
CSNK1D,Rs104894561,rising time compared to most people
CSNK1D,Rs104894561,~4 hour shift towards earlier bedtime
CSNK1D,Rs104894561,Familial Advanced Sleep Phase syndrome 2
CSNK1D,Rs104894561,Familial Advanced Sleep Phase syndrome 2 (FASPS2)
CTLA4,Rs4553808,myasthenia gravis 
CTLA4,Rs3087243,type 1 diabetes odds ratio 1.37 and 1.28
CTLA4,Rs3087243,acute rejection development
CTLA4,Rs3087243,acute rejection
CTLA4,Rs3087243,risk factor for developing rheumatoid arthritis (RA)
CTLA4,Rs3087243,type-1 diabetes
CTLA4,Rs3087243,autoimmune thyroid disease
CTLA4,Rs3087243,type-1 diabetes
CTLA4,Rs3087243,1.5 fold increased risk of type-1 diabetes
CTLA4,Rs3087243,autoimmune thyroid disease
CTLA4,Rs3087243,1.3 fold increased risk of autoimmune thyroid disease
CTLA4,Rs231778,artefact
CTLA4,Rs231725,biliary cirrhosis
CTLA4,Rs12992492,vitiligo 
CTLA4,Rs11571316,type-1 diabetes
CTLA4,Rs3087243,autoimmune thyroid disease
CTNNA2,Rs1446109,bipolar disorder
CTNNA2,Rs1446109,"cognition, behavior and emotion"
CTNNA2,Rs1446109,left-right asymmetrical brain function
CTNNA2,Rs1446109,handedness
CTNNA2,Rs1446109,European
CTNNA3,Rs16922827,retracted
CTNNA3,Rs2306402,late-onset Alzheimer's disease
CTNNA3,Rs2306402,Caucasian patients
CTSD,Rs17571,risk of Alzheimer's disease
CTSD,Rs17571,risk of variant Creutzfeldt-Jakob disease
CTSD,Rs17571,sporadic Alzheimer's disease:
CTSD,Rs17571,9.75 fold increase in risk of vCJD
CTSD,Rs17571, Alzheimer disease.
CTSD,Rs17571,Alzheimer's disease
CTSD,Rs17571,Alzheimer's disease
CTSD,Rs17571,Alzheimer's disease
CTSD,Rs17571,Alzheimer's disease
CTSD,Rs17571,cognitive ability and cognitive ageing
CTSD,Rs17571,Alzheimer disease
CTSD,Rs17571,vCJD 
CTSD,Rs17571,vCJD 
CTSD,Rs17571,Variant Creutzfeldt-Jakob disease
CTSD,Rs17571,Creutzfeldt-Jakob disease
CTSD,Rs17571,Creutzfeldt-Jakob disease
CUBN,Rs10508517,diastolic blood pressure
CUBN,Rs10904849,colorectal cancer
CYP17A1,Rs743572,breast cancer
CYP17A1,Rs743572,endometriosis
CYP17A1,Rs743572,gastric cancer
CYP17A1,Rs743572,non-small cell lung cancer
CYP17A1,Rs743572,polycystic ovary syndrome
CYP17A1,Rs743572,African American
CYP17A1,Rs743572,Solitary and multiple uterine leiomyomas
CYP17A1,Rs743572,Endometriosis
CYP17A1,Rs743572,breast cancer
CYP17A1,Rs743572,prostate cancer
CYP17A1,Rs743572,endometriosis
CYP17A1,Rs743572,southern Chinese women
CYP17A1,Rs743572,prostate cancer
CYP17A1,Rs743572,Chinese women
CYP17A1,Rs743572,Caucasian women
CYP17A1,Rs743572,breast cancer
CYP17A1,Rs743572,uterine leiomyomas
CYP17A1,Rs743572,Polycystic ovary syndrome
CYP17A1,Rs743572,postmenopausal breast cancer
CYP17A1,Rs1004467,blood pressure
CYP17A1,Rs1004467,blood pressure and hypertension
CYP17A1,Rs743572,short menstrual cycles
CYP17A1,Rs743572,prostate cancer
CYP17A1,Rs743572,breast and prostate cancer
CYP17A1,Rs743572,prostate cancer
CYP17A1,Rs743572,colorectal cancer
CYP17A1,Rs743572,endometrial cancer
CYP17A1,Rs743572,endometrial cancer
CYP17A1,Rs743572,fibrocystic breast conditions
CYP17A1,Rs743572,Chinese women
CYP17A1,Rs743572,Brazilian women
CYP17A1,Rs743572,African-American men
CYP19A1,Rs700518,potentially linked in a gender-specific manner to hypertension
CYP19A1,Rs727479,age 
CYP19A1,Rs727479,Caucasian 
CYP19A1,Rs727479,Polymorphisms 
CYP19A1,Rs727479,Caucasian 
CYP19A1,Rs727479,polymorphisms 
CYP19A1,Rs727479,endometrial cancer
CYP19A1,Rs4646,metastatic breast cancer
CYP19A1,Rs2470152,osteoporosis
CYP19A1,Rs3751591,age
CYP19A1,Rs3751591,natural menopause
CYP19A1,Rs2470152,serum E2 and E1 levels
CYP19A1,Rs2470152,osteoporosis
CYP19A1,Rs2470152,breast cancer
CYP19A1,Rs2470152,prostate cancer
CYP19A1,Rs2470152,breast cancer
CYP19A1,Rs727479,females
CYP19A1,Rs4646,breast cancer
CYP19A1,Rs727479,breast cancer
CYP19A1,Rs2470152,prostate cancer
CYP19A1,Rs727479,breast cancer
CYP19A1,Rs727479,breast cancer
CYP19A1,Rs727479,postmenopausal
CYP19A1,Rs727479,polymorphism 
CYP19A1,Rs727479,Post-Menopausal Women
CYP19A1,Rs727479,Breast Cancer
CYP19A1,Rs727479,women 
CYP19A1,Rs727479,fibrocystic breast conditions
CYP19A1,Rs727479,breast cancer
CYP19A1,Rs727479,postmenopausal women
CYP19A1,Rs727479,gastric cancer
CYP19A1,Rs727479,ovarian cancer
CYP19A1,Rs727479,polymorphisms 
CYP19A1,Rs727479,women
CYP19A1,Rs727479,postmenopausal 
CYP19A1,Rs727479,polymorphisms 
CYP19A1,Rs727479, breast carcinoma
CYP19A1,Rs727479,polymorphism 
CYP19A1,Rs727479,Breast Cancer
CYP19A1,Rs727479,Polymorphisms 
CYP19A1,Rs2470144,rheumatoid arthritis
CYP19A1,Rs10046,breast cancer
CYP19A1,Rs2470144,epithelial ovarian cancer
CYP19A1,Rs12594287,"the 3 snps rs17703883, rs12594287 and rs16964201 affect bone mineral density in men"
CYP19A1,Rs12594287,bone mineral density
CYP19A1,Rs12594287,bone mineral density
CYP19A1,Rs10046,Breast Cancer
CYP19A1,Rs10046,breast cancer
CYP19A1,Rs10046,gastric cancer
CYP19A1,Rs10046,epithelial ovarian cancer
CYP19A1,Rs10046,postmenopausal breast cancer
CYP19A1,Rs10046,Polycystic ovary syndrome
CYP19A1,Rs10046,female reproductive disorders
CYP19A1,Rs10046,breast carcinoma
CYP19A1,Rs10046,ovarian cancer
CYP19A1,Rs10046,breast cancer
CYP19A1,Rs10046,blood pressure
CYP19A1,Rs10046,cancer
CYP19A1,Rs10046,hypertension
CYP19A1,Rs2470144,gastric cancer
CYP19A1,Rs16964201,bone mineral density
CYP19A1,Rs16964201,bone mineral density
CYP19A1,Rs10046,breast cancer
CYP19A1,Rs17703883,bone mineral density
CYP19A1,Rs2470144,matrix metalloproteinase
CYP19A1,Rs2470144,olymorphisms in the estrogen receptor 1
CYP19A1,Rs2470144,postmenopausal
CYP19A1,Rs2470144,high-density single-nucleotide polymorphism
CYP19A1,Rs2470144,osteoporosis
CYP19A1,Rs16964201,"the 3 snps rs17703883, rs12594287 and rs16964201 affect bone mineral density in men"
CYP19A1,Rs2470144,Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19
CYP19A1,Rs2470144,height variation
CYP19A1,Rs2470144,CYP19 gene polymorphisms
CYP19A1,Rs2470144,lymphoma
CYP19A1,Rs2470144,gastric cancer
CYP19A1,Rs2470144,lymphoma.
CYP19A1,Rs2470144,Breast Cancer
CYP19A1,Rs2470144,breast cancer
CYP19A1,Rs2470144,osteoporosis
CYP19A1,Rs17703883,"the 3 snps rs17703883, rs12594287 and rs16964201 affect bone mineral density in men"
CYP19A1,Rs17703883,bone mineral density
CYP19A1,Rs2470144,rheumatoid arthritis
CYP1A1,Rs2470893,leukemia
CYP1A1,Rs2470893,childhood leukemia risk
CYP1A1,Rs2470893,lung cancer
CYP1A1,Rs2470893,habitual caffeine consumption
CYP1A1,Rs2470893,Paternal smoking
CYP1A2,Rs2470890,sporadic colorectal cancers
CYP1A2,Rs2470890,sporadic colorectal cancers:
CYP21A2,I5005427,Congenital adrenal hyperplasiars
CYP21A2,I5005433,Congenital adrenal hyperplasiars
CYP21A2,I5005437,Congenital adrenal hyperplasia
CYP2C19,Rs3814637,Association of warfarin dose with genes involved in its action and metabolism. The largest prospective warfarin-treated cohort supports genetic forecasting.
CYP2C8,Rs3832694,Cytochrome 
CYP2C8,Rs1934951,osteonecrosis of the jaw
CYP2C8,Rs1934980,Bisphosphonate-related osteonecrosis of the jaw
CYP2C8,Rs1934951,osteonecrosis of the jaw
CYP2C8,Rs1113129,chronic kidney disease
CYP2C8,Rs1934951,myeloma
CYP2C9,Rs2017319,Polymorphisms
CYP2C9,Rs2017319,gene transcription
CYP2C9,Rs2017319,mRNA processing
CYP2C9,Rs2017319,allelic expression imbalance
CYP2C9,Rs4086116,genome-wide association
CYP2C9,Rs4086116,acenocoumarol maintenance dosage
CYP2D6,Rs28360521,SNP
CYP2D6,Rs28360521,the significance of either allele
CYP2E1,Rs4646976,haplotypes
CYP2J2,Rs890293,hypertension
CYP2J2,Rs890293,ischemic events
CYP2J2,Rs890293,cardiovascular events
CYP2J2,Rs10889160,myocardial infarction
CYP2J2,Rs10889160,myocardial infarction.
CYP2J2,Rs10889160,myocardial infarction
CYP2J2,Rs11572325,myocardial infarction
CYP3A4,Rs4646437,human liver microsomes.
CYP3A4,Rs4646437,"genetic polymorphisms,"
CYP3A4,Rs4646437,"cyclosporine concentration, and dose requirement in transplant recipients."
CYP4F2,Rs2108622,cerebral infarction
CYP7A1,Rs1125226,Linkage disequilibrium blocks
CYP7A1,Rs1125226,haplotype structure
DAB2IP,Rs7025486,intracranial aneurysm
DAB2IP,Rs7025486,ischemic stroke
DAB2IP,Rs7025486,AAA
DAB2IP,Rs7025486,type 2 diabetes
DAB2IP,Rs7025486,hypertension
DAB2IP,Rs7025486,peripheral arterial disease (PAD)
DAB2IP,Rs7025486,abdominal aortic aneurysm (AAA)
DAB2IP,Rs7025486,pulmonary embolism (PE)
DAB2IP,Rs7025486,myocardial infarction
DAB2IP,Rs7025486,peripheral arterial disease PAD
DAB2IP,Rs7025486,pulmonary embolism
DAB2IP,Rs7025486,type 2 diabetes
DAB2IP,Rs7025486,hypertension
DAB2IP,Rs7025486,peripheral arterial disease (PAD)
DAB2IP,Rs7025486,abdominal aortic aneurysm (AAA)
DAB2IP,Rs7025486,20% increased risk of the various vascular diseases
DAB2IP,Rs7025486,peripheral arterial disease PAD
DAB2IP,Rs7025486,arterial and venous disease
DAB2IP,Rs7025486,abdominal aortic aneurysm (AAA)
DAB2IP,Rs7025486,early onset myocardial infarction (MI)
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs1571801,aggressive prostate cancer
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs1571801,aggressive prostate cancer
DAB2IP,Rs1571801,aggressive prostate cancer
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs1571801,aggressive prostate cancer
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs1571801,prostate cancer.
DAB2IP,Rs1571801,aggressive prostate cancer
DAB2IP,Rs1571801,aggressive prostate cancer
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs7025486,vascular diseases
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,bipolar disorder
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,boys
DAO,Rs3918346,bipolar affective disorder
DAO,Rs3918346,Korea
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs4623951,schizophrenia
DAO,Rs3918346,bipolar disorder
DAO,Rs4623951,high anxiety
DAO,Rs4623951,schizophrenia
DAO,Rs4623951,schizophrenia
DAO,Rs4623951,schizophrenia
DAO,Rs4623951,schizophrenia
DAO,Rs4623951,schizophrenia
DAO,Rs3918346,autism spectrum
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia 
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,autism 
DAO,Rs3918346,bipolar affective disorder
DAO,Rs3918346,schizophrenia 
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,polymorphisms 
DAO,Rs3918346,autism spectrum disorders
DAO,Rs3918346,schizophrenia 
DAO,Rs3918346,bipolar affective disorder
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,bipolar disorder
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,bipolar 
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAOA,Rs947267,schizophrenia
DAOA,Rs947267,schizophrenia
DAOA,Rs947267,schizophrenia
DAPK1,Rs4877365,Alzheimer's disease
DAPK1,Rs4878104,Alzheimer's disease
DAPK1,Rs4878104,Alzheimer's disease
DAPK1,Rs4878104,Alzheimer's disease
DBH,Rs739398,dopamine turnover
DBH,Rs6271,decreased homospecific activity
DBH,Rs6271,differential secretion
DBH,Rs6271,decreased homospecific activity and differential secretion
DBH,Rs739398,Aggressive behavior
DCC,Rs17468382,Parkinson's disease.
DCC,Rs17468382,Parkinson's disease
DCC,Rs2270954,schizophrenia
DCC,Rs2270954,schizophrenia
DCDC2,Rs793862,Caucasian populations
DCDC2,Rs793862,severely dyslexic individuals
DCDC2,Rs793862,dyslexia
DCDC2,Rs793862,dyslexic individuals
DCDC2,Rs793862,dyslexic individuals
DCDC2,Rs793862,dyslexic 
DCDC2,Rs793862,dyslexic
DCDC2,Rs793862,Caucasian 
DCDC2,Rs793862,dyslexic 
DCDC2,Rs793862,dyslexic
DCDC2,Rs793862,dyslexia
DCDC2,Rs793862,dyslexic 
DCHS1,Rs757309797,sources for thoracic aortic aneurysm.
DCHS1,Rs757309797,mitral valve prolapse
DCHS1,Rs757309797,thoracic aortic aneurysm
DCHS1,Rs201457110,mitral valve prolapse
DCHS1,Rs201457110,MVP
DDC,Rs2329340,autism
DDC,Rs2329340,migraine with aura
DDC,Rs2044859,increased incidence of migraine
DDC,Rs2044859,with aura
DDC,Rs2044859,without aura
DDC,Rs2044859,migraine patients
DDC,Rs2044859,migraine with aura
DDC,Rs11974297,increased incidence of migraine
DDC,Rs11974297,migraine patients
DDC,Rs11974297,without aura
DDC,Rs11974297,migraine with aura
DDC,Rs11761683,increased incidence of migraine
DDC,Rs11761683,with aura
DDC,Rs11761683,without aura
DDC,Rs11761683,migraine patients
DDC,Rs11761683,migraine with aura
DDC,Rs11974297,with aura
DGKH,Rs1012053,Bipolar disorder
DHCR7,Rs138659167,Smith-Lemli-Opitz syndrome
DHCR7,Rs138659167,SLO syndrome
DHCR7,Rs28938174,SLO
DHDDS,Rs764831063,Blueprint Genetics Retinal dystrophy
DHDDS,Rs764831063,Blueprint Genetics Retinal dystrophy
DHODH,Rs3213422,rheumatoid arthritis
DHODH,Rs3213422,rheumatoid arthritis
DISC1,Rs1322784,schizophrenia
DISC1,Rs821577,"neurodevelopmental, synaptogenic"
DISC1,Rs821577,schizophrenia
DISC1,Rs6675281,schizophrenia
DISC1,Rs3738402,schizophrenia
DISC1,Rs821577,bipolar disorder
DISC1,Rs1538979,schizophrenia
DISC1,Rs1322784,asperger's syndrome
DISC1,Rs1322784,asperger's syndrome
DISC1,Rs1538979,bipolar disorder
DKK4,Rs2073664,POLB locus.
DLK1,Rs1802710,brain tumors
DLK1,Rs1802710,lymphomaspopular 
DNAI1,Rs1060503515,p.Tyr397Thrfs
DNAI1,Rs397515363,primary ciliary dyskinesia
DNAJC13,Rs387907571,Parkinson's disease
DNAJC13,Rs387907571,Parkinson's disease
DNAJC13,Rs387907571,autosomal dominant Parkinson's disease
DNAJC13,Rs387907571,Dutch-German-Russian Mennonite heritage
DNAJC13,Rs387907571,to be a causative mutation for autosomal dominant Parkinson's disease
DNAJC13,Rs387907571,Caucasian Parkinson's patients
DNM1,Rs2502731,functional polymorphism of dynamin 1 gene with nicotine
DNM1,Rs3003609,heavier smoking 
DNM1,Rs3003609,nicotine dependence
DNM2,Rs892086,Alzheimer's disease
DNM2,Rs892086,ess DNM2 mRNA in their brains
DNM2,Rs892086,Alzheimer's disease
DNM3,Rs2421947,LRRK2 mutation
DNM3,Rs2421947,Parkinson's disease
DNM3,Rs2421947,Parkinson's disease
DOCK7,Rs267606655,coron
DOCK7,Rs267606655, artery disease
DOCK7,Rs267606655,minor allele
DOCK7,Rs267606655,coronary artery disease
DOCK7,Rs267606655,coronary artery disease.
DOCK7,Rs398122987,ANGPTL3
DPP6,Rs10260404,"60404(C;C) homozygotes, 1.60 (CI: 1.32-1.92).A ""C-C"" "
DPP6,Rs3807218,familial idiopathic ventricular fibrillation
DPP6,Rs10239794,ALS
DPP6,Rs10239794,European
DPP6,Rs10239794,ALS
DPP6,Rs10239794,Lou Gehrig's disease
DPP6,Rs10239794,ALS
DPYD,Rs1801160,cancer
DRD1,Rs5326,(early onset) schizophrenia
DRD1,Rs4532,autism
DRD1,Rs155417,associated with severity and temperament of alcoholism.
DRD1,Rs265981,autism
DRD1,Rs155417,polymorphism of dopamine receptor D1
DRD1,Rs155417,alcoholism
DRD1,Rs155417,severity and temperament of alcoholism
DRD1,Rs155417,polymorphism of dopamine receptor
DRD2,Rs4648318,Tourette syndrome
DRD2,Rs4648317,higher nicotine dependence scores
DRD2,Rs4648317,higher rates of smoking
DRD2,Rs4648317,"smoking and higher nicotine dependence scores,"
DRD2,Rs4648317,receptor 
DRD2,Rs4648317,D2 
DRD2,Rs4648317,dopamine 
DRD2,Rs2242592,behavioral inhibition
DRD2,Rs2242592,schizophrenia
DRD2,Rs2242592,schizophrenia
DRD2,Rs2242592,susceptibility 
DRD2,Rs2242592,schizophrenia
DRD2,Rs1800496,independent aspect of decision making in a learning paradigm
DRD2,Rs2242592,impulsivity/sensation seeking
DRD3,Rs167771,autism spectrum disorder
DRD4,Rs1800955,Anorexia Nervosa
DRD4,Rs587776842,nervous system dysfunctio
DRD4,Rs587776842,DRD4 gene
DRD4,Rs4331145,schizophrenia
DRD4,Rs1800955,schizophrenic
DRD4,Rs747302,chromosome 11
DRD4,Rs1800955,schizophrenia
DRD4,Rs1800955,idiopathic intellectual disability
DRD4,Rs1800955,schizophrenia
DRD4,Rs1800955,borderline personality traits
DRD4,Rs1800955,dopaminergic polymorphisms
DRD4,Rs1800955,Anorexia Nervosa
DRD4,Rs1800955,schizophrenia
DRD4,Rs1800955,personality
DRD4,Rs1800955,schizophrenia
DRD4,Rs1800955,borderline 
DRD4,Rs1800955,dopaminergic gene polymorphisms
DSP,Rs2076295,IIP
DSP,Rs2076295,IFP
DSP,Rs2076295,IIP
DSP,Rs2076295,IIP
DSP,Rs2076295,disrupts epithelial homeostasis
DSP,Rs2076295,loss of tissue integrity
DSP,Rs2076295,arrhythmogenic right ventricular dysplasia
DSP,Rs2076295,"arrhythmogenic right ventricular dysplasia , keratodermas"
DSP,Rs2076295,alopecia
DSP,Rs2076295,protein desmoplakin
DSP,Rs2076295,IFP
DSP,Rs2076295,alopecia
DSP,Rs2076295,epithelial homeostasis
DSP,Rs2076295,alveolar epithelia
DSP,Rs2076295,keratodermas
DSP,Rs2076295,idiopathic pulmonary fibrosis
DSP,Rs2076295,IIP
DSP,Rs140474226,sudden cardiac death patient
DSP,Rs140474226,dilated cardiomyopathy 
DSP,Rs140474226,arrhythmogenic right ventricular dysplasia
DSP,Rs140474226,cardiomyopathy
DSP,Rs140474226,arrhythmogenic right ventricular dysplasia;
DSP,Rs2076295,IIP
DSP,Rs2076295,interstitial pneumonia
DSP,Rs2076295,SNPs
DSP,Rs2076295,lung diseases
DSP,Rs2076295,ulmonary fibrosis
DSP,Rs2076295,"progressive scarring of the alveolar interstitium,"
DSP,Rs2076295,hypoxemic respiratory insufficiency
DSP,Rs2076295,death
DSP,Rs2076295,IIP.
DSP,Rs2076295,SNPs
DSPP,Rs28929492,deafness
DSPP,Rs28929492,deafness
DTNA,Rs104894654,left ventricular noncompaction.
DTNBP1,Rs760761,anxiety
DTNBP1,Rs760761,depression
DTNBP1,Rs760761,major depressive disorder
DTNBP1,Rs760761,neuroticism
DTNBP1,Rs760761,worse performance on memory tasks
DTNBP1,Rs760761,alterations in schizotypal beliefs and experiences
DTNBP1,Rs760761,"decreased attentional capacity,"
DTNBP1,Rs760761,schizophrenia
DVWA,Rs11718863,osteoarthritis
DVWA,Rs7639618,osteoarthritis
DVWA,Rs7639618,knee osteoarthritis
DVWA,Rs9864422,osteoarthritis 
DVWA,Rs9864422,Japanese
EDA2R,Rs1385699,baldness
EDA2R,Rs1385699,SNP 
EDA2R,Rs1385699,androgenetic alopecia
EDN1,Rs5370,systolic blood pressure
EDN1,Rs5370,diabetics
EDN1,Rs5370,type-2 diabetes
EDN1,Rs587777231,OMIM
EDN1,Rs5370,edema
EDN1,Rs5370,edema
EDN1,Rs5370,pulse pressure
EDN1,Rs5370,diabetic retinopathy
EDN1,Rs5370,lower HDL cholesterol
EDN1,Rs5370,Hypertension
EDN1,Rs5370,type-2 diabetes
EDN1,Rs5370,diabetic retinopathy
EDN1,Rs5370,edema
EDN1,Rs5370,rheumatoid arthritis
EDN1,Rs5370,HDL cholesterol
EDN1,Rs5370,rheumatoid arthritis
EGF,Rs4444903,acute respiratory distress syndrome
EGF,Rs4444903,females 
EGF,Rs4444903,Indian 
EGF,Rs4444903,gliomas 
EGF,Rs4444903,oligodendrogliomas 
EGF,Rs4444903,glioblastomas 
EGF,Rs4444903,schizophrenia
EGF,Rs4444903,glioma 
EGF,Rs4444903,gallbladder cancer
EGF,Rs4444903,lung cancer
EGF,Rs4444903,Singapore-Chinese
EGF,Rs4444903,psoriatic arthritis
EGF,Rs4444903,lung cancer
EGF,Rs4444903,Chinese 
EGF,Rs718768,proliferative vitreoretinopathy
EGF,Rs4444903,renal cell carcinoma
EGF,Rs4444903,hepatocellular carcinoma
EGF,Rs4444903,chronic HBV infection
EGF,Rs718768,endometrial cancer
EGF,Rs4444903,race
EGF,Rs4444903,Korean 
EGF,Rs4444903,sex
EGF,Rs4444903,chronic HBV infection
EGF,Rs4444903,hepatocellular carcinoma (liver cancer)
EGF,Rs4444903,alcoholic cirrhosis
EGF,Rs4444903,Indian gallbladder cancer patients
EGF,Rs4444903,only in females
EGF,Rs4444903,acute respiratory distress syndrome risk
EGF,Rs4444903,hepatocellular carcinoma
EGF,Rs4444903,hepatocellular carcinoma (liver cancer)
EGF,Rs4444903,gliomas
EGF,Rs4444903,glioblastomas
EGF,Rs4444903,oligodendrogliomas
EGF,Rs4444903,epidermal growth factor
EGF,Rs4444903,schizophrenia
EGF,Rs4444903,gallbladder cancer
EGF,Rs4444903,Caucasian 
EGF,Rs4444903,chronic HBV infection
EGF,Rs4444903,hepatocellular carcinoma
EGF,Rs4444903,cirrhosis 
EGF,Rs4444903,lung cancer
EGF,Rs4444903,lung cancer
EGF,Rs4444903,bladder cancer
EGF,Rs4444903,age
EGFR,Rs121434568,non-small cell lung cancer
EGFR,Rs121434568,non-small cell lung cancer
EGFR,Rs121434568,tumors
EGFR,Rs121434568,non-small cell lung cancer
EGFR,Rs121434568,non-small cell lung cancer
EGFR,Rs121434568,tumors
EGLN1,Rs186996510,hypoxia 
EGLN1,Rs186996510,hypoxia
EGLN1,Rs186996510,Tibetans 
EGLN1,Rs186996510,family hypoxia-inducible factor
EGLN1,Rs12097901,hypoxia
EGLN1,Rs186996510,Tibetans
EIF2AK4,Rs587777208,pulmonary hypertension
EIF2AK4,Rs587777208,EIF2AK4 gene 
EIF2AK4,Rs587777208,pulmonary venoocclusive disease
EIF2AK4,Rs587777208,pulmonary capillary hemangiomatosis
EIF2AK4,Rs587777107,pulmonary venoocclusive disease (PVOD)
EIF2AK4,Rs587777107,pulmonary capillary hemangiomatosis (PCH)
EIF2AK4,Rs587777107,pulmonary hypertension
EIF2AK4,Rs587777106,pulmonary venoocclusive disease
EIF2AK4,Rs587777106,pulmonary capillary hemangiomatosis
EIF2AK4,Rs587777105,pulmonary venoocclusive disease
EIF2AK4,Rs587777106,pulmonary hypertension
EIF2AK4,Rs587777105,pulmonary hypertension
EIF2AK4,Rs587777102,pulmonary hypertension
EIF2AK4,Rs587777105,pulmonary capillary hemangiomatosis
EIF2AK4,Rs587777102,pulmonary venoocclusive disease
EIF2AK4,Rs587777103,pulmonary hypertension
EIF2AK4,Rs587777102,pulmonary capillary hemangiomatosis
EIF2AK4,Rs587777103,pulmonary venoocclusive disease
EIF2AK4,Rs587777104,pulmonary hypertension
EIF2AK4,Rs587777104,ulmonary capillary hemangiomatosis
EIF2AK4,Rs587777104,pulmonary venoocclusive disease
EIF2AK4,Rs587777103,pulmonary capillary hemangiomatosis
EIF3G,Rs2305795,narcolepsy
EIF3G,Rs2305795,narcolepsy
EIF4G1,Rs113169049,late-onset disease
EIF4G1,Rs113388242,dominant mutation
EIF4G1,Rs113388242,familial Parkinson's disease
EIF4G1,Rs113169049,Parkinson's disease
EIF4G1,Rs113388242,Parkinson's disease
EIF4G1,Rs113169049,familial Parkinson's disease
EIF4G1,Rs113169049,Parkinson's disease
EIF4G1,Rs112176450,Parkinson's disease
EIF4G1,Rs113169049,eukaryotic translation initiation factor 4 gamma
ELAC2,Rs4792311,prostate cancer
ENG,Rs1800956,intracranial aneurysms
ENG,Rs1800956,intracranial aneurysms
ENG,Rs1800956,intracranial aneurysm
ENOSF1,Rs3819102,endometrial cancer
ENOSF1,Rs3819102,endometrial cancer
ENPP1,Rs121908248,arterial calcification
ENPP1,Rs121908248,hypophosphatemic rickets
EPAS1,Rs17039192,knee osteoarthritis
EPAS1,Rs17039192,knee osteoarthritis
EPCAM,Rs1126497,breast cancer
EPCAM,Rs1126497,breast cancer
EPHA2,Rs11260867," A study involving a case-control cohort from Northern Italy, comprising 126 unrelated"
EPOR,Rs121918116,erythrocytosis
EPOR,Rs121918116,rare mutation in the EPOR erythropoietin receptor gene on chromosome 19
EPOR,Rs121918116,autosomal dominant erythrocytosis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs27044, ankylosing spondylitis.
ERAP1,Rs2549782,pre-eclampsia
ERAP1,Rs2549782,unpaired African American
ERAP1,Rs2549782,pre-eclampsia
ERAP1,Rs10050860,polymorphisms 
ERAP1,Rs10050860,nkylosing spondylitis
ERAP1,Rs10050860,ERAP1
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,familial ankylosing spondylitis.
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs2549782,Chilean maternal-fetal dyads
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,familial ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,familial ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERBB4,Rs839523,schizophrenia
ERBB4,Rs7598440,schizophrenia
ERBB4,Rs707284,psychosis risk variants
ERBB4,Rs707284,bipolar affective disorder
ERBB4,Rs707284,major depressive disorder and schizophrenia
ERBB4,Rs707284,synaptic plasticity and schizophrenia.
ERBB4,Rs707284,schizophrenia
ERBB4,Rs707284,schizophrenia
ERBB4,Rs707284,schizophreni
ERCC2,Rs13181,breast cancer
ERCC2,Rs13181,Lung cancer
ERCC2,Rs13181,bladder cancer 
ERCC2,Rs13181,bladder cancer
ERCC2,Rs13181,bladder cancer
ERCC2,Rs13181,lung adenocarcinoma
ERCC2,Rs13181,Locally Advanced Head and Neck Cancer
ERCC2,Rs13181,gastric and colorectal cancer
ERCC2,Rs13181,gallbladder cancer
ERCC2,Rs13181,esophageal squamous cell carcinoma
ERCC2,Rs13181,non-small cell lung cancer
ERCC2,Rs13181,lung adenocarcinoma
ERCC2,Rs13181,sophageal cancer
ERCC2,Rs13181,sophageal adenocarcinoma
ERCC2,Rs13181,systemic lupus erythematosus
ERCC2,Rs13181,colorectal cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,breast cancer risk
ERCC2,Rs13181,renal cell carcinoma
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,human breast cancer
ERCC2,Rs13181,pancreatic adenocarcinoma
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,non-melanoma skin cancer 
ERCC2,Rs13181,Gallbladder cancer
ERCC2,Rs13181,adult glioma
ERCC2,Rs13181,esophageal squamous cell carcinoma 
ERCC2,Rs13181,bladder
ERCC2,Rs13181,oral precancer and cancer
ERCC2,Rs13181,colorectal cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,lung adenocarcinoma
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,cancer
ERCC2,Rs13181,bladder cancer
ERCC2,Rs13181,Lung cancer
ERCC2,Rs13181,colorectal cancer
ERCC2,Rs13181,ung cancer
ERCC2,Rs13181,breast cancer risk
ERCC2,Rs13181,esophageal adenocarcinoma
ERCC2,Rs13181,pancreatic adenocarcinoma
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,non-melanoma skin cancer
ERCC2,Rs13181,cancer
ERCC2,Rs13181,cancer
ERCC2,Rs13181,non-Hodgkin lymphoma
ERCC2,Rs13181,cancer
ERCC2,Rs13181,esophageal cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,cutaneous melanoma risk
ERCC2,Rs13181,ung cancer risk
ERCC2,Rs13181,lung cancer risk
ERCC2,Rs13181,neck squamous cell cancer
ERCC2,Rs13181,colorectal cancer risk
ERCC2,Rs13181,cancer cells
ERCC2,Rs13181,cancer
ERCC2,Rs13181,Bladder cancer
ERCC2,Rs13181,breast cancer
ERCC2,Rs13181,cancer
ERCC2,Rs13181,pancreatic adenocarcinoma
ERCC2,Rs13181,Polymorphisms
ERCC2,Rs13181,esophageal adenocarcinoma
ERCC2,Rs13181,Polymorphisms
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,non-melanoma skin cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,Genetic polymorphisms
ERCC2,Rs13181,single nucleotide polymorphisms
ERCC2,Rs13181,cancer cells
ERCC2,Rs13181,Allelic imbalance
ERCC2,Rs13181,non-Hodgkin lymphoma (NHL)
ERCC2,Rs13181,Bladder cancer
ERCC2,Rs13181,non-small cell lung cancer patients
ERCC2,Rs13181,genetic polymorphisms
ERCC2,Rs13181,adult glioma
ERCC2,Rs13181,esophageal cancer
ERCC2,Rs13181, lung cancer
ERCC2,Rs13181,Polymorphisms
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,ovarian cancer 
ERCC2,Rs13181,cutaneous melanoma
ERCC2,Rs13181,non-Hodgkin lymphoma (NHL)
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,renal cell carcinoma
ERCC2,Rs13181,breast cancer 
ERCC2,Rs13181,adiposity
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,adult glioma
ERCC2,Rs13181,esophageal cancer
ERCC2,Rs13181,human lung cancer
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,cutaneous melanoma
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,head and neck squamous cell cancer
ERCC2,Rs13181, oral precancer
ERCC2,Rs13181,colorectal cancer 
ERCC2,Rs13181,esophageal squamous cell carcinoma
ERCC2,Rs13181,gastric and colorectal cancer
ERCC2,Rs13181,gallbladder cancer
ERCC2,Rs13181,Head and Neck Cancer
ERCC2,Rs13181,lung adenocarcinoma
ERCC2,Rs13181,lung adenocarcinoma
ERCC2,Rs13181,bladder cancer
ERCC2,Rs13181,bladder cancer
ERCC2,Rs13181,bladder cancer risk
ERCC2,Rs13181,Lung cancer
ERCC2,Rs13181,breast cancer
ERCC2,Rs13181,esophageal cancer
ERCC2,Rs13181,colorectal cancer
ERCC2,Rs13181,Lung Cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,lung cancer
ERCC6,Rs3793784,lung cancer risk.
ERCC6,Rs3793784,age-related macular degeneration
ERCC6,Rs3793784,age related macular degeneration
ERCC6,Rs3793784,macular degeneration
ESCO2,Rs80359869,Roberts syndrome
ESCO2,Rs80359862,Roberts syndrome
ESCO2,Rs80359862,phocomelia
ESCO2,Rs80359861,Roberts syndrome
ESCO2,Rs80359861,phocomelia
ESCO2,Rs80359869,phocomelia
ESCO2,Rs80359851,ESCO2
ESCO2,Rs80359851,Nmd efficiency
ESCO2,Rs80359851,Nmd efficiency
ESCO2,Rs80359851,intertissue and interindividual variation
ESCO2,Rs80359851,homozygous frameshift mutation
ESR1,Rs2234693,Down syndrome
ESR1,Rs2234693,reproductive disorders
ESR1,Rs2234693,osteoporotic
ESR1,Rs2234693,osteoporosis
ESR1,Rs2234693,hypogonadotropic hypogonadism
ESR1,Rs2234693,Polycystic ovary syndrome
ESR1,Rs2234693,reproductive disorders:
ESR1,Rs2234693, psychiatric disorders.
ESR1,Rs2234693,cardiovascular phenotypes
ESR1,Rs2234693,Alzheimer's disease
ESR1,Rs2234693,obesity and lipolysis
ESR1,Rs2234693,osteonecrosis
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,obesity
ESR1,Rs3020314,breast cancer
ESR1,Rs2234693,cancer 
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,cardiovascular risk
ESR1,Rs2234693,migraine susceptibility.
ESR1,Rs2234693,stroke
ESR1,Rs2234693,osteoporosis 
ESR1,Rs2234693,acute lymphoblastic leukemia
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs3020314,estrogen receptor-positive breast cancer risk (C) ha
ESR1,Rs3020314,follicular lymphoma
ESR1,Rs3020314,estrogen receptor-positive breast cancer risk
ESR1,Rs3020314,follicular lymphoma
ESR1,Rs2295190,increased risk for ovarian cancer
ESR1,Rs2295190,ovarian cancer
ESR1,Rs2234693,osteoporosis
ESR1,Rs2234693,histopathological tumo
ESR1,Rs2234693,prostate cancer
ESR1,Rs2234693,HIV-infected
ESR1,Rs2234693,spontaneous abortion
ESR1,Rs2234693,late-life depression
ESR1,Rs2234693,prostate cance
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,schizophrenia
ESR1,Rs2234693,menopause
ESR1,Rs2234693,pediatric acute lymphoblastic leukemia
ESR1,Rs2234693,hyperlipidemia
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,prostate cance
ESR1,Rs2234693,endometrial cancer
ESR1,Rs2234693,obesity
ESR1,Rs2234693,anxiety disorders
ESR1,Rs2234693,schizophrenia
ESR1,Rs2234693, breast conditions
ESR1,Rs2234693,fertilization
ESR1,Rs2234693,interaction between lean tissue mass
ESR1,Rs2234693,lipoprotein cholesterol
ESR1,Rs2234693,myocardial infarction
ESR1,Rs2234693,stroke
ESR1,Rs2234693,ischemic stroke
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,endometrial cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,body height
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,endometrial cancer
ESR1,Rs2234693,prostate cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,prostate cancer
ESR1,Rs2234693,prostate cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs2179922,height
ESR1,Rs1999805,increases susceptibility to Bone mineral density variations
ESR1,Rs2234693,endometrial cancer
ESR1,Rs2234693,Alzheimer's disease
ESR1,Rs2234693,type 2 diabetes
ESR1,Rs2234693,plasma lipid
ESR1,Rs2234693,osteoporosis
ESR1,Rs2234693,sexual dimorphism
ESR1,Rs2234693,HIV
ESR1,Rs2234693,anxiety disorders
ESR1,Rs2234693,lung adenocarcinoma
ESR1,Rs2234693,lupus erythematosus
ESR1,Rs2234693,schizophrenia
ESR1,Rs2234693,osteoarthritis
ESR1,Rs2234693,Down syndrome
ESR1,Rs2234693,hot flushes
ESR1,Rs2234693,menopause
ESR1,Rs2234693,osteoarthritis
ESR1,Rs2234693,altered bone mineral density
ESR1,Rs2234693,knee osteoarthritis
ESR1,Rs2234693,obesity
ESR1,Rs2234693,spontaneous abortion
ESR1,Rs2234693,reproductive disorders
ESR1,Rs2234693,dry eye
ESR1,Rs2234693,reproductive disorders
ESR1,Rs2234693,psychiatric disorders
ESR1,Rs2234693,apolipoprotein levels
ESR1,Rs2234693,body composition in pediatric acute lymphoblastic leukemia
ESR1,Rs2234693,schizophrenics
ESRRB,Rs2360997,attention-deficit/hyperactivity disorder
ESRRB,Rs2360997,autism spectrum disorder
EXO1,Rs1776180,female centenarians
EXO1,Rs1776180,associated with longevity
EXO1,Rs1776180,longevity
EXO1,Rs1635498,breast cancer
EXO1,Rs1047840,breast cancer.
EXO1,Rs1047840,breast cancer
EXO1,Rs1635517,breast cancer
F11,Rs121965063,Ashkenazi Jews
F11,Rs281875251,Factor XI deficiency
F11,Rs281875251,Factor XI deficiency
F11,Rs373297713,deficiency-causing mutations
F12,Rs1801020,"Affects heart disease risk for both men and women, based on a study of two Finnish population cohorts"
F2,Rs1799963,venous thromboembolism
F2,Rs1799963,PFO
F2,Rs1799963,patent foramen ovale (PFO)
F2,Rs1799963,cerebral ischemia
F2,Rs1799963,ischemic stroke
F2,Rs1799963,hole in the heart
F2,Rs1799963,Venous thromboembolism
F2,Rs1799963,OR
F2,Rs1799963,Venous thrombosis
F2,Rs1799963,Cerebral venous sinus thrombosis
F2,Rs1799963,Venous Thromboembolism
F2,Rs1799963,thromboembolism
F5,Rs6025,deep venous thrombosis
F5,Rs6025,venous thrombosis
F5,Rs6025,thromboembolic events
F5,Rs6025,postmenopausal women
F5,Rs6025,breast cancer
F5,Rs6025,women
F5,Rs6025,cerebral vein or cerebral sinus thrombosis
F5,Rs6025,thrombosis
F5,Rs6025,venous thromboembolism
F5,Rs6025,ischemic stroke
F5,Rs6025,venous thromboembolism
F5,Rs6025,women
F5,Rs6025,Lemierre's syndrome
F5,Rs6025,ischemic stroke
F5,Rs6025,amyotrophic lateral sclerosis
F5,Rs6025,venous thromboembolism
F5,Rs6025,ischemic stroke
F5,Rs6025,venous thromboembolism
F5,Rs6025,candidate genes with blood pressure progressio
F5,Rs6025,hypertension
F5,Rs6025,Sao Miguel's healthy population
F5,Rs6025,migraine
F5,Rs6025,Sri Lankan population
F5,Rs6025,inflammation and thrombosis
F5,Rs6025,venous thromboembolism
F5,Rs6025,colorectal cancer risk
F5,Rs6025,coronary heart disease
F5,Rs6025,Sinhalese women
F5,Rs7542281,Leiden mutation
F5,Rs6025,thrombosis
F5,Rs7542281,ischemic stroke events
F5,Rs6025,pre-eclampsia or venous thromboembolism
F5,Rs6019,GC
F5,Rs6025,women
F5,Rs6025,obstetric complications
F5,Rs1800595,venous thrombosis
F5,Rs2269648,Leiden mutation
F5,Rs2269648,ischemic stroke events
F5,Rs4524,deep vein thrombosis
F5,Rs4524,deep vein thrombosis
F5,Rs4524,deep vein thrombosis
F5,Rs4524,deep vein thrombosis
F5,Rs6019,PTD
F5,Rs6019,PTD
F5,Rs6019,fetal growth.
F5,Rs6019,maternal smoking
F5,Rs6019,non-smoking mothers
F5,Rs6019,fetal growth.
F5,Rs6019,PTD
F5,Rs6025,venous thromboembolism
F5,Rs6025,women
F5,Rs6025,overweight smokers
F5,Rs6025,nonsmokers younger than 40 years of age with a body mass index below 25 kg/m2
F5,Rs6025,venous thromboembolism
F5,Rs6025,venous thromboembolism
F5,Rs6019,CC
F5,Rs6025,cerebral venous sinus thrombosis
F5,Rs6025,Caucasian adults in the Danish population
F5,Rs6025, venous thrombosis 
F5,Rs6025,thrombosis
F5,Rs6025,women
F5,Rs6025,men
F5,Rs6025,Venous Thromboembolism
F5,Rs6025,pulmonary embolism
F9,I5007022,Hemophilia
FABP2,Rs5861422,Type 2 diabetes-associated fatty acid
FADS1,Rs174547,coronary heart disease
FADS1,Rs174547,cardiovascular risk
FADS1,Rs174546,allergic diseases
FADS1,Rs174547,familial combined hyperlipidemia
FADS1,Rs174547,carotid artery disease
FADS2,Rs66698963,eart disease and colon cancer
FADS2,Rs66698963,heart disease 
FADS2,Rs66698963,colon cancer
FADS2,Rs66698963,more susceptible to inflammation
FADS2,Rs968567,rheumatoid arthritis
FADS2,Rs968567,rheumatoid arthritis
FADS3,Rs7115739,enetic signatures of diet and climate adaptation
FADS3,Rs7115739,genetic 
FADS3,Rs7115739,Greenlandic 
FADS3,Rs7115739,Inuit 
FADS3,Rs7115739,show 
FAH,Rs80338899,hereditary tyrosinemia type 1 mutation
FAH,Rs80338899,hereditary tyrosinemia type I
FAH,Rs80338899,stop mutation
FAH,Rs11555096,Tyrosinemia Type I
FAH,I5012867,Tyrosinemia 
FAH,I5012867,Tyrosinemia Type I
FAH,I5012867,Tyrosinemia Type I
FAH,I5012861,Tyrosinemia
FAH,I5012867,Tyrosinemia Type I
FAM13A,Rs7671167,lung cancer
FANCC,I4000336,Fanconi Anemia
FANCC,I4000336,Fanconi Anemiars
FANCC,Rs104886456,Fanconi anemia
FANCC,Rs104886456,"Fanconi anemia,"
FANCC,Rs104886456,Fanconi anemia
FANCM,Rs144567652,breast cancer 
FCGR2B,Rs1050501,systemic lupus erythematosus
FECH,Rs2272783,nonfunctional FECH allele
FECH,Rs2272783,lowered expression of that enzyme.
FECH,Rs2272783,erythropoietic protoporphyria
FECH,Rs2269219,protoporphyria
FECH,Rs2269219,erythropoietic 
FGF23,Rs28937882,R179W
FGF23,Rs28937882,Arg179Trp
FGFR2,Rs7895676,sporadic postmenopausal ER+ breast cancer
FGFR2,Rs7895676,breast cancer
FGFR2,Rs7895676,breast cancer
FGFR2,Rs7895676,breast cancer
FGFR3,Rs121913114,achondroplasia
FGFR3,Rs121913105,"SADDAN dysplasia"""
FGFR3,Rs121913105,achondroplasia
FGFR3,I6010295,Achondroplasiars
FGFR3,I6010295,Achondroplasiars
FGFR3,I5001267,Achondroplasia
FGFR3,I5053815,Achondroplasia
FGFR3,I5001280,Achondroplasia
FGFR3,Rs28931614,achondroplasia
FGFR3,I5001264,Achondroplasia
FGFR3,I6010281,Achondroplasia
FGFR3,Rs28931614,dwarfism
FGFR3P1,Rs13202464,B27 Syndromes
FGFR4,Rs2011077,prostate cancer
FGFR4,Rs641101,coronary artery disease
FGFR4,Rs641101,Fibroblast growth factor receptor 4 polymorphisms
FGFR4,Rs351855,prostate cancer
FGFR4,Rs351855,prostate-cancer
FGFR4,Rs351855,prostate cancer
FGFR4,Rs641101,coronary artery disease
FGFR4,Rs351855,metastatic prostate cancer
FGFR4,Rs351855,prostate cancer and benign prostate hyperplasia
FGFR4,Rs351855,prostate cancer
FGFR4,Rs351855,node-positive breast cancer
FGFR4,Rs2011077,benign prostate hyperplasia
FGFR4,Rs351855,prostate cancer
FKBP5,Rs9470080,aggressive behavior
FKBP5,Rs9470080, childhood trauma
FKBP5,Rs9470080,aggressive behavior
FKBP5,Rs9470080,inflammatory bowel disease
FKBP5,Rs9470080,depressive symptoms
FKBP5,Rs9470080,cortisol secretion
FKBP5,Rs9470080,PTSD
FKBP5,Rs9470080,childhood trauma
FKBP5,Rs3800373,PTSD
FKBP5,Rs9470080,glucocorticoid resistance
FKBP5,Rs9470080,depressive symptoms
FKBP5,Rs9470080,adult PTSD symptoms
FKBP5,Rs9296158,PTSD
FKBP5,Rs9296158,severity of child abuse
FKBP5,Rs4713902,bipolar disorder
FKBP5,Rs3800373,severity of child abuse
FKBP5,Rs9470080,inflammatory bowel disease
FKRP,Rs28937900,Limb-girdle muscular dystrophy-dystroglycanopathy
FLCN,Rs41419545,Folliculin mutations
FLCN,Rs41419545,COPD
FLG,Rs41370446,loss of normal protein function
FLG,Rs558269137,ichthyosis vulgaris
FLG,Rs558269137,ichthyosis vulgaris
FLG,Rs150597413,ichthyosis 
FLG,Rs558269137,atopic dermatitis
FLG,Rs558269137,eczema
FLG,Rs558269137,ichthyosis vulgaris
FLG,Rs558269137,atopic dermatitis
FLG,Rs61816761,eczema
FLG,Rs61816761,ichthyosis vulgaris
FLG,Rs754812742,ichythosis vulgaris
FLG,Rs61816761,atopic dermatitis
FLG,Rs61816761,atopic dermatitis
FLG,Rs61816761,asthma predisposition
FLG,Rs61816761,type 1 diabetes
FLG,Rs142991475,loss of normal protein function
FLG,Rs558269137,eczema.
FLG,Rs140980397,European and African American ancestry.
FLG,Rs61816761,ichthyosis vulgaris
FLG,Rs138726443,eczema
FLG,Rs140980397,FLG gene
FLG,Rs114733570,protein truncation
FLG,Rs114733570,loss of normal protein function through protein truncation
FLG,Rs121909626,ichthyosis vulgaris
FLG,Rs121909626,dermatitis
FLG,Rs121909626,Japanese patients
FLG,Rs121909626,ichthyosis vulgaris
FLG,Rs121909626,Japanese families
FLG,Rs121909626,atopic dermatitis
FLG,Rs121909626,severe presentation of the disease
FLG,Rs121909626,Japanese patients
FLG,Rs121909626,atopic dermatitis
FLG,Rs121909626,Japanese controls
FLG,Rs138726443,eczema
FLG,Rs138726443,chthyosis vulgaris
FLG,Rs138726443,ichthyosis vulgaris
FLG,Rs121909626,ichthyosis vulgaris
FLNB,Rs80356520,vertebral segmentation
FLNB,Rs80356520,"disrupt vertebral segmentation, joint formation and skeletogenesis."
FLNB,Rs80356520,skeletogenesis
FLNB,Rs80356520,vertebral segmentation
FLNB,Rs80356520,skeletogenesis
FLNB,Rs80356520,joint formation
FLNB,Rs80356520,joint formation
FMO3,Rs1736557,trimethylaminuria
FMO3,Rs72549320,trimethylaminuria
FMO3,Rs72549321,trimethylaminuria
FMO3,Rs72549323,trimethylaminuria
FMO3,Rs72549326,trimethylaminuria
FMO3,Rs72549326,trimethylaminuria.
FMO3,Rs72549334,trimethylaminuria
FMO3,Rs72549334,trimethylaminuria
FMO3,Rs72549334,trimethylaminuria
FMO3,Rs72549334,homozygous minor genotype
FN1,Rs137854488,glomerulopathy with fibronectin deposits
FOXE1,Rs1867277,thyroid cancer
FOXE1,Rs1867277,thyroid cancer
FOXE1,Rs1867277,SNP 
FOXE1,Rs1867277,thyroid cancer
FOXO3,Rs12212067,rheumatoid arthritis
FOXO3,Rs12212067,Crohn's disease
FOXO3,Rs12212067,FOXO3A gene
FOXO3,Rs1935949,longevity
FOXO3,Rs2764264,greater odds of longevity
FOXP2,Rs10227893,may impair speech
FOXP2,Rs117717824,scalp 
FOXP2,Rs117717824,hair 
FOXP2,Rs17137124,may impair speech
FOXP2,Rs2396753, grey matter concentration
FOXP2,Rs2396753,schizophrenia
FOXP3,Rs3761548,allergic rhinitis
FOXP3,Rs3761548,atopy
FOXP3,Rs3761548,type I diabetes
FOXP3,Rs3761548,psoriasis
FOXP3,Rs3761548,Type I Diabetes
FOXP3,Rs3761548,psoriasis
FOXP3,Rs3761547,Idiopathic 
FOXP3,Rs3761547,Juvenile 
FOXP3,Rs3761548,Autoimmune thyroiditis and diabetes
FSHR,Rs1394205,29
FSHR,Rs1394205,ak
FSHR,Rs6166,less fecund women
FTO,Rs3751812,body weight
FTO,Rs3751812,body weight
FTO,Rs3751812,african americans
FTO,Rs7193144,early onset obesity
FTO,Rs9937053,body weight
FTO,Rs9932754,body mass index
FTO,Rs9932754,severe obesity
FTO,Rs9932754,body weight
FTO,Rs9932754,severe obesity
FTO,Rs9932754,Japanese
FTO,Rs1861868,obesity 
FTO,Rs9932754,body weight
FTO,Rs1477196,obesity risk
FTO,Rs9922619,body weight
FTO,Rs1477196,obesity
FTO,Rs1477196,diabetes
FTO,Rs121918214,growth retardation
FTO,Rs121918214,developmental delay
FTO,Rs121918214,coarse facies
FTO,Rs121918214,growth retardation
FTO,Rs121918214,early death
FTO,Rs121918214,coarse facies
FTO,Rs121918214,early death
FTO,Rs1477196,Physical activity
FTO,Rs1477196,obesity
FTO,Rs1477196,diabetes
FTO,Rs121918214,developmental delay
FUS,Rs929867,CVID
FUS,Rs929867,common variable immunodeficiency
FUS,Rs929867,common variable immunodeficiency
FUT2,Rs1047781,Japanese
FUT2,Rs1047781,Caucasians
FUT2,Rs1047781,Japanese
FXN,Rs143340609,Friedreich's ataxia
FXN,Rs143396368,Friedreich's ataxia
FXN,Rs143396368,Friedreich's ataxia
FXN,Rs143396368,compound heterozygote
FXN,Rs144104124,Friedreich's ataxia
FXN,Rs56214919,Friedreich's ataxia
FXN,Rs144610605,Friedreich's ataxia
FXN,Rs146818694,Friedreich's ataxia
FXN,Rs146818694,Friedreich's ataxia
FXN,Rs147211454,Friedreich's ataxia
FXN,Rs148698100,Friedreich's ataxia
FXN,Rs150676454,Friedreich's ataxia
FXN,Rs151206121,Friedreich's ataxia
FXN,Rs151206121,Friedreich's ataxia
FXN,Rs56214919,Friedreich's ataxia
FXN,Rs143232208,Friedreich's ataxia
FXN,Rs142157346,Friedreich's ataxia
FXN,Rs144104124,Friedreich's ataxia
FXN,Rs142133355,Friedreich's ataxia
FXN,Rs142157346,Friedreich's ataxia
FXN,Rs104894107,Friedreich's ataxia
FXN,Rs138034837,Friedreich's ataxia
FXN,Rs138034837,Friedreich's ataxia
FXN,Rs138446138,Friedreich's ataxia
FXN,Rs138446138,Friedreich's ataxia
FXN,Rs138837292, Friedreich's ataxia
FXN,Rs140472905,Friedreich's ataxia
FXN,Rs138446138,Friedreich's ataxia
FXN,Rs140987490,mutation in the FXN gene on chromosome 9
FXN,Rs140987490,Friedreich's ataxia
FXN,Rs141526971,Friedreich's ataxia
FXN,Rs141526971,Friedreich's ataxia
FXN,Rs141526971,Friedreich's ataxia
FXN,Rs141935559,Friedreich's ataxia
FXN,Rs141935559,Friedreich's ataxia
FXN,Rs140472905,Friedreich's ataxia
FYCO1,Rs1545985,prostate cancer
FYCO1,Rs7652331,prostate cancer
G6PC,Rs80356487,glycogen storage disease type 1a
G6PC,Rs80356487,glycogen storage disease type 1a
G6PC,Rs1801175,severity of the disease
G6PC,Rs80356487,glycogen storage disease type 1a
G6PC,Rs1801175,Ashkenazi Jews
G6PC,Rs1801175,Glycogen storage disease type 1A
G6PC,Rs1801175,Glycogen storage disease type 1A
G6PD,Rs1163458456,c.99A
G6PD,Rs137852318,"Overall, while the minor allele is reported to lead to a mild phenotype, for the moment it continues to be reported in ClinVar,"
G6PD,Rs137852318,benign
G6PD,Rs137852318,mild phenotype
G6PD,Rs137852330,favism
G6PD,Rs137852330,hemolytic anemia
G6PD,Rs137852330,chronic granuloma
G6PD,Rs137852330,hemolytic anemia
G6PD,Rs1557229572,Gln449His
G6PD,Rs267606835,hemolytic anemia
G6PD,Rs267606835,chronic granuloma
G6PD,Rs267606835,hemolytic anemia
G6PD,Rs76723693,The authors suggest that when using Hb1Ac values to diagnose
G6PD,Rs76723693,type-2 diabetes
G6PD,Rs76723693, type-2 diabetes
G6PD,Rs76723693,men 
G6PD,Rs76723693,women
G6PD,Rs76723693,type-2 diabetes
G6PD,Rs76723693,type-2 diabetes
G6PD,Rs76723693,lowering HbA1c values
G6PD,Rs76723693,heterozygous women
G6PD,Rs76723693,hemizygous men
G6PD,Rs1050829,malarial infection 
G6PD,Rs267606835,chronic granuloma
G6PD,Rs1050829,malarial infection
G6PD,Rs1050828,African Americans
G6PD,Rs1050828,"lower red blood cell, hemoglobin and hematocrit counts"
G6PD,Rs1050829,G6PD deficiency
G6PD,Rs1050828,African ancestry
G6PD,Rs1050828,red blood cells
G6PD,Rs1050828,malarial regions
G6PD,Rs1050828,malarial infection
G6PD,Rs1050828,lowering HbA1c values by ~0.88%-units 
G6PD,Rs1050828, Hb1Ac values
G6PD,Rs1050828,type-2 diabetes
G6PD,Rs1050828,eastern Sudan (Hausa and Massalit)
G6PD,Rs1050828, Massalit individuals
G6PD,Rs1050828,malarial infection
G6PD,Rs1050828,Hb1Ac level
G6PD,Rs1050828,African American individuals
G6PD,Rs1050828,erythrocyte phenotype
G6PD,Rs1050828,Caucasian
G6PD,Rs1050828,mean corpuscular volume
G6PD,Rs1050828,malarial infection
G6PD,Rs1050828,G6PD deficiency
G6PD,Rs1050828,mean corpuscular hemoglobin
G6PD,Rs1050828,African American medical patients
G6PD,Rs1050828,African Americans 
G6PD,Rs1050828,"lower red blood cell, hemoglobin and hematocrit counts"
G6PD,Rs1050828,oxidative damage
GAB2,Rs2373115,Alzheimer's disease
GAB2,Rs7107174,testicular cancer
GAB2,Rs7107174,testicular cancer
GAB2,Rs7101429,Alzheimer's disease
GAB2,Rs2373115,Alzheimer's
GAB2,Rs2373115,Alzheimer's disease
GAB2,Rs2373115,Alzheimer
GAB2,Rs2373115, late-onset Alzheimer's disease
GAB2,Rs2373115,Alzheimer's
GAB2,Rs2373115,increased risk for Alzheimer's disease among ApoE4 carriers
GAB2,Rs2373115,odds ratio of 4.06 
GAB2,Rs2373115,risk of Alzheimer's disease
GAB2,Rs2373115,risk (OR 4.1) of late-onset Alzheimer's disease
GAB2,Rs2373115,Alzheimer's risk.
GAB2,Rs10793294,Alzheimer's
GAB2,Rs10793294,alleles modify
GAB2,Rs10793294,Alzheimer's risk
GABRA1,Rs2279020,methamphetamine use disorder
GABRA2,Rs497068,illicit drug use
GABRA2,Rs497068,smoking
GABRA2,Rs497068,alcohol dependence
GABRA2,Rs497068,influences behavior
GABRA2,Rs279871,Alcoholism
GABRA2,Rs497068,alcoholism spectrum disorders
GABRA2,Rs279844,Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism.
GABRA2,Rs279858,Alcoholism
GABRA2,Rs279844,autism
GABRA2,Rs279844,autism
GABRA2,Rs279836,Alcoholism
GABRA4,Rs2280073,autism
GABRA4,Rs2280073,autism
GABRB1,Rs2351299,autism
GABRB1,Rs2351299,autism
GABRD,Rs142619552,GRIN2A
GABRD,Rs142619552,frequently mutated in melanoma
GABRD,Rs142619552,Exome sequencing
GAD1,Rs3791850,neuroticism
GAD1,Rs3791878,schizophrenia
GAD1,Rs3791850,African Americans
GAD1,Rs3791850,Alcohol Dependence
GAD1,Rs3791850,alcohol dependence
GAD1,Rs3791850,major depression
GAD1,Rs3791850,Heroin addiction
GAD1,Rs3791850,neuroticism
GAD1,Rs3791850,major depression
GAD1,Rs3791850,anxiety disorders
GAD1,Rs3791850,glutamic acid decarboxylase genes
GAD1,Rs3791850,anxiety disorders
GAD1,Rs1978340,heroin dependence.
GAD1,Rs1978340,alcohol dependence
GADL1,Rs201973599,bipolar disorder
GADL1,Rs201973599,lithium treatment
GADL1,Rs201973599,bipolar disorder
GALC,Rs387906955,Krabbe disease
GALC,Rs387906955,pathogenic
GALC,Rs398123175,Krabbe disease
GALC,Rs398123175,Krabbe disease
GALC,Rs398123177,Krabbe disease
GALC,Rs748573754,Krabbe disease
GALC,Rs398123177,Krabbe disease
GALC,Rs748573754,Krabbe 
GALC,Rs748573754,disease 
GALC,Rs387906955,Krabbe disease
GALC,Rs749893889,Krabbe disease
GALC,Rs398123177,Krabbe disease
GALC,Rs387906954,Krabbe disease
GALC,Rs750524447,Krabbe disease
GALC,Rs387906954,Krabbe disease
GALC,Rs147313927,Krabbe disease
GALC,Rs200378205,Krabbe disease
GALC,Rs374635469,Krabbe disease
GALC,Rs374635469,pathogenic
GALC,Rs374635469,probably pathogenic
GALC,Rs121908010,Krabbe disease
GALC,Rs374635469,Krabbe disease
GALC,Rs374635469,Krabbe disease
GALC,Rs387906954, compound heterozygote
GALC,Rs387906954,compound heterozygote
GALC,Rs387906952,Krabbe disease
GALC,Rs387906952,Krabbe disease
GALC,Rs387906954,Krabbe disease
GALNT3,Rs16851009,Parkinson's disease
GALNT3,Rs16851009,Parkinson disease
GALNT3,Rs16851009,Parkinson disease
GALNT3,Rs16851009,Parkinson disease 
GALNT3,Rs16851009,PARK10
GALT,Rs111033640,Duarte galactosemia
GALT,Rs2070074,galactosemia
GALT,Rs2070074,Galactosemia
GALT,Rs75391579,galactosemia
GALT,Rs75391579,rs75391579(G)
GAMT,Rs80338736,man.
GAMT,Rs80338736,Guanidinoacetate methyltransferase deficiency
GAMT,Rs80338736,error of creatine metabolism
GAMT,Rs80338736,Guanidinoacetate methyltransferase deficiency
GAMT,Rs80338736,Guanidinoacetate methyltransferase deficiency
GATA3,Rs570613,breast cancer
GATA3,Rs570613,Breast Cancer
GATA3,Rs570613,breast cancer
GBA,Rs421016,amino acid change in the GBA gene
GBA,Rs421016,Gaucher disease 
GBA,Rs421016,Gaucher disease
GBA,Rs421016,"type I, II, or III Gaucher disease"
GBA,Rs421016,Parkinson's
GBA,Rs421016,Parkinson's disease 
GBA,Rs421016,Gaucher disease 
GBA,Rs421016,Gaucher disease 
GBA,Rs421016,Gaucher patients 
GBA,Rs76763715,Gaucher disease
GBA,Rs76763715,neurological symptoms
GBA,Rs76763715,mild symptoms
GBA,Rs76763715,Gaucher's disease Type I
GBA,Rs76763715,"""non-neuropathic"" type"
GBA,Rs76763715,neurological symptoms
GBA,Rs80356769,a chemical cleavage and GC-clamped denaturing gradient gel electropho
GBA,Rs80356769,ucosid
GBA,Rs421016,Leu444Pro
GBA,Rs421016,Gaucher's disease
GBA,Rs421016,L444P 
GBA,Rs76763715,type 1 Gaucher disease
GBA,Rs364897,Gaucher's Disease
GBA,I4000386,Gaucher's disease
GBA,I4000419,Gaucher's disease
GBA,I4000419,Gaucher Disease
GBA,I4000419,Gaucher's disease
GBA,I4000419,Gaucher's disease
GBA,Rs104886460,Gaucher's disease
GBA,Rs104886460,Gaucher Type I
GBA,Rs364897,type I Gaucher disease
GBA,Rs104886460,Gaucher Type I disease
GBA,Rs104886460,Type II disease
GBA,Rs2230288,polymorphism
GBA,Rs2230288,"""modifier"" variant"
GBA,Rs2230288,rapid eye movement sleep behavior disorder (RBD)
GBA,Rs2230288,synucleinopathies
GBA,Rs2230288,Parkinson's disease
GBA,Rs2230288,Gaucher disease.
GBA,Rs2230288,rapid eye movement sleep behavior disorder (RBD)
GBA,Rs2230288,Parkinson's disease.
GBA,Rs2230288,Gaucher disease
GC,Rs4752,dihydroxyvitamin 
GC,Rs7041,COPD
GC,Rs7041,chronic obstructive pulmonary disease
GC,Rs4752,prostate cancer
GC,Rs2282679,vitamin D serum concentrations
GC,Rs2282679,vitamin D insufficiency
GC,Rs17467825,obesity-related traits
GC,Rs4752,Asthma
GCDH,Rs121434369,glutaric acidemia I disease
GCDH,Rs121434369,glutaric acidemia I
GCDH,Rs121434369,Caucasians
GCDH,Rs121434369,glutaric acidemia
GCH1,Rs4411417,capsaicin pain
GCH1,Rs4411417,tolerance to pain
GCH1,Rs7142517,Lumbar Degenerative Disc Disease
GCH1,Rs752688,capsaicin pain
GCH1,Rs752688,Polymorphisms
GCH1,Rs8007201,cyclohydrolase
GCH1,Rs8007201,cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence
GCH1,Rs8007201,higher tolerance to pain
GCH1,Rs8007201,higher tolerance to pain
GCH1,Rs886039379,autosomal dominant dopa-responsive dystonia
GCH1,Rs998259,Lumbar Degenerative Disc Disease
GCH1,Rs8007201,tetrahydrobiopterin
GCH1,Rs4411417,higher tolerance to pain
GCH1,Rs2878172,Vasoocclusive Pain
GCH1,Rs2878172,Sickle Cell Anemia
GCH1,Rs10483639,coronary artery disease
GCH1,Rs11158026,Parkinson's disease
GCH1,Rs17738966,Vasoocclusive Pain
GCH1,Rs17738966,Susceptibility to Vasoocclusive Pain
GCH1,Rs17738966,Impaired Vascular Function
GCH1,Rs17738966,Impaired Vascular Function in Sickle Cell Anemia
GCH1,Rs2878172,Impaired Vascular Function in Sickle Cell Anemia
GCH1,Rs2878172,Susceptibility to Vasoocclusive Pain
GCH1,Rs2878172,Impaired Vascular Function
GCH1,Rs17738966,Sickle Cell Anemia
GCH1,Rs4411417,Polymorphisms
GCHFR,Rs7164342,antidepressants
GCHFR,Rs7164342,transcriptional activity
GCHFR,Rs7164342,response to SSRI antidepressants
GCHFR,Rs7164342,polymorphism
GCHFR,Rs7164342,response to SSRI antidepressants.
GCHFR,Rs7163862,antidepressants
GCHFR,Rs7163862,polymorphism
GCHFR,Rs7163862,response to SSRI antidepressants.
GCHFR,Rs7163862,transcriptional activity
GCHFR,Rs7163862,response to SSRI antidepressants
GEMIN4,Rs7813,renal cell carcinoma
GEMIN4,Rs7813,esophageal cancer
GEMIN4,Rs7813,schizophrenia 
GEMIN4,Rs7813,nucleotide polymorphisms
GGH,Rs11545076,lymphoblastic leukemia
GGH,Rs11545078,lymphoblastic leukemia
GGH,Rs719235,lymphoblastic leukemia
GHRL,Rs27647,ghrelin
GHRL,Rs27647,ype 2 diabetes
GHRL,Rs27647,ith obesity.
GHRL,Rs27647,ghrelin receptor gene polymorphisms
GHRL,Rs27647,adiposity
GHRL,Rs27647,obesity
GHRL,Rs27647,ghrelin
GHRL,Rs26802,risk of type 2 diabetes mellitus
GHRL,Rs26802,metabolic syndrome
GHRL,Rs27647,type 2 diabetes
GHRL,Rs26802,African-American male birth weight.
GHRL,Rs26802,HDL cholesterol levels
GJB2,Rs28931595,deafness
GJB2,Rs72561723,recessive and dominant
GJB2,Rs72561723,keratitis-ichthyosis-deafness syndrome
GJB2,Rs72561723,deafness
GJB2,Rs35887622,hearing impairment
GJB2,Rs35887622,hearing loss
GJB2,Rs35887622,mild-moderate non-syndromic sensorineural hearing loss
GJB2,Rs35887622,Autosomal recessive nonsyndromic neurosensory deafness 
GJB2,Rs35887622,deafness
GJB2,Rs72561723,deafness 
GJB2,Rs35887622,hearing loss
GJB2,Rs35887622,non-syndromic sensorineural deafness 
GJB2,Rs35887622,relatively late onset and progression
GJB2,Rs35887622,mild hearing impairment
GJB2,Rs35887622,deafness
GJB2,Rs28931595,deafness
GJB2,Rs28931594,keratitis-ichthyosis-deafness syndrome
GJB2,Rs35887622,hearing loss
GJB2,Rs72561723, keratitis-ichthyosis-deafness syndrome.
GJB2,Rs28931594,deafness
GJB2,Rs80338947,hereditary hearing loss
GJB2,Rs80338943,deafness
GJB2,Rs80338943,Chinese deaf population
GJB2,Rs80338943,hearing loss
GJB2,Rs80338943,Japanese
GJB2,Rs80338943,childhood deafness
GJB2,Rs80338943,narcotic dependence
GJB2,Rs80338943,nursing
GJB2,Rs80338943,pain
GJB2,Rs80338943,Nursing
GJB2,Rs80338943,Asian
GJB2,Rs80338943,deafness
GJB2,Rs80338943,"Reevaluation of nursing concession to the patient's request, resulting in the development of narcotic dependence."
GJB2,Rs80338943,non-syndromic deafness
GJB2,Rs80338942,"Known as 167delT, this is the most common nonsyndromic recessive deafness-associated SNP in Ashkenazi Jewish populations"
GJB2,Rs80338939,autosomal recessive nonsyndromic hearing loss
GJB2,Rs767178508,deafness
GJB2,Rs72561723,deafness
GJB2,Rs72561723,keratitis-ichthyosis-deafness syndrome.
GJB2,Rs28931594,keratitis-ichthyosis-deafness syndrome
GJB2,Rs28931593,deafness
GJB2,Rs28931594,deafness
GJB2,I6011292,recessive GJB2 gene variant associated with deafness
GJB2,I6011292,gene variant associated with deafness
GJB2,I5012709,associated with deafness
GJB2,I5012709,gene variant associated with deafness
GJB2,I5012707,deafness
GJB2,I5012698,deafness
GJB2,I6011293,deafness
GJB2,I5004479,gene variant associated with deafness
GJB2,I5002002,deaf
GJB2,I5002001,deafness
GJB2,I5001996,deafness
GJB2,I5001987,1048
GJB2,I4000435,Hearing loss
GJB2,I4000434,Connexin
GJB2,I4000434,Nonsyndromic Sensorineural
GJB2,I5002003,deafness
GJB2,I6011302,deafness
GJB2,I6011293,recessive
GJB2,I6011302,recessive GJB2 gene
GJB2,Rs28931593,deafness
GJB2,Rs28931592,deafness
GJB2,Rs28931592,deafness
GJB2,Rs104894404,nonsyndromic hearing loss and deafness or keratoderma palmoplantar deafness
GJB2,I6011479,1048
GJB2,I6011302,deafness
GJB2,I6011465,deafness
GJB2,I6011465,deafness
GJB2,I6011476,deafness
GJB2,I6011458,associated with deafness
GJB2,I6011452,deafness
GJB2,I6011385,deafness
GJB2,I6011385,recessive GJB2 gene variant associated with deafness
GJB2,I6011363,deafness
GJB2,I6011362,deafness
GJB2,I6011362,gene variant associated with deafness
GJB2,I6011464,associated with deafness
GLA,Rs28935490,fabry disease
GLA,Rs28935490,hypertrophic cardiomyopathy
GLA,Rs28935490,fabry disease
GLA,Rs28935490,hypertrophic cardiomyopathy.
GLA,Rs28935490,mental retardation
GLA,Rs28935490,mental retardation.
GLA,Rs28935490,fabry disease
GLA,Rs199473684,Fabry disease
GLA,Rs28935490,hypertrophic cardiomyopathy
GLA,Rs199473684,Fabry disease
GLA,Rs199473684,Fabry disease.
GLCCI1,Rs37973,bronchial asthma 
GLCCI1,Rs37973,pulmonary function
GLCCI1,Rs37973,forced expiratory volume
GLCCI1,Rs37973,asthma
GLCCI1,Rs37973,asthma
GLCCI1,Rs37973,asthmatics corticosteroid treatment
GLCCI1,Rs37973,bronchial asthma
GLCCI1,Rs37973,inflammation
GLCCI1,Rs37973,asthma
GLCCI1,Rs37973,inflammatory cells apoptosis
GLDC,I5007987,hyperglycinemia
GLDC,Rs121964979,Ala389Val
GLDC,I5007986,Non-ketotic
GLDC,I5007986,hyperglycinemia
GLDC,I5007985,hyperglycinemia
GLDC,I5007984,Non-ketotic hyperglycinemia
GLIS3,Rs1574285,type-1 diabetes
GLIS3,Rs1574285,type-1 diabetes
GLIS3,Rs1574285,type-1 diabetes
GMPR,Rs1042391,guanosine monophosphate reductase
GMPR,Rs1042391,Identification of common variant alleles of the human guanosine monophosphate reductase gene.
GNPTAB,Rs137853825,stuttering
GNPTAB,Rs137853824,GNPTAB gene
GNPTAB,Rs137853824,stuttering
GNPTAB,Rs137853823,stuttering 
GNPTAB,Rs137853823,Female 
GNPTAB,Rs137853823,stuttering 
GNPTAB,Rs137853823,stutterers 
GNPTG,Rs137853826,stuttering 
GNPTG,Rs137853826,stuttering
GNPTG,Rs137853826,GNPTG 
GNPTG,Rs137853826,rs137853826 
GNPTG,Rs137853826,A25E
GNPTG,Rs137853826,Ala25Glu 
GNPTG,Rs137853826,stuttering
GNPTG,Rs137853826,TSR3 gene
GOLM1,Rs10868366,Alzheimer's disease
GOLM1,Rs10868366,Alzheimer's disease
GOLM1,Rs10868366,Alzheimer's disease
GOLM1,Rs10868366,Alzheimer's disease
GOLM1,Rs7019241,Alzheimer's disease
GOLM1,Rs7019241,Alzheimer's disease
GPX1,Rs1050450,early onset lung cancer
GPX1,Rs1050450,Kashin-Beck disease
GPX1,Rs1050450,osteoarthritis
GPX1,Rs1050450,degenerative osteoarthropathy
GPX1,Rs1050450,osteoarthritis
GPX1,Rs1050450,medulloblastoma
GPX1,Rs1050450,adult brain tumors
GPX1,Rs1050450,prostate cancer
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,schizophrenia
GPX1,Rs1050450,disabling osteoarthropathy
GPX1,Rs1050450,New Zealand
GPX1,Rs1050450,asthma
GPX1,Rs1050450,lung cancer
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,coronary artery calcification
GPX1,Rs1050450,type 2 diabetes
GPX1,Rs1050450,lung cancer
GPX1,Rs1050450,adult brain tumors
GPX1,Rs1050450,oldest old
GPX1,Rs1050450,schizophrenia
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,healthy humans
GPX1,Rs1050450,prostate cancer risk
GPX1,Rs1050450,European men
GPX1,Rs1050450,men
GPX1,Rs1050450,Auckland
GPX1,Rs1050450,breast cancer risk
GPX1,Rs1050450,coronary artery calcification in type 2 diabetes
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,lung cancer
GPX1,Rs1050450,osteoarthritis
GPX1,Rs1050450,Kashin-Beck disease (KBD)
GPX1,Rs1050450,degenerative osteoarthropathy
GPX1,Rs1050450,KBD 
GPX1,Rs1050450,osteoarthritis
GPX1,Rs1050450,Kashin-Beck disease (KBD) is a disabling osteoarthropathy
GPX1,Rs1050450,KBD
GPX1,Rs1050450,lung cancer
GPX1,Rs1050450,coronary artery calcification in type 2 diabetes
GPX1,Rs1050450,early onset lung cancer
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,adult brain tumors
GPX1,Rs1050450,schizophrenia
GPX1,Rs1050450,breast cancer risk
GPX1,Rs1050450,prostate cancer
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,KBD
GPX1,Rs1050450,osteoarthropathy
GPX1,Rs1050450,Kashin-Beck disease (KBD)
GPX1,Rs1050450,osteoarthritis
GPX1,Rs1050450,degenerative osteoarthropathy
GPX1,Rs1050450,KBD
GPX1,Rs1050450,osteoarthritis
GPX1,Rs1050450,Kashin-Beck disease (KBD)
GPX1,Rs1050450,tumor susceptibility
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,Childhood Cancer Survivor Study
GPX1,Rs1050450,medulloblastoma 
GPX4,Rs757228,SNP
GRHPR,I5012628,Primary hyperoxaluria
GRHPR,I5012628,Primary hyperoxaluria type 2
GRHPR,Rs80356708,Primary hyperoxaluria type 
GRHPR,Rs80356708,Northern Europeans
GRHPR,Rs80356708,primary hyperoxaluria type II.
GRHPR,Rs80356708,primary hyperoxaluria type 2.
GRHPR,I5012628,SNP
GRID1,Rs2814331,hair 
GRID1,Rs2814331,scalp 
GRIK1,Rs726002,breast cancer
GRIK1,Rs2832407,alcoholism
GRIK1,Rs2832407,alcoholism
GRIN1,Rs11146020,schizophrenia
GRIN1,Rs771610568,pathogenic variant
GRIN1,Rs771610568,pathogenic variant
GRIN1,Rs771610568,pathogenic variant
GRIN1,Rs771610568,pathogenic variant
GRIN2B,Rs3764028,reporter 
GRIN2B,Rs3764028,rs3764028 
GRIN2B,Rs3764028,transcriptional 
GRIN2B,Rs1805502,Alzheimer's disease
GRIN2B,Rs1805502,anterior cingulate glutamatergic concentration
GRM3,Rs13242038,schizophrenia
GRM3,Rs2228595,schizophrenia
GRM3,Rs6465084,schizophrenia
GRM3,Rs13242038,association 
GRN,Rs63751243,ubiquitin-positive frontotemporal lobar degeneration.
GRN,Rs63751294,frontotemporal dementia
GRN,Rs63751294,primary progressive aphasia
GRN,Rs63751243,ubiquitin-positive frontotemporal lobar degeneration
GRN,Rs63751294,frontotemporal dementia
GRN,Rs794729669,frontotemporal dementia
GRN,Rs794729672,frontotemporal
GRN,Rs63751243,"exhibit aphasia,"
GRN,Rs63751294,progranulin haploinsufficiency
GRN,Rs63751243,amyotrophic lateral sclerosis.
GRN,Rs606231221,frontotemporal dementia
GRN,Rs63751243,"rs63751243, also known as c.26C>A, p.Ala9Asp and A9D, represents a relatively rare mutation in the GRN gene on chromosome 17. OMIM reports the rs63751243(A) allele as representing a dominantly inherited mutation associated with ubiquitin-positive frontotemporal loba"
GRN,Rs63751243,"rs63751243, also known as c.26C>A, p.Ala9Asp and A9D, represents a relatively rare mutation in the GRN gene on chromosome 17. OMIM reports the rs63751243(A) allele as representing a dominantly inherited mutation associated with ubiquitin-positive frontotemporal lobar "
GRN,Rs63751243,extrapyramidal features
GRN,Rs63751243,aphasia
GRN,Rs63751243,amyotrophic lateral sclerosis
GRN,Rs794729672,dementia
GRN,Rs606231221,ominant mutation pathogenic
GRN,Rs606231220,frontotemporal 
GRN,Rs193026789,frontotemporal dementia.
GRN,Rs63751243,extrapyramidal features
GRN,Rs794729672,frontotemporal dementia
GSK3B,Rs6779828,schizophrenia
GSK3B,Rs4072520,schizophrenia
GSK3B,Rs6779828,association with schizophrenia
GSK3B,Rs13321783,Chinese major depressive disorder.
GSK3B,Rs13321783,antidepressant treatment
GSK3B,Rs4072520,association with schizophrenia
GSTP1,Rs6591255,American children
GSTP1,Rs6591255,asthma
GSTP1,Rs1871042,childhood allergic disease
GSTP1,Rs1871042,childhood allergic disease.
GSTP1,Rs1871042,cognitive ability
GSTP1,Rs1871042,cognition
GSTP1,Rs1871042,oxidative stress
GSTP1,Rs17593068,studies
GSTP1,Rs17593068,genomic 
GSTP1,Rs1871042,cognitive ageing
GSTP1,Rs1695,docetaxel-induced peripheral neuropathy
GSTP1,Rs1695, premenopausal women
GSTP1,Rs1695,greater breast cancer risk
GSTP1,Rs1695,women
GSTP1,Rs1695,0 Chinese women
GSTP1,Rs1695, asthma
GSTP1,Rs1695,asthma
GSTP1,Rs1695,North American
GSTP1,Rs1695,asthma risk
GSTP1,Rs17593068,functional 
HBA1,I4990131,Alpha Thalassemia
HBA2,I5900735,Thalassemia
HBA2,I5900735,Alpha Thalassemia
HBA2,I5900722,Alpha Thalassemia
HBA2,I5900722,Alpha Thalassemia
HBA2,I5004432,Thalassemia
HBA2,I5900654,Thalassemia
HBA2,I5004436,Alpha Thalassemia
HBA2,I4990131,Alpha Thalassemia
HBA2,I5900722, Alpha Thalassemia
HBB,Rs34690599,beta-thalassaemia
HBB,Rs34690599,Beta Thalassemia/ The beta-thalassaemia mutations
HBB,Rs33986703,beta 0 thalassemia
HBB,Rs33986703,beta-zero thalassemia mutation
HBB,Rs33986703,beta-zero thalassemia mutation
HBB,Rs33986703,beta 0 thalassemia
HBB,Rs33915217,South India
HBB,Rs33915217,Cubans
HBB,Rs33915217,Caribbean
HBB,Rs33931746,SNP allele-frequency
HBB,Rs33915217,Bulgaria
HBB,Rs33915217,beta thalassemia
HCG27,Rs6903896,photic sneeze reflex
HDC,Rs1894236,Tourette syndrome
HDC,Rs854150,Tourette syndrome
HERC2,Rs916977,blue eye color
HERC2,Rs2238289,hair and eye colours
HERC2,Rs2238289,blue eye color
HERC2,Rs1667394,green versus blue eye color
HERC2,Rs1667394,Blond rather than brown hair
HERC2,Rs1667394,Blue rather than green eyes
HERC2,Rs1667394,Blue rather than brown eyes
HEXA,Rs117160567,Tay Sachs
HEXA,I4000391,Tay-Sachs Disease
HEXA,I4000436,Tay-Sachs Disease
HEXA,I4000436,Tay-Sachs Disease
HEXA,I4000436,adult form
HFE,Rs1800730,mild form of hemochromatosis
HFE,I3002468,hemochromatosis
HHEX,Rs5015480,type-2 diabetes
HHEX,Rs8050136,type-2 diabetes
HHEX,Rs8050136,obesity
HIF1A,Rs11549465,type 1 diabetes
HIF1A,Rs11549465,type 2 diabetes
HLA-B,Rs79556279,BD
HLA-B,Rs79556279,Behçet's disease (BD)
HLA-B,Rs79556279,Behçet's disease
HLA-B,Rs6903896,photic sneeze reflex
HLA-B,Rs4349859,familial ankylosing spondylitis
HLA-B,Rs2073724,HIV-1 infection
HLA-B,Rs2073724,HIV-DNA
HLA-B,Rs2073724,HIV-RNA
HLA-B,Rs2073724,Distinct genetic loci
HLA-B,Rs2073724,HIV-DNA levels
HLA-B,Rs13202464,B27 Syndromes
HLA-B,Rs2073724,HIV-1 infection
HLA-DPA1,Rs9277378,lymphoma
HLA-DPB1,Rs9277535,Hepatitis B infection
HLA-DPB1,Rs9277535,reduce risk
HLA-DPB1,Rs9277378,lymphoma
HLA-DPB1,Rs9277535,Hepatitis B infection
HLA-DQA1,Rs1071630,Steroid-sensitive nephrotic syndrome
HLA-DQA1,Rs1071630,Steroid-sensitive nephrotic syndrome
HLA-DQB1,Rs1049225,Common variable immunodeficiency disorder 
HLA-DQB1,Rs1063355,"asthma,"
HLA-DQB1,Rs1063355,anti-CCP-positive rheumatoid arthritis.
HLA-DQB1,Rs1063355,mold and biotoxin susceptible patients
HLA-DQB1,Rs1063355,Disorders of the Respiratory Tract in Children
HLA-DQB1,Rs1063355,rheumatoid arthritis
HLA-DQB1,Rs7775228,osteoarthritis 
HLA-DQB1,Rs7775228,osteoarthritis
HLA-DQB1,Rs7775228,fever 
HLA-DQB1,Rs7775228,Primary biliary cirrhosis
HLA-DRA,Rs9268645,markers
HLA-DRA,Rs9268645,multiple sclerosis
HLA-DRA,Rs3129878,azoospermia (lack of sperm)
HLA-DRA,Rs1041885,rheumatoid arthritis.
HLA-DRA,Rs1041885,Genome-wide association
HLA-DRA,Rs1041885,anti-cyclic citrullinated peptide
HLA-DRA,Rs1041885,rheumatoid arthritis.
HLA-DRB1,Rs7451962,sclerosis 
HMBS,Rs536814318,intermittent porphyria.
HMBS,Rs536814318,acute intermittent porphyria
HMBS,Rs536814318,acute intermittent porphyria
HMBS,Rs536814318,acute intermittent porphyria
HMGA2,Rs17179670,SNP implicated in Tooth Development
HMGA2,Rs1042725,height
HMGA2,Rs10784502,intracranial volume
HMGCR,Rs17238540,atherosclerosis
HMGCR,Rs17238540,myocardial infarction
HMGCR,Rs17238540,atherosclerosis
HMGCR,Rs17238540,stroke
HMGCR,Rs17238540,stroke
HMGCR,Rs17238540,lower cholesterol levels
HMGCR,Rs17238540,nonfatal myocardial infarction
HMGCR,Rs12654264,colorectal cancer
HMGCR,Rs12654264,cardiovascular disease
HMGCR,Rs12654264,cancer
HMGCR,Rs12654264,colorectal cancer
HMGCR,Rs12654264,CRC
HMGCR,Rs12654264,colorectal cancer
HMGCR,Rs12654264,cardiovascular disease
HNF1A,Rs140491072,maturity-onset diabetes of the young (MODY)-3
HNF1A,Rs151344538,Polygenic risk variants
HNF1A,Rs151344538,type 2 diabetes
HNF1A,Rs151344539,Polygenic risk variants
HNF1A,Rs193922587,maturity-onset diabetes
HNF1A,Rs193922587,diabetes
HNF1A,Rs193922587,diabetes
HNF1A,Rs193922587,maturity-onset diabetes of the young (MODY)-3
HNF1A,Rs151344539,type 2 diabetes
HNF1A,Rs140491072,maturity-onset diabetes
HNF1A,Rs140491072,diabetes
HNF1A,Rs1183910,"associated with higher total cholesterol, LDL choesterol and HDL cholesterol"
HNF1A,Rs140491072,diabetes
HNF1A,Rs1169288,lower HDL cholesterol
HNF1A,Rs1169288,lower CRP levels
HNF1A,Rs1169300,cancer 
HNF1A,Rs1169288,lower HDL cholesterol
HNF1A,Rs1169300,prostate or breast cancer
HNF1A,Rs1169305,now considered benign in ClinVar
HNF1A,Rs1169305,benign 
HNF1A,Rs1169300,lung cancer
HNF1B,Rs757210,HNF1B gene
HNF1B,Rs3760511,carriers of the C allele
HNF1B,Rs3760511,Prostate cancer
HNF1B,Rs7405696,early-onset prostate cancer
HNF1B,Rs7405696,early-onset prostate cancer
HNF1B,Rs757210,Nondiabetic
HNF1B,Rs757210,lipoprotein traits
HNMT,Rs1050891,sunset yellow
HNMT,Rs1050891,food additives
HNMT,Rs1050891,carmoisine
HNMT,Rs1050891,ADHD 
HNMT,Rs1050891,ponceau 4R
HNMT,Rs1050891,allura red AC and sodium benzoate
HNMT,Rs1050891,quinoline yellow
HNMT,Rs1050891,tartrazine
HNMT,Rs1050891,age 3 and 8/9
HNMT,Rs1050891,ADHD
HNMT,Rs1050891,food additives
HNMT,Rs1050891,ncrease in ADHD behavior
HNMT,Rs1050891,lack of a C allele
HNMT,Rs1050891,increase in ADHD behavior
HNMT,Rs1050891,ADHD
HNMT,Rs1050891,lack of a C allele
HNMT,Rs1050891,HNMT gen
HNMT,Rs1050891,ADHD
HNMT,Rs1050891,ADHD 
HPD,Rs1154510,hawkinsinuria
HRAS,Rs28933406,somatic mutation
HRAS,Rs28933406,somatic mutation
HRAS,Rs104894229,Gly12Ser
HSD3B2,Rs770815049,chromosome 1
HSD3B2,Rs770815049,rare mutation in the HSD3B2 gene on chromosome 1
HSPA12A,Rs12259842,freckles
HSPA12A,Rs12259842,freckles.
HSPA1A,Rs1061581,noise-induced hearing loss
HSPA1L,Rs2075800,hearing loss
HSPA1L,Rs2075800,rheumatoid arthritis
HSPA1L,Rs2075800,myocardial infarction
HSPA1L,Rs2075800,Inflammatory gene polymorphism
HSPA1L,Rs2075800,noise-induced hearing loss
HSPA1L,Rs2075800,uveitis
HSPA1L,Rs2075800,sarcoidosis
HSPA1L,Rs2075800,postoperative myocardial infarction
HSPA1L,Rs1061581,noise-induced hearing loss
HSPA1L,Rs2075800,rheumatoid arthritis
HTR2A,Rs594242,suicidal behavior
HTR2A,Rs655888,chronic fatigue syndrome
HTR2A,Rs655888,chronic fatigue syndrome
HTR2A,Rs7322347,attention-deficit/hyperactivity disorder
HTR2A,Rs7322347,ADHD
HTR2A,Rs7322347,attention-deficit/hyperactivity
HTR2A,Rs7330461,Caucasian patients
HTR2A,Rs7330461,schizophrenia
HTR2A,Rs7984966,attention-deficit/hyperactivity
HTR2A,Rs7984966,ADHD
HTR2A,Rs594242,impulsive suicidal behavior
HTR2A,Rs7322347,"5HT2A, DDC and MAOB"
HTR2A,Rs594242,aggression
HTR2A,Rs1923886,is protective against bipolar disorder
HTR2A,Rs582385,schizophrenia
HTR2A,Rs1923886,haplotype CCGCA
HTR2A,Rs1923886,rarer haplotype CCACG confers risk to the disorder
HTR2A,Rs594242,anger
HTR2A,Rs2224721,is protective against bipolar disorder
HTR2A,Rs2224721,rarer haplotype CCACG confers risk to the disorder
HTR2A,Rs2224721,haplotype CCGCA
HTR2A,Rs2770296,is protective against bipolar disorder
HTR2A,Rs2770296,rarer haplotype CCACG confers risk to the disorder
HTR2A,Rs582385,suicidal ideation
HTR2A,Rs582385,Irish
HTR2A,Rs2770296,haplotype CCGCA
HTR2C,Rs6318,heart attack
HTR2C,Rs6318,bipolar disorder
HTR2C,Rs6318,autistic 
HTR2C,Rs6318,bipolar affective disorder
HTR2C,Rs6318,schizophrenic
HTR2C,Rs6318,anti-psychotic induced weight
HTR2C,Rs6318,higher stress-related cortisol levels
HTR2C,Rs518147,schizophrenia
HTR2C,Rs518147,metabolic syndrome
HTR2C,Rs518147,schizophrenia 
HTR2C,Rs6318,bipolar affective disorder
HTR3A,Rs1062613,schizophrenia
HTR3A,Rs1176713,serotonin
HTR3A,Rs1176713,hydroxytryptamine 
HTR3A,Rs1176713,schizophrenia 
HTRA1,Rs3793917,age-related macular degeneratio
HTRA1,Rs3793917,association with age-related macular degeneration
HTRA1,Rs3793917,strongly associated with age-related macular degeneration
HTRA1,Rs3793917,age related macular degeneration
HTRA1,Rs3793917,age-related macular degeneration
HTRA1,Rs3793917,age-related macular degeneration
HTRA1,Rs3793917,age-related macular degeneration
HTRA1,Rs3793917,age-related macular degeneration
HTRA1,Rs3793917,age-related macular degeneration
HTRA1,Rs3793917,nature age related macular degeneration
HTRA1,Rs3793917,anti-vascular endothelial growth
IBD5,Rs6596075,Crohn's disease
IBD5,Rs6596075,Crohn's disease
IBD5,Rs11739135,Crohn's disease
IBD5,Rs11739135,Crohn's disease
IDO2,Rs4503083,SNP
IDS,Rs781997631,MPS type II
IFNL3,Rs8103142,chronic hepatitis C 
IFNL3,Rs8103142,hepatitis C
IFNL3,Rs8103142,hepatitis C
IFNL3,Rs8103142,interleukin-28B
IFNL4,Rs12979860,fibrosis 
IFNL4,Rs12979860,HIV
IFNL4,Rs12979860,HIV/hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,liver fibrosis
IFNL4,Rs12979860,chronic hepatitis C 
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,-hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C.
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,Hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860, hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C 
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C 
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,chronic hepatitis C
IFNL4,Rs12979860,chronic hepatitis C
IFNL4,Rs12979860,African
IFNL4,Rs12979860,Hepatitis C
IFNL4,Rs12979860,hepatitis C virus
IFNL4,Rs12979860,chronic hepatitis C
IFNL4,Rs12979860,hepatitis B virus 
IFNL4,Rs12979860,HIV 
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C 
IFNL4,Rs12979860,chronic hepatitis C 
IFNL4,Rs12979860,chronic hepatitis C
IFNL4,Rs12979860,viral hepatitis
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860, hepatitis C
IFNL4,Rs12979860,hepatitis C virus
IFNL4,Rs12979860,hepatitis C virus
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,chronic hepatitis C
IFNL4,Rs12979860,hepatitis 
IFNL4,Rs12979860,hepatitis 
IFNL4,Rs12979860,hepatitis 
IFNL4,Rs12979860,hepatitis 
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C.
IFNL4,Rs12979860,HIV/hepatitis C
IFNL4,Rs12979860,hepatitis C 
IFNL4,Rs12979860,chronic hepatitis C
IFNL4,Rs12979860,HCV-infected
IFNL4,Rs12979860,hepatitis C 
IFNL4,Rs12979860,HIV
IFNL4,Rs12979860,hepatitis C
IGF1,Rs2195239,proliferative benign breast disease
IGF1,Rs2195239,multiple myeloma.
IGF1,Rs2195239,reast cancer risk
IGF1,Rs2195239,breast cancer
IGF1,Rs2195239,mammographic density
IGF1,Rs12423791,prostate cancer
IGF1R,Rs34516635,longevity and ageing
IGF1R,Rs34516635,maximal lifetime appearance|height
IGF2BP2,Rs11705701,obesity
IGF2BP2,Rs11705701,type-2 diabetes
IGF2BP2,Rs11705701,insulin sensitivity
IGF2BP2,Rs11705701,obesity
IGF2BP2,Rs11705701,insulin sensitivity
IKBKAP,I4000400,Familial Dysautonomia
IKBKAP,Rs111033171,Tay–Sachs disease
IKBKAP,Rs111033171,cystic fibrosis
IKBKAP,Rs111033171,familial dysautonomia
IL10,Rs1800871,Epstein-Barr virus
IL10,Rs1800896,allergy
IL10,Rs1800871,systemic sclerosis
IL10,Rs1800871,heparin-induced thrombocytopenia.
IL10,Rs1800871,AIDS-related non-Hodgkin lymphoma 
IL10,Rs1800871,rheumatoid arthritis
IL10,Rs1800871,Crohn's disease
IL10,Rs1800896,asthma
IL10,Rs1800871,gastric cancer
IL10,Rs1800896,cancer
IL10,Rs3024490,pro-inflammatory response
IL10,Rs3024490,Behçet's disease
IL10,Rs3024490,inflammatory bowel (IBD) or celiac disease
IL10,Rs3024490,IBD
IL10,Rs3024490,IBD and celiac disease
IL10,Rs3024490,lower IL-10 expression
IL10,Rs3024490,higher TNF gene expression
IL10,Rs3024492,allergy
IL10,Rs3024496,asthma
IL10,Rs3024496,allergy
IL10,Rs1800896,anti-inflammatory
IL10,Rs1800871,prostate cancer
IL10,Rs3024492,asthma
IL10,Rs1800871,Asthma
IL10,Rs1800871,knee osteoarthritis
IL10,Rs1518111,Asthma
IL10,Rs1518111,cytomegalovirus
IL10,Rs1518111,acute coronary syndrome
IL10,Rs1518111,tuberculosis
IL10,Rs1518111,benign prostate hyperplasia
IL10,Rs1518111,Behcet's disease
IL10,Rs1800871,Crohn's disease
IL10,Rs1800871,Alzheimer's disease
IL10,Rs1800871,Behçet's disease
IL10,Rs1800871,endometriosis
IL10,Rs1800871,postoperative myocardial infarction
IL10,Rs1800871,Crohn's disease
IL10,Rs1800871,non-Hodgkin lymphoma.
IL10,Rs1800871,melanoma
IL10,Rs1800871,biliary tract cancers and stones
IL10,Rs1800871,B-cell lymphoma
IL10,Rs1800871,non-Hodgkin lymphoma
IL10,Rs1800871,rheumatoid arthritis patients
IL10,Rs1800871,infection following esophagectomy
IL10,Rs1800871,non-Hodgkin's lymphoma.
IL10,Rs1800871,hepatitis C virus infection
IL12B,Rs3212227,psoriatic arthritis (PsA)
IL12B,Rs3212227,cervical cancer
IL12B,Rs3212227,cervical cancer
IL12B,Rs3212227,psoriatic arthritis
IL12B,Rs3212227,psoriasis
IL12B,Rs3212227,psoriasis
IL12B,Rs3212227,PsA
IL12B,Rs3212227,psoriasis
IL12B,Rs2288831,Asthma
IL12B,Rs2288831,Asthma
IL12B,Rs2288831,susceptibility to tuberculosis
IL12B,Rs2288831,pulmonary tuberculosis
IL12B,Rs2288831,tuberculosis
IL12B,Rs2288831,pulmonary tuberculosis
IL12B,Rs2288831,tuberculosis
IL12B,Rs2288831,Asthma
IL12B,Rs2288831,pulmonary tuberculosis
IL12RB2,Rs3790568,radiation dermatitis
IL12RB2,Rs3790568,susceptibility to radiation dermatitis
IL12RB2,Rs3790568,susceptibility to radiation dermatitis
IL12RB2,Rs3790565,biliary cirrhosis
IL12RB2,Rs3790565,Primary biliary cirrhosis
IL16,Rs4778889,Graves' disease
IL16,Rs4778889,nasopharyngeal carcinoma
IL16,Rs4778889,adiation-induced toxicity
IL16,Rs4778889,risk of coronary artery disease
IL16,Rs4778889,gene polymorphism
IL17A,Rs2275913,bone marrow transplantation
IL17A,Rs2275913,acute Graft-Versus-Host Disease
IL17A,Rs2275913,gastric cancer
IL17A,Rs2275913,gastric cancer
IL17A,Rs2275913,gastric cancer
IL17A,Rs2275913,acute Graft-Versus-Host Disease
IL17A,Rs2275913,gastric cancer
IL17A,Rs2275913,Japanese
IL17A,Rs2275913,gastric cancer
IL17A,Rs2275913,gastric cancer
IL18,Rs187238,respiratory syncytial virus infection
IL18,Rs187238,coronary artery disease
IL18,Rs187238,Alzheimer's disease
IL18,Rs187238,rheumatoid arthritis
IL18,Rs187238,renal cell carcinoma patients
IL18,Rs187238,Czech
IL18,Rs187238,allergic disorders
IL18,Rs187238,coeliac disease
IL18,Rs187238,preeclampsia
IL18,Rs187238,spontaneous miscarriage
IL18,Rs187238,severe malarial anemia
IL18,Rs187238,Hepatitis B
IL18,Rs187238,Chinese
IL18,Rs187238,idiopathic recurrent pregnancy loss
IL18,Rs187238,Tunisian
IL18,Rs1946518,cervical cancer
IL18,Rs1946519,cervical cancer
IL18,Rs3882891,insulin 
IL18,Rs3882891,levels
IL18,Rs3882891,postprandial 
IL18,Rs187238,kidney
IL18,Rs187238,childhood
IL18,Rs187238,Chinese
IL18,Rs187238,Caucasian males
IL18,Rs187238,men
IL18,Rs187238,hypertension
IL18,Rs187238,sudden cardiac death (SCD)
IL18,Rs187238,coronary heart disease (CHD)
IL18,Rs187238,SCD
IL18,Rs187238,CHD
IL18,Rs187238,hypertension
IL18,Rs187238,oral lichen planus
IL18,Rs187238,complicated plaques
IL18,Rs187238,hypertension
IL18,Rs187238,coronary atherosclerotic plaque areas
IL18,Rs187238,coronary atherosclerotic plaques
IL18,Rs187238,sudden cardiac death
IL18,Rs187238,CHD-related SCD or CAD
IL18,Rs187238,Dalmatian
IL18,Rs187238,type 1 diabetes
IL18,Rs187238,Southern Croatia
IL18,Rs187238,human immunodeficiency virus type I infection in adolescents and adults
IL18,Rs187238,type 1 diabetes
IL18,Rs187238,celiac disease
IL18,Rs187238,rheumatoid arthritis
IL18,Rs187238,European
IL18RAP,Rs2272127,herpes simplex virus 1
IL18RAP,Rs2272127,schizophrenia
IL18RAP,Rs2272127, herpes
IL18RAP,Rs2272127,schizophrenia
IL18RAP,Rs2272127,herpes
IL18RAP,Rs2272127,schizophrenia 
IL18RAP,Rs2272127,and 
IL18RAP,Rs2272127,rs2272127 
IL18RAP,Rs2272127,herpes
IL18RAP,Rs2272127,schizophrenia
IL18RAP,Rs11465702,seropositivity
IL18RAP,Rs11465702,herpes 
IL18RAP,Rs11465702,schizophrenia
IL18RAP,Rs11465702,herpes
IL18RAP,Rs11465702,schizophrenia
IL18RAP,Rs2272127,P 
IL19,Rs2243191,hepatitis B
IL19,Rs2243191,idiopathic arthritis
IL1B,Rs1143634, Nephropathy in Type I Diabetes
IL1B,Rs1143634,Myasthenia gravis
IL1B,Rs1143634,Joint destruction in Rheumatoid Arthritis
IL1B,Rs1143634,Inflammatory bowel disease
IL1B,Rs1143634,Peptic ulcer disease
IL1B,Rs1143634, Duodenal ulcer
IL1B,Rs1143634,Alzheimer's disease
IL1B,Rs1143627,basal cell carcinoma of skin.
IL1B,Rs1143634,higher levels of obesity or inflammatory markers
IL1B,Rs1143634,larger waist circumference
IL1B,Rs1143634,Western Australian coronary heart disease (CHD) population
IL1B,Rs1143634,Periodontitis 
IL1B,Rs1143627,glucocorticoid resistance
IL1B,Rs1143627,inflammatory bowel disease
IL1B,Rs1143627,rheumatoid arthritis:
IL1B,Rs1143627,hepatocellular carcinoma
IL1B,Rs1143634,Alopecia Areata
IL1B,Rs1143634, Periodontitis 
IL1B,Rs16944,schizophrenia
IL1B,Rs1143634,Ulcerative colitis
IL1B,Rs3087258,detoxification outcome
IL1B,Rs3087258,alcohol toxicity
IL1B,Rs3087258,alcohol dependence disorder
IL1B,Rs3087258,alcohol dependence disorder
IL1B,Rs3087258,Genetic polymorphisms
IL1B,Rs3087258,detoxification outcome
IL1B,Rs3087258,alcohol toxicity
IL1B,Rs1143634, pancreatic cancer
IL1B,Rs16944,bipolar disorder
IL1B,Rs16944,depression
IL1B,Rs16944,impaired ability to achieve remission
IL1B,Rs16944,bipolar individuals
IL1B,Rs16944,schizophrenic
IL1B,Rs1143627,hepatitis B vaccine
IL1B,Rs16944,multiple mental illnesses
IL1B,Rs16944,inflammatory
IL1B,Rs16944, Osteoarthritis
IL1B,Rs1143627,radiation-induced toxicity
IL1B,Rs16944,gray matter and hypoactivity
IL1B,Rs1143627,neonatal sepsis
IL1B,Rs1143627,cancers of the upper aerodigestive tract
IL1B,Rs1143627,follicular lymphoma
IL1B,Rs1143627,celiac disease
IL1B,Rs1143627,Children
IL1B,Rs1143627,Helicobacter pylori infection
IL1B,Rs1143627,ankylosing spondylitis
IL1B,Rs1143627,basal cell carcinoma of skin
IL1B,Rs1143627,osteoarthritis
IL1B,Rs1143627,cancer anorexia/weight loss syndrome
IL1B,Rs1143627,lung cancer
IL1B,Rs1143627,esophagectomy
IL1B,Rs1143627,infection
IL1B,Rs1143627,hand osteoarthritis
IL1B,Rs1143627,cancers of the upper aerodigestive tract
IL1B,Rs1143627,celiac disease
IL1B,Rs1143627,non-small cell lung cancer
IL1B,Rs1143627,arteriovenous malformation
IL1B,Rs1143627,cognition
IL1B,Rs1143627,mood disorders
IL1B,Rs1143627,rheumatoid arthritis
IL1B,Rs1143627,non-small cell lung cancer
IL1B,Rs1143627,cancer anorexia/weight loss syndrome
IL1B,Rs1143627,high-dose treatment with stem cell
IL1B,Rs1143627,multiple myeloma
IL1B,Rs1143627,race
IL1B,Rs1143627,brain arteriovenous malformation
IL1B,Rs1143627,breast cancer
IL1B,Rs1143627,Organochlorine exposure
IL1B,Rs1143627,intracranial hemorrhage
IL1B,Rs1143627,Korean keratoconus patients
IL1B,Rs1143627,childhood-onset mood disorders
IL1B,Rs1143627,non-small cell lung cancer
IL1B,Rs1143627,smoking
IL1B,Rs1143627,China
IL1B,Rs1143627,biliary tract cancers and stones
IL1B,Rs1143627,diffuse large B-cell lymphoma
IL1B,Rs1143627,non-Hodgkin lymphoma
IL1B,Rs1143627,hay-fever
IL1RL1,Rs1420101,nasal polyposis
IL1RL1,Rs1420101,asthma in childhood
IL1RL1,Rs1420101,Asthma
IL1RL1,Rs13431828,chronic rhinosinusitis
IL1RL1,Rs1420101,asthma
IL1RN,Rs315952,knee osteoarthritis
IL1RN,Rs423904,Ulcerative colitis
IL1RN,Rs423904,Ulcerative colitis
IL1RN,Rs9005,knee osteoarthritis
IL2,Rs2069772,Cervical and vulvar cancer
IL20,Rs2981573,palmoplantar pustulosis
IL20,Rs2981573,chronic hepatitis B
IL21,Rs907715,rheumatoid arthritis
IL23R,Rs1495965,Iranian
IL23R,Rs1495965,Behcet's disease
IL23R,Rs7517847,Crohn's disease
IL23R,Rs7517847,Crohn's Disease
IL23R,Rs1495965,north Indians
IL23R,Rs7517847,Crohn's disease
IL23R,Rs7517847,Crohn's disease
IL23R,Rs7517847,Italian patients
IL23R,Rs7517847,ulcerative colitis
IL23R,Rs7517847,Crohn's disease
IL23R,Rs1495965,ulcerative colitis
IL23R,Rs1495965,German
IL23R,Rs1495965,colonic Crohn's disease
IL23R,Rs1495965,systemic lupus erythematosus
IL23R,Rs1495965,celiac disease
IL23R,Rs1495965,psoriasis
IL23R,Rs1495965,IBD
IL23R,Rs1495965,"Swedish, Finnish, Hungarian and Italian"
IL23R,Rs1495965,Crohn's disease
IL23R,Rs1495965,Brazilian population
IL23R,Rs1495965,Crohn's disease susceptibility
IL23R,Rs1495965,Crohn's disease
IL23R,Rs7517847,Crohn's Disease
IL23R,Rs1495965,early disease onset
IL23R,Rs7517847,New Zealand populations
IL23R,Rs7539625,Crohn's disease
IL23R,Rs7517847,German Crohn's disease
IL23R,Rs7539625,osteonecrosis of femoral head
IL23R,Rs7517847,north Indians
IL23R,Rs7517847,ulcerative colitis
IL23R,Rs7517847,colonic Crohn's disease
IL23R,Rs7517847,German children
IL23R,Rs7517847,Crohn's disease
IL23R,Rs7517847,Chinese Han population
IL23R,Rs7517847,Vogt-Koyanagi-Harada syndrome
IL23R,Rs7517847,Hungarian population
IL23R,Rs7517847,Sjogren syndrome
IL23R,Rs7517847,ankylosing spondylitis
IL23R,Rs7517847,Spanish rheumatoid arthritis cohort
IL23R,Rs7517847,autoimmune conditions
IL23R,Rs7517847,celiac disease
IL23R,Rs7517847,psoriasis
IL23R,Rs7517847,Italian
IL23R,Rs7517847,Hungarian
IL23R,Rs7517847,Finnish
IL23R,Rs7517847,Swedish
IL23R,Rs7517847,Spanish IBD patients
IL23R,Rs7517847,celiac disease and multiple sclerosis
IL23R,Rs7517847,Brazilian population
IL23R,Rs7517847,Crohn's disease
IL23R,Rs7517847,myocardial infarction
IL23R,Rs7517847,systemic lupus erythematosus
IL23R,Rs1495965,Spanish
IL23R,Rs1495965,rheumatoid arthritis
IL23R,Rs1495965,systemic sclerosis
IL23R,Rs11465770,Crohn's disease
IL23R,Rs11465770,Crohn's disease
IL23R,Rs11209032,systemic sclerosis
IL23R,Rs11209032,ankylosing spondylitis
IL23R,Rs11209032,systemic sclerosis
IL23R,Rs11209032,ankylosing spondylitis
IL23R,Rs11209032,systemic sclerosis
IL23R,Rs11209032,ankylosing spondylitis
IL23R,Rs10889677,European ancestry
IL23R,Rs10889677,Graves' disease
IL23R,Rs10889677,North American patients
IL23R,Rs10889677,Caucasian patients.
IL23R,Rs10889677,ankylosing spondylitis
IL23R,Rs10889677,Jewish
IL23R,Rs10889677,Crohn's disease
IL23R,Rs10889677,ulcerative colitis 
IL23R,Rs10889677,Graves ophthalmopathy
IL23R,Rs10889677,"Graves' disease,"
IL23R,Rs10889677,ankylosing spondylitis
IL23R,Rs10889677,Crohn's disease
IL23R,Rs10489629,ankylosing spondylitis.
IL23R,Rs10489629,Caucasian
IL23R,Rs1495965,inflammatory bowel disease
IL23R,Rs11465770,Crohn's disease
IL23R,Rs11465770,Crohn's disease
IL23R,Rs10889677,non-Jewish populations.
IL23R,Rs11465770,protective 
IL23R,Rs1495965,ankylosing spondylitis
IL23R,Rs1495965,Caucasian patients
IL23R,Rs1495965,ehcet's disease
IL23R,Rs1495965,early disease onse
IL23R,Rs1495965,colonic Crohn's disease
IL23R,Rs1495965,systemic lupus erythematosus
IL23R,Rs1495965,Crohn's disease
IL23R,Rs1495965,Crohn's disease susceptibility
IL23R,Rs1495965,German Crohn's disease
IL23R,Rs1495965,Behçet's disease
IL23R,Rs1495965,inflammatory bowel disease
IL23R,Rs1495965,rheumatoid arthritis
IL23R,Rs1495965,Behçet's disease
IL23R,Rs1495965,ankylosing spondylitis
IL23R,Rs1343151,Crohn's Disease 
IL23R,Rs1343151,rheumatoid arthritis 
IL23R,Rs1343151,rheumatoid arthritis 
IL23R,Rs1343151,ankylosing spondylitis
IL23R,Rs1343151,Crohn's Disease
IL23R,Rs1343151,rheumatoid arthriti
IL23R,Rs1343151,ankylosing spondylitis
IL23R,Rs11805303,Crohn's disease
IL23R,Rs11465804,ankylosing spondylitis
IL23R,Rs1495965,systemic sclerosis
IL23R,Rs11465770,T allele
IL2RA,Rs3118470,autoimmune thyroiditis
IL2RA,Rs3118470,Type I Diabetes
IL2RA,Rs3118470,type I diabetes
IL2RA,Rs3118470,diabetes
IL2RA,Rs3118470,pre-diabetes to diabetes 
IL2RA,Rs3118470,diabetes
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,Rheumatoid arthritis
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,Rheumatoid arthritis
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,autoimmune myasthenia gravis
IL31,Rs6489188,were strongly associated with nonatopic eczema
IL31,Rs6489188,nonatopic eczema
IL31,Rs11608363,were strongly associated with nonatopic eczema
IL31,Rs11608363,nonatopic eczema
IL4,Rs2243274,children.
IL4,Rs2243274,African American
IL4,Rs2243274,European ancestry
IL4,Rs2243274,type 1 diabetes.
IL4,Rs2243274,type I diabetes
IL4,Rs2243268,Plasmodium falciparum malaria
IL4,Rs2243268,biliary tract cancers and stones
IL4,Rs2243268,Cytokine polymorphisms
IL4,Rs2243268,non-Hodgkin lymphoma
IL4,Rs2243268,type 1 diabetes
IL4,Rs2243268,autoimmune conditions
IL4,Rs2243268,non-Hodgkin lymphoma
IL4,Rs2070874,elayed-t
IL4,Rs2243250,myocardial infarction
IL4,Rs2243268,type 1 diabetes
IL4,Rs2070874,Leishmania chagasi
IL4,Rs2070874,prostate cancer
IL4,Rs2070874,Visceral leishmaniasis (VL)
IL4,Rs2070874,Visceral leishmaniasis
IL4,Rs2070874, with
IL4,Rs2070874,ng fro
IL4,Rs2070874,prostate cancer
IL4,Rs2070874,rs2070874
IL4,Rs2070874,Leishmania chagasi
IL6,Rs2069832,prostate cancer
IL6,Rs2069832,breast cancer
IL6,Rs2069832,diabetic patients.
IL6,Rs2069832,prostate cancer
IL6,Rs2069832,prostate cancer
IL6,Rs2069832,breast cancer
IL6,Rs2069832,colon and rectal cancer
IL6,Rs2069832,prostate cancer
IL6,Rs2069837,Alzheimer's disease
IL6,Rs2069861,type 2 diabetes
IL6,Rs2069837,Alzheimer's
IL6,Rs2069837,Alzheimer's disease
IL6,Rs2069837,gender
IL6,Rs2069832,breast cancer
IL6,Rs2069861,susceptibility to melanoma
IL6,Rs2069861,mmunogenetics of seasonal influenza vaccine response
IL6,Rs2069861,risk and systemic inflammation
IL6,Rs7802308,coronary artery disease
IL6,Rs7802308,Asian Indian sibling pairs
IL6,Rs7802308,coronary artery disease
IL6,Rs2069837,Alzheimer's disease
IL6,Rs2069830,stroke
IL6,Rs2069832,colon and rectal cancer
IL6,Rs1800797,coronary artery disease
IL6,Rs13306435,sciatica patients
IL6,Rs13306435,sciatica
IL6,Rs2066992,coronary artery disease
IL6,Rs13306435,haplotype
IL6,Rs1524107,type 2 diabetic patients
IL6,Rs1524107,prostate cancer
IL6,Rs1524107,cardiovascular disease
IL6,Rs1800796,abdominal aortic aneurysm
IL6,Rs1800796,osteoarthritis
IL6,Rs1800796,coronary artery disease
IL6,Rs13306435,IL6 gene
IL6,Rs1800796,elevated blood pressure
IL6,Rs1800796,coronary artery disease
IL6,Rs1800796,Asian Indian
IL6,Rs1800796,polymorphism
IL6,Rs1800796,abdominal aortic aneurysm
IL6,Rs1800796,symptomatic DIP OA
IL6,Rs1800796,coronary artery disease
IL6,Rs1800797,interphalangeal osteoarthritis
IL6,Rs1800797,disease
IL6,Rs1800796,abdominal aortic aneurysm
IL6R,Rs4537545,Inflammation
IL6R,Rs4537545,Crohn disease
IL6R,Rs4537545,"psoriasis, and inflammation"
IL6R,Rs6684439,melanoma
IL6R,Rs6684439,melanoma
IL6R,Rs6684439,melanoma
IL6R,Rs6694817,cardiovascular genetic
IL6R,Rs6684439,melanoma risk
IL6R,Rs6684439,heterozygous
IL6R,Rs6694817,cardiovascular genetic risk
IL6R,Rs6694817,SNP
IL6R,Rs6694817,cardiovascular genetic risk score
IL6R,Rs4537545,inflammatory effects
IL6R,Rs6684439,melanoma
IL6R,Rs4537545,inflammatio
IL6R,Rs4129267,diabetes 
IL6R,Rs4537545,Crohn disease
IL6R,Rs2229238,diabetes
IL6R,Rs4129267,autoimmune inflammatory conditions
IL6R,Rs4129267,Asians
IL6R,Rs4129267,Cardiovascular Disease
IL6R,Rs4537545,psoriasis
IL6R,Rs4129267,Asthma 
IL6R,Rs4129267,Caucasians
IL6R,Rs4129267,Breast cancer
IL6R,Rs4537545,increases IL-6r and IL-6 levels
IL6R,Rs4537545,inflammatory effects
IL6R,Rs4537545,amniotic fluid protein concentrations
IL6R,Rs4537545,Inflammation
IL6R,Rs4537545,stress-related
IL6R,Rs4129267,Crohn disease
IMMP2L,Rs12531640,10^-6
IMPDH1,Rs72624951,Blueprint Genetics Retinal dystrophy
IMPDH1,Rs72624951,Blueprint Genetics Retinal dystrophy
INSL6,Rs77375493,idiopathic myelofibrosis
INSL6,Rs77375493,thrombocythemia
INSL6,Rs77375493,polycythemia vera
INSL6,Rs77375493,cancers of the blood
INSL6,Rs77375493,myeloproliferative disorders
INSL6,Rs77375493,idiopathic myelofibrosis
INSL6,Rs77375493,thrombocythemia
INSL6,Rs77375493,olycythemia vera
INSL6,Rs10815149,due to stem cells over producing too many of one type of cell
INSL6,Rs77375493,ssociated with several myeloproliferative disorders
INSL6,Rs3780378,"body fat, insulin sensitivity and lipid profile."
INSL6,Rs121912472,myeloproliferative disorders
INSL6,Rs121912472,myeloproliferative
INSL6,Rs10815149,myeloproliferative neoplasm
INSL6,Rs10815149,myeloproliferative neoplasm
INSL6,Rs10815149,myeloproliferative neoplasm
INSL6,Rs77375493,cancers of the blood
INSR,Rs2860174,migraine 
INSR,Rs2860174,migraine 
IRAK1,Rs1059703,cerebral infarction
IRAK1,Rs1059703,Japanese adults
IRF1,Rs2070729,circulating fibrinogen levels
IRF1,Rs2070729,three African
IRF1,Rs2070729,severe malaria
IRF1,Rs2070729,malaria
IRF1,Rs2070729,Lack of association of interferon regulatory factor 1 with severe malaria in affected child-parental trio studies across three African populations. Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts
IRF5,Rs2004640,rheumatoid arthritis
IRF5,Rs2004640,increasing SLE risk
IRF5,Rs2004640,systemic lupus erythematosus (SLE)
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,lupus erythematosus
IRF5,Rs10954213,primary biliary cirrhosis
IRF5,Rs10954213,IgA nephropathy
IRF5,Rs10954213,lupus nephritis
IRF5,Rs10954213,Shandong Han population
IRF5,Rs10954213,SLE
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,discoid and subacute cutaneous lupus erythematosus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,systemic lupus erythematosus patients
IRF5,Rs10954213,multiple sclerosis
IRF5,Rs2004640,systemic sclerosis
IRF5,Rs2004640,rheumatoid arthritis
IRF5,Rs2004640,multiple sclerosis
IRF5,Rs3807306,multiple sclerosis
IRF5,Rs6953165,SLE
IRF5,Rs6953165,SLE
IRF5,Rs6953165,SLE
IRF5,Rs6953165,SLE
IRF5,Rs6953165,SLE
IRF5,Rs6953165,SLE
IRF5,Rs6953165,SLE
IRF5,Rs6953165,SLE
IRF5,Rs41298401,SLE
IRF5,Rs41298401,SLE
IRF5,Rs41298401,SLE
IRF5,Rs41298401,SLE
IRF5,Rs41298401,SLE
IRF5,Rs41298401,SLE
IRF5,Rs41298401,SLE
IRF5,Rs41298401,SLE
IRF5,Rs3807306,systemic lupus erythematosus
IRF5,Rs10954213,psoriasis
IRF5,Rs10954213,Swedish
IRF5,Rs10954213,Sjogren's syndrome
IRF5,Rs10954213,human lupus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,subacute cutaneous lupus erythematosus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,high serum interferon-alpha activity
IRF5,Rs10954213,psoriasis
IRF5,Rs10954213,primary biliary cirrhosis
IRF5,Rs10954213,Sjogren's syndrome
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,SLE
IRF5,Rs10954213,SLE
IRF5,Rs10954213,SLE
IRF5,Rs10954213,SLE
IRF5,Rs10954213,SLE
IRF5,Rs10954213,Systemic Lupus Erythematosus
IRF5,Rs10954213,lupus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,SLE
IRF5,Rs10954213,lupus nephritis
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,UK SLE families
IRF5,Rs10954213,Japanese SLE patients
IRF5,Rs10954213,increasing SLE risk
IRF5,Rs10954213,Caucasian
IRF5,Rs10954213,SLE
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,SLE
IRF5,Rs10954213,SLE
IRF5,Rs10954213,Japanese
IRF5,Rs10954213,SLE
IRF5,Rs10954213,SLE
IRF5,Rs10954213,Japanese
IRF5,Rs10954213,Systemic Lupus Erythematosus
IRF5,Rs10954213,systemic sclerosis
IRF5,Rs10954213,IgA nephropathy
IRF5,Rs10954213,Korean
IRS1,Rs1801123,breast cancer
IRS1,Rs1801123,type I diabetes
ITGA2B,Rs76811038,Glanzmann's thrombasthenia
ITGA2B,Rs80277041,Glanzmann's thrombasthenia
ITGA2B,Rs80002943,Glanzmann's thrombasthenia
ITGA2B,Rs137852911,Glanzmann's thrombasthenia
ITGA2B,Rs137852906,Glanzmann's thrombasthenia
ITGA2B,Rs137852909,Glanzmann's thrombasthenia
ITGA2B,Rs137852908,Glanzmann's thrombasthenia
ITGA2B,Rs137852907,Glanzmann's thrombasthenia
ITGA2B,Rs137852910,Glanzmann's thrombasthenia
ITGAV,Rs3738919,CI: 1.3â€“2.9
ITGAV,Rs3738919,rheumatoid arthritis (RA)
ITGAV,Rs3738919,rheumatoid arthritis (RA)
ITGAV,Rs3738919,RA
ITGAV,Rs9333289,autosomal recessive retinitis pigmentosa
ITGB3,Rs5918,Non-Hodgkin Lymphoma
ITGB3,Rs5918,heart attack
ITGB3,Rs5918,myocardial infarction
ITGB3,Rs5918,early onset heart disease
ITGB3,Rs5918,breast cancer
ITGB3,Rs5918,"heart disease,"
ITGB3,Rs5918,"myocardial infarction,"
ITGB3,Rs5918,"2' allele of the platelet specific alloantigen system is encoded by rs5918(C), and it has"
ITGB3,Rs5918,blood-thinning
ITPA,Rs6139030,thrombocytopenia
ITPA,Rs6139030,Hepatitis C
ITPA,Rs1127354,chronic hepatitis C
ITPA,Rs1127354,anemia 
ITPA,Rs6139030,thrombocytopenia 
ITPA,Rs1127354,rheumatoid arthritis
ITPA,Rs1127354,autosomal recessive anonychia
ITPA,Rs1127354,febrile neutropenia
ITPA,Rs1127354,hemolytic anemia
ITPKC,Rs28493229,Kawasaki disease
ITPKC,Rs28493229,cervical squamous cell carcinoma
ITPKC,Rs28493229,Kawasaki Disease
ITPKC,Rs28493229,Han Chinese
ITPKC,Rs28493229,Kawasaki Disease
ITPKC,Rs28493229,Kawasaki disease
ITPKC,Rs28493229,Kawasaki Disease
ITPKC,Rs28493229,coronary artery aneurysms
ITPKC,Rs28493229,Kawasaki Disease
ITPKC,Rs28493229, Kawasaki disease
ITPKC,Rs28493229,Kawasaki disease.
ITPKC,Rs28493229,coronary artery aneurysms
ITPKC,Rs28493229,coronary artery lesion
ITPKC,Rs28493229,Intravenous Immunoglobulin-Resistant Kawasaki Disease
ITPKC,Rs28493229,Kawasaki Disease:
ITPKC,Rs28493229,Kawasaki Diseas
ITPKC,Rs28493229,Kawasaki Disease
ITPKC,Rs28493229,cervical squamous cell carcinoma
ITPKC,Rs28493229,coronary artery aneurysms
ITPR3,Rs3748079,rheumatoid arthritis
JAK2,Rs77375493,idiopathic myelofibrosis
JAK2,Rs77375493,thrombocythemia
JAK2,Rs77375493,polycythemia vera
JAK2,Rs77375493,cancers of the blood
JAK2,Rs77375493,myeloproliferative disorders
JAK2,Rs77375493,thrombocythemia
JAK2,Rs77375493,olycythemia vera
JAK2,Rs77375493,cancers of the blood
JAK2,Rs77375493,idiopathic myelofibrosis
JAK2,Rs3780378,"body fat, insulin sensitivity and lipid profile."
JAK2,Rs121912472,myeloproliferative disorders
JAK2,Rs121912472,myeloproliferative
JAK2,Rs10815149,myeloproliferative neoplasm
JAK2,Rs10815149,due to stem cells over producing too many of one type of cell
JAK2,Rs10815149,myeloproliferative neoplasm
JAK2,Rs10815149,myeloproliferative neoplasm
JAK2,Rs77375493,ssociated with several myeloproliferative disorders
JUP,Rs113994177,Naxos disease
JUP,Rs113994177,woolly hair
JUP,Rs113994177,palmoplantar keratoderma
JUP,Rs113994177,arrhythmogenic right ventricular cardiomyopathy
KCNA3,Rs2821557,olfactory dysfunction
KCNA3,Rs2821557,olfactory function
KCNA3,Rs2821557,olfactory dysfunction
KCNA3,Rs2821557,fasting plasma glucose
KCNA3,Rs2821557,olfactory dysfunction
KCNA3,Rs2821557,loss of olfactory function
KCNA5,Rs45477792,affecting an amino acid in exon 1 of the KCNA5 potassium channel gene
KCNA5,Rs45477792,cardiac arrhythmias
KCNA5,Rs45477792,cardiac arrhythmias
KCNB1,Rs756529,LV hypertrophy in humans
KCNE1,Rs727957,Influences QT interval
KCNE1,Rs74315445,long QT syndrome
KCNE1,Rs74315445,long QT syndrome
KCNE1,Rs74315445,long QT syndrome
KCNE1,Rs74315445,catecholaminergic polymorphic ventricular tachycardia
KCNE1,Rs74315445,Lange-Nielsen and Romano-Ward forms of Long-QT syndrome
KCNE1,Rs74315445,jervell
KCNE1,Rs74315445,suppress IKs function
KCNE1,Rs74315445,Lange-Nielsen syndrome
KCNE1,Rs1805128,Influences QT interval
KCNE1,Rs74315445,Jervell
KCNH2,Rs121912515,long QT syndrome
KCNH2,Rs121912515,long QT syndrome
KCNH2,Rs121912515,QT syndrome
KCNH2,Rs121912515,long QT syndrome
KCNH2,Rs121912515,polymorphisms 
KCNH2,Rs1036145,activity in the dorsolateral prefrontal cortex
KCNH2,Rs1036145,declarative memory task
KCNH2,Rs1036145,hippocampal activity
KCNH2,Rs1036145,hippocampal volume
KCNH2,Rs1036145, risk for schizophrenia
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,type 2 Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome 
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,type 2 Bartter syndrome
KCNJ11,Rs80356616,neonatal diabetes syndrome and other neurological features
KCNJ11,Rs80356616,epilepsy
KCNJ11,Rs80356616,developmental delay
KCNJ11,Rs80356616,neonatal diabetes
KCNJ11,Rs80356616,neonatal diabetes plus neurological features
KCNJ11,Rs80356616,neonatal diabetes
KCNJ11,Rs80356616,permanent neonatal diabetes
KCNJ11,Rs80356616,permanent neonatal diabetes
KCNJ11,Rs5215,type-1 diabetes
KCNJ11,Rs193929336,activating mutations
KCNJ11,Rs193929336,neonatal diabetes
KCNJ11,Rs193929336,permanent neonatal diabetes
KCNJ11,Rs193929336,activating mutations
KCNJ11,Rs80356616,Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
KCNMA1,Rs762705295,pathogenic variant
KCNQ1,Rs120074194,forme fruste long-QT syndrome
KCNQ1,Rs120074194,long-QT syndrome genes
KCNQ1,Rs120074194,Jervell and Lange-Nielsen syndrome
KCNQ1,Rs120074194,long QT syndrome
KCNQ1,Rs120074194,swimming-triggered arrhythmia syndromes
KCNQ1,Rs120074194,Vasoactive intestinal polypeptide (VIP)
KCNQ1,Rs120074194,Huntington's disease
KCNQ1,Rs120074194,Lange-Nielsen syndrome
KCNQ1,Rs120074194,long-QT syndrome
KCNQ1,Rs120074194,Jervell
KCNQ1,Rs120074194,Huntington's disease
KCNQ1,Rs120074194,long QT syndrome
KCNQ1,Rs120074195,long-QT syndrome
KCNQ1,Rs120074195,short QT-interval syndrome
KCNQ1,Rs12576239,Influences QT interval
KCNQ1,Rs120074194,forme fruste long-QT syndrome
KCNQ1,Rs120074193,sudden death
KCNQ1,Rs120074194,swimming-triggered arrhythmia syndromes
KCNQ1,Rs120074193,long-QT syndrome 
KCNQ1,Rs120074193,lethal cardiac arrhythmias
KCNQ1,Rs104894252,cardiac arrhythmias
KCNQ1,Rs104894252,long QT syndrome
KCNQ1,Rs104894252,cardiac arrhythmias
KCNQ1,Rs104894252,cardiac arrhythmias
KCNQ1,Rs104894252,long QT syndrome
KCNQ1,Rs104894252,long QT syndrome
KCNQ1,Rs104894252,cardiac arrhythmias
KCNQ1,Rs120074188,Recessive Romano-Ward syndrome
KCNQ1,Rs120074188,FAMILION long QT syndrome
KCNQ1,Rs120074190,mutation 
KCNQ1,Rs120074190,mutations 
KCNQ1,Rs120074190,QT syndrome
KCNQ1,Rs120074193,arrhythmogenic trigger
KCNQ1,Rs120074193,inherited long QT syndrome
KCNQ1,Rs104894252,cardiac arrhythmias
KCNQ4,Rs80358271,autosomal dominant deafness
KCNQ4,Rs80358279,deafness
KCNQ4,Rs80358276,autosomal dominant hearing loss
KCNQ4,Rs28939710,deafness
KCNQ4,Rs80358279,KCNQ4 pore-region mutation
KCNQ4,Rs28937589,deafness
KCNQ4,Rs28937589,deafness
KCNQ4,Rs28937588,deafness
KCNQ4,Rs28937588,deafness
KCNQ4,Rs28939710,deafness Mutations
KDM5D,Rs2032623,"Association of Y chromosome haplogroup I with HIV progression, and HAART outcome."
KDR,Rs7691507,VEGF
KDR,Rs7691507,VEGFR
KDR,Rs2125489,neovascular age-related macular degeneration
KDR,Rs1870377,Gilbert's syndrome
KDR,Rs1870377,age-related macular degeneration
KDR,Rs7691507,KDR
KDR,Rs1870377,Pazopanib-induced hyperbilirubinemia
KDR,Rs1870377,Gilbert's syndrome UGT1A1 polymorphism
KDR,Rs1531289,chronic myeloid leukemia
KDR,Rs1531289,neovascular age-related macular degeneration
KDR,Rs1531289,Polymorphisms in the VEGFA and VEGFR-2 genes
KDR,Rs1870377,Gilbert's syndrome
KEL,Rs8176059,Non-ABO Blood Groups
KIAA0319,Rs4352670,dyslexia
KIAA0319,Rs4352670,developmental dyslexia
KIAA0319,Rs4352670,KIAA0319 on chromosome 6p
KIAA0319,Rs4236032,developmental dyslexia
KIAA0319,Rs4236032,developmental dyslexia
KIAA0319,Rs12193738,reading disabilities
KIAA0319,Rs12193738,histone
KIAA0319,Rs4236032,susceptibility to developmental dyslexia.
KIF1A,Rs548204329,hereditary spastic paraplegia
KIF1B,Rs10492972,multiple sclerosis
KIF1B,Rs10492972,multiple sclerosis
KIF1B,Rs10492972,Alzheimer disease
KIF1B,Rs10492972,multiple sclerosis
KIF1B,Rs10492972,disease
KIF1B,Rs10492972,multiple sclerosis
KIF1B,Rs10492972,multiple sclerosis
KIF5A,Rs113247976,Lou Gehrig's disease
KIF5A,Rs113247976,ALS
KIF5A,Rs113247976,ALS
KIF5A,Rs113247976,minor allele of this SNP
KIF5A,Rs113247976,Lou Gehrig's disease
KIF5A,Rs113247976,ALS
KIF5A,Rs113247976,Lou Gehrig's disease
KIRREL3,Rs1939992,Autosomal recessive ichthyosis with hypotrichosis
KIT,Rs28933968,somatic mutation
KIT,Rs28933968,somatic mutation
KITLG,Rs3782179,testicular cancer
KITLG,Rs4590952,protection from sun damage
KITLG,Rs4590952,testicular cancer
KITLG,Rs4590952,protection from sun damage
KITLG,Rs4590952,testicular cancer
KITLG,Rs3782179,testicular cancer
KITLG,Rs3782179,Testicular germ cell tumor 
KITLG,Rs12821256,Europeans
KITLG,Rs12821256,blond hair color
KITLG,Rs12821256,more likely to have blond than brown hair color
KITLG,Rs12821256,Dutch
KITLG,Rs12821256,Icelanders
KITLG,Rs12821256,blond than brown hair color
KITLG,Rs12821256,blond hair color
KITLG,Rs12821256,lighter hair color
KL,Rs211239,sickle cell anemia
KL,Rs211239,priapism
KL,Rs211239,priapism
KL,Rs2249358,priapism
KL,Rs2249358,anemia 
KL,Rs2249358,priapism
KLF6,Rs10508266,Lung cancer
KLF6,Rs10508266,Lung cancer risk.
KLK3,Rs17632542,PSA levels
KLK3,Rs17632542,prostate cancer
KRAS,Rs17388587,risk of endometriosis.
KRIT1,Rs886039402,1267
KRIT1,Rs267607204,cerebral cavernous malformation
KRT14,Rs60831116,DERMATOPATHIA PIGMENTOSA RETICULARIS
KSR2,Rs10444502,decreased total cholesterol levels
KSR2,Rs4767631,LDL cholesterol
LAMA2,Rs12193446,risk of nearsightedness
LAMB3,I5012671,Herlitz typers
LAMB3,I5012672,Epidermolysis bullosa
LAMB3,I5012671,epidermolysis bullosa
LAMB3,I5012671,junctional
LAMB3,I5012671,epidermolysis bullosa
LAMB3,I5012669,Herlitz typers
LAMB3,I5012669,junctional
LAMB3,I5012669,epidermolysis bullosa
LAMB3,I5012669,epidermolysis bullosa
LAMB3,I5012669,"epidermolysis bullosa, junctional, Herlitz type"
LBP,Rs2232596,hematopoietic cell
LDB3,Rs121908338,left ventricular noncompaction
LDB3,Rs45487699,left ventricular noncompaction
LDB3,Rs121908337,ventricular noncompaction
LDLRAP1,Rs755104973,pathogenic variant
LEP,Rs2167270,rheumatoid arthritis
LEP,Rs2167270,colon cancer
LEP,Rs2167270,hypertension
LEP,Rs2167270,prostate cancer
LEP,Rs2167270,Adipokine
LEP,Rs2071045,obesity-related genes
LEP,Rs17151919,spina bifida.
LEP,Rs2071045,Genetic polymorphisms
LEP,Rs2071045,endometrial cancer
LEP,Rs2071045,obesity-related genes
LEP,Rs2071045,weight regain
LEP,Rs17151919,spina bifida
LEP,Rs2071045,endometrial cancer
LEPR,Rs6700896,ower CRP and associated with increased weight and body mass index
LEPR,Rs6700896,increased weight and body mass index
LHCGR,Rs2293275,spermatogenetic damage
LHCGR,Rs2293275,male infertility
LHCGR,Rs13405728,PCOS
LHCGR,Rs2293275,polycystic ovary syndrome
LHCGR,Rs2293275,Alzheimer's disease
LHCGR,Rs13405728,PCOS
LHCGR,Rs2293275,breast cancer
LHCGR,Rs13405728,hirsutism
LHCGR,Rs13405728,polycystic ovary syndrome
LHCGR,Rs121912532,mutations of the LH receptor gene
LHCGR,Rs13405728,Polycystic Ovary Syndrome
LHCGR,Rs121912518,familial male precocious puberty
LHCGR,Rs121912518,familial male precocious puberty
LIG4,Rs10131,invasive serous ovarian cancer
LIG4,Rs10131,DNA damage response
LINC-PINT,Rs6971499,pancreatic cancer
LINC-PINT,Rs6971499,European
LINC-PINT,Rs6971499,Pancreatic cancer
LIPC,Rs8023503,hyperalphalipoproteinemia
LIPC,Rs261332,Elevated HDL-Cholesterol
LIPC,Rs1800588,colorectal cancer
LIPC,Rs1800588,risk for carotid artery disease
LIPC,Rs1800588,coronary artery disease
LIPC,Rs1800588,higher HDL levels
LIPC,Rs1800588,coronary heart disease
LIPT1,Rs786205156,mutations
LIPT1,Rs137973334,lipoyltransferase 1 deficiency
LIPT1,Rs137973334,lipoyltransferase 1 deficiency
LIPT1,Rs137973334,severe metabolic disorder often leading to death soon after birth
LIPT1,Rs786205156,causative
LIPT1,Rs786205156,lipoyltransferase 1 deficiency
LIPT1,Rs786205156,severe metabolic disorder
LIPT1,Rs786205156,mutation
LIPT1,Rs786205156,severe metabolic disorde
LMNA,Rs267607577,cardiomyopathy
LMNA,Rs267607577,cardiomyopathy
LOC729065,Rs2200733,atrial fibrillation
LOC729065,Rs2200733,atrial flutter
LOC729065,Rs2200733,atrial fibrillation
LOC729065,Rs2200733,AF/AFL disease
LOC729065,Rs2200733,higher risk for postoperative atrial fibrillation
LOC729065,Rs2200733,AF 
LOC729065,Rs2200733,atrial fibrillation 
LOC729065,Rs2200733,ischemic stroke 
LOC729065,Rs2200733,cardioembolic stroke (CES) (
LOC729065,Rs2200733,ischemic stroke 
LOC729065,Rs2200733,AF/AFL disease
LOC729065,Rs2200733,atrial flutter (AFL) 
LOC729065,Rs2200733,atrial fibrillation (AF)
LOC729065,Rs2200733,cardioembolic stroke
LOXL1,Rs3825942,XFS
LOXL1,Rs3825942,primary open angle glaucoma
LOXL1,Rs3825942,glaucoma
LOXL1,Rs3825942,exfoliation ''syndrome''
LOXL1,Rs3825942,exfolation ''glaucoma''
LOXL1,Rs3825942,XFG
LOXL1,Rs3825942,exfoliation glaucoma
LOXL1,Rs3825942,pseudoexfoliation (PEX)
LOXL1,Rs3825942,pseudoexfoliation glaucoma (PEXG)
LOXL1,Rs3825942,pseudoexfoliation glaucoma
LOXL1,Rs3825942,Decreased total antioxidants status
LOXL1,Rs893817,primary open-angle glaucoma
LOXL1,Rs893817,pseudoexfoliation glaucoma
LOXL1,Rs3825942,GGT
LOXL1,Rs3825942,XFG
LOXL1,Rs1078967,exfoliation glaucoma
LOXL1,Rs3825942,glaucoma
LOXL1,Rs3825942,exfoliation syndrome
LOXL1,Rs3825942,exfoliation glaucoma
LOXL1,Rs3825942, glaucoma
LOXL1,Rs3825942,firmed as risk for pseudoexfoliation (PEX) and pseudoexfoliation glaucom
LOXL1,Rs3825942,"lele was the risk allele, in contrast to other populations.{PMID "
LOXL1,Rs3825942,"drome'', which has "
LOXL1,Rs2165241,open-angle glaucoma
LOXL1,Rs2165241,Glaucoma
LOXL1,Rs2165241,exfoliation glaucoma
LOXL1,Rs201011613,XFS
LOXL1,Rs201011613,exfoliation syndrome (XFS)
LOXL1,Rs1078967,glaucoma
LOXL1,Rs3825942,blindness
LPA,Rs7770628,protein levels
LPA,Rs55730499,longevity
LPA,Rs55730499,longevity
LPA,Rs55730499,longevity
LPL,Rs285,coronary disease
LPL,Rs285,Alzheimer's disease
LPP,Rs1464510,type 1 diabetes
LPP,Rs9860547,Allergies
LPP,Rs9851967,Celiac Disease
LPP,Rs4686484,celiac disease
LPP,Rs9860547,Allergies
LPP,Rs4686484,altered risk for celiac disease
LPP,Rs1464510,coeliac disease
LPP,Rs1464510,type 1 diabetes
LPP,Rs1464510,celiac disease
LPP,Rs1464510,type 2 diabetes
LPP,Rs1464510,autoimmune and inflammatory diseases
LPP,Rs1464510,juvenile idiopathic arthritis
LPP,Rs1464510,coeliac disease susceptibility
LPP,Rs1464510,type 1 diabetes
LPP,Rs1464510,celiac disease
LPP,Rs1464510,type 1 diabetes
LPP,Rs1464510,type 2 diabetes
LPP,Rs13076312,Vitiligo
LPP,Rs13076312,Vitiligo
LPP,Rs1464510,autoimmune and inflammatory diseases
LRP4,Rs2306033,Osteoporotic fractures
LRP5,Rs4988321,"vertebral fractures and reduced bone mineral density (BMD),"
LRP5,Rs4988321,bone mass
LRP5,Rs4988321,high-bone-mass disorders
LRP5,Rs4988321,bone mass
LRP5,Rs4988321,osteoporosis
LRP5,Rs4988321,fractures
LRP5,Rs4988321,bone mass
LRP5,Rs4988321,bone density
LRP5,Rs4988321,osteoporotic or osteopenic men
LRP5,Rs4988321,Oropharyngeal skeletal disease
LRP5,Rs4988321,Oropharyngeal skeletal disease
LRP5,Rs4988321,reduced lumbar spine BMD
LRP5,Rs4988321,vertebral fractures
LRP5,Rs4988321,reduced bone mineral density (BMD)
LRP5,Rs4988321,vertebral fractures
LRP5,Rs4988321,bone mineral density
LRP5,Rs4988321,femoral neck BMD
LRP5,Rs4988321,BMD
LRP5,Rs4988321,spine BMD
LRP5,Rs4988321,peak bone mass in non-sedentary men
LRP5,Rs4988321,Oropharyngeal skeletal disease
LRP5,Rs4988321,high-bone-mass disorders
LRP5,Rs4988321,osteoporosis-pseudoglioma syndrome
LRP5,Rs4988321,high-bone-mass disorders
LRP5,Rs4988321,bone mass 
LRP5,Rs4988321,osteoporosis-pseudoglioma syndrome
LRP5,Rs4988321,bone mineral density
LRP5,Rs3736228, reduced bone mineral density
LRP5,Rs3736228,osteoporosis 
LRP5,Rs3736228,osteoporotic 
LRP5,Rs3736228,osteoporosis 
LRP5,Rs3736228,decreased bone mineral density
LRP5,Rs3736228,osteoporosis 
LRP5,Rs3736228,osteoporotic 
LRP5,Rs3736228,osteoporotic 
LRP5,Rs3736228,Caucasian 
LRP5,Rs3736228,men
LRP5,Rs491347,associated with obesity phenotypes
LRP5,Rs28939709,Autosomal recessive familial exudative vitreoretinopathy
LRP5,Rs4988300,obesity
LRP5,Rs4988300,obesity
LRP5,Rs4988321,vertebral fractures
LRP5,Rs4988321,reduced bone mineral density
LRP5,Rs4988321,vertebral fractures
LRP5,Rs4988321,reduced lumbar spine BMD density
LRP5,Rs4988321,femoral neck BMD
LRP5,Rs4988321,BMD
LRP5,Rs4988321,hip or spine BMD
LRP5,Rs4988321,osteoporotic or osteopenic men
LRP5,Rs4988321,physical activity
LRP5,Rs4988300,obesity
LRP5,Rs4988321,bone mass
LRPPRC,I5012749,French Canadian Type
LRPPRC,I5012749,Leigh syndrome
LRPPRC,I5012749,Leigh syndrome
LRRC43,Rs11608363,nonatopic eczema
LRRC43,Rs11608363,were strongly associated with nonatopic eczema
LRRC43,Rs6489188,nonatopic eczema
LRRC43,Rs6489188,were strongly associated with nonatopic eczema
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease.
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,familial Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson patients
LRRK2,Rs34637584,leukemia
LRRK2,Rs34637584,Parkinson patients
LRRK2,Rs34637584,colon cancer
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease 
LRRK2,Rs34637584,Parkinson's Disease 
LRRK2,Rs35801418,autosomal dominant Parkinson disorder
LRRK2,Rs35870237,autosomal dominant Parkinson disease
LRRK2,Rs35870237,definitely pathogenic
LRRK2,Rs7308720,Parkinson disease
LRRK2,Rs34637584,Parkinso
LRRK2,Rs34637584,Parkinson's disease.
LRRK2,Rs34637584, Parkinson's diseas
LRRK2,Rs34637584,Parkinson
LRRK2,Rs33939927,Parkinson's disease
LRRK2,Rs33939927,Parkinson disease
LRRK2,Rs33939927,Parkinson's disease
LRRK2,Rs33939927,Parkinson disease
LRRK2,Rs33949390,Parkinson's disease
LRRK2,Rs33995883,Parkinson's disease
LRRK2,Rs33995883,Parkinson's
LRRK2,Rs33995883,Crohn's disease
LRRK2,Rs33939927,Movement Disorder
LRRK2,Rs34637584,colon cancer
LRRK2,Rs34637584,Parkinson's Disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LSAMP,Rs4404477,main coronary artery disease
LSAMP,Rs4404477,heart disease
LSAMP,Rs1676232,heart disease
LSAMP,Rs1676232,main coronary artery disease
LSP1,Rs3817198,breast cancer
LSP1,Rs3817198,SNPs
LSP1,Rs3817198,breast cancer
LTA,Rs928815,Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes in the population
LTA,Rs746868,population of South Croatia
LTA,Rs746868,type 1 diabetes
LTA,Rs746868,myocardial infarction
LTA,Rs746868,Polish population
LTA,Rs746868,gastric cancer
LTA,Rs746868,breast cancer
LTA,Rs746868,myocardial infarction
LTA,Rs2844482,endometriosis
LTA,Rs2844482,rubella vaccine-induced immunity
LTA,Rs2844482,endometriosis
LTA,Rs1800630,SLE
LTA,Rs1800630,SLE 
LTA,Rs1800630,systemic lupus erythematosus (SLE)
LTA,Rs1800630, Raynaud's phenomenon
LTA,Rs746868, C
LUM,Rs3759223,pathological myopia
LUM,Rs3759223,high myopia
LUM,Rs3759223,high myopia
LUM,Rs2268578,corneal thickness.
LUM,Rs3759223,High myopia
LUM,Rs2268578,"breast cancer,"
LUM,Rs2268578,normal variation in central corneal thickness
LUM,Rs2268578,breast cancer
LUM,Rs2268578,breast cancer
LUM,Rs2268578,decorin and lumican genes
LZTS1,Rs28937897,somatic mutation
LZTS1,Rs28937897,somatic mutation
MAD1L1,Rs28939694,somatic mutation
MAD1L1,Rs28939694,somatic mutation
MAOA,Rs6609257,ADHD
MAOA,Rs72554632,mild mental retardation
MAOA,Rs72554632,impulsive aggressiveness
MAOA,Rs72554632,Brunner syndrome
MAOA,Rs72554632,Brunner syndrome
MAOA,Rs72554632,mild mental retardation
MAOA,Rs72554632,impulsive aggressiveness
MAOA,Rs72554632,Brunner syndrome
MAOA,Rs6609257,Sexually dimorphic
MAOA,Rs3027400,and 528 sex-matched migraine-free controls Differential association 
MAOA,Rs3027407,Sexually dimorphic
MAOA,Rs3027400,Sexually dimorphic
MAOA,Rs3027400,neuropsychological functioning
MAOA,Rs3027400,migraine-free
MAOA,Rs3027400,migraine
MAOA,Rs3027400,migraine without aura
MAOA,Rs3027407,Financial and psychological risk
MAOA,Rs3027400,migraine without aura among a sample of 528 migraine patients
MAOB,Rs3027415,adult ADHD inattentive type
MAOB,Rs3027415,attention-deficit/hyperactivity disorder
MAOB,Rs3027415,adult ADHD inattentive type
MAOB,Rs1799836,conditional logistic regression
MAOB,Rs1799836,Parkinson's disease
MAOB,Rs1799836,Parkinson's disease
MAOB,Rs3027415,attention-deficit/hyperactivity disorder
MAP2K5,Rs12593813,restless legs syndrome
MAP2K5,Rs12593813,Restless Legs Syndrome
MAP2K5,Rs12593813,sleep disorder
MAP2K5,Rs11635424,sleep disorder
MAP2K5,Rs11635424,restless legs syndrome
MAP2K5,Rs11635424,common sleep disorder
MAP2K5,Rs11635424,restless legs syndrome
MAP2K5,Rs11635424,restless legs syndrome
MAPT,Rs3785883,Parkinson's disease
MAPT,Rs63750424,Alzheimer's disease
MAPT,Rs63750424,frontotemporal dementia
MAPT,Rs3785883,Parkinson's disease
MAPT,Rs3785883,Parkinson disease
MAPT,Rs3785883,Creutzfeldt-Jakob disease
MAPT,Rs3785883,late onset Alzheimer's disease
MAPT,Rs3785883,Parkinson's disease
MAPT,Rs3785883,Parkinson's disease
MAPT,Rs3785883,Parkinson disease
MAPT,Rs3785883,Parkinson's disease
MAPT,Rs3785883,Parkinson disease
MAPT,Rs3785883,Parkinson's disease
MAPT,Rs3785883,Alzheimer's disease
MAPT,Rs1800547,parkinson's disease
MAPT,Rs143624519,neurodegenerative diseases
MAPT,Rs143624519,"neurodegenerative conditions, including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies"
MAPT,Rs143624519,neurodegenerative diseases
MAPT,Rs143624519,autosomal-dominant disease
MAPT,Rs3785883,Parkinson disease
MAPT,Rs143624519,Alzheimer's disease
MAPT,Rs143624519, increases susceptibility to several neurodegenerative conditions
MAPT,Rs143624519,dementia with Lewy bodies
MAPT,Rs1800547,Parkinson's disease
MAPT,Rs1800547,late-onset Parkinson's disease
MAPT,Rs1800547,parkinson's disease
MAPT,Rs1800547,Parkinson's disease
MAPT,Rs143624519,frontotemporal dementia
MAT1A,Rs2993763,SNP
MAX,Rs7158173,waist circumference
MAX,Rs7158173,waist circumference
MBL2,Rs1800451,ulmonary tuberculosis
MBL2,Rs1800451,asymptomatic Plasmodium falciparum infection
MBL2,Rs1800451,noninfectious systemic inflammatory response syndrome.
MBL2,Rs1800451,type 1 diabetes
MBL2,Rs1800451,late-onset Alzheimer disease
MBL2,Rs1800451,diabetic nephropathy.
MC1R,Rs2228479,"red (or blond) hair and poor tanning,"
MC1R,Rs2228479,ommonly associated with red (or blond) hair and poor tanning
MC1R,Rs2228479,poor tanning
MC1R,Rs2228479,red (or blond) hair
MC1R,Rs1805008,MelanomaParkinson's disease
MC1R,Rs1805008,red hair color (redheads)
MC1R,Rs1805007,Freckling
MC1R,Rs1805007,melanoma
MC1R,Rs1805007,mutations 
MC1R,Rs1805007,red hair
MC1R,Rs1805007,redheads 
MC1R,Rs1805007,females
MC1R,Rs1805007,redheaded
MC1R,Rs1805007,red hair color (redheads)
MC1R,Rs11547464,red hair color
MC1R,Rs11547464,missense mutation
MC1R,Rs11547464,red hair color
MC1R,Rs1805007,mutation 
MC2R,Rs28926173,longevity
MC2R,Rs28926173,longevity
MC2R,Rs28926173,longevity
MC2R,Rs1893220,infantile spasms
MC2R,Rs2186944,infantile spasms
MC4R,Rs13447324,obesity
MC4R,Rs10871777,Obesity
MC4R,Rs10871777,Obesity
MC4R,Rs12970134,associated with obesity
MC4R,Rs12970134,common obesity variant
MC4R,Rs12970134,diabetes risk in women
MC4R,Rs12970134,obesity 
MC4R,Rs12970134,obesity-associated
MC4R,Rs12970134,effects on body mass index and insulin resistance
MC4R,Rs12970134,polycystic ovary syndrome
MC4R,Rs12970134,metabolic syndrome
MC4R,Rs12970134,small for gestational age
MC4R,Rs12970134,obesity in polycystic ovary syndrome
MC4R,Rs13447324,obesity
MCOLN1,I4000425,Mucolipidosis
MDM2,Rs937283,hereditary retinoblastoma.
MDM4,Rs1380576,MDM4 variant
MDM4,Rs1380576,HPV16-associated squamous cell carcinoma of oropharynx.
MDM4,Rs4245739,apoptosis
MDM4,Rs4245739,Europe
MDM4,Rs4245739,United States.
MDM4,Rs4245739,"prostate cancer,"
MDM4,Rs4245739,Breast Cancer
MDM4,Rs4245739,ovarian cancer
MDM4,Rs4245739,squamous cell carcinoma
MECP2,Rs1734792,systemic lupus erythematosus
MECP2,Rs1734792,systemic lupus erythromatosis
MECP2,Rs1734792,systemic lupus erythematosus.
MECP2,Rs1734792,Korean 
MECP2,Rs1734792,lupus 
MECP2,Rs1734792,Caucasian 
MECP2,Rs1734792,lupus 
MECP2,Rs1734792,systemic lupus erythromatosis
MECP2,Rs1734787,"CI: 1.26â€“1.60, p = 1.6Ã—10e-08"
MECP2,Rs1734787,Caucasian
MECP2,Rs1734787,Korean
MECP2,Rs1734792,female 
MECP2,Rs1734787,female disease
MECP2,Rs1734787,systemic lupus erythromatosis
MEFV,Rs121907890,"Sephardic Jews,"
MEFV,Rs121907890,Arab and Armenian
MEFV,Rs121907890,familial Mediterranean fever
MEFV,Rs224204,juvenile idiopathic arthritis
MEFV,Rs224204,juvenile idiopathic arthritis
MEFV,Rs224204,Caucasian
MEFV,Rs28940580,familial Mediterranean fever
MEFV,Rs28940580,familial Mediterranean fever
MEFV,Rs28940580,infectious disease
MEFV,Rs121907890,"Turks,"
MEFV,Rs28940580,inflammatory response
MEFV,Rs28940580,not an infectious disease
MEFV,Rs61752717,arthritis
MEFV,Rs61752717,arthralgia
MEFV,Rs61752717," amyloidosis,"
MEFV,Rs28940580,inflammatory response
MEFV,Rs121907890,Mediterranean fever
MEFV,Rs104895097,familial Mediterranean fever 
MEFV,Rs11466023,familial Mediterranean fever
MEFV,I4000406,Familial Mediterranean Fever
MEFV,I4000407,Familial Mediterranean Fever
MEFV,I4000407,autosomal recessive
MEFV,I4000409,Mediterranean Feverrs
MEFV,Rs104895079,Mediterranean fever (FMF)
MEFV,Rs104895079,familial Mediterranean fever
MEFV,Rs121907890,familial Mediterranean fever
MEFV,Rs104895079,familial Mediterranean fever (FMF)
MEFV,Rs104895081,Mediterranean fever (FMF)
MEFV,Rs104895081,familial Mediterranean fever
MEFV,Rs104895081,familial Mediterranean fever (FMF)
MEFV,Rs104895081,familial Mediterranean fever
MEFV,Rs104895093,familial Mediterranean fever
MEFV,Rs104895094,Mediterranean fever
MEFV,Rs104895079,familial Mediterranean fever
MEIS1,Rs6710341,sleep disorder
MEIS1,Rs6710341,restless legs syndrome
MEIS1,Rs6710341,restless legs syndrome
MEIS1,Rs6710341,sleep disorder
MEIS1,Rs9789535,restless leg syndrome
MEIS1,Rs6710341,restless legs syndrome
MEIS1,Rs2192954,restless leg syndrome
MEIS1,Rs12469063,d with restless 
MEIS1,Rs12469063,restless legs syndrome
MEIS1,Rs12469063,restless legs syndrome
MEIS1,Rs12469063,common sleep disorder
MEIS1,Rs12469063,restless legs syndrome
MEIS1,Rs12469063, Replication of restless legs syndrome loci in three European populat
MEIS1,Rs12469063,restless legs syndrome
MEIS1,Rs12469063,restless legs syndrome
MEN1,Rs28931612,somatic mutation
MEN1,Rs28931612,somatic mutation
MET,Rs38857,Caucasian
MET,Rs38857,autism
MET,Rs2237717,nasal polyps
MET,Rs2237717,rhinosinusitis
MET,Rs2237717,schizophrenia
MET,Rs38857,schizophrenia
MET,Rs2237717,tumor metastasis
MET,Rs2237717,neurocognition
MET,Rs2237717,chronic rhinosinusitis
MET,Rs2237717,ability to recognize facial emotion
MET,Rs2237717,schizophrenia
MET,Rs2237717,autism 
MFN2,Rs864622480,Charcot-Marie-Tooth disease
MFN2,Rs864622480,pathogenic 
MFN2,Rs864622480,"Charcot-Marie-Tooth disease,"
MGMT,Rs2308327,colorectal cancer risk
MGMT,Rs2308327,lung cancer
MGMT,Rs2308327,lung cancer
MGMT,Rs12268840,adenocarcinoma of the esophagus
MGMT,Rs12268840,adenocarcinoma of the esophagus
MICA,Rs1051792,"rs1051792, also known as MICA-129, Val129Met and V129M, is a G>A transition at residue 129 of the MHC class I polypeptide-related sequence A MICA gene."
MICA,Rs1051792,and an increased risk of relapse 
MICA,Rs1051792,"According to these results, the presence of the G allele in the patient associated with the incidence of cGvHD "
MICA,Rs1051792,"This risk was independent of acute GvHD, suggesting that the residue 129 play a role in alloimmune responses and thus maybe protective against GvHD,"
MICA,Rs1051792,transplant
MICA,Rs1051792,associated with a reduced overall survival and an increased risk of relapse
MICA,Rs4349859,familial ankylosing spondylitis
MICA,Rs4418214,AIDS
MIR4761,Rs165688,rs165688
MIR4761,Rs4633,endometrial cancer
MIR4761,Rs4633,Schizophrenia Susceptibility Genetic
MIR4761,Rs165631,breast cancer
MIR4761,Rs165631,breast cancer
MIR4761,Rs165631,breast cancer
MIR4761,Rs165631,breast cancer
MIR4761,Rs165631,breast cancer
MIR4761,Rs165631,breast cancer
MLH1,Rs1800734,immunohistochemistry 
MLH1,Rs193922370,hereditary colon cancer
MLLT10,Rs11012732,meningioma
MLLT10,Rs11012732,meningioma
MMACHC,Rs751828470,PRDX1
MMACHC,Rs751828470,pathogenic variant
MMEL1,Rs3748816,Primary Biliary Cirrhosis
MMEL1,Rs3748816,rheumatoid arthritis
MMEL1,Rs3748816,celiac disease
MMEL1,Rs6684865,rheumatoid arthritis
MMEL1,Rs3748816,rheumatoid arthritis
MMEL1,Rs3748816,celiac disease
MMEL1,Rs3748816,primary biliary cirrhosis
MMEL1,Rs3748816,primary biliary cirrhosis
MMP1,Rs1144393,chronic kidney disease
MMP2,Rs7201,small vessel infarcts
MMP2,Rs2241145,breast cancer
MMP2,Rs2241145,stroke
MMP2,Rs2287074,lacunar stroke
MMP2,Rs2287074,small vessel infarcts
MMP2,Rs2287074,lacunar stroke
MMP2,Rs2287074,small vessel infarcts
MMP2,Rs2287076,lacunar stroke
MMP2,Rs2287076,small vessel infarcts
MMP2,Rs2287076,small vessel infarcts
MMP2,Rs243847,breast cancer
MMP2,Rs7201,lacunar stroke
MMP2,Rs7201,small vessel infarcts
MMP2,Rs7201,lacunar stroke
MMP2,Rs2241145,small vessel infarcts
MMP2,Rs2287076,lacunar stroke
MMP2,Rs2241145,acunar stroke
MMP2,Rs2241145,lacunar stroke
MMP2,Rs2241145,breast cancer susceptibility
MMP2,Rs2241145,stroke
MMP2,Rs1030868,lacunar stroke
MMP2,Rs1030868,small vessel infarcts
MMP2,Rs1030868,lacunar stroke
MMP2,Rs1030868,small vessel infarcts
MMP2,Rs2241145,lacunar stroke.
MMP2,Rs2241145,small vessel infarcts
MMP2,Rs2241145,breast cancer
MMP2,Rs2241145,small vessel infarcts
MMP2,Rs2241145,breast cancer
MMP2,Rs2241145,stroke
MMP2,Rs2241145,stroke
MMP2,Rs2241145,breast cancer
MMP2,Rs2241145,stroke.
MMP2,Rs2241145,small vessel infarcts
MMP2,Rs2241145,lacunar stroke
MMP3,Rs650108,Achilles tendinopathy
MMP3,Rs650108,SNPs
MMP3,Rs650108,Achilles tendinopathy
MMP3,Rs3025058,reduced risk of recurrent venous thromboembolism
MMP3,Rs3025058,coronary atherosclerosis
MMP3,Rs3025058,coronary artery disease
MMP3,Rs3025058,risk for myocardial infarction
MMP3,Rs3025058,worse progression of coronary artery disease after angioplasty.
MMP7,Rs12184413,breast cancer
MMP7,Rs11568819,breast cancer
MMP7,Rs11568819,breast cancer
MMP7,Rs11568819,endometrial cancer risk
MMP7,Rs11568819,breast cancer
MMP7,Rs11568819,breast cancer
MMP7,Rs11568819,endometrial cancer
MMP7,Rs12184413,breast cancer
MMP7,Rs12184413,endometrial cancer
MMP9,Rs17576,leukemia
MMP9,Rs17577,Alzheimer's disease
MMP9,Rs17577,lung cancer
MMP9,Rs17576,type 2 diabetes
MMP9,Rs17577,non-atopic asthma
MMP9,Rs2250889,lung cancer
MMP9,Rs17577,breast cancer
MMP9,Rs17577,cutaneous malignant melanoma
MMP9,Rs17576,glaucoma
MMP9,Rs17576,chronic obstructive pulmonary disease
MMP9,Rs17576,hepatitis B virus infection
MMP9,Rs17576,malignant melanoma
MMP9,Rs17576,Alzheimer's disease
MMP9,Rs17576,heart disease
MMP9,Rs17576,myocardial infarction
MMP9,Rs17576,lung cancer
MMP9,Rs17576,cigarette smoking
MMP9,Rs17576,lymphoma
MPL,Rs146249964,Ashkenazi Jewish
MPL,Rs146249964,CAMT
MPZ,Rs121913584,pathogenic for Charcot-Marie-Tooth disease type 1B
MPZ,Rs121913584,Charcot-Marie-Tooth disease
MPZ,Rs121913584,Charcot-Marie-Tooth disease type 1B
MRE11A,Rs774277300,hereditary cancer-predisposing syndrome
MRE11A,Rs774277300,colorectal cancer
MSH2,I5008753,Lynch syndromer
MSH2,I5900960,Lynch syndrome
MSH2,Rs2303428,Endometrial cancer
MSH2,Rs2303428,sporadic renal cell carcinoma
MSH2,Rs2303428,Endometrial cancer
MSH2,Rs2303428,invasive serous ovarian cancer
MSH2,Rs2303428,microsatellite-unstable colorectal cancer
MSH2,Rs2303428,sporadic renal cell carcinoma
MT-CO3,I3001497,influences haplogroups
MT-ND1,Rs41524046,SNP 
MT-ND1,Rs41402945,ancestral_allele
MT-ND1,Rs41402945,haplogroup
MT-ND1,Rs41402945,derived
MT-ND1,Rs41402945,derived_allele
MT-ND1,Rs41402945,ancestral
MT-ND1,Rs41402945,PhyloTree
MT-ND1,Rs41402945,haplogroups
MT-ND1,Rs199476118,Leber's optic atrophy
MT-ND1,Rs41402945,haplogroup
MT-ND4,Rs2853493,Mitochondrial Haplogroup
MT-ND4,Rs2853493,11467
MT-ND4,Rs2853493,A11467G
MT-ND4,Rs28358282,ancestral
MT-ND4,Rs28358282,haplogroup
MT-ND4,Rs28358282,haplogroups
MT-ND4,Rs199476112,Leber's optic atrophy
MT-ND4,Rs199476112,Leber's optic atrophy
MT-ND4,I3000989,haplogroups
MT-ND4,I3000989,haplogroup
MT-ND4,I3000989,ancestral_haplogroup
MT-ND4,I3000989,derived_haplogroup
MT-ND5,I3001191,derived_haplogroup
MT-ND5,I3001191,haplogroup
MT-ND5,I3001191,ancestral
MT-ND5,I3001191,haplogroups
MT-ND5,I3001191,derived_haplogroup
MT-ND5,I3001191,ancestral_allele
MT-ND5,I3001191,haplogroup
MT-ND5,I3001191,ancestral_haplogroup
MT-ND5,I3001191,derived_allele
MTHFD1,Rs760889414,MTHFD1
MTHFD1,Rs760889414,pathogenic variant
MTHFD1,Rs760889414,Glu225Ter
MTHFD1,Rs760889414,pathogenic variant
MTHFD1,Rs2236225,hanolamine N-methyltransferase and methylenetetrahydrofol
MTHFD1,Rs2236225,ha
MTHFD1,Rs2236225,enetic polymorphisms in methyl-group metabolism and epigenetics: lessons from humans and mouse models. Low-penetrance alle
MTHFD1,Rs2236225,"genase influence biomarkers of choline metabolism when folate intake is restricted. Epigenetic mechanisms for nutrition determinants of later health outcomes. Development of a fingerprinting panel using medically relevant polymorphisms. 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Genetics of human neural tube defects. Application of sex-specific single-nucleotide polymorphism filters in genome-wide association data. Populat"
MTHFD1,Rs2236225,teine metabolism in celiac disease. Folate and choline metabolism gene variants in relation to ovarian cancer risk in the Polish populati
MTHFD1,Rs2236225, are associated with nonsyndromic cleft lip and/or palate in 
MTHFD1,Rs1076991,embryonic development.
MTHFD1,Rs2236225,nucleotide polymorphisms in one-carbon metabolism genes with prostate cancer risk. Lack of association of polymorphisms
MTHFD1L,Rs6922269,coronary artery disease
MTHFD1L,Rs6922269,heart disease
MTHFD1L,Rs12525353,blood pressure
MTHFD1L,Rs11754661,Alzheimer's disease
MTHFR,Rs4846048,"Associated with lean body mass but not fat body mass in a study of ~1,800 Caucasians"
MTHFR,Rs3737964,"Associated with lean body mass but not fat body mass in a study of ~1,800 Caucasians"
MTHFR,Rs2066462,SNP 
MTHFR,Rs1801131,schizophrenia
MTHFR,Rs1801131,glioma
MTHFR,Rs1801131,meningioma
MTHFR,Rs1801131,brain cancer
MTHFR,Rs1801131,schizophrenia 
MTHFR,Rs1801131,brain cance
MTHFR,Rs17421511,schizophrenia
MTHFR,Rs2066470,"Associated with lean body mass but not fat body mass in a study of ~1,800 Caucasians"
MTHFR,Rs17421511,schizophrenia
MTHFR,Rs17367504,0.89 x odds of high blood pressure
MTHFR,Rs17367504,High Blood Pressure 
MTHFR,Rs17367504, high blood pressure
MTHFR,Rs17367504,Hypertension
MTHFR,Rs17367504,Blood Pressure
MTHFR,Rs17037396,schizophrenia
MTHFR,Rs17037396,schizophrenia
MTHFR,Rs17037396,schizophrenia
MTHFR,Rs17421511,schizophrenia
MTRR,Rs2303080,shortage
MTRR,Rs2303080,Mutation
MTRR,Rs2303080,Methyl-B12
MTRR,Rs2303080,"Mutation can cause shortage, suggesting a need for more B12."
MTRR,Rs162036,glaucoma
MTRR,Rs162036,pseudoexfoliation syndrome
MTRR,Rs162036,glaucoma
MTRR,Rs162036,single nucleotide polymorphisms
MTRR,Rs162036,pseudoexfoliation syndrome
MTRR,Rs162036,prostate cancer risk
MTRR,Rs162036,single nucleotide polymorphisms
MTRR,Rs162036,prostate cancer
MTTP,Rs755155385,Blueprint Genetics Retinal dystrophy
MTTP,Rs146064714,abetalipoproteinemia
MTTP,Rs17029215,severity of coronary atherosclerosis
MTTP,Rs755155385,Blueprint Genetics Retinal dystrophy
MUT,Rs535411418,pathogenic mutation
MUT,Rs121918253,pathogenic variant seen in Japan
MUTYH,Rs143353451,hereditary cancer-predisposing syndrome
MUTYH,Rs371848318,OMIM
MUTYH,Rs34612342,multiple adenomatous polyps
MUTYH,Rs34612342,Germline bi-allelic mutations
MUTYH,Rs3219489,age-related macular degeneration
MUTYH,Rs3219489,non-small cell lung cancer risk
MUTYH,Rs3219489,breast cancer
MUTYH,Rs34612342,colorectal cancer
MUTYH,Rs3219489,Bladder cancer
MUTYH,Rs147487160,Gene Mutations
MUTYH,Rs147487160,Germline Cancer
MUTYH,Rs147487160,Colorectal Cancer
MUTYH,Rs147487160,Early-Onset Colorectal Cancer
MUTYH,Rs143353451,polyposis
MUTYH,Rs3219489,rimary sclerosing cholangitis and cholangiocarcinoma
MVK,Rs2287218,IS
MVK,Rs2287218,CHD
MVK,Rs2287218,increased risk of coronary heart disease 
MVK,Rs2287218,ischemic stroke
MYBPC3,Rs113358486,familial hypertrophic cardiomyopathy (HCM)
MYBPC3,Rs11570112,hypertrophic cardiomyopathy
MYBPC3,Rs113358486,hypertrophic cardiomyopathy
MYBPC3,Rs113358486,Hypertrophic Cardiomyopathy
MYBPC3,Rs113358486,cardiomyopathy
MYBPC3,Rs113358486,pathogenicity
MYBPC3,Rs113358486,hypertrophic cardiomyopathy
MYBPC3,Rs113358486,Hypertrophic Cardiomyopathy
MYBPC3,Rs111683277,idiopathic dilated cardiomyopathy
MYBPC3,Rs11570112,pathogenic mutation
MYBPC3,Rs111683277,familial or idiopathic dilated cardiomyopathy
MYBPC3,Rs111683277,hypertrophic cardiomyopathy
MYBPC3,Rs111683277,familial hypertrophic cardiomyopathy (HCM)
MYBPC3,Rs111437311,"c.1624+2T>C, is reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy"
MYBPC3,Rs111437311,Hypertrophic cardiomyopathy
MYBPC3,Rs111437311,familial hypertrophic cardiomyopathy (HCM
MYBPC3,I5046245,familial hypertrophic cardiomyopathy
MYBPC3,I5046245,familial hypertrophic cardiomyopathy
MYBPC3,I5046245,familial hypertrophic cardiomyopathy
MYBPC3,Rs111683277,hypertrophic cardiomyopathy
MYH14,Rs648298,deafness
MYH14,Rs28940307,deafness
MYH14,Rs648298,deafness
MYH14,Rs28940306,deafness
MYH14,Rs28940306,deafness
MYH14,Rs28940307,deafness
MYH6,Rs365990,Icelandic
MYH6,Rs365990,"European descent,"
MYH6,Rs365990,atrial fibrillation
MYH6,Rs365990,ick sinus syndrome
MYH6,Rs365990,advanced AV block
MYH7,I6015303,hypertrophic cardiomyopathy
MYH7,I6015303,familial hypertrophic cardiomyopathy
MYH9,Rs80338835,The May-Heggllin/Fechtner Syndrome Consortium
MYH9,Rs80338835,May-Hegglin anomaly.
MYH9,Rs80338835,Fechtner and Sebastian syndromes
MYH9,Rs80338835,May-Hegglin anomaly
MYH9,Rs80338835,May-Hegglin anomaly
MYH9,Rs80338829,Fechtner and Sebastian syndromes
MYH9,Rs80338829,May-Hegglin anomaly
MYH9,Rs739097,nonsyndromic cleft lip and palate
MYH9,Rs80338827,Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene.
MYH9,Rs80338827,"May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. "
MYH9,Rs80338827,macrothrombocytopenias
MYH9,Rs739097,kidney disease
MYH9,Rs739097,schizophrenia with non-deficit in sustained attention and executive function
MYH9,Rs80338828,hereditary deafness
MYLK,Rs936170,lower risk of asthma
MYLK,Rs387906781,familial aortic dissections
MYLK,Rs387906781,familial aortic dissections
MYLK,Rs387906781,cause familial aortic dissections
MYLK,Rs387906781,familial aortic dissections
MYLK,Rs387906781,familial aortic dissections
MYO18B,Rs869312740,pathogenic variant
MYO6,Rs28936391,deafness
MYO6,Rs28936390,deafness
MYO6,Rs28936390,deafness
MYO6,Rs28936391,deafness
MYO7A,Rs111033178,syndrome 
MYO7A,Rs111033178,Usher 
MYO7A,Rs1052030,deafness
MYO7A,Rs1052030,vestibular dysfunction
MYOC,Rs74315329,glaucoma
MYOC,Rs74315329,glaucoma
MYOC,Rs74315329,family history
MYOC,Rs74315330,Myocilin mutations
MYOC,Rs74315329,early-onset or juvenile onset
MYOC,Rs74315329,open angle glaucoma
MYOC,Rs74315329,adults
NAGPA,Rs139526942,stuttering
NBN,Rs1805794,oral premalignant lesions
NBN,Rs1805794,breast cancer
NBN,Rs1805794,glioma
NBN,Rs1805794,cell carcinoma
NBN,Rs1805794,breast cancer
NBN,Rs1805794,bladder cancer
NBN,Rs1805794,lung cancer
NBN,Rs1805794,acute lymphoblastic leukemia
NBN,Rs1805794,Bladder cancer
NBN,Rs1805794,non-Hodgkin's lymphoma
NBN,Rs1805794,Prostate Cancer
NBN,Rs1805794,breast cancer
NBN,Rs1805794,primary antibody deficiency syndromes IgAD and CVID
NBN,Rs1805794,systemic lupus erythematosus
NBN,Rs1805794,non-Hodgkin lymphoma (NHL)
NBN,Rs1805794,cancer
NBN,Rs1805794,bladder cancer
NBN,Rs1805794,breast cancer
NBN,Rs34767364,breast cancer.
NBN,Rs34767364,breast cancer
NBN,Rs34767364,Variations in the NBN/NBS1 gene
NBN,Rs34767364,breast cancer
NBN,Rs1805794,non-Hodgkin's lymphoma
NBN,Rs1805794,Prostate Cancer
NBN,Rs1805794,acute lymphoblastic leukemia
NBN,Rs1805794,CVID
NBN,Rs1805794,primary antibody deficiency syndromes IgAD
NBN,Rs1805794,systemic lupus erythematosus
NBN,Rs1805794,ovarian cancer
NBN,Rs1805794,Breast cancer
NBN,Rs1805794,bladder cancer
NBN,Rs1805794,invasive serous ovarian cancer
NBN,Rs1805794,ovarian cancer
NBN,Rs1805794,breast cancer
NBN,Rs1805794,Breast cancer 
NBN,Rs1805794,breast cancer
NBN,Rs1805794,bladder cancer
NBN,Rs1805794,breast cancer
NBN,Rs1805794,on-Hodgkin lymphoma
NBN,Rs1805794,non-Hodgkin's lymphoma.
NBN,Rs1805794,Taiwanese patients.
NBN,Rs1805794,ovarian cancer.
NBN,Rs1805794,bladder cancer
NBN,Rs1805794,reast cancer
NBN,Rs1805794,French Canadian
NBN,Rs1805794,adult glioma
NBN,Rs1805794,renal cell carcinoma
NBN,Rs1805794,oral premalignant lesions
NBN,Rs1805794,Bladder cancer
NBN,I5012770,numerous cancers
NBN,I5012770,Nijmegen breakage syndrome
NBN,Rs1805794,breast cancer
NBN,Rs1805794,bladder cancer.
NBN,Rs1805794,breast cancer.
NBN,Rs1805794,bladder cancer
NBN,Rs1805794,smoking
NBN,Rs1805794,ovarian cancer
NBN,Rs1805794,breast cancer
NBN,Rs1805794,cancer
NBN,Rs1805794,breast cancer
NBN,Rs1805794,familial breast cancer
NBN,Rs1805794,ovarian cance
NBN,Rs1805794,adult glioma
NBN,Rs1805794,breast cancer
NBN,Rs1805794,bladder cancer
NBN,Rs1805794,oral premalignant lesions
NBN,Rs1805794,lung cancer
NBN,Rs1805794,non-Hodgkin lymphoma
NBN,Rs1805794,Bladder cancer
NBN,Rs1805794,bladder cancer.
NBN,Rs1805794,renal cell carcinoma
NCF4,Rs4821544,carriers of the C allele
NCF4,Rs4821544,Crohn's disease
NCF4,Rs4821544,ileal Crohn's disease
NCF4,Rs4821544,inflammatory bowel disease
NDRG1,I5008730,Charcot-Marie-Tooth disease
NDST3,Rs11098403,increased risk for schizophrenia
NEFL,Rs58640772,pathogenic variant
NF1,Rs199474785,L844Fsee
NF1,Rs199474785,p.Leu844Phe
NF2,Rs587776562,neurofibromatosis
NF2,Rs587776562,neurofibromatosis
NF2,Rs587776562,type 2
NFKB1,Rs4648022,Non-Hodgkin's lymphoma
NFKB1,Rs4648022,NHL
NFKB1,Rs4648127,lung cancer
NFKBIL1,Rs2230365,rheumatoid arthritis
NFKBIL1,Rs2230365,non-Hodgkin lymphoma
NGF,Rs6330,females
NGF,Rs6330,trait anxiety
NGF,Rs6330,males
NGF,Rs6330,males
NGF,Rs6330,females
NGF,Rs6330,anxiety related personality traits
NGF,Rs6330,subjects of German descent
NGF,Rs6330,females had higher levels of trait anxiety
NGF,Rs6330,anxiety related personality traits
NGF,Rs6330,gender-dependent
NGF,Rs6330,German descent
NGLY1,Rs201337954,congenital disorder of deglycosylation (CDDG)
NGLY1,Rs201337954,disorder of deglycosylation 
NINJ2,Rs11833579,ischemic stroke
NINJ2,Rs11833579,total stroke and ischemic stroke
NINJ2,Rs11833579,ischemic (or incident) stroke.
NINJ2,Rs11833579,stroke
NINJ2,Rs11833579,stroke
NLRP1,Rs6502867,linked to generalized vitiligo 
NLRP1,Rs6502867,vitiligo
NLRP1,Rs6502867,generalized vitiligo
NLRP1,Rs12150220,juvenile idiopathic arthritis
NLRP1,Rs12150220,rheumatoid arthritis
NLRP1,Rs12150220,systemic lupus erythematosus
NLRP1,Rs12150220,type-1 diabetes
NLRP1,Rs12150220,autoimmune Addison's disease
NLRP1,Rs12150220,autoimmune diseases
NLRP1,Rs115799546,malignant melanoma
NLRP1,Rs115799546,multiple sclerosis
NLRP1,Rs12150220,multiple sclerosis
NLRP3,Rs3806265,juvenile idiopathic arthritis
NLRP3,Rs3806265,juvenile idiopathic arthritis
NLRP3,Rs145268073,hearing loss
NLRP3,Rs145268073,autoinflammatory diseases
NLRP3,Rs145268073,"related periodic fevers syndromes"".Overall, "
NOD2,Rs2067085,gastric cancer in a Chinese population
NOD2,Rs2076756,Crohn's disease
NOD2,Rs2067085,ulcerative colitis among North Indians
NOD2,Rs2067085,risk for Crohn disease in Ashkenazi Jews
NOD2,Rs2067085,gastric cancer
NOD2,Rs2067085,ulcerative colitis
NOD2,Rs2067085,cancer 
NOD2,Rs2067085,gastric cancer
NOD2,Rs2067085,ulcerative colitis
NOD2,Rs2067085,ulcerative colitis
NOD2,Rs2067085,gastric 
NOD2,Rs2076756,Crohn's disease
NOD2,Rs2067085,Crohn disease
NOD2,Rs2076756,Crohn's disease
NOD2,Rs2067085,Helicobacter 
NOD2,Rs2076756,pediatric-onset inflammatory bowel disease
NOD2,Rs2076756,Crohn's disease
NOD2,Rs2076756,European populations
NOD2,Rs2076756,Crohn's disease
NOD2,Rs2076756,Asthma
NOD2,Rs2076756,pediatric-onset inflammatory bowel disease
NOD2,Rs2076756,underlie human diseases
NOD2,Rs2076756,cancer etiology
NOD2,Rs5743277,inflammatory bowel disease
NOD2,Rs5743277,inflammatory bowel disease
NOD2,Rs5743277,inflammatory bowel disease
NOD2,Rs5743289,autoinflammatory disorders
NOD2,Rs5743289,autoinflammatory disorders
NOD2,Rs9302752,The risk allele is C
NOD2,Rs2076756,Asthma
NOD2,Rs2067085,disease 
NOD2,Rs104895462,Blau syndrome
NOD2,Rs2067085,Ashkenazi 
NOD2,Rs104895431,inflammatory bowel disease
NOD2,Rs104895431,inflammatory bowel disease
NOD2,Rs104895460,mutations
NOD2,Rs104895460,Blau syndrome
NOD2,Rs104895461,mutations in Blau syndrome
NOD2,Rs104895461,mutations
NOD2,Rs104895461,Blau syndrome
NOD2,Rs104895462,mutations in Blau syndrome
NOD2,Rs104895462,mutations
NOD2,Rs2067085,Crohn 
NOD2,Rs17221417,Crohn's disease
NOD2,Rs17221417,Crohn disease
NOD2,Rs17221417,not associated with the risk of type 2 diabetes
NOD2,Rs17221417,Crohn's disease
NOD2,Rs104895460,mutations in Blau syndrome
NOD2,Rs17221417,inflammation
NOD2,Rs2067085,Crohn disease
NOD2,Rs2066847,Crohn's disease
NOD2,Rs2066845,inflammatory bowel disease
NOD2,Rs2066845,Chinese 
NOD2,Rs17221417,Crohn disease
NOD2,Rs2066845,psoriatic arthritis
NOD2,Rs2066845,sarcoidoisis
NOD2,Rs2066844,inflammatory bowel disease
NOD2,Rs2066844, Crohn's disease
NOD2,Rs2066844,Crohn's disease 
NOD2,Rs17221417,type 2 diabetes
NOD2,Rs17221417,autoimmune and inflammatory diseases
NOD2,Rs2066845,Crohn's disease
NOS1,Rs73208120,colorectal cancer
NOS1,Rs41279104,depressive disorder
NOS1,Rs41279104,depressive disorder
NOS1,Rs3782221,Parkinson's disease
NOS1,Rs41279104,mood disorders
NOS1,Rs3782221,schizophrenia
NOS1,Rs3782206,paranoid schizophrenia
NOS1,Rs3782206,Chinese
NOS1,Rs3782221,Bipolar I disorder
NOS1AP,Rs10918594,diabetic EAs
NOS1AP,Rs12029454,Influences QT interval
NOS1AP,Rs12742393,schizophrenia risk factor
NOS1AP,Rs12742393,schizophrenia
NOS1AP,Rs12742393,enhanced transcription factor binding
NOS1AP,Rs12742393,gene expression
NOS1AP,Rs12742393,schizophrenia
NOS1AP,Rs7538490,type-2 diabetes
NOS1AP,Rs7538490,diabetes
NOS1AP,Rs7538490,obesity
NOS1AP,Rs7538490,type-2 diabetes
NOS1AP,Rs7538490,type-2 diabetes
NOS1AP,Rs7538490,diabetes
NOS1AP,Rs7538490,obesity
NOS1AP,Rs10918594,abnormal heart rhythms
NOS1AP,Rs16857031,Influences QT interval
NOS1AP,Rs10918594,cardiac problem
NOS1AP,Rs10918594,abnormal heart rhythms
NOS1AP,Rs10494366,blacks
NOS1AP,Rs10494366,abnormal heart rhythms
NOS1AP,Rs10494366,Caucasian ancestry
NOS1AP,Rs10494366,shorter QT intervals
NOS1AP,Rs10494366,longer QT interval
NOS1AP,Rs10494366,sudden death due to a cardiac problem
NOS1AP,Rs10494366,longer QT interval
NOS1AP,Rs10494366,longer QT interval
NOS1AP,Rs10494366,increase in QT interval
NOS1AP,Rs10494366,increased mortality risk
NOS1AP,Rs10494366,mortality rates were higher
NOS1AP,Rs10494366,reduced mortality rate
NOS1AP,Rs10494366,adjusted QT interval
NOS1AP,Rs10494366,whites
NOS1AP,Rs10494366,whites
NOS1AP,Rs10494366,diabetic EAs
NOS2,Rs2297518,Korean men with benign prostatic hyperplasia
NOS2,Rs2779251,inflammatory bowel disease
NOS2,Rs2297518,urinary bladder cancer
NOS2,Rs2297518,aphthous stomatitis
NOS2,Rs2297518,rheumatoid arthritis
NOS2,Rs2297518,non-small cell lung cancer
NOS2,Rs2297518,radiation-induced toxicity
NOS2,Rs2297518,prostatic volume
NOS2,Rs2297518,cognition
NOS2,Rs2297518,invasive pneumococcal disease
NOS2,Rs2297518,prostate cancer
NOS2,Rs2297518,China
NOS2,Rs2297518,biliary tract cancers and stones
NOS2,Rs2297518,Parkinson's disease
NOS2,Rs2297518,inflammatory bowel disease
NOS2,Rs2779251,chronic lymphocytic leukemia
NOS2,Rs2297518,type 2 diabetes
NOS2,Rs2779251,inflammatory bowel disease susceptibility.
NOS2,Rs4795067,polymorphisms 
NOS2,Rs4795067,Parkinson's disease
NOS2,Rs8078340,South African population
NOS2,Rs8078340,susceptibility to TB
NOS2,Rs8078340,malaria-resistance
NOS2,Rs8078340,malaria-resistance variants
NOS2,Rs8078340,malaria
NOS2,Rs8078340,malaria 
NOS2,Rs8078340,TB
NOS2,Rs4795067,psoriatic arthritis
NOS2,Rs8078340,ec
NOS2,Rs4795067,adult brain tumors
NOS2,Rs2297518,cognitive ability and cognitive ageing
NOS2,Rs4795067,Parkinson's disease
NOS2,Rs4795067,synthase 
NOS2,Rs4795067,psoriatic arthritis
NOS2,Rs4795067,brain tumors
NOS2,Rs4795067,oxidative stress
NOS2,Rs8078340,malaria suscepti
NOS2,Rs2297518,inflammatory responses
NOS2,Rs2297518,rinary bladder cancer pathogenesis
NOS2,Rs2297518,non-Hodgkin lymphoma
NOS2,Rs2297518,lung cancer
NOS2,Rs2297518,benign prostatic hyperplasia
NOS2,Rs2297518,fetal growth
NOS2,Rs2297518,Parkinson's disease
NOS2,Rs2297518,inflammatory bowel disease 
NOS2,Rs2297518,non-Hodgkin lymphoma
NOS2,Rs2297518,Parkinson's disease
NOS2,Rs2297518,synthase gene polymorphisms and prostate cancer risk.
NOS2,Rs2297518,diabetes-associated combination of SNPs
NOS2,Rs2297518,lung cancer.
NOS2,Rs1060826,Parkinson's disease.
NOS2,Rs1060826,respiratory syncytial virus bronchiolitis
NOS2,Rs1060826,Parkinson disease
NOS2,Rs1060826,Parkinson's disease
NOS2,Rs1060822,aphthous stomatitis
NOS2,Rs2297518,rheumatoid arthritis
NOS2,Rs2297518,aphthous stomatitis
NOS2,Rs2297518,biliary tract cancers and stones
NOS2,Rs2297518,non-Hodgkin lymphoma
NOS2,Rs2297518,urinary bladder cancer pathogenesis
NOS2,Rs2297518,aphthous stomatitis
NOS2,Rs2297518,rheumatoid arthritis
NOS2,Rs2297518,urinary bladder cancer
NOS2,Rs2297518,benign prostatic hyperplasia
NOS2,Rs2297518,prostatic volume
NOS2,Rs2297518,pneumococcal disease
NOS2,Rs2297518,prostate cancer
NOS2,Rs2297518,non-small cell lung cancer
NOS2,Rs2297518,Parkinson's disease
NOS2,Rs2297518,inflammatory bowel disease
NOS2,Rs2297518,non-Hodgkin lymphoma
NOS2,Rs2297518,rheumatoid arthritis
NOS2,Rs2297518,prostatic hyperplasia
NOS2,Rs2297518,pneumococcal disease
NOS2,Rs2297518,Parkinson's disease
NOS2,Rs2297518,biliary tract cancers and stones
NOS3,Rs3918227,Parkinson's disease
NOS3,Rs3918227,hypoxic-ischemic encephalopathy
NOS3,Rs4496877,nephropathy
NOS3,Rs891512,blood pressure
NOS3,Rs891512,hypertension
NOS3,Rs891512,diastolic blood pressure
NOS3,Rs891512,systolic blood pressure
NOS3,Rs891512,suicide
NOS3,Rs3918227,polymorphisms
NOS3,Rs891512,blood pressure
NOS3,Rs3918227,hypoxic-ischemic encephalopathy
NOS3,Rs3918227,Parkinson's disease
NOS3,Rs3918227,hypoxic-ischemic encephalopathy
NOS3,Rs3918227,Parkinson's disease
NOS3,Rs3918227,hypoxic-ischemic encephalopathy
NOS3,Rs3918227,Parkinson's disease
NOS3,Rs3918226,coronary heart disease 
NOS3,Rs3918226,essential hypertension
NOS3,Rs3918226,venous thromboembolism
NOS3,Rs3918226,hypertension
NOS3,Rs3918226,venous thromboembolism
NOS3,Rs3918226,hypertension
NOS3,Rs3918226,type 2 diabetes mellitus
NOTCH1,Rs41309764,bicuspid aortic valve
NOTCH1,Rs41309764,progressive aortic valve disease
NPAS2,Rs2305160,depressive disorders.
NPAS2,Rs2305160,prostate cancer
NPAS2,Rs2305160,non-Hodgkin's lymphoma
NPAS2,Rs1811399,inheritance
NPAS2,Rs1811399,autism
NPAS2,Rs1811399,autism
NPAS2,Rs1811399,autism
NPHS2,Rs12406197,benign
NPHS2,Rs12406197,Likely benign
NPPA,Rs5067,asthma 
NPPA,Rs5067,asthma 
NPPB,Rs198389,chronic heart failure (CHF) 
NPTN,Rs7171755,cortical thickness
NPTN,Rs7171755,cortical thickness
NPTN,Rs7171755,slight decrease in verbal and nonverbal intelligence (IQ)
NPTN,Rs7171755,verbal and nonverbal IQ
NPTN,Rs7171755,verbal and nonverbal intelligence
NPY,Rs16139,depressive disorders
NPY,Rs16147,Early-Onset atherosclerosis
NPY,Rs16139,depressive disorder
NPY,Rs16139,diabetic retinopathy
NPY,Rs16139,metabolic syndrome
NPY,Rs16139,polymorphisms
NPY,Rs16139,early-onset atherosclerosis
NPY,Rs1468271,early-onset atherosclerosis
NR1H3,Rs61731956,70% chance of developing the disease
NR1H3,Rs61731956,multiple sclerosis
NR1H3,Rs61731956,"severe, progessive disease"
NR1H3,Rs61731956,multiple sclerosis
NR1H3,Rs61731956,multiple sclerosis
NR1H3,Rs61731956,multiple sclerosis
NR1H3,Rs11039155,heart disease
NR1H3,Rs11039155,type-2 diabetes
NR1H3,Rs11039155,metabolic syndrome
NR1H3,Rs11039155,heart disease
NR1H3,Rs11039155,diabetes
NR1H3,Rs11039155,metabolic syndrome
NR1I2,Rs1523127,chronic periodontitis
NR1I2,Rs1523127,inflammatory bowel disease
NR1I2,Rs1523127,deep vein thrombosis
NR1I2,Rs1523127,deep vein thrombosis.
NR3C1,Rs6195,Glucocorticoid receptor polymorphism
NR3C1,Rs6195,anovulatory polycystic ovary syndrome
NR3C1,Rs6195,Genetic polymorphisms
NR3C1,Rs6195,inflammatory bowel disease
NR3C1,Rs6195,bipolar patients
NR3C1,Rs6195,asthma
NR3C1,Rs6195,Glucocorticoid receptor gene polymorphisms
NR3C1,Rs6195,acute lymphoblastic leukemia
NR3C1,Rs6195,altered bone mineral density
NR3C1,Rs6195,Crohn's disease
NR3C1,Rs6195,asthma
NR3C1,Rs6195,glucocorticoid receptor polymorphisms
NR3C1,Rs6195,blood pressure
NR3C1,Rs6195,Glucocorticoid receptor gene
NR3C1,Rs6195,glucocorticoid resistance
NR3C1,Rs6195,glucocorticoid receptor polymorphism
NR3C1,Rs10052957,growth in fetal and early postnatal life
NR3C1,Rs10052957,completed suicide
NR3C1,Rs10052957,inflammatory bowel disease
NR3C1,Rs6195,altered gene expression
NR3C1,Rs10052957,polymorphisms 
NR3C1,Rs10052957,polymorphism 
NR3C1,Rs10052957,bipolar patients.
NR3C1,Rs10052957,growth 
NR3C1,Rs10482682,Glucocorticoid receptor gene variant in the 3' untranslated region is associated with multiple measures of blood pressure
NR3C1,Rs6195,glucocorticoid sensitivity
NR3C1,Rs6195,coronary artery disease
NR3C1,Rs6195,increased body mass index
NR3C1,Rs10052957,inflammatory bowel disease
NRG1,Rs3924999,Alzheimer's disease with psychosis
NRG1,Rs3924999,Alzheimer's disease with psychosis
NRXN1,Rs6721498,increased risk for nicotine dependence.
NRXN1,Rs6721498,nicotine dependence.
NRXN1,Rs2193225,nicotine dependence
NRXN1,Rs2024513,"associated with higher risk,"
NRXN1,Rs2024513,schizophrenia
NRXN1,Rs2024513,schizophrenia
NRXN1,Rs12623467,susceptibility to Substance dependence
NRXN1,Rs12623467,Substance dependence
NRXN1,Rs12467557,C allele
NRXN1,Rs2024513,schizophrenia
NRXN3,Rs7147705,ALS
NSD1,Rs28932178,autism spectrum disorders and macrocephaly
NSD1,Rs28932178,increased risk for autism
NSD1,Rs28932178,Sotos syndrom
NSD1,Rs28932178,autistic patients
NSD1,Rs28932178, overgrowth syndrome
NSD1,Rs28932178,macrocephaly
NSD1,Rs28932178,autism spectrum disorders
NSD1,Rs28932178,macrocephaly and learning disabilities
NSMCE3,Rs199905054,pneumonia
NSMCE3,Rs199905054,chromosome breakage syndrome
NSMCE3,Rs199905054,lung disease immunodeficiency and chromosome breakage syndrome (LICS)
NSMCE3,Rs199905054,fatal pneumonia
NSMCE3,Rs199905054,lung disease immunodeficiency
NSMCE3,Rs199905054,chromosome breakage syndrome
NUDT15,Rs116855232,leukopenia
NUDT15,Rs116855232,leukopenia
OBSCN,Rs71180793,Bipolar Disorder
OBSCN,Rs71180793,ventricular noncompaction
OBSCN,Rs55883237,left ventricular noncompaction
OBSCN,Rs55883237,"left ventricular noncompaction,"
OCA2,Rs4778138,freckling
OCA2,Rs4778241,blue eyes
OCA2,Rs4778241,blue eye color
OCA2,Rs4778241,blue-brown eye color
OCA2,Rs4778241,hair color and skin pigmentation
OCA2,Rs4778241,blue-brown eye color
OGG1,Rs2304277,risk of ovarian cancer
OGG1,Rs2304277,mutation 
OGG1,Rs1052133,lung cancer
OGG1,Rs1052133,lung cancer
OGG1,Rs1052133,gallbladder cancer
OGG1,Rs1052133,bladder cancer
OGG1,Rs2304277,cancer 
OGG1,Rs1052133,lung cancer
OGG1,Rs1052133,gallbladder cancer
OGG1,Rs1052133,bladder cancer
OGG1,Rs1052133,lung cancer
OGG1,Rs1052133,lung cancer
OGG1,Rs1052133,gallbladder cancer
OGG1,Rs1052133,lung cancer
OPRD1,Rs533123,European anorexia nervosa patients
OPRD1,Rs533123,anorexia nervosa
OPRD1,Rs533123,anorexia nervosa
OPRD1,Rs2236857,Heroin addiction
OPRD1,Rs2234918,heroin addiction
OPRD1,Rs12749204,Substance dependence
OPRD1,Rs1042114,carriers of the G allele
OPRD1,Rs2234918,gender
OPRM1,Rs1799972,depressive disorder.
OPRM1,Rs10485057,higher likelihood of smoking initiation and nicotine dependence.
OPRM1,Rs10485057,higher likelihood of smoking initiation and nicotine dependence.
OPRM1,Rs10485057,nicotine dependence.
OPRM1,Rs1799972,depressive disorder
OPRM1,Rs1799972,citalopram treatment
OPRM1,Rs1799972,citalopram treatment
OPTN,Rs825411,Paget’s disease of bone
OPTN,Rs825411,Paget’s disease of bone
OPTN,Rs1561570,Paget’s disease of bone
OPTN,Rs1561570,Paget’s disease of bone
OR7D4,Rs5020278,Genetic variation in a human odorant receptor alters odour perception
OR7D4,Rs5020278,smell of a testosterone-derived steroid
OR7D4,Rs5020278,"perceive the smell to be both weaker, and more sweet, with some likening it to vanilla or honey"
ORMDL3,Rs8067378,asthma
ORMDL3,Rs8067378,Asthma-susceptibility
ORMDL3,Rs8067378,asthma and autoimmune disease
ORMDL3,Rs8067378,mexican children
ORMDL3,Rs8067378,asthma
ORMDL3,Rs8067378,childhood asthma
ORMDL3,Rs8067378,childhood asthma
ORMDL3,Rs8067378,autoimmune disease
ORMDL3,Rs8067378,asthma
ORMDL3,Rs8067378, mexican children
ORMDL3,Rs8067378,asthma
ORMDL3,Rs8067378,Asthma
ORMDL3,Rs8067378,asthma 
ORMDL3,Rs2305480,asthma
ORMDL3,Rs2305480,asthma
ORMDL3,Rs8067378,asthma
ORMDL3,Rs2305480,asthma
ORMDL3,Rs4378650,African American 
ORMDL3,Rs2305480,asthma
ORMDL3,Rs4378650,Puerto Ricans
ORMDL3,Rs8067378,childhood asthma
ORMDL3,Rs8067378,susceptibility to childhood asthma
ORMDL3,Rs4378650,asthma 
OTC,Rs5963409,Alzheimer's disease
OTOF,Rs28937591,deafness
OTOF,Rs28937591,deafness
OXT,Rs17339677,oxytocin/neurophysin
OXTR,Rs53576,grey matter volume
OXTR,Rs53576,saliva cortisol levels
OXTR,Rs53576,structural and functional alterations
OXTR,Rs53576,stress
OXTR,Rs53576,difficulty hearing
OXTR,Rs53576,stress
OXTR,Rs53576,hear and understand conversations in noisy environments.
OXTR,Rs53576,maternal education level
OXTR,Rs53576,sensitive parenting
OXTR,Rs53576,"marital discord, depression, and education status"
OXTR,Rs53576,"affect, loneliness and intelligence"
OXTR,Rs53576,hypothalamus volume
OXTR,Rs53576,hearing and understanding
OXTR,Rs53576,reward dependence
OXTR,Rs53576,autism 
OXTR,Rs53576,autism
OXTR,Rs53576, G to A change
OXTR,Rs53576,"Culture, distress,"
OXTR,Rs53576,depression
OXTR,Rs53576,marital discord
OXTR,Rs53576,autism
OXTR,Rs53576,more sensitive
OXTR,Rs53576,more empathetic
OXTR,Rs53576,less lonely
OXTR,Rs53576,higher levels of dispositional empathy 
OXTR,Rs53576,less affected by stress 
OXTR,Rs53576,heart rates
OXTR,Rs53576,prosocial temperament
OXTR,Rs53576,stress 
OXTR,Rs53576,emotional reactivity
OXTR,Rs53576,empathy
OXTR,Rs53576,empathy
OXTR,Rs2268490,OXTR
OXTR,Rs2268490,prosociality
OXTR,Rs237887,OXTR
OXTR,Rs237887,prosociality
OXTR,Rs53576,empathetic
OXTR,Rs53576,feel less lonely
OXTR,Rs53576,Korean 
OXTR,Rs53576,Americans
OXTR,Rs53576,stress
OXTR,Rs53576,marital discord
OXTR,Rs53576,depression
OXTR,Rs53576,Forty-five female
OXTR,Rs53576,Two hundred three healthy German male university students
OXTR,Rs4564970,Alcohol and aggressive behavior
OXTR,Rs53576,female
OXTR,Rs53576,lower cortisol responses to stress
OXTR,Rs53576,grey matter volume in the hypothalamus
OXTR,Rs53576,prosocial temperament
OXTR,Rs53576,Caucasian 
OXTR,Rs53576,autism
OXTR,Rs53576,"empathetic, feel less lonely, employ more sensitive parenting techniques, and have lower rates of autism"
OXTR,Rs53576,sensitive parents
OXTR,Rs53576,empathy and stress
OXTR,Rs53576,more empathetic
OXTR,Rs53576,less lonely
OXTR,Rs53576,emotional support seeking.
OXTR,Rs53576,empathy and stress
P2RY11,Rs2305795,narcolepsy
P2RY11,Rs2305795,narcolepsy
PADI3,Rs144944758,Uncombable hair syndrome
PADI3,Rs142129409,Uncombable hair syndrome variant
PADI3,Rs142129409,Uncombable hair syndrome
PADI4,Rs1748035,polymorphism
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs2240335,Rheumatoid Arthritis
PADI4,Rs2240335,carriers of the G allele
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs2240335,Rheumatoid Arthritis
PADI4,Rs2240340,rheumatoid arthritisin
PADI4,Rs2240335,Rheumatoid Arthritis
PADI4,Rs2240339,Rheumatoid Arthritis
PADI4,Rs2240339,Rheumatoid Arthritis
PADI4,Rs2240340,rheumatoid arthritis (RA)
PADI4,Rs2240340,rheumatoid arthritis
PADI4,Rs2240340,rheumatoid arthritis
PADI4,Rs2240340,rheumatoid arthritis (RA)
PADI4,Rs2240335,increases susceptibility to Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis 
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,disequilibrium with a polymorphism
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs11203367,Rheumatoid Arthritis
PADI4,Rs11203367,Rheumatoid Arthritis
PADI4,Rs11203367,Rheumatoid Arthritis
PADI4,Rs1621005,Rheumatoid Arthritis
PADI4,Rs1621005,Arthritis 
PADI4,Rs1748031,Rheumatoid Arthritis
PADI4,Rs1621005,Rheumatoid 
PADI4,Rs1748031,susceptibility
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748031,T allele
PAH,Rs5030858,mutant
PAH,Rs5030858,phenylketonuria
PAH,Rs5030858,SNP 
PAH,Rs5030858,phenylketonuria
PAH,Rs5030858,phenylalanine hydroxylase
PAH,I4000475,Phenylketonuriars
PAH,I4000475,42933
PAH,I4000475,ketonu
PAH,I4000472,Phenylketonuria
PAH,I4000470,Phenylketonuriar
PAH,I4000478,Phenylketonuriars
PALB2,Rs180177102,breast cancer
PALB2,Rs180177102,cancer 
PALB2,Rs515726065,Breast-Cancer
PALB2,Rs515726124,Breast-Cancer
PALB2,Rs515726124,PALB2see
PALB2,Rs515726124,Breast-Cancer
PALLD,Rs1071738,metastasis
PARK7,Rs74315353,Parkinson disease 
PARK7,Rs74315353,Parkinson disease
PARK7,Rs3766606,sporadic Parkinson's disease
PARK7,Rs74315354,Haplotype
PARK7,I5047046,digenic
PARK7,I5047046,recessive/early-onset
PARK7,I5047046,Parkinson's disease
PARK7,Rs3766606,Parkinson's disease
PAX2,Rs75399846,pathogenic variant
PCDH11X,Rs5984894,Alzheimer's disease
PCDH11X,Rs5984894,Alzheimer disease
PCDH11X,Rs5984894,increased risk for the disease in females
PCDH11X,Rs5984894,Alzheimer's disease
PCDH11X,Rs5984894,X chromosome
PCDH11X,Rs5984894,SNP
PCDH11X,Rs5984894,Alzheimer's disease
PCSK9,Rs72646508,coronary events
PCSK9,Rs67608943,coronary events
PCSK9,Rs67608943,lowered LDL-C level 
PCSK9,Rs67608943,coronary events
PCSK9,Rs67608943,lowered LDL-C level
PCSK9,Rs562556,LDL cholesterol levels.
PCSK9,Rs505151,cholesterol metabolism
PCSK9,Rs505151,higher LDL cholesterol levels
PCSK9,Rs505151,women
PCSK9,Rs505151,men 
PCSK9,Rs505151,polygenic hypercholesterolemia
PCSK9,Rs67608943,plasma LDL-C levels being up to 40% lower than average
PCSK9,Rs505151,serum lipid levels
PCSK9,Rs505151,low-density lipoprotein cholesterol levels
PCSK9,Rs505151,higher LDL cholesterol levels
PCSK9,Rs28942111,autosomal dominantly inherited familial hypercholesterolemia
PCSK9,Rs28362286,Coronary Artery Risk
PCSK9,Rs28362263,coronary events.
PCSK9,Rs28362263,coronary events.
PCSK9,Rs28362263,coronary events
PCSK9,Rs28362263,coronary events.
PCSK9,Rs2479409,PCSK9
PCSK9,Rs2479409,Molecular population genetics of PCSK9
PCSK9,Rs505151,European 
PDE4B,Rs952635,type-2 diabetes
PDE4B,Rs4655595,type-2 diabetes
PDE4B,Rs4655595, type-2 diabetes
PDE4D,Rs1544791,Asthma
PDE4D,Rs1544791,Asthma-susceptibility
PDX1,Rs80356661,Agenesis of human pancreas
PDX1,Rs80356661,insulin promoter factor 1
PDX1,Rs80356661,Agenesis of human pancreas
PDZD7,Rs753034799,pathogenic variant
PEMT,Rs4244593,schizophrenia
PEMT,Rs4244593,PEMT gene in schizophrenia
PEMT,Rs4244593,schizophrenia
PER2,Rs121908635,sleep disorder
PER2,Rs121908635,Familial Advanced Sleep Phase Syndrome
PEX1,Rs61750420,peroxisome biogenesis disorders 
PEX1,Rs61750420,Zellweger syndrome
PEX1,Rs61750420,peroxisome biogenesis disorders
PEX1,Rs28939678,peroxisome biogenesis disorders
PEX7,Rs61753238,autosomal recessive disorder Rhizomelic chondrodysplasia punctata type 1 disorder
PEX7,Rs267608255,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs1805137,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs148591292,Rhizomelic chondrodysplasia punctata type
PEX7,Rs148591292,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs121909154,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs121909153,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs1805137,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs121909153,Rhizomelic chondrodysplasia punctata type 1
PEX7,I6055954,Rhizomelic chondrodysplasia punctata type 1
PEX7,I6055953,Rhizomelic chondrodysplasia punctata type 1
PEX7,I6055953,Rhizomelic chondrodysplasia punctata type 1
PEX7,I5006214,Rhizomelic chondrodysplasia punctata type 1
PEX7,I3002517,Rhizomelic Chondrodysplasia
PEX7,Rs121909153, chondrodysplasia punctata
PGR,Rs3740753,breast cancer risk
PGR,Rs3740753,endometrial cancer
PGR,Rs10895068,female reproductive cancer:
PGR,Rs10895068,ovarian cancer
PGR,Rs10895068,ovarian cancer
PGR,Rs10895068,postmenopausal breast cancer
PGR,Rs10895068,breast cancer
PGR,Rs10895068,female reproductive cancer
PGR,Rs10895068,ovarian cancer
PGR,Rs481775,colorectal cancer
PGR,Rs10895068,breast cancer
PGR,Rs660541,ovarian and breast cancer
PGR,Rs608995,ovarian cancer
PGR,Rs516693,ovarian and breast cancer
PGR,Rs543215,endometrial cancer is ambiguous
PGR,Rs543215,ovarian and breast cancer
PGR,Rs608995,ovarian cancer
PGR,Rs608995,ovarian cancer
PGR,Rs608995,ovarian cancer
PGR,Rs10895068,ovarian cancer
PGR,Rs608995,Ovarian Cancer
PGR,Rs613120,endometrial cancer is ambiguous
PGR,Rs613120,ovarian and breast cancer
PGR,Rs660541,endometrial cancer is ambiguous
PGR,Rs516693,endometrial cancer is ambiguous
PGR,Rs10895068,ovarian cancer
PGR,Rs1042838,European 
PGR,Rs10895068,breast cancer
PGR,Rs10895068,"(breast, endometrial and ovarian) cancer"
PGR,Rs1042838,ovarian cancer
PGR,Rs1042838,endometrial cancer
PGR,Rs1042838,ovarian cancer
PGR,Rs1042838,ovarian cancer
PGR,Rs1042838,ovarian cancer
PGR,Rs1042838,invasive endometrioid subtype
PGR,Rs1042838,ovarian cancer
PGR,Rs1042838,ovarian cancer
PGR,Rs1042838,Caucasians
PGR,Rs1042838,serous (endometrial) cancers
PGR,Rs1042838,endometrial cancer
PGR,Rs1042838,female 
PGR,Rs1042838,endometrial cancer
PGR,Rs10895068,postmenopausal breast cancer
PGR,Rs1042838,Breast Cancer
PGR,Rs10895068,breast cancer
PGR,Rs1042838,endometriosis
PGR,Rs1042838,breast cancer
PGR,Rs1042838,breast cancer
PGR,Rs1042838,breast cancer
PGR,Rs1042838,males
PGR,Rs1042838,females 
PGR,Rs1042838,breast cancer
PHIP,Rs768324201,pathogenic variant
PIEZO1,Rs200970763,xerocytosis
PIEZO1,Rs200970763,xerocytosis
PIEZO1,Rs200970763,xerocystosis
PINK1,Rs3131713,whites
PINK1,Rs3131713,higher PINK1 transcript levels
PINK1,Rs45539432,Parkinson disease
PINK1,Rs45539432,Parkinson's
PINK1,Rs3131713,European 
PINK1,Rs45539432,Parkinson's disease
PINK1,Rs3131713,plasma nonesterified fatty acid 
PINK1,I5003747,Parkinson's disease
PINK1,Rs3131713,diabetes
PINK1,Rs3131713,obesity 
PINK1,Rs10799655,higher PINK1 transcript levels.
PINK1,Rs10799655,abundance and plasma nonesterified fatty acid concentrations
PINK1,Rs10799655,diabetes
PINK1,Rs10799655,obesity 
PINK1,Rs3131713,transcript abundance
PITX1,Rs121909109,talipes equinovarus
PITX1,Rs6872664,autism
PITX1,Rs6872664,autism
PKD1,Rs199476098,autosomal dominant polycystic kidney disease
PKD1,Rs199476098,highly likely pathogenic
PKD1,Rs199476098,definitely pathogenic
PKD1,Rs199476098,Polycystic Kidney disease
PKD1,Rs199476098,autosomal dominant polycystic kidney disease
PKD1,Rs199476098,autosomal dominant polycystic kidney disease
PKD1,Rs199476098,highly likely pathogenic
PKD1,Rs199476098,definitely pathogenic
PKD1,Rs199476098,Polycystic Kidney disease
PKD1,Rs199476098,Polycystic Kidney disease
PKD1,Rs369825780,autosomal dominant polycystic kidney disease
PKD1,Rs199476098,autosomal dominant polycystic kidney disease
PKD1,Rs199476098,Polycystic Kidney disease
PKD1,Rs199476100,autosomal dominant polycystic kidney disease
PKD1,Rs199476100,Polycystic Kidney disease
PKD1,Rs199476100,autosomal dominant polycystic kidney disease
PKD1,Rs199476100,Polycystic Kidney disease
PKD1,Rs199476100,autosomal dominant polycystic kidney disease
PKD1,Rs199476101,Polycystic Kidney disease
PKD1,Rs199476101,autosomal dominant polycystic kidney disease
PKD1,Rs200520583,autosomal dominant polycystic kidney disease
PKD1,Rs2432403,definitely pathogenic
PKD1,Rs2432403,highly likely pathogenic
PKD1,Rs2432403,autosomal dominant polycystic kidney disease
PKD1,Rs199476099,Polycystic Kidney disease
PKD1,Rs199476098,autosomal dominant polycystic kidney disease
PKD1,Rs199476094,autosomal dominant polycystic kidney disease
PKD1,Rs199476097,autosomal dominant polycystic kidney disease
PKD1,Rs199476098,Polycystic Kidney disease
PKD1,Rs1057518897,polycystic kidney disease
PKD1,Rs1057518897,multiple renal cysts
PKD1,Rs1057518897,hypertension
PKD1,Rs1060499702,polycystic kidney disease
PKD1,Rs1060499702,autosomal dominant polycystic kidney disease
PKD1,Rs1060499718,utosomal dominant polycystic kidney disease
PKD1,Rs148812376,end-stage renal disease (ESRD) 
PKD1,Rs148812376, autosomal dominant polycystic kidney disease
PKD1,Rs148812376,ADPKD
PKD1,Rs148812376,few cysts
PKD1,Rs1064794207,"polycystic kidney disease,"
PKD1,Rs151257298,polycystic kidney disease
PKD1,Rs199476097,Polycystic Kidney disease
PKD1,Rs151257298,SNP 
PKD1,Rs199476096,Polycystic Kidney disease
PKD1,Rs199476095,Polycystic Kidney disease
PKD1,Rs199476094,Polycystic Kidney disease
PKD1,Rs199476096,autosomal dominant polycystic kidney disease
PKD1,Rs1616940,definitely pathogenic
PKD1,Rs1616940,autosomal dominant polycystic kidney disease
PKD1,Rs1616940,polycystic kidney disease
PKD1,Rs151257298,autosomal dominant polycystic kidney disease
PKD1,Rs1616940,highly likely pathogenic
PKD1L3,Rs9938025,dry earwax
PKD1L3,Rs9938025,European ancestry
PKD2,Rs145877597,Autosomal Polycystic Kidney Disease 
PKD2,Rs749004212,PKD mutation database as definitely pathogenic
PKHD1,I6016692,PKHD1
PKHD1,I6016818,see PKHD
PKHD1,I6016808,PKHD
PKHD1,I6016714,7837se
PKHD1,I6016699,polycystic kidney disease
PKHD1,I5012611,Polycystic kidney disease
PKHD1,I6016787,see
PKHD1,I5000047,Polycystic Kidney
PKHD1,I5000047,Autosomal Recessive
PKHD1,I5000046,polycystic kidney disease
PKHD1,I5000044,polycystic kidney disease
PKHD1,I5012609,polycystic kidney disease
PKHD1,I5000043,Autosomal recessive polycystic kidney disease
PKHD1,I5000043,Autosomal recessive polycystic kidney disease
PKNOX2,Rs12284594,each G increased risk of multiple addictions
PKNOX2,Rs12284594,white women
PKNOX2,Rs12284594,multiple addictions
PKNOX2,Rs750338,substance dependence
PKP2,Rs121434421,right ventricular dysfunction
PLA2G6,Rs2284063,Melanoma
PLB1,Rs1534480,excessive sweating
PLB1,Rs1534480,SNP 
PLCB1,Rs718712,insomnia
PLCB1,Rs718712,insomnia
PLCE1,Rs2274223,Han Chinese
PLCE1,Rs2274223,esophageal cancer
PLCE1,Rs2274223,esophageal squamous cell carcinoma
PLCE1,Rs2274223,greater risk for gastric cancer
PLIN1,Rs894160,"subjects with higher complex carbohydrate intake, the minor allele was protective against obesity"
PLIN1,Rs894160,"subjects with lower carbohydrate intake, the minor allele was associated with increased obesity"
PLIN1,Rs894160,Obesity
PLIN1,Rs894160,weight loss
PLIN1,Rs894160,increased obesity
PLIN1,Rs894160,type 2 diabetes
PLIN1,Rs894160,obesity
PLIN1,Rs894160,Obesity 
PLIN1,Rs894160,metabolic syndrome risk
PLTP,Rs3843763,high-density lipoprotein
PLTP,Rs3843763,cholesterol plasma
PLXNB3,Rs6643791,higher vocabulary performance scores
PLXNB3,Rs6643791,ncreased white matter volume
PMEL,Rs765828110,pigment dispersion syndrome (PDS) in the iris
PMEL,Rs765828110,pigmentary glaucoma
PMEL,Rs765828110,blindness in young adults
PMEL,Rs765828110,pigment dispersion syndrome
PMEL,Rs773241850,pigmentary glaucoma (PG)
PMEL,Rs765828110,blindness
PMEL,Rs773241850,pigment dispersion syndrome (PDS)
PMEL,Rs773241850,blindness
PMEL,Rs756974126,a major cause of blindness
PMEL,Rs765828110,pigmentary glaucoma
PMEL,Rs756974126,pigmentary glaucoma (PG)
PMEL,Rs756974126,pigment dispersion syndrome (PDS)
PMEL,Rs142410496,blindness in young adults
PMEL,Rs756974126,pigmentary glaucoma
PMEL,Rs756974126,pigment dispersion syndrome
PMEL,Rs748713829,blindness
PMEL,Rs748713829,pigmentary glaucoma 
PMEL,Rs148258956,pigment dispersion syndrome
PMEL,Rs148258956,pigmentary glaucoma
PMEL,Rs148258956,blindness
PMEL,Rs148258956,"n the iris, which 15-20% of the time develops into pigmentary glaucoma "
PMEL,Rs756974126,blindness
PMEL,Rs142410496,pigmentary glaucoma (PG)
PMEL,Rs142410496,pigment dispersion syndrome (PDS)
PMM2,Rs28936415,Congenital disorder of glycosylation
PMM2,Rs28936415,glycosylation
PMM2,Rs28936415,Congenital disorder
PMM2,I5012680,Congenital Disorder of Glycosylation Type 1a
PMM2,I5012680,Congenital Disorder of Glycosylation
PMM2,Rs28936415,Congenital disorder
PMS2,Rs267608154,Lynch syndrome
PMS2,Rs1805323,"multiple spinocerebellar ataxia,"
PMS2,Rs1059060,cancer cells
PMS2,Rs1805323,poly-glutamine (aka Poly-Q) diseases
PMS2,Rs1805323,Huntington disease
PNMT,Rs3764351,N-methyltransferase gene
PNPLA3,Rs2281135,human diseases and traits.
PNPLA3,Rs738409,alcoholic liver disease
PNPLA3,Rs738409,alcoholic cirrhosis
PNPLA3,Rs738409,Nonalcoholic fatty liver disease
PNPLA3,Rs738409,increased hepatic fat levels 
POLD1,Rs201503929,colorectal cancer
POLD1,Rs201212113,Heterozygotes
POLD1,Rs201503929,Heterozygotes
POLD1,Rs201212113,colorectal cancer
POLD1,Rs397514632,colorectal cancer
POLD1,Rs397514633,colorectal cancer
POLD1,Rs397514633,Heterozygotes
POLD1,Rs397514632,endometrial cancer
POLD1,Rs201038430,Heterozygotes
POLD1,Rs201038430,colorectal cancer
POLD1,Rs201010746,colorectal cancer
POLD1,Rs199700312,Heterozygotes
POLD1,Rs199700312,colorectal cancer
POLD1,Rs146530638,Heterozygotes
POLD1,Rs146530638,colorectal cancer
POLD1,Rs143340270,Heterozygotes
POLD1,Rs143340270,colorectal cancer
POLD1,Rs1052471,Heterozygotes
POLD1,Rs1052471,colorectal cancer
POLD1,Rs201010746,Heterozygotes
POLE,Rs483352909,for females
POLE,Rs483352909,males
POLE,Rs483352909,colorectal cancer
POLE,Rs483352909,CRC
POLE,Rs483352909,colorectal cancer
POLE,Rs483352909,age 70 years
POLE,Rs200403177,significantly higher risk of colorectal cancer
POLE,Rs200403177,colorectal cancer
POLE,Rs138207610,colorectal cancer
POLE,Rs138207610,colorectal cancer
POLE,Rs483352909,cumulative risk of developing CRC
POLG,Rs113994098,ophthalmoparesis 
POLG,Rs113994098,dysarthria
POLG,Rs113994098,sensory ataxic neuropathy
POLG,Rs113994098,mitochondrial DNA depletion syndrome type 4A (Alpers syndrome)
POLG,Rs113994098,ataxias
POLG,Rs113994097,dysarthria
POLG,Rs113994097,sensory ataxic neuropathy
POLG,Rs113994097,mitochondrial DNA depletion syndrome type 4A (Alpers syndrome) 
POLG,Rs113994097,ataxias
POLG,Rs113994097,ophthalmoparesis (SANDO)
POLR3B,Rs138249161,hypomyelinating leukodystrophy
PON2,Rs12704795,Lou Gehrig's disease
PON2,Rs17876088,ALS
PON2,Rs17876088,Lou Gehrig's disease
PON2,Rs7493,atherosclerosis
PON3,Rs10487132,amyotrophic lateral sclerosis
POP1,Rs769183311,OMIM 
POT1,Rs756198077,minor allele
POT1,Rs756198077,Inherited dominantly
POT1,Rs756198077,colorectal cancer
PPARA,Rs4253778,type 2
PPARA,Rs4253778, diabetes
PPARA,Rs4253623,postmenopausal women and hypertensive men/women
PPARA,Rs4253623,slightly higher risk of nonfatal myocardial infarction
PPARA,Rs4253623,hypertensive
PPARA,Rs4253623,nonfatal myocardial infarction
PPARG,Rs709158,obesity
PPARG,Rs709158,inflammatory responses
PPARG,Rs709158, baseline cholesterol levels
PPARG,Rs709158,obesity
PPARG,Rs709158,single nucleotide polymorphisms
PPARG,Rs6802898,type-2 diabetes
PPARG,Rs28936407,somatic mutation
PPARG,Rs28936407,somatic mutation
PPARG,Rs2292101,Framingham Heart
PPARG,Rs2292101,diabetes
PPARG,Rs2197423,type-2 diabetes
PPARG,Rs1801282,vascular death
PPARG,Rs1801282,symptomatic coronary artery disease
PPARG,Rs1801282,diabetes.
PPARG,Rs1801282,ischemic heart disease
PPARG,Rs1801282,metabolic syndrome
PPARG,Rs1151996,bone mass
PPARG,Rs13073869,lung cancer
PPARG,Rs13073869,type 2 diabetes
PPARG,Rs13073869,diabetes
PPARG,Rs1801282,type-2 diabetes 
PPARG,Rs17036314,overweight
PPARG,Rs17036314,peroxisome proliferator-activated receptor gamma PPARG gene
PPARG,Rs17036314,type-2 diabetes (T2D)
PPARG,Rs1801282,"metabolic syndrome,"
PPARG,Rs1801282,ype-2 diabetes 
PPARG,Rs1801282,diabetes
PPARG,Rs1801282,coronary artery disease
PPARG,Rs17036314,impaired glucose tolerance (IGT)
PPARGC1A,Rs7665116,Huntington’s disease
PPARGC1A,Rs7665116,Huntington disease
PPARGC1A,Rs7665116,Huntington disease age of onset.
PPARGC1A,Rs7665116,Huntington’s patients of Italian descent 
PPARGC1A,Rs7665116,loss of motor coordination symptom of Huntington’s disease
PPARGC1A,Rs7665116,German patients 
PPARGC1A,Rs7665116,Huntington’s age of onset
PPARGC1A,Rs7665116,Huntington’s disease
PPARGC1A,Rs7665116,Huntington’s disease
PPARGC1A,Rs2970848,Huntington disease.
PPARGC1A,Rs2290602,nonalcoholic fatty liver disease (NAFLD)
PPARGC1A,Rs2290602,polymorphisms
PPARGC1A,Rs2290602,nonalcoholic fatty liver disease (NAFLD)
PPARGC1A,Rs7665116,Huntington’s disease
PPARGC1B,Rs251468,freckles
PPARGC1B,Rs251468,freckles.
PPP2R5D,Rs863225081,de novo (dominant) missense variant
PPP2R5D,Rs863225081,macrocephaly
PPP2R5D,Rs863225081,hypotonia
PPP2R5D,Rs863225082,hypotonia
PPP2R5D,Rs863225082,intellectual disability
PPP2R5D,Rs863225082,macrocephaly
PPP2R5D,Rs863225081,autism
PPP2R5D,Rs863225082,autism
PPP2R5D,Rs863225081,autism
PPP2R5D,Rs863225081,hypotonia
PPP2R5D,Rs863225081,intellectual disability
PPP2R5D,Rs863225081,autism
PPP2R5D,Rs863225081,hypotonia
PPP2R5D,Rs863225081,macrocephaly
PPP2R5D,Rs863225081,dominant
PPP2R5D,Rs863225079,hypotonia
PPP2R5D,Rs863225079,macrocephaly
PPP2R5D,Rs863225079,intellectual disability
PPP2R5D,Rs863225079,autism
PPP2R5D,Rs863225079,"macrocephaly, hypotonia"
PPP2R5D,Rs863225081,macrocephaly
PPT1,Rs137852696,Neuronal ceroid lipofuscinosis
PPT1,Rs137852696,Neuronal ceroid lipofuscinosis 
PPT1,Rs137852696,lipofuscinosis
PPT1,Rs137852695,Neuronal ceroid lipofuscinosis 
PPT1,Rs137852695,lipofuscinosis
PPT1,I5012623,Neuronal ceroid lipofuscinosis
PPT1,Rs137852695,Neuronal ceroid lipofuscinosis
PRF1,Rs104894182,Cys279Tyr
PRKCA,Rs4790904,post-traumatic stress disorder
PRKCA,Rs4790904,memory capacity
PRKCH,Rs3783799,stroke
PRKCH,Rs3783799,Chinese Han population
PRKCH,Rs3783799,lacunar infarction
PRKCH,Rs3783799,Japanese patients
PRKCH,Rs3783799,subcortical silent brain infarction
PRKCH,Rs3783799,stroke
PRKCH,Rs3783799,ubcortical silent brain infarction
PRKCH,Rs3783782,rheumatoid arthritis
PRKCH,Rs3783782,rheumatoid arthritis
PRKCH,Rs3783799,Asian populations
PRNP,Rs28933385,Creutzfeldt-Jakob disease
PRNP,Rs28933385,Creutzfeldt-Jacob disease 
PRNP,Rs28933385,Creutzfeldt-Jakob disease
PRNP,Rs28933385,Familial Creutzfeldt-Jakob disease 
PRNP,Rs28933385,supranuclear palsy
PRNP,Rs28933385,Familial Creutzfeldt-Jakob disease 
PRNP,Rs28933385,encephalopathy 
PRNP,Rs28933385,Fatal Familial Insomnia
PRNP,Rs28933385,familial Creutzfeldt-Jakob disease 
PRNP,Rs1799990,primary progressive aphasia
PRNP,Rs1799990,Creutzfeldt-Jakob disease
PRNP,Rs1799990,CJD
PRNP,Rs1799990,vCJD
PRNP,Rs1799990,vCJD
PRNP,Rs1799990,Creutzfeldt-Jakob disease
PRNP,Rs11538758,neurodegeneration
PRNP,Rs11538758,inherited Gerstmann-Straussler-Scheinker syndrome
PRNP,Rs28933385,Creuzfeldt-Jakob Disease
PROC,Rs369504169,low anticoagulant activity
PROC,Rs2069912,sepsis 
PROC,Rs2069912,organ dysfunction
PROC,Rs121918148,Glu62Ala
PROC,Rs146922325,venous thromboembolism
PROC,Rs146922325,venous thromboembolism 
PRODH,Rs450046,schizophrenia
PRODH,Rs4819756,schizophrenia
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,anxiety
PRODH,Rs450046,schizophrenia
PRODH,Rs2870983,schizophrenia
PRODH,Rs450046,schizophrenia
PROM1,Rs796051882,Blueprint Genetics Retinal dystrophy
PROM1,Rs796051882,Blueprint Genetics Retinal dystrophy
PROS1,Rs138925964,VTE
PROS1,Rs138925964,venous thromboembolism
PROS1,Rs138925964,2 - 4 fold higher VTE risk
PROS1,Rs1131691605,SNP
PROS1,Rs121918472,venous thromboembolism
PROS1,Rs138925964,venous thromboembolism
PRRC2A,Rs1046089,malaria.
PRRC2A,Rs1046089,BAT2 gene
PRRC2A,Rs1046089,SNP 
PRRC2A,Rs1046089,severe malaria
PRRC2A,Rs1046089,severe malaria
PRRC2A,Rs3132453,Non-Hodgkin Lymphoma 
PRSS1,Rs144422014,hereditary pancreatitis
PRSS1,Rs111033566, (T;T). It
PRSS1,Rs111033566, to
PRSS1,Rs111033566,n from
PRSS1,Rs111033565,Hereditary pancreatitis
PRSS1,Rs111033565,chronic pancreatitis
PRSS1,Rs111033565,pancreatitis
PRSS1,Rs111033565,caused by a mutation in the cationic trypsinogen gene
PSEN1,Rs63750231,SNP
PSEN1,Rs63750083,early-onset Alzheimer's disease
PSEN1,Rs63750083,Alzheimer's disease
PSEN1,Rs63750218,Alzheimer's disease.
PSEN1,Rs63750218,Alzheimer's disease
PSEN1,Rs63750227,25G>A
PSEN1,Rs63750231,early-onset Alzheimer's disease
PSEN1,Rs63750231,early-onset Alzheimer's disease
PSEN1,Rs63750231,dominant mutation
PSEN1,Rs63750083,Jalisco mutation
PSEN1,Rs63750231,dominant mutation leading
PSEN1,Rs63750231,early-onset Alzheimer's disease
PSEN1,Rs63750231,SNP
PSEN1,Rs63750231,SNP 
PSEN1,Rs63750299,early-onset Alzheimer's disease
PSEN1,Rs63750301,Alzheimer's
PSEN1,Rs63750307,Alzheimer's disease
PSEN1,Rs63750307,Alzheimer's
PSEN1,Rs63750307,mutation 
PSEN1,Rs63750231,Alzheimer's disease
PSEN1,Rs63750083,Alzheimer's disease
PSEN1,I5047571,early-onset Alzheimer's disease
PSEN1,Rs63750004,pathogenic
PSEN1,I5047571,early-onset Alzheimer's disease.
PSEN1,I5047580,early-onset Alzheimer's disease
PSEN1,I5047580,gene mutation potentially associated with early-onset Alzheimer's disease
PSEN1,Rs17125721,Alzheimer's disease
PSEN1,Rs28930977,ALZHEIMER DISEASE
PSEN1,Rs28930977,Dementia
PSEN1,Rs28930977,SPASTIC PARAPARESIS
PSEN1,Rs28930977,APRAXIA
PSEN1,Rs28930977,"ALZHEIMER DISEASE,"
PSEN1,Rs63750004,Alzheimer's disease
PSEN1,Rs28930977,"Dementia,"
PSEN1,Rs28930977,SPASTIC PARAPARESIS
PSEN1,Rs28930977,"APRAXIA,"
PSEN1,Rs63749805,pathogenic for early-onset Alzheimer's disease
PSEN1,Rs63749824,Alzheimer's disease
PSEN1,Rs63749885,Alzheimer's
PSEN1,Rs63749911,Alzheimer's disease
PSEN1,Rs63750004,early-onset Alzheimer's disease
PSEN1,Rs28930977,FAMILIAL
PSEN2,Rs63750215,Alzheimer's disease
PSEN2,Rs63750197,incomplete penetrance
PSEN2,Rs63750048,Alzheimer's disease
PSEN2,Rs63750197,Alzheimer's disease
PSEN2,Rs63750110,early-onset Alzheimer's disease
PSEN2,Rs63750215,causative for early-onset
PSEN2,Rs63750197,dilated cardiomyopathy
PSEN2,Rs63750666,Alzheimer's disease
PSEN2,Rs63750666,Alzheimer's
PSEN2,Rs63750666,early-onset Alzheimer's disease
PSEN2,Rs63750666,Alzheimer's
PSEN2,Rs63750666,early-onset Alzheimer's disease
PSEN2,Rs63750812,Alzheimer's disease
PSEN2,Rs755101354,early-onset Alzheimer's disease
PSEN2,Rs755101354,early-onset Alzheimer's disease
PSEN2,Rs775145486,Alzheimer's disease
PSEN2,Rs63749884,Alzheimer's
PSEN2,Rs63750666,2 PSEN2 gene
PSEN2,Rs63749884,early-onset Alzheimer's disease;
PSEN2,Rs367855127,early-onset Alzheimer's disease
PSEN2,Rs61761208,minor allele
PSEN2,Rs150400387,mutation 
PSEN2,Rs150400387,Alzheimer's disease
PSEN2,Rs150400387,autosomal dominant manner
PSEN2,Rs150400387,Korean 
PSEN2,Rs150400387,Alzheimer's
PSEN2,Rs150400387,mutation
PSEN2,Rs200754713,Frontotemporal dementia
PSEN2,Rs28936379,Alzheimer's disease
PSEN2,Rs28936379,Alzheimer's disease
PSEN2,Rs367855127,early-onset Alzheimer's disease
PSEN2,Rs533813519,Alzheimer's disease
PSEN2,Rs533813519,early-onset Alzheimer's disease
PSEN2,Rs533813519,autosomal dominant manner
PSEN2,Rs61761208,AlzForum
PSEN2,Rs61761208,early-onset Alzheimer's disease
PSEN2,Rs61761208,Alzheimer's disease
PSEN2,Rs61761208,Alzheimer's disease
PSG2,Rs707746,amyotrophic lateral sclerosis
PSG2,Rs707746,amyotrophic lateral sclerosis
PSG2,Rs707746,amyotrophic lateral sclerosis
PSG2,Rs707746,Essential Tremor
PSG2,Rs707746,amyotrophic lateral sclerosis
PTEN,Rs1057520900,hamartoma tumor syndrome
PTEN,Rs1057520900,likely to be a benign variant
PTEN,Rs1060500116,The minor allele
PTEN,Rs1060500116,Cowden syndrome
PTEN,Rs1060500116,hamartoma tumor syndrome
PTEN,Rs1060500116,truncation
PTEN,Rs1060500116,Cowden syndrome
PTEN,Rs1060500116,stop codon and a truncated protein
PTGS2,Rs689469,polymorphisms in the COX-2 gene
PTGS2,Rs5275,prostate cancer risk
PTGS2,Rs5275,coronary and carotid calcium
PTGS2,Rs5275,Diabetes
PTGS2,Rs5275,aggressive prostate cancer
PTGS2,Rs5275,colorectal cancers
PTGS2,Rs5275,oral premalignant lesions
PTGS2,Rs5275,colon cancer
PTGS2,Rs5275,cervical cancer
PTGS2,Rs5275,acute coronary syndrome in coronary artery disease
PTGS2,Rs5275,cancers
PTGS2,Rs5275,advanced colorectal adenoma
PTGS2,Rs5275,breast cancer risk
PTGS2,Rs5275,Parkinson's disease
PTGS2,Rs5275,prostate cancer risk
PTGS2,Rs5275,prostate cance
PTGS2,Rs5275,colorectal cancer Allellic
PTGS2,Rs5275,Caucasian bladder cancer patients
PTGS2,Rs5275,depression
PTGS2,Rs5275,gastric cancer
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,prostate cancer
PTGS2,Rs5275,coronary thrombosis
PTGS2,Rs5275,esophageal cancer
PTGS2,Rs5275,breast cancer risk
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,lung cancer
PTGS2,Rs5275,Danish
PTGS2,Rs5275,Gallbladder cancer
PTGS2,Rs689465,breast cancer
PTGS2,Rs689465,acute myeloid leukemia
PTGS2,Rs689465,gastric cancer
PTGS2,Rs689465,Helicobacter pylori infection
PTGS2,Rs689465,esophageal cancer
PTGS2,Rs689465,mild asthma
PTGS2,Rs689465,asthma
PTGS2,Rs689465,breast cancer prognosis:
PTGS2,Rs689465,Chinese population.
PTGS2,Rs689465,acute myeloid leukemi
PTGS2,Rs689465,gastric cancer.
PTGS2,Rs689465,esophageal cancer
PTGS2,Rs689465,Australian patients.
PTGS2,Rs689465,mild asthma
PTGS2,Rs5275,treatment resistant depression
PTGS2,Rs5275,chinese population
PTGS2,Rs5275,gastric cancer
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,coronary thrombosis
PTGS2,Rs5275,esophageal cancer
PTGS2,Rs5275,Gallbladder cancer
PTGS2,Rs5275,hepatocellular carcinoma
PTGS2,Rs5275,Scottish and Danish
PTGS2,Rs5275,inflammatory diseases
PTGS2,Rs5275,colorectal cancer
PTGS2,Rs5275,lung cancer
PTGS2,Rs5275,Korean population
PTGS2,Rs5275,chronic inflammatory diseases
PTGS2,Rs5275,coronary thrombosis
PTGS2,Rs5275,esophageal cancer
PTGS2,Rs5275,Gallbladder cancer
PTGS2,Rs5275,hepatocellular carcinoma
PTGS2,Rs5275,lung cancer
PTGS2,Rs5275,olorectal cancer
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,colon cancer
PTGS2,Rs5275,prostate cancer risk.
PTGS2,Rs5275,oral premalignant lesions
PTGS2,Rs5275,colorectal cancers
PTGS2,Rs5275,coronary artery disease
PTGS2,Rs5275,coronary syndrome
PTGS2,Rs5275,Diabetes
PTGS2,Rs5275,knee osteoarthritis
PTGS2,Rs5275,prostate cancer risk
PTGS2,Rs5275,cancers
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,Parkinson's disease
PTGS2,Rs5275,colorectal adenoma
PTGS2,Rs5275,colorectal cancer
PTGS2,Rs4648261,reduction in colorectal cancer risk
PTGS2,Rs4648261,colorectal cancer risk
PTGS2,Rs5275,inflammatory bowel disease
PTGS2,Rs5275,prostate cancer susceptibility
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,chronic inflammatory diseases
PTGS2,Rs5275,bladder cancer
PTGS2,Rs5275,colorectal cancer
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,prostate cancer
PTGS2,Rs5275,colon cancer
PTGS2,Rs5275,prostate cancer
PTGS2,Rs5275,coronary artery disease
PTGS2,Rs5275,gastric cancer
PTGS2,Rs5275,polymorphisms
PTGS2,Rs5275,polymorphisms
PTGS2,Rs5275,knee osteoarthritis
PTGS2,Rs5275,prostaglandin-endoperoxide synthase 2 variant
PTGS2,Rs5275,prostate cancer
PTGS2,Rs5275,cervical cancer
PTGS2,Rs5275,acute coronary syndrome
PTGS2,Rs5275,polymorphisms
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,polymorphism
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,polymorphisms
PTGS2,Rs5275,polymorphisms
PTGS2,Rs5275,colorectal cancer
PTGS2,Rs5275,polymorphism
PTGS2,Rs5275,Parkinson's disease
PTGS2,Rs5275,prostate cancer
PTGS2,Rs5275,colorectal adenoma
PTGS2,Rs5275,cancers
PTPN11,Rs12229892,gastric cancer
PTPN11,Rs12229892,polymorphism and gastric atrophy
PTPN2,Rs1893217,PTPN2 gene
PTPN2,Rs1893217,autophagy
PTPN2,Rs1893217,Crohn's disease
PTPN2,Rs1893217,ANGPT1
PTPN2,Rs1893217,type 1 diabetes.
PTPN2,Rs1893217,PTPN2
PTPN2,Rs1893217,celiac disease
PTPN2,Rs1893217,type 1 diabetes
PTPN2,Rs1893217,type I diabetes.
PTPN2,Rs1893217,diabetes
PTPN2,Rs1893217,diabetes
PTPN2,Rs1893217,diabetes
PTPN2,Rs1893217,type-1 diabetes
PTPN2,Rs1893217,COG6
PTPN2,Rs1893217,Crohn's disease-associated polymorphism
PTPN2,Rs1893217,Crohn's disease
PTPN2,Rs1893217,type 1 diabetes
PTPN2,Rs1893217,diabetes
PTPN2,Rs1893217,pre-diabetes to diabete
PTPN2,Rs1893217,multiple sclerosis
PTPN2,Rs1893217,type-1 diabetes
PTPN2,Rs1893217,type 1 diabetes
PTPN2,Rs1893217,celiac disease
PTPN2,Rs1893217,idiopathic arthritis 
PTPN2,Rs1893217,autoimmune diseases 
PTPN2,Rs1893217,type I diabetes
PTPN2,Rs1893217,Crohn's disease
PTPN22,Rs33996649,Crohn's disease
PTPN22,Rs33996649,Caucasian
PTPN22,Rs33996649,rheumatoid arthritis
PTPN22,Rs33996649,Chinese
PTPN22,Rs33996649,RA
PTPN22,Rs33996649,rheumatoid arthritis
PTPN22,Rs33996649,rheumatoid arthritis
PTPN22,Rs33996649,ulcerative colitis
PTPN22,Rs33996649,autoimmune diseases
PTPN22,Rs1310182,rheumatoid arthritis
PTPN22,Rs1310182,psoriasis of early onset
PTPN22,Rs1310182,type 1 diabetes
PTPN22,Rs1310182,rheumatoid arthritis
PTPN22,Rs12730735,rheumatoid arthritis
PTPN22,Rs12730735,rheumatoid arthritis
PTPN22,Rs12730735,rheumatoid arthritis
PTPN22,Rs12730735,rheumatoid arthritis
PTPN22,Rs1310182,rheumatoid arthritis
PTPRD,Rs4626664,Restless Legs Syndrome: 
PTPRD,Rs4626664,restless legs syndrome
PTPRD,Rs4626664,restless legs syndrome
PTPRD,Rs4626664,Restless Legs Syndrome
PTPRD,Rs4626664,restless legs syndrome
PTPRD,Rs1975197,estless legs syndrome
PTPRD,Rs1975197,restless legs syndrome
PTPRD,Rs4626664,restless legs syndrome
PTPRQ,Rs61729287,deafness
PTPRQ,Rs749210663,deafnes
PYGM,Rs119103252,PYGM gene
QDPR,Rs744731,bipolar disorder
QDPR,Rs744731,bipolar disorder
RAB27A,Rs104894497,familial hemophagocytic lymphohistiocytosis
RAB27A,Rs104894497,Griscelli syndrome
RAB27A,Rs104894497,Griscelli syndrome
RAB27A,Rs104894497,familial hemophagocytic
RAB27A,Rs104894497,pathogenic
RAB6B,Rs2280673,Hemochromatosis
RAD50,Rs2240032,repair pathway genes and familial breast cancer
RAD50,Rs2244012,smokers
RAPSN,Rs45547231,congenital myasthenic syndrome
RAPSN,Rs104894299,congenital myasthenic syndrome
RAPSN,Rs104894299,congenital myasthenic syndrome
RAPSN,Rs104894299,congenital myasthenic syndrome.
RAPSN,Rs104894299,"ongenital myasthenic syndrome. For more information, see OMIM 601592.0001."
RAPSN,Rs104894299,congenital myasthenic syndrome
RAPSN,Rs104894299,congenital myasthenic syndrome
RAPSN,Rs104894299,"ongenital myasthenic syndrome. For more information, see OMIM 601592.0001."
RAPSN,Rs104894299,inherited recessively
RARG,Rs2229774,cardiotoxicity
RARG,Rs2229774,cancer
RARG,Rs2229774,cancer
RB1,Rs2854344,ovarian cancer risk
RB1,Rs2854344,ovarian cancer
RB1,Rs2854344,white non-Hispanic
RB1,Rs2854344,invasive epithelial ovarian cancer
RB1,Rs2854344,women
RB1,Rs2854344,ovarian cancer
RB1,Rs2854344,breast cancer
RB1,Rs2227311,ovarian cancer
RB1,Rs2854344,ovarian cancer
RBFOX1,Rs3785234,major depression
RBFOX1,Rs7498702,psychiatric disorders
RELN,Rs7341475,schizophrenia
RELN,Rs7341475, schizophrenia
RELN,Rs7341475,schizoaffective disorder
RELN,Rs7341475,schizoaffective disorder
RELN,Rs607755,Alzheimer's disease
RELN,Rs3914132,hearing loss
RELN,Rs3914132,otosclerosis
RELN,Rs7341475,schizophrenia
RET,Rs2435357,males
RET,Rs3026785,protection from Hirschsprung disease
RET,Rs2742234,Chinese 
RET,Rs2742234,Hirschsprung's disease 
RET,Rs2742234,RET 
RET,Rs2742234,Hirschsprung's disease
RET,Rs2435357,Hirschsprung disease
RET,Rs17158558,Hirschsprung disease
RET,Rs2435357,Hirschsprung disease
RET,Rs2435357,Hirschsprung disease
RET,Rs1800860,renal insufficiency
RET,Rs1800860,hypertension
RET,Rs1800860,Caucasian
RET,Rs17158558,Hirschsprung disease
RET,Rs2435357,males
RGS2,Rs4606,post-traumatic stress disorder
RGS2,Rs4606,postdisaster 
RGS2,Rs4606,African 
RGS2,Rs4606,Caucasian
RGS2,Rs4606,schizophrenia 
RGS2,Rs4606,Parkinson's 
RGS2,Rs4606,social anxiety disorder
RGS2,Rs4606,Americans
RGS2,Rs4606,avoident
RGS2,Rs4606,shy
RGS2,Rs4606,anxiety related disorders
RGS2,Rs4606,anxiety
RGS2,Rs4606,behaviourally restrained
RGS2,Rs2746072,immunoreactivity
RGS2,Rs2746072,polymorphisms
RGS7,Rs670659,deep vein thrombosis
RGS7,Rs670659,deep vein thrombosis
RGS7,Rs670659,deep vein thrombosis
RGS7,Rs670659,deep vein thrombosis
RHCE,Rs676785,blood group
RNASEL,Rs486907,SNP
RNASEL,Rs486907,cancer
RNASEL,Rs486907,cancers
RNASEL,Rs486907,cancer
RNASEL,Rs486907,prostate cancer
RNASEL,Rs486907,hereditary-prostate-cancer (HPC)
RNASEL,Rs486907,cancer
RNASEL,Rs486907,cancers
RNASEL,Rs486907,cancer
RNASEL,Rs486907,prostate cancer
RNASEL,Rs486907,SNP 
RNASEL,Rs486907,Finnish families
RNASEL,Rs486907,prostate cancer
RNASEL,Rs486907,hereditary-prostate-cancer (HPC)
RNASEL,Rs486907,cancers
RNASEL,Rs486907,cancer risk
RNASEL,Rs486907,SNP 
RNASEL,Rs486907,hereditary-prostate-cancer (HPC)
RNASEL,Rs486907,prostate cancer
RNASEL,Rs486907,increased cancer risk
RNASEL,Rs486907,increased cancer risk
RNASEL,Rs486907,cancers
RNASEL,Rs486907,cancer 
RNASEL,Rs3738579,cancer forms
RNASEL,Rs3738579,breast cancer
RNASEL,Rs3738579,head and neck squamous cell carcinomas
RNASEL,Rs3738579,carcinoma of the uterine cervix
RNLS,Rs2576178,hypertension
RNLS,Rs2296545,hypertension
RNLS,Rs2296545,chromosome 10
RNLS,Rs2296545,late-onset Alzheimer disease
RNLS,Rs2296545,Renalase gene
RORA,Rs12912233,circadian rhythm
RORA,Rs12912233,trait depression 
RTEL1,Rs6010620,German
RTEL1,Rs6010620,skin inflammation
RTEL1,Rs6010620,skin lesions of AD
RTEL1,Rs6010620,AD
RTEL1,Rs6010620,non-atopic inflammatory diseases
RTEL1,Rs6010620,sporadic AD
RTEL1,Rs6010620,central and northern parts of China
RTEL1,Rs6010620,AD
RTEL1,Rs6010620,European
RTEL1,Rs6010620,Chinese
RTEL1,Rs6010620,adults
RTEL1,Rs6010620,Germany
RTEL1,Rs6010620,Chinese Han
RTEL1,Rs6010620,children
RTEL1,Rs6010620,chronic inflammatory skin disorders
RTEL1,Rs6010620,AD
RTEL1,Rs6010620,eczema
RTEL1,Rs6010620,atopic dermatitis (AD)
RTEL1,Rs201540674,mutation
RTEL1,Rs6010620,AD
RYR1,Rs121918596,malignant hyperthermia
RYR1,Rs121918596,SNP in the RYR1 gene
RYR1,Rs193922747,malignant hyperthermia
RYR1,Rs193922747,malignant hyperthermia
RYR1,Rs193922770,malignant hyperthermia
RYR1,Rs193922770,malignant hyperthermia
RYR1,Rs193922807,hyperthermia
RYR1,Rs193922772,hyperthermia
RYR1,Rs193922772,malignant hyperthermia.
RYR1,Rs193922807,malignant hyperthermia
RYR1,Rs193922878,hyperthermia
RYR1,Rs121918594,malignant hyperthermia and central core disease
RYR1,Rs193922772,malignant hyperthermia
RYR1,Rs121918594,malignant hyperthermia
RYR1,Rs118192122,malignant hyperthermia
RYR1,Rs118192177,malignant hyperthermia
RYR1,Rs121918592,malignant hyperthermia
RYR1,Rs118192161,malignant hyperthermia
RYR1,Rs118192161,melanoma
RYR1,Rs118192161,malignant hyperthermia
RYR1,Rs118192161,central core disease
RYR1,Rs118192170,SNP
RYR1,Rs118192163,malignant hyperthermia when heterozygous
RYR1,Rs118192172,malignant hyperthermia
RYR1,Rs118192172,MH
RYR1,Rs118192172,female
RYR1,Rs118192175,malignant hyperthermia
RYR1,Rs118192175,increased susceptibility to malignant hyperthermia
RYR1,Rs118192170,central core disease
RYR2,Rs34967813,amilial polymorphic ventricular tachycardia
RYR2,Rs41315858,arrhythmogenic right ventricular cardiomyopathy type 2 
RYR2,Rs41315858,arrhythmogenic right ventricular cardiomyopathy
RYR2,Rs34967813,arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)
RYR2,Rs34967813,"genotype negative, exercise-induced long QT syndrome"
RYR2,Rs34967813,Cardiac Arres
RYR2,Rs34967813,cardiac arrest
RYR2,Rs34967813,catecholaminergic polymorphic ventricular tachycardia
RYR2,Rs34967813,heart failure and sudden cardiac death
SARDH,Rs140559739,sarcosinemia
SCARB1,Rs4765623,gain significant weight
SCARB1,Rs4765623,gain significant weight 
SCARB1,Rs74830677,high plasma HDL-C levels
SCARB1,Rs74830677,coronary heart disease
SCARB1,Rs74830677,coronary heart disease
SCG3,Rs3764220,resistant (OR 9.3) to obesity
SCG3,Rs3764220,obesity phenotype
SCG3,Rs3764220,transcriptional activity
SCG3,Rs3764220,minor alleles seemed to be resistant
SCG3,Rs3764220,obesity
SCG3,Rs3764220,obesity
SCG3,Rs3764220,obesity phenotype
SCN2A,Rs121917749,benign familial neonatal-infantile seizures
SCN2A,Rs121917750,benign familial neonatal-infantile seizures
SCN3A,Rs774195502,pathogenic variant
SCN4A,Rs121908548,"cramps in the fingers, toes, and eyelids"
SCN4A,Rs121908548,potassium-aggravated myotonia
SCN4A,Rs121908548,muscle weakness 
SCN4A,Rs121908548,paramyotonia congenita
SCN4A,Rs121908548,potassium aggravated myotonia
SCN5A,Rs12053903,Influences QT interval
SCN9A,Rs73969684,pain-related disorders
SCN9A,Rs73969684,yawning
SCN9A,Rs73969684,paroxysmal extreme pain disorder
SCN9A,Rs73969684,small fiber neuropathy
SCN9A,Rs4369876,congenital insensitivity to pain
SCN9A,Rs12478318,patient carrying this complex allele
SCN9A,Rs12478318,small fiber neuropathy
SCN9A,Rs12478318,pain
SCN9A,Rs12478318,mall fiber neuropathy
SCN9A,Rs12478318,lower post-operative pain following surgery
SCN9A,Rs121908917, insensitivity to pain
SCN9A,Rs121908917,insensitivity to pain
SCN9A,Rs121908916,insensitivity to pain
SCN9A,Rs121908910,insensitivity to pain
SCN9A,Rs12478318,increased pain
SDHB,Rs74315366,pheochromocytoma
SDHB,Rs74315366,malignant sympathetic extraadrenal paragangliomas
SDHB,Rs74315366,phaeochromocytoma
SDHB,Rs74315366,paragangliomas
SDHB,Rs74315366,sporadic sympathetic paragangliomas.
SDHB,Rs74315366,familial malignant sympathetic extraadrenal paragangliomas
SDHB,Rs74315366,pressure
SDHB,Rs74315366,paragangliomas
SDHB,Rs111430410,hereditary paragangliomatosis
SDHB,Rs74315366,extraadrenal 
SDHB,Rs111430410,renal oncocytoma
SDHB,Rs111430410,familial renal cell carcinoma
SDHB,Rs111430410,Germline SDHB mutations
SDHB,Rs111430410,hereditary paragangliomatosis
SDHB,Rs111430410,renal phenotype
SDHB,Rs111430410,renal oncocytoma
SDHB,Rs111430410,familial renal cell carcinoma
SDHD,Rs11214077,benign 
SDHD,Rs34677591,cancers
SDHD,Rs34677591,paragangliomas
SDHD,Rs34677591,pheochromocytomas
SDHD,Rs34677591,cancers
SDHD,Rs34677591,paragangliomas and pheochromocytomas
SELE,Rs5361,4X higher risk for recurrent venous thromboembolism (VTE)
SELE,Rs5361,homozygous carriers
SELE,Rs5361,thrombotic disorders
SELE,Rs5361,recurrent venous thromboembolism
SELE,Rs5361,thrombotic disorders
SEPSECS,Rs267607035,pathogenic 
SEPSECS,Rs267607035,Pontocerebellar 
SEPSECS,Rs267607035,Pontocerebellar hypoplasia type 2D
SEPSECS,Rs267607035,Pontocerebellar hypoplasia type 2D
SEPSECS,Rs267607036,Pontocerebellar hypoplasia type 2D
SEPSECS,Rs267607036,Pontocerebellar hypoplasia type 2D
SEPSECS,Rs773876739,Pontocerebellar hypoplasia type 2D
SERPINA1,Rs7151526,anca-associated vasculitides
SERPINA1,Rs28931569,emphysema
SERPINA1,Rs28931569,emphysema
SERPINA1,Rs28931568,emphysema
SERPINA1,Rs28931568,emphysema
SERPINA1,Rs1802959,liver disease
SERPINA1,Rs1802959,emphysema
SERPINA1,Rs7151526,A recent study showed
SERPINA1,Rs1802959,liver disease
SERPINA1,Rs1802959,emphysema
SERPINA1,Rs1802959,Alpha 1-antitrypsin deficiency
SERPINA1,Rs1303,pulmonary emphysema
SERPINA1,Rs121912713,bleeding disorder
SERPINA1,Rs121912713,thrombin
SERPINA1,Rs1802959,Alpha 1-antitrypsin deficiency
SERPINA1,Rs121912713,dominant mutation
SERPINA3,Rs17473,pulmonary 
SERPINA3,Rs17473,emphysema
SERPINA3,Rs1800463,pulmonary emphysema
SERPINA3,Rs1800463,pulmonary emphysema
SERPINA3,Rs4934,Lung cancer
SERPINA3,Rs4934,chronic obstructive pulmonary disease
SERPINC1,Rs121909547,thrombophilia
SERPINC1,Rs121909547,Korean venous thromboembolism
SERPINC1,Rs121909547,Korean venous thromboembolism
SERPINC1,Rs121909547,thrombophilia
SERPINC1,Rs121909547,thromboembolism patients screened for thrombophilia
SERPINE1,Rs34857375,ovarian response
SERPINE1,Rs6092,autism spectrum disorder
SERPINE1,Rs6092,depression
SERPINE1,Rs6092,predicts osteonecrosis in children with acute lymphoblastic leukemia
SERPINE1,Rs6092,pneumonia
SERPINE1,Rs6092,obesity
SERPINE1,Rs6092,myocardial infarction
SERPINE1,Rs6092,menopause
SERPINE1,Rs6092,associated with obesity and fat distribution
SERPINE1,Rs34857375,endometriosis
SERPINE1,Rs34857375,Polycystic ovary syndrome
SERPINE1,Rs34857375,Functional genetic polymorphisms
SERPINE1,Rs34857375,Functional genetic polymorphisms
SERPINE1,Rs34857375,ovarian response
SERPINE1,Rs34857375,female reproductive disorders
SERPINE1,Rs34857375,Functional genetic polymorphisms
SERPINE1,Rs34857375,Polycystic ovary syndrome
SERPINE1,Rs34857375,female reproductive disorders
SERPINE1,Rs2227692,gastric cancer
SERPINE1,Rs2227692,gastric cancer
SERPINE1,Rs2227692,gastric cancer
SERPINE1,Rs2227692,gastric cancer
SERPINE1,Rs34857375,female reproductive disorders
SERPINF1,Rs1136287,macular degeneration
SERPINF1,Rs1136287,ARMD
SERPINF1,Rs1136287,macular degeneration
SERPING1,Rs1005510,not associated with age-related macular degeneration
SERPING1,Rs121907948,c.1397G>A
SERPING1,Rs1005510,SERPING1 
SERPING1,Rs1005510,macular degeneration
SERPING1,Rs1005510,age-related macular degeneration
SETD1A,Rs61744449,schizophrenia
SETD1A,Rs869312831,developmental disorders
SETD1A,Rs869312831,schizophrenia
SETD1A,Rs869312831,schizophrenia and developmental disorders
SETD1A,Rs869312830,schizophrenia and developmental disorders.
SETD1A,Rs869312829,developmental disorders
SETD1A,Rs869312829,schizophrenia
SETD1A,Rs869312829,loss-of-function
SETD1A,Rs869312829,developmental disorders
SETD1A,Rs869312829,schizophrenia 
SETD1A,Rs869312829,developmental disorders
SETD1A,Rs770913157,developmental disorders
SETD1A,Rs869312829,also known as c.518-2A>G Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.
SETD1A,Rs754369980,schizophrenia
SETD1A,Rs754369980, and developmental disorders
SETD1A,Rs755127868,schizophrenia
SETD1A,Rs755127868,developmental disorders
SETD1A,Rs61744449,developmental disorders
SETD1A,Rs761709838,developmental disorders
SETD1A,Rs770913157,schizophrenia
SETD1A,Rs761709838,schizophrenia
SETD1A,Rs869312829,schizophrenia
SEZ6L,Rs688034,heart disease
SEZ6L,Rs688034,coronary artery disease
SEZ6L,Rs688034,heart disease
SEZ6L,Rs688034,coronary artery disease
SEZ6L,Rs688034,heart disease
SEZ6L,Rs688034,coronary artery disease
SEZ6L,Rs688034,heterozygotes
SEZ6L,Rs688034,homozygotes
SGLT1,Rs33954001,sugar metabolism
SGLT1,Rs33954001,haplotype in the SGLT1 gene
SGLT1,Rs17683430,sugar metabolism
SGLT1,Rs17683011,sugar metabolism
SGLT1,Rs17683011,haplotype in the SGLT1 gene
SGLT1,Rs17683430,haplotype in the SGLT1 gene
SGSH,Rs770947426,recessively inherited disorder
SGSH,Rs770947426,Sanfilippo syndrome type A
SGSH,Rs144143780,mucopolysaccharidosis type IIIA
SGSH,Rs144143780,mucopolysaccharidosis type IIIA (MPS3A).
SGSH,Rs144143780,Sanfilippo syndrome type A
SGSH,Rs144143780,Sanfilippo syndrome type A
SGSH,Rs144143780,mucopolysaccharidosis type IIIA
SGSH,Rs144143780,Sanfilippo syndrome type A
SGSH,Rs104894635,mucopolysaccharidosis type IIIA
SGSH,Rs104894635,"Sanfilippo syndrome type A,"
SGSH,Rs144143780,mucopolysaccharidosis type IIIA
SH2B3,Rs148636776,erythrocytosis type 1 
SH2B3,Rs148636776,thrombocythemia
SH2D1A,Rs111033627,Lymphoproliferative syndrome
SH2D1A,Rs111033630,X-linked Lymphoproliferative syndrome
SH2D1A,Rs111033630,X-linked Lymphoproliferative syndrome
SH2D1A,Rs111033627,pathogenic
SH2D1A,Rs111033627,X-linked Lymphoproliferative syndrome
SH2D1A,Rs111033623,Lymphoproliferative syndrome
SH2D1A,Rs111033626,Lymphoproliferative syndrome
SH2D1A,Rs111033624,X-linked Lymphoproliferative syndrome
SH2D1A,Rs111033624,Lymphoproliferative syndrome
SH2D1A,Rs111033623,Lymphoproliferative syndrome
SH2D1A,Rs111033626,"Lymphoproliferative syndrome, type 1"
SHANK3,Rs767058690,SHANK3 gene
SHANK3,Rs767058690,autism 
SHANK3,Rs767058690,Phelan-McDermid syndrome.
SHBG,Rs6259,human spermatogenic defect
SHBG,Rs6259,endometrial cancer
SHBG,Rs6259,Ovarian cancer
SHBG,Rs6259,Polycystic ovary syndrome
SHBG,Rs6259,postmenopausal breast cancer
SHBG,Rs6259,gastric cancer
SHBG,Rs6259,premenopausal
SHBG,Rs6259,postmenopausal women
SHBG,Rs6259,systemic lupus erythematosus
SHBG,Rs6259,schizophrenia
SHBG,Rs6259,type 2 diabetes
SHBG,Rs6259,postmenopausal women
SHBG,Rs6259,polycystic ovary syndrome
SHBG,Rs6259,breast cancer
SHBG,Rs6259,premenopausal women
SHBG,Rs6257,globulin
SHBG,Rs6259,endometrial cancer
SHBG,Rs6259,polycystic ovary syndrome
SHBG,Rs6259,systemic lupus
SHBG,Rs6259,endometrial cancer
SHBG,Rs6259,cancer 
SHBG,Rs6259,with polycystic ovary syndrome. Quantitative trait analysis suggests polymorphisms of estrogen-related genes regulate human sperm concentrations and motility.
SHBG,Rs6259,ess of Mendelian randomization in observational epidemiolog
SHBG,Rs6257,type 2 diabetes in postmenopausal women
SHBG,Rs6259,postmenopausal women
SHBG,Rs6257,Ovarian cancer
SHBG,Rs6257,breast cancer
SHBG,Rs6257,Ovarian cancer risk
SHBG,Rs6257,potential breast cancer variant
SHBG,Rs1799941,Sex Hormone Regulation
SHBG,Rs12150660,gastric cancer
SHOX,Rs137852552,SHOX Deficiency
SHOX,Rs137852552,idiopathic short stature
SHOX,Rs137852552,skeletal abnormalities
SHOX,Rs137852552,Turner syndrome
SHROOM3,Rs17319721,increased expression
SHROOM3,Rs17319721,chronic kidney disease
SHROOM3,Rs17319721,kidney transplant rejection
SIPA1,Rs3741378,breast cancer
SIRT1,Rs3758391,lower cardiovascular disease
SIRT1,Rs3758391,Finnish adults
SIRT1,Rs3758391,improved cognition
SIRT1,Rs3758391,better cognitive function
SIRT1,Rs10997875,bipolar disorder
SIRT1,Rs10997875,schizophrenia
SIRT1,Rs10997875,major depressive disorder
SIRT1,Rs3758391,longevity
SIX5,Rs80356461,branchio-oto-renal syndrome
SLC12A3,Rs138977195,Familial hypokalemia-hypomagnesemia
SLC12A3,Rs138977195,recessively inherited
SLC12A3,Rs2289116,diabetic nephropathy and type-2 diabetes
SLC12A6,Rs35583475,Andermann syndrome
SLC12A6,Rs35583475,recessively inherited
SLC12A6,Rs35583475,Andermann syndrome
SLC12A6,Rs35583475,Andermann syndrome
SLC12A6,Rs121908428,ACCPN mutations
SLC12A6,Rs35583475,Andermann syndrome
SLC16A11,Rs117767867,Native American population
SLC16A11,Rs117767867,type-2 diabetes
SLC16A11,Rs117767867,east Asian
SLC16A11,Rs117767867,Europeans
SLC16A11,Rs117767867,Africans.
SLC17A5,I5012634,disease
SLC17A5,I5012634,disease
SLC18A1,Rs2270641,schizophrenia 
SLC18A1,Rs2270641,European descent
SLC18A1,Rs2270641,schizophrenia
SLC18A1,Rs2270641,European descent
SLC18A2,Rs60912143,SNP denoted a reduced transcription activity haplotype
SLC19A1,Rs1051266,serum folate or homocysteine levels methotrexate
SLC19A1,Rs1051266,higher red blood cell folate concentrations
SLC19A1,Rs1051266,GA and AA genotypes
SLC19A1,Rs1051266,plasma folate women
SLC1A2,Rs1042113,schizophrenia
SLC1A2,Rs1042113,Koreans
SLC1A2,Rs1042113,neurological disorders
SLC1A2,Rs1042113,amyotrophic lateral sclerosis.
SLC22A4,Rs1050152,Crohn's disease
SLC22A4,Rs11568506,psoriasis
SLC22A4,Rs11568506,Crohn's disease
SLC22A4,Rs2073838,rheumatoid arthritis
SLC22A4,Rs2073838,rheumatoid arthritis
SLC22A5,Rs17622208,Crohn's Disease
SLC22A5,Rs17622208,IBD risk factor
SLC24A5,Rs2470102,Skin color
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs6716901,Asperger syndrome
SLC25A12,Rs6716901,Asperger syndrome
SLC25A12,Rs2292813,Autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A13,Rs80338727,mutations
SLC26A4,Rs111033244,Pendred Syndrome
SLC26A4,Rs111033220,Pendred Syndrome
SLC26A4,Rs111033199,Pendred Syndrome
SLC26A4,Rs111033199,hearing loss condition
SLC26A4,Rs111033199,hearing loss
SLC26A4,Rs111033199,Pendred Syndrome
SLC26A4,I5012618,Hearing loss
SLC26A4,I5012616,Pendred Syndromers
SLC26A4,I5012618,Pendred Syndromers
SLC26A4,I5012616,Pendred Syndrome
SLC26A4,I5012616,Hearing loss
SLC26A4,I5000696,Pendred Syndrome
SLC26A4,I5000696,Hearing loss
SLC26A4,I5000003,Pendred Syndrome
SLC26A4,I5000003,Hearing loss
SLC26A4,I5000003,Hearing loss
SLC26A4,I5012616,Hearing loss
SLC30A8,Rs3802177,type-2 diabetes
SLC30A8,Rs3802177,SNP 
SLC30A8,Rs3802177,type-2 diabetes
SLC30A8,Rs200185429,type-2 diabetes
SLC30A8,Rs200185429,type-2 diabetes
SLC30A8,Rs200185429,diabetes
SLC30A8,Rs3802177,type-2 diabetes
SLC37A4,Rs80356489, Hepatocellular carcinoma in type 1a glycogen storage disease with identification of a glucose-6-phosphatase
SLC37A4,Rs80356489,glycogen storage disease type 1b
SLC37A4,Rs80356489,This mutation is reported by 23andMe as accounting for approximately 40%
SLC37A4,Rs80356489,Hepatocellular carcinoma
SLC37A4,I5012878,Glycogen Storage Disease Type 1
SLC37A4,I5012878,Glycogen Storage Disease Type 1brs
SLC37A4,Rs80356489,Hepatocellular carcinoma
SLC39A4,Rs1057523837,acrodermatitis enteropathica
SLC39A4,Rs1057523837,pathogenic
SLC45A2,Rs6867641,skin color variation
SLC45A2,Rs6867641,Promoter polymorphisms
SLC45A2,Rs35391,hair color
SLC45A2,Rs35391,alleles
SLC45A2,Rs35391,skin pigmentation
SLC45A2,Rs26722,hair color and skin pigmentation
SLC45A2,Rs26722,"darker eye, hair, and skin color"
SLC45A2,Rs183671,hair graying
SLC45A2,Rs26722,skin cancer
SLC4A1,Rs2285644,Oriental people of Mongolian descent
SLC4A1,Rs5036,"benign,"
SLC4A1,Rs5036,variation in anion transport in erythrocytes
SLC4A1,Rs2285644,Non-ABO Blood Groups
SLC4A1,Rs2285644,South American Indians
SLC4A1,Rs2285644,Chinese 
SLC4A1,Rs5036,variation in anion transport in erythrocytes
SLC4A1,Rs2285644,Japanese 
SLC4A1,Rs2285644,indigenous American (North or South) ancestors
SLC4A1,Rs2285644,people with some ancestors from those groups
SLC4A1,Rs2285644,East Asian
SLC4A1,Rs2285644,Asians
SLC4A1,Rs2285644,Caucasians and Blacks
SLC4A1,Rs2285644,East Asians
SLC4A1,Rs2285644,indigenous peoples of the Americas (in both North and South America)
SLC4A1,Rs2285644,Di(a-b+)
SLC4A1,Rs2285644,(Di(a+b+)
SLC4A1,Rs2285644,Di(a+b+)
SLC4A1,Rs2285644,Asians
SLC6A2,Rs5558,rare Cysteine variant
SLC6A2,Rs5568,ADHD
SLC6A2,Rs5568,associated with better response to treatment of ADHD
SLC6A2,Rs5569,ADHD
SLC6A2,Rs5558,decrease in desipramine
SLC6A2,Rs5558,major depression
SLC6A2,Rs5558,decrease in desipramine
SLC6A2,Rs5558,major depression
SLC6A2,Rs5558,increased norepinephrine transport
SLC6A2,Rs3785157,ADHD
SLC6A2,Rs3785143,Attention deficit hyperactivity disorder
SLC6A2,Rs36029,antidepressant response
SLC6A2,Rs36029,Pharmacogenetics of antidepressant response
SLC6A2,Rs1861647,ADHD
SLC6A2,Rs11568324,protection for ADHD
SLC6A2,Rs5558,insensitivity to protein kinase C
SLC6A3,Rs6350,acute post-surgical pain
SLC6A3,Rs431905514,31+
SLC6A3,Rs37022,ipolar disorder
SLC6A3,Rs37022,alcohol-dependent
SLC6A3,Rs2963238,schizophrenia
SLC6A3,Rs2963238,extrapyramidal syndrome
SLC6A3,Rs2963238,cocaine abuse
SLC6A3,Rs6350,Financial and psychological risk attitudes
SLC6A3,Rs2963238,severe symptoms upon alcohol withdrawal
SLC6A3,Rs2963238,extrapyramidal syndrome in schizophrenia.
SLC6A3,Rs2963238,seizures
SLC6A3,Rs2963238,alcohol withdrawa
SLC6A3,Rs2652511,attention deficit/hyperactivity disorder
SLC6A3,Rs2652511,attention-deficit/hyperactivity disorder
SLC6A3,Rs2652511,attention deficit hyperactivity disorder
SLC6A3,Rs2963238,seizures
SLC6A4,Rs6354,serotonin transporter gene
SLC6A4,Rs6354,functional polymorphism
SLC6A4,Rs4583306,panic disorder
SLC6A4,Rs4583306,haplotype 
SLC6A4,Rs4251417,diarrhoea predominant irritable bowel syndrome in women
SLC6A4,Rs4251417,ADHD
SLC6A4,Rs6354,diarrhoea predominant irritable bowel syndrome
SLC6A4,Rs4251417,functional polymorphism in the serotonin transporter gene
SLC6A4,Rs4251417,NEO-PI-R Neuroticism
SLC6A4,Rs4583306,panic disorder
SLC6A4,Rs6354,autism
SLC6A4,Rs6354,Serotonin transporter polymorphisms
SLC6A4,Rs6354,polymorphisms
SLC6A4,Rs6354,frontotemporal lobar degeneration
SLC6A4,Rs6354,portopulmonary hypertension
SLC6A4,Rs6354,Neuroticism
SLC6A4,Rs6354,Flanking Single Nucleotide Polymorphisms
SLC6A4,Rs6354,Depression
SLC6A4,Rs6354,Anxiety
SLC6A4,Rs6354,Personality Measures
SLC6A4,Rs6354,systemic sclerosis
SLC6A4,Rs4251417,Sexually dimorphic
SLC6A4,Rs6354,rigid-compulsive behaviors
SLC6A4,Rs4251417,diarrhoea predominant irritable bowel syndrome
SLC6A4,Rs2066713,schizophrenia
SLC6A4,Rs28914832,drinking intensity.
SLC6A4,Rs11080122,Neuroticism
SLC6A4,Rs2066713,diarrhoea
SLC6A4,Rs2066713,irritable bowel syndrome
SLC6A4,Rs2066713,ADHD
SLC6A4,Rs2066713,autism
SLC6A4,Rs2066713,schizophrenia
SLC6A4,Rs2066713,Chronic Fatigue Syndrome
SLC6A4,Rs2066713,depression
SLC6A4,Rs2066713,migraine
SLC6A4,Rs3794808,"Association of serotonin transporter gene variation with smoking, chronic obstructive pulmonary disease, and its depressive symptoms"
SLC6A4,Rs2066713,diarrhoea
SLC6A4,Rs2066713,sclerosis
SLC6A4,Rs2066713,Neuroticism
SLC6A4,Rs2066713,Chronic Fatigue Syndrome
SLC6A4,Rs2066713,depression
SLC6A4,Rs2066713,migraine
SLC6A4,Rs2066713,ystemic sclerosis
SLC6A4,Rs25532,obsessive compulsive disorder
SLC6A4,Rs25532,obsessive compulsive disorder (OCD) 
SLC6A4,Rs28914832,autism
SLC6A4,Rs28914832,autism
SLC6A4,Rs2066713,irritable bowel syndrome
SLC7A5,Rs757972971,autism
SLC9A9,Rs1995356,depression
SLCO1B1,Rs4363657,homozygotes
SLCO1B1,Rs4363657,myopathy
SLCO1B1,Rs4363657,statin-induced myopathy
SLCO1B1,Rs4363657,lower cholesterol levels
SLCO1B1,Rs11045879,bilirubin levels and unconjugated hyperbilirubinemia
SLCO1B1,Rs4363657,statin metabolism
SLCO1B3,Rs11045585,leukopenia/neutropenia
SLCO1B3,Rs11045585,leukopenia/neutropenia
SLCO1B3,Rs11045585,leukopenia/neutropenia
SLCO1B3,Rs11045585,leukopenia/neutropenia
SLCO1B3,Rs11045585,leukopenia/neutropenia
SLCO1B3,Rs11045585,non-leukopenia/neutropenia
SLITRK1,Rs9546538,Tourette syndrome
SMAD3,Rs17293443,giving birth to fraternal (dizygotic) twins
SMAD3,Rs17228212,heart disease
SMAD3,Rs17228212,SNP 
SMAD3,Rs17228212,Myocardial infarction
SMAD6,Rs12913975,brain metastasis
SMAD6,Rs12913975,brain metastasis
SMAD6,Rs12913975,different cancers
SMAD7,Rs736839,Disease
SMAD7,Rs736839,Monogenic Disease
SMAD7,Rs736839,sickle cell anemia
SMAD7,Rs736839,sickle cell leg ulcers
SMAD7,Rs736839,sickle cell disease
SMAD7,Rs736839,sickle cell anemia
SMAD7,Rs736839,sickle cell anemia
SMAD7,Rs736839,Sickle Cell Anemia
SMAD7,Rs736839,disease
SMAD7,Rs58920878,colorectal cancer
SMAD7,Rs58920878,colorectal cancer
SMAD7,Rs4939827,colorectal cancer
SMAD7,Rs4939827,colorectal cancer
SMAD7,Rs4464148,colorectal cancer
SMAD7,Rs12953717,colorectal cancer
SMAD7,Rs736839,sickle cell anemia
SMN1,Rs104893934,spinal muscular atrophy
SMN1,Rs104893934,Werdnig-Hoffmann disease
SMN1,Rs104893934,spinal muscular atrophy
SMN1,Rs104893934,Werdnig-Hoffmann disease
SMN1,Rs104893935,type 1 or 2 spinal muscular atrophy
SMN1,Rs77804083,recessively inherited type 2 spinal muscular atrophy
SMN1,Rs76871093,type 2 or 3 spinal muscular atrophy
SMN1,Rs75660264,type 3 spinal muscular atrophy
SMN1,Rs76871093,type 2 or 3 spinal muscular atrophy
SMN1,Rs76871093,spinal muscular atrophy
SMN1,Rs76871093, spinal muscular atrophy
SMN1,Rs77804083,type 2 spinal muscular atrophy
SMN1,Rs104893935,type 1 or 2 spinal muscular atrophy
SMN1,Rs104893932,type 3 spinal muscular atrophy
SMN1,Rs104893922, inherited type 1 spinal muscular atrophy
SMN1,Rs104893932,allele 
SMN1,I5005728,spinal muscular atrophy
SMN1,I5005729,muscular atrophy
SMN1,I5005733,spinal muscular atrophy
SMN1,I5005734,spinal muscular atrophy
SMN1,Rs104893932,rs104893932
SMN1,I5005738,spinal muscular atrophy
SMN1,I5005735,spinal muscular atrophy
SMN1,Rs104893922,utation in the SMN1 gene on chromosome 5.T
SMN1,Rs104893930,recessively inherited type 2 spinal muscular atrophy
SMN1,Rs104893930,spinal muscular atrophy
SMN1,Rs104893932,muscular 
SMN1,Rs104893932,atrophy
SMN1,I5005739,spinal muscular atrophy
SMN2,Rs4916,spinal muscular atrophy (SMA)
SMN2,Rs4916,spinal muscular atrophy
SMPD1,Rs387906289,Niemann-Pick Disease Type A
SMPD1,Rs387906289,Niemann-Pick Disease Type A
SMPD1,I4000381,Niemann-Pick Disease Type
SMPD1,I4000430,Disease 
SMPD1,Rs120074118,Niemann-Pick Disease Type A
SNAP25,Rs3746544,attention-deficit hyperactivity disorder
SNAP25,Rs8636,disorder 
SNAP25,Rs8636,hyperactivity 
SNAP25,Rs3746544,attention-deficit hyperactivity disorder
SNAP25,Rs3746544,ADHD
SNAP25,Rs3746544, major depressive disorder
SNAP25,Rs3746544,ADHD
SNAP25,Rs3746544, ADHD
SNAP25,Rs3746544,schizophrenia
SNAP25,Rs3746544,schizophrenia
SNAP25,Rs8636,attention deficit hyperactivity disorder
SNAP25,Rs3746544,ADHD
SNAP25,Rs3746544,major depressive disorder
SNAP25,Rs3746544,ADHD
SNAP25,Rs3746544, ADHD
SNAP25,Rs3746544,ADHD
SNAP25,Rs362584,personality_traits
SNAP25,Rs362584,neurotic traits
SNAP25,Rs363043,higher intelligence in children
SNAP25,Rs3746544,schizophrenia
SNAP25,Rs362584,neurotic traits
SNAP25,Rs3746544,schizophrenia
SNAP25,Rs3746544,ADHD
SNAP25,Rs3746544,ADHD 
SNAP25,Rs3746544,Korean
SNAP25,Rs3746544, ADHD
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,Parkinson’s disease
SNCA,Rs2736990,SNP 
SNCA,Rs2736990,PD 
SNCA,Rs2736990,PD 
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD 
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,Parkinson
SNCA,Rs2736990,PD 
SNCA,Rs2736990,PD 
SNCA,Rs2736990,PD 
SNCA,Rs2736990,PD 
SNCA,Rs2736990,PD
SNCA,Rs2736990,Parkinson's disease
SNCA,Rs431905511,Parkinson disease
SNCA,Rs431905511,Parkinson disease
SNCA,Rs431905511,autosomal dominant Parkinson disease
SNCA,Rs7684318,The risk allele appears
SNCA,Rs2736990,PD 
SNCA,Rs2736990,PD
SNCA,Rs2736990,SNP 
SNCA,Rs2736990,PD
SNCA,Rs104893875,Parkinson disease
SNCA,Rs104893875,Parkinson 
SNCA,Rs2736990,PD
SNCA,Rs104893875,Parkinson disease
SNCA,Rs104893875,autosomal dominant Parkinson disease
SNCA,Rs104893877,Parkinson's disease
SNCA,Rs104893877,Parkinson's disease
SNCA,Rs104893877,Parkinson disease.
SNCA,Rs104893877,Parkinson's disease
SNCA,Rs104893877,Parkinson's disease
SNCA,Rs104893878,autosomal dominant Parkinson disease
SNCA,Rs104893875,disease
SNCA,Rs2736990,Parkinson’s disease
SNCA,Rs2736990,neurodegenerative disorder characterized by the degradation of dopamine-producing neurons in the substantia nigra
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs104893878,Parkinson disease
SNCA,Rs2736990,PD
SNX10,Rs398123011,osteopetrosis
SNX10,Rs398123011,osteopetrosis
SNX10,Rs398123011,mutation
SNX9,Rs78503206,less chance of thinking cilantro tastes like soap
SNX9,Rs78503206,thinking cilantro tastes like soap
SOAT1,Rs1044925,Guangxi Bai
SOAT1,Rs1044925,Ku Yao
SOAT1,Rs1044925,Han
SOAT1,Rs1044925,Alzheimer's disease
SOAT1,Rs1044925,Alzheimer's disease
SOAT1,Rs1044925,cerebrospinal fluid cholesterol levels
SOAT1,Rs1044925,brain amyloid load
SOAT1,Rs1044925,Alzheimer's disease.
SOAT1,Rs1044925,Alzheimer's disease
SOAT1,Rs1044925,Alzheimer's disease
SOCS1,Rs33977706,SNP 
SOCS1,Rs33977706,obesity
SOCS1,Rs33977706,obesity
SOCS2,Rs11107116,4.7 mm of adult height
SOCS2,Rs11107116,faster growth during infancy
SOD1,Rs1041740,cardiovascular mortality
SOD1,Rs121912438,polymorphism
SOD1,Rs121912441,amyotrophic lateral sclerosis
SOD1,Rs121912442,A polymorphism on the SOD1 gene known as A4V.
SOD1,Rs121912442,polymorphism
SOD2,Rs2758346,Alzheimer's disease
SOD2,Rs2758346,Alzheimer's disease.
SOD2,Rs2855116,late-onset Alzheimer's disease
SOD2,Rs2855116,Alzheimer's disease
SOD3,Rs8192288,COPD.
SOD3,Rs8192288,chronic obstructive pulmonary disease
SOD3,Rs8192288,chronic obstructive pulmonary disease
SOD3,Rs8192287,COPD.
SOD3,Rs8192287,chronic obstructive pulmonary disease
SOD3,Rs8192287,chronic obstructive pulmonary disease
SOD3,Rs1799895,detrimental in pulmonary vascular disease
SOD3,Rs1799895,alveolar lung disease
SOD3,Rs1799895,ischemic heart disease
SOD3,Rs1799895,risk for lung disease
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,Alzheimer's
SORL1,Rs3824968,cerebrovascular and neurodegenerative changes related to Alzheimer disease
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,mild cognitive impairment
SORL1,Rs3824968,progression of mild cognitive impairment to dementia
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,Risk for Late-onset Alzheimer Disease
SORL1,Rs689021,Alzheimer's disease.
SORL1,Rs689021,Alzheimer's disease
SORL1,Rs689021,Down syndrome.
SORL1,Rs689021,Alzheimer's disease
SORL1,Rs689021,Alzheimer's disease
SORL1,Rs689021,Alzheimer's 
SORL1,Rs689021,Alzheimer disease.
SORL1,Rs689021,Alzheimer's disease:
SORL1,Rs689021,Alzheimer's disease
SORL1,Rs3824968,late-onset Alzheimer's disease
SORL1,Rs3824968,cerebral small-vessel disease in hypertensive patients
SORL1,Rs3824968, Alzheimer's disease
SORL1,Rs3824968,Alzheimer's disease 
SORL1,Rs2070045,"SORL1 gene,"
SORL1,Rs11218343,Alzheimer’s disease
SORL1,Rs1699103,Alzheimer's disease
SORL1,Rs3824968,lzheimer's disease in adults with Down syndrome
SORL1,Rs2070045,Alzheimer's disease
SORL1,Rs3824968,Down syndrome
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,Alzheimer's disease in adults with Down syndrome
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,late-onset Alzheimer's disease
SORL1,Rs3824968,Alzheimer's
SORL1,Rs3824968,cerebrovascular and neurodegenerative changes related to Alzheimer disease.
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,mild cognitive impairment
SORL1,Rs3824968,progression of mild cognitive impairment to dementia.
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,Risk for Late-onset Alzheimer Disease in the Chinese Population.
SORL1,Rs3824968,cerebral small-vessel disease in hypertensive patients
SORL1,Rs3824968,Alzheimer's disease
SORT1,Rs17646665,Swedish/Scandinavian
SORT1,Rs17646665,Alzheimer's Disease
SOX5,Rs10842262,non-obstructive azoospermia
SOX5,Rs1464500,schizophrenics
SPINK5,Rs2303064,atopic dermatitis
SPTA1,Rs35948326,autosomal recessive spherocytosis
SPTLC1,Rs119482081,"hereditary sensory neuropathy,"
SPTLC1,Rs119482081,type 1
SPTLC1,Rs119482081,ulcers
SRD5A2,Rs523349,epithelial ovarian cancer
SRD5A2,Rs523349,non-Hispanic
SRD5A2,Rs523349,invasive 
SRD5A2,Rs523349,white 
SRD5A2,Rs523349,ovarian cancer 
SRD5A2,Rs523349,ovarian cancer
SRD5A2,Rs523349,ovarian cancer
SRD5A2,Rs523349,ovarian cancer
SRD5A2,Rs523349,Caucasian 
SRD5A2,Rs523349,ovarian cancer
SRD5A2,Rs523349,invasive epithelial ovarian cancer
SRD5A2,Rs523349,ovarian cancer
SRD5A2,Rs523349,ovarian cancer
SRD5A2,Rs523349,ovarian cancer
SREBF1,Rs11868035,type 2 diabetes
SREBF1,Rs11868035,Parkinson's disease
SREBF1,Rs11868035,schizophrenia
SREBF1,Rs11868035,type-2 diabetes
SREBF1,Rs11868035,type 2 diabetes
SREBF1,Rs11868035,type-2 diabetes
SREBF1,Rs11868035,schizophrenia
SREBF1,Rs2297508,type-2 diabetes
SREBF1,Rs11868035,type-2 diabetes
SREBF1,Rs11868035,Parkinson's disease
SREBF1,Rs11868035,Parkinson's disease
SREBF1,Rs2297508,type-2 diabetes
SRRM2,Rs149019598,Papillary thyroid carcinoma (PTC)
SSUH2,Rs116840776,muscular dystrophy
SSUH2,Rs72546667,muscular dystrophy.
SSUH2,Rs28936685,rippling muscle disease
SSUH2,Rs116840798,skeletal muscle
SSUH2,Rs116840788,CAV3 
SSUH2,Rs116840788,CAV3 
SSUH2,Rs116840785,rippling muscle disease
SSUH2,Rs116840785,rippling muscle disease
SSUH2,Rs116840785,rippling muscle disease
SSUH2,Rs116840785,rippling muscle disease.
SSUH2,Rs116840782,rippling muscle
SSUH2,Rs116840782,muscular dystrophy genes
SSUH2,Rs116840782,novel caveolin-3 mutation
SSUH2,Rs116840782,rippling muscle
SSUH2,Rs116840782,muscular dystrophy
SSUH2,Rs116840776,sudden infant death syndrome.
SSUH2,Rs72546667,hyper-CK-emia
STAR,Rs193922393,Congenital adrenal hyperplasia
STAR,Rs193922393,homozygous frameshift mutation
STAR,Rs193922393,congenital lipoid adrenal hyperplasia
STAT3,Rs7211777,carriers of the AT haplotype
STAT3,Rs6503695,multiple sclerosis 
STAT3,Rs6503695,chronic myeloid leukemia
STAT3,Rs6503695,nonalcoholic fatty liver disease
STAT3,Rs6503695,male 
STAT3,Rs7211777,breast cancer
STAT3,Rs6503695,obesity 
STAT3,Rs6503695,twins
STAT3,Rs6503695,female 
STAT3,Rs6503695,insulin resistance
STAT3,Rs6503695,obesity 
STAT3,Rs6503695,insulin resistance
STAT4,Rs7601754,ystemic lupus erythematosus 
STAT4,Rs7601754,lupus erythematosus
STAT4,Rs7601754,systemic lupus erythematosu
STAT4,Rs7601754,rheumatoid arthritis 
STAT4,Rs8179673,Inflammatory Bowel Diseases
STAT4,Rs7574865,multiple sclerosis
STAT4,Rs7574865,ulcerative colitis
STAT4,Rs7574865,Crohn's disease
STAT4,Rs7601754,rheumatoid arthritis
STAT4,Rs7574865,Scleroderma
STAT4,Rs7601754,Korean population
STAT4,Rs7601754, Hong Kong Chinese
STAT4,Rs7601754,systemic lupus erythematosus
STAT4,Rs7601754,systemic lupus erythematosus
STAT4,Rs7601754,systemic lupus erythematosus
STAT4,Rs7601754,Japanese population
STAT4,Rs7601754,systemic lupus erythematosus
STAT4,Rs7574865,rheumatoid arthritis
STAT4,Rs8179673,rheumatoid arthritis
STAT4,Rs8179673,lupus erythematosus
STAT4,Rs8179673,type 1 diabetes
STAT4,Rs8179673,juvenile idiopathic arthritis
STAT4,Rs8179673,Crohn's disease
STAT4,Rs7601754,severe disease manifestations 
STAT4,Rs7574865,type-1 diabetes
STAT4,Rs11889341,Bowel Diseases
STAT4,Rs7574865,SLE
STAT4,Rs7574865, autoimmune disease
STAT4,Rs10181656,rheumatoid arthritis
STAT4,Rs10181656,type 1 diabetes
STAT4,Rs10181656,systemic lupus erythematosus
STAT4,Rs10181656,Inflammatory Bowel Diseases
STAT4,Rs10181656, type 1 diabetes
STAT4,Rs10181656,rheumatoid arthritis and juvenile idiopathic arthritis
STAT4,Rs10181656,systemic lupus erythematosus
STAT4,Rs10181656,rheumatoid arthritis
STAT4,Rs10181656,colonic Crohn's disease
STAT4,Rs10181656,early disease 
STAT4,Rs10181656,systemic lupus erythematosus (SLE
STAT4,Rs10181656,IgA nephropathy
STAT4,Rs10181656,lupus nephritis
STAT4,Rs11889341,juvenile idiopathic arthritis
STAT4,Rs11889341,rheumatoid arthritis
STAT4,Rs11889341,lupus erythematosus
STAT4,Rs7574865,rheumatoid arthritis
STAT4,Rs7574865,lupus (SLE)
STAT4,Rs11889341,lupus erythematosus
STAT4,Rs11889341,lupus erythematosus
STAT4,Rs11889341,rheumatoid arthritis
STAT4,Rs11889341,polymorphisms
STAT5B,Rs6503691,SNPs
STAT5B,Rs6503691,chronic myeloid leukemia
STAT5B,Rs6503691,cervical cancer
STAT5B,Rs6503691,polymorphisms
STAT5B,Rs6503691,dilated cardiomyopathy
STAT5B,Rs9900213,chronic myeloid leukemia
STOX1,Rs10509305,pre-eclampsia
STOX1,Rs10509305,pregnancy-induced hypertension
SUOX,Rs773125,rheumatoid arthritis
SUOX,Rs773125,rheumatoid arthritis
SUOX,Rs202085145,Sulfocysteinuria
SUOX,Rs121908007,sulfite oxidase deficiency
SUOX,Rs121908009,SULFITE OXIDASE DEFICIENCY
SUOX,Rs121908007,sulfite oxidase deficiency
SUOX,Rs202085145,sulfite oxidase deficiency
SURF1,Rs28933402,Leigh syndrome
SURF1,Rs782316919,Leigh syndrome
SYPL2,Rs62623713,morbidly obese
SYPL2,Rs62623713,morbid obesity
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,psoriasis vulgaris
TAB2,Rs237025,diabetic nephropathy
TAB2,Rs237025,Type I Diabetes 
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,type 2 diabetes 
TAB2,Rs237025,rheumatoid arthritis 
TAB2,Rs237025,juvenile idiopathic arthritis
TAB2,Rs237025,type 1 diabetes
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,I Diabetes Genetics Consortium
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,genome-wide single-nucleotide polymorphisms
TAB2,Rs237025,diabetic nephropathy loci
TAB2,Rs237025,type 2 diabetes
TAB2,Rs237025,Vogt-Koyanagi-Harada (VKH) syndrome
TAB2,Rs237025,ubiquitin-like modifier 4 (SUMO4) polymorphisms
TAB2,Rs237025,rheumatoid arthritis 
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,juvenile idiopathic arthritis
TAB2,Rs237025,rheumatoid arthritis 
TAB2,Rs237025,rheumatoid arthritis 
TAB2,Rs237025,type 1 diabetes
TAB2,Rs237025,juvenile idiopathic arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,diabetic nephropathy
TAB2,Rs237025,type 2 diabetes
TAB2,Rs237025,psoriasis vulgaris
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,type 2 diabetes
TAB2,Rs237025,Type I Diabetes
TAB2,Rs237025,type-1 diabetes
TAB2,Rs237025,type 1 diabetes 
TAB2,Rs237025,rheumatoid arthritis 
TAB2,Rs237025,nile idiopathic arthritis
TAB2,Rs237025,rheumatoid arthritis 
TAB2,Rs237025,diabetic nephropathy 
TAB2,Rs237025,type 2 diabetes
TAB2,Rs237025,psoriasis vulgaris
TAB2,Rs237025,rheumatoid arthritis
TAP2,Rs1800454,systemic lupus erythematosus
TARDBP,Rs80356719,amyotrophic lateral sclerosis
TARDBP,Rs80356719,TARDBP mutations in amyotrophic lateral sclerosis
TARDBP,Rs80356717,familial amyotrophic lateral sclerosis
TARDBP,Rs80356717,mutations in individuals with sporadic
TARDBP,Rs80356715,sporadic and familial amyotrophic lateral sclerosis
TARDBP,Rs80356715,familial and sporadic amyotrophic lateral sclerosis
TARDBP,Rs80356715,sporadic amyotrophic lateral sclerosis
TARDBP,Rs80356715,sporadic amyotrophic lateral sclerosis
TAS1R,Rs307377,Influences taste
TAS1R,Rs307377,tasting ability
TAS1R3,Rs307377,Influences taste
TAS1R3,Rs307377,tasting ability
TBX21,Rs4794067,lupus
TBX21,Rs4794067,risk of intractable Graves' disease
TBX21,Rs4794067,decrease the risk of lupus
TBX21,Rs4794067,aspirin-induced asthma
TBX21,Rs4794067,intractable Graves' disease
TBX21,Rs4794067,2.15 fold higher risk
TBX21,Rs4794067,aspirin-induced asthma
TBX21,Rs16947078,allergic asthma
TBX21,Rs2240017,heterozygotes. These heterozgotes are reported to improve better over time in response to corticosteroid treatment for asthma than the rs2240017(G;G) homozygotes.
TBX21,Rs16947078,Caucasian children
TBX21,Rs11650354,allergic asthma
TBX21,Rs11650354,allergic asthma
TBX21,Rs11650354,allergic asthma
TBX21,Rs11650354,allergic asthma
TBXAS1,Rs4725563,ischemic stroke
TBXAS1,Rs4725563,non-fatal myocardial infarction
TBXAS1,Rs4725563,"eicosanoid genes,"
TCF7L2,Rs7903146,diabetes
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,Type-2 diabetes
TCF7L2,Rs7895340,coronary artery disease 
TCF7L2,Rs7895340,glucose intolerance
TCF7L2,Rs7895340,nephropathy
TCF7L2,Rs7895340,cardiovascular disease
TCF7L2,Rs7895340,colon cancer
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7895340,type 2 diabetes
TCF7L2,Rs7895340,type 2 diabetes
TCF7L2,Rs7895340,coronary artery disease
TCF7L2,Rs7895340,polymorphism
TCF7L2,Rs7895340,polycystic ovary syndrome (PCOS)
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,type 2 diabetes
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7895340,glucose intolerance
TCF7L2,Rs7903146,1.97-fold (CI:1.37 - 2.82) increased odds for type 2 diabetes 
TCF7L2,Rs7903146,association with type 2 diabetes
TCF7L2,Rs7903146,odds ratio of 1.25
TCF7L2,Rs7903146,increased risk of colorectal cancer
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,each risk allele increased type-2 diabetes risk by 1.34x
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,impaired insulin secretion
TCF7L2,Rs7903146,risk for type-2 diabetes
TCF7L2,Rs7903146,associated with type-2 diabetes
TCF7L2,Rs7903146,strongly predicted future type-2 diabetes.
TCF7L2,Rs7903146,risk of Type-2 diabetes
TCF7L2,Rs7903146,type 2 diabetes
TCF7L2,Rs7903146,colorectal cancer
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,type-2 diabetes.
TCF7L2,Rs7895340,polycystic ovary syndrome
TCF7L2,Rs7895340,obese
TCF7L2,Rs7895340,cardiovascular disease
TCF7L2,Rs290487,susceptibility to type 2 diabetes
TCF7L2,Rs290487,type 2 diabetes
TCF7L2,Rs290481,metabolic syndrome
TCF7L2,Rs290481,women
TCF7L2,Rs290481,glucose intolerance
TCF7L2,Rs290481,polycystic ovary syndrome
TCF7L2,Rs290481,Alzheimer disease
TCF7L2,Rs290487,type 2 diabetes
TCF7L2,Rs290481,disease
TCF7L2,Rs290481,Pleiotropic 
TCF7L2,Rs290481,metabolic syndrome
TCF7L2,Rs290481,glucose intolerance
TCF7L2,Rs290481,polycystic ovary syndrome
TCF7L2,Rs290481,late-onset Alzheimer disease
TCF7L2,Rs11196205,type-2 diabetes
TCF7L2,Rs7895340,all-cause mortality
TCF7L2,Rs290481,Alzheimer 
TCF7L2,Rs290487,type 2 diabetes
TCF7L2,Rs10885406,type-2 diabetes
TCF7L2,Rs3814570,Crohn's disease
TCF7L2,Rs7895340,single nucleotide polymorphisms
TCF7L2,Rs7895340,colon cancer
TCF7L2,Rs7895340,reduced acute insulin response
TCF7L2,Rs7895340,gene polymorphisms
TCF7L2,Rs7895340,gene polymorphism
TCF7L2,Rs290487,type 2 diabetes
TCF7L2,Rs7895340,type 2 diabetes
TCF7L2,Rs7895340,nephropathy
TCF7L2,Rs7895340,gene polymorphisms
TCF7L2,Rs7895340,type 2 diabetes
TCF7L2,Rs3814570,PCOS
TCF7L2,Rs3814570,glucose intolerance in women
TCF7L2,Rs3814570,polycystic ovary syndrome (PCOS)
TCF7L2,Rs3814570,ulcerative colitis
TCF7L2,Rs3814570,colonic Crohn's disease
TCF7L2,Rs7895340,impairment of glucose metabolism
TCHH,Rs11803731,variance in hair morphology
TCHH,Rs11803731,facial and scalp hair features
TCN1,Rs526934, lower plasma vitamin B12 levels
TCN1,Rs526934,educe transport of cobalamin
TDP2,Rs9461045,dyslexia
TDP2,Rs9461045,dyslexia A
TDP2,Rs3212236,developmental dyslexia
TDP2,Rs3212236,developmental dyslexia
TDP2,Rs2143340,dyslexic
TDP2,Rs2143340,dyslexia
TDP2,Rs2143340,poor reading performance
TDP2,Rs2143340,dyslexia
TECTA,Rs28939690,deafness
TECTA,Rs28939690,deafness
TECTA,Rs28939691,deafness
TECTA,Rs28939691,deafness
TEK,Rs80338909,inherited venous malformations
TEK,Rs80338909,Multiple cutaneous and mucosal venous malformations
TEK,Rs80338909,Multiple cutaneous and mucosal venous malformations
TEK,Rs80338909,venous malformations.
TEK,Rs80338909,cutaneous and mucosal venous malformations.
TEK,Rs80338908,venous malformations
TEK,Rs80338908,cutaneous and mucosal venous malformations
TEK,Rs80338908,venous malformations
TEK,Rs80338908,Vascular dysmorphogenesis
TEK,Rs80338908,Multiple cutaneous and mucosal venous malformations
TEK,Rs387906745,Multiple cutaneous and mucosal venous malformations.
TEK,Rs80338908,Vascular dysmorphogenesis
TENM2,Rs2937573,Sensitivity to the Sound of Chewing (Misophonia)
TENM2,Rs2937573,Misophonia
TENM2,Rs2937573,Sensitivity to the Sound of Chewing
TENM2,Rs2937573,Misophonia
TERC,Rs12696304,ancer
TERC,Rs12696304,cancer
TERC,Rs12696304,heart disease
TERC,Rs12696304,European 
TERC,Rs12696304,heart disease
TERC,Rs12696304,some forms of cancer
TERC,Rs12696304,mean leukocyte telomere
TERC,Rs12696304,reduced longevity
TERC,Rs12696304,heart disease
TERC,Rs12696304,premature aging
TERC,Rs12696304,age-associated diseases
TERT,Rs2736100,cancer
TERT,Rs2736100,cancer
TERT,Rs2736100,lung adenocarcinoma
TERT,Rs2736100,ovarian cancer risk
TERT,Rs2736100,cervical cancer
TERT,Rs2736100,glioma
TERT,Rs2736100,bladder cancer risk
TERT,Rs2736100,lung cancer
TERT,Rs2736100,glioma
TERT,Rs2736100,serous ovarian cancer
TERT,Rs2736100, lung cancer
TERT,Rs2736100,lung adenocarcinoma
TERT,Rs2736098,European
TERT,Rs2736098,Asians
TERT,Rs2736100,Glioma
TERT,Rs2736098,pancreatic cancer
TERT,Rs2736100,risk of lung adenocarcinoma
TERT,Rs2736100,high-grade glioma
TERT,Rs2736100,lung cancer
TERT,Rs2736100,Lung cancer susceptibility
TF,Rs1049296,Alzheimer's disease
TF,Rs1049296,Alzheimer's
TF,Rs1799852,deficiency anaemia risk
TF,Rs1799899,iron deficiency anemia
TF,Rs1799899,anemia in menstruating white women.
TFR2,Rs80338881,hemochromatosis
TFR2,Rs80338891,severe iron overload
TFR2,Rs80338891,Hemochromatosis
TFR2,Rs80338881,pathogenic mutations
TFR2,Rs80338881,adult hemochromatosis
TFR2,Rs80338881,hemochromatosis genes
TFR2,Rs80338881,pathogenic mutations of adult hemochromatosis
TFR2,Rs80338881,Juvenile hemochromatosis
TFR2,Rs80338881,pathogenic mutations of adult hemochromatosis genes
TFR2,Rs80338881,Juvenile hemochromatosis
TFR2,Rs80338881,Juvenile hemochromatosis
TGFB1,Rs4803455,high myopia
TGFB1,Rs1800469,breast cancer
TGFB1,Rs1800469,COPD
TGFB1,Rs1800469,smoking is the main risk factor
TGFB1,Rs1800469,chronic obstructive pulmonary disease (COPD)
TGFB1,Rs1800469,women
TGFB1,Rs1800469,poor cosmetic
TGFB1,Rs4803455,high myopia
TGFB1,Rs1800469,breast cancer
TGFB1,Rs1800469,women
TGFB1,Rs1800469,Caucasian
TGFB1,Rs1800469,COPD
TGFB1,Rs1800469,smokers
TGFB1,Rs1800469,smoking
TGFB1,Rs1800469,chronic obstructive pulmonary disease (COPD)
TGFB1,Rs1800469,radiation-induced fibrosis (scarring)
TH,Rs6356,schizophrenia
TH,Rs6356,schizophrenia
TH,Rs6356,Dopaminergic pathway gene polymorphisms
TH,Rs6356,Type I Diabetes
TH,Rs6356,type I diabetes
TH,Rs6356,single nucleotide polymorphisms
TH,Rs6356,essential hypertension
TH,Rs3842727,suicidal behavior
TH,Rs10840491,schizophrenia.
TH,Rs10840491,schizophrenia
TH,Rs10840491,polymorphism
TH,Rs10840491,lack of association
TH,Rs10840491,schizophrenia
TH,Rs6356,cardiovascular risk
THSD1,Rs9536062,non-immune hydrops fetalis
TIMP2,Rs8179090,Polymorphisms 
TIMP2,Rs8179090,thoracic adolescent idiopathic scoliosis
TIMP2,Rs8179090,breast cancer
TIMP2,Rs8179090,thoracic adolescent idiopathic scoliosis
TIMP2,Rs8179090,polymorphism 
TIMP2,Rs8179090,thoracic adolescent idiopathic scoliosis.
TIMP2,Rs8179090,Polymorphisms
TIMP2,Rs8179090,breast cancer
TIMP2,Rs8179090,polymorphism
TIMP2,Rs8179090, breast cancer
TIPARP,Rs2665390,ovarian cancer
TIPARP,Rs2665390,ovarian cancer
TIPARP,Rs7651446,epithelial ovarian cancer
TLR1,Rs5743551,gram-positive infection in sepsis
TLR1,Rs5743592,eastern India
TLR1,Rs5743551, sepsis-related
TLR2,Rs3804100, diabetes 
TLR2,Rs3804100,allergic asthma
TLR2,Rs3804100,Asthma
TLR2,Rs3804100,type-1 diabetes
TLR2,Rs3804100,allergic asthma
TLR3,Rs5743305,Toll-like receptor signaling pathway
TLR3,Rs5743305,cancer risk
TLR3,Rs5743305,polymorphisms
TLR3,Rs5743305,Toll-like receptor signaling pathway
TLR3,Rs1879026,measles vaccine
TLR3,Rs5743305,prostate cancer
TLR4,Rs11536889,oxidative stress genes
TLR4,Rs11536889,asthma
TLR4,Rs11536889,prostate cancer risk
TLR4,Rs11536889,gastric atrophy
TLR4,Rs11536889,hepatitis B
TLR4,Rs11536889,neutropenia
TLR4,Rs11536889,leukemia
TLR4,Rs11536889,prostate cancer
TLR4,Rs1927911,nonfatal myocardial infarction
TLR4,Rs1927911,hypertensive men/women
TLR4,Rs1927911,nonfatal myocardial infarction
TLR4,Rs1927911,postmenopausal women
TLR4,Rs1927911,hypertensive men/women
TLR4,Rs1927911,nonfatal myocardial infarction
TLR4,Rs1927911,postmenopausal women
TLR4,Rs1927911,hypertensive men/women
TLR4,Rs1927911,postmenopausal women
TLR4,Rs11536889,liver fibrosis
TLR4,Rs11536889,chronic hepatitis 
TLR4,Rs11536889,autoimmune pancreatitis
TLR4,Rs11536889,leukemia
TLR4,Rs11536889,prostate cancer
TLR4,Rs11536889,myocardial infarction
TLR4,Rs11536889,chemic stroke
TLR4,Rs11536889,autoimmune pancreatitis
TLR4,Rs11536889,prostate cancer
TLR4,Rs11536889,liver fibrosis
TLR4,Rs11536889,prostate cancer
TLR4,Rs11536889,chronic hepatitis C
TLR4,Rs11536889,prostate cancer
TLR4,Rs11536889,severe gastric atrophy
TLR4,Rs11536889,hepatitis B
TLR4,Rs11536889,leukemia
TLR4,Rs11536889,prostate cancer
TLR4,Rs11536889,myocardial infarction
TLR4,Rs11536889,ischemic stroke
TLR4,Rs11536889,asthma
TLR6,Rs5743815,Non-Hodgkin Lymphoma
TLR6,Rs5743809,Kawasaki disease
TLR6,Rs5743815,TLR6 gene
TLR6,Rs5743809,causative
TLR6,Rs5743809,Kawasaki disease
TMC1,Rs1796993,autosomal recessive hearing impairment.
TMEM43,Rs113449357,cardiomyopathy
TMEM43,Rs63750743,"Carrying a single rs63750743(T) allele is reported to lead, sooner or later, to arrhythmogenic right ventricular dysplasia type 5"
TMIE,Rs28942097,deafness
TMIE,Rs28942096,deafness
TMIE,Rs28942097,deafness
TMIE,Rs28941781,deafness
TMIE,Rs28941781,deafness
TMIE,Rs28942096,deafness
TMPRSS3,Rs28939084,deafness
TMPRSS3,Rs28939084,deafness
TNF,Rs3093664,asthma
TNF,Rs3093664,allergy
TNF,Rs3093664,prostate cancer
TNF,Rs3093664,rheumatoid arthritis
TNF,Rs3093664, type 1 diabetes
TNF,Rs3093664,polymorphisms
TNF,Rs3093664,lymphotoxin-alpha
TNF,Rs3093664,tumor necrosis factor
TNF,Rs3093664,polymorphisms
TNF,Rs3093664,female reproductive disorders
TNF,Rs3093664,traffic-related air pollution
TNF,Rs3093664,tumor necrosis factor
TNF,Rs3093662,ict rheumatoid arthritis using random forests. Leprosy and the adaptation of human toll-like receptor 1. Evaluatio
TNF,Rs3093662,d severe malaria in African populations. Association of MICA with rheumatoid arthritis independent of known HLA-DRB1 risk alleles in a family-based and a case control study. Toll-lik
TNF,Rs3093662,morphisms and female reproductive disorders: part II--endometriosis. Distinct genetic loci control plasma HIV-RNA and cellula
TNF,Rs1800630,SLE
TNF,Rs1800630,SLE 
TNF,Rs1800630,systemic lupus erythematosus (SLE)
TNF,Rs1800630, Raynaud's phenomenon
TNF,Rs3093664,allergic disease
TNFAIP3,Rs2230926,Systemic lupus erythematosus (SLE)
TNFAIP3,Rs2230926,systemic lupus erythematosus (SLE)
TNFAIP3,Rs2230926,Sjogren's Syndrome-associated Non-Hodgkin Lymphoma
TNFAIP3,Rs5029939,Systemic lupus erythematosus
TNFAIP3,Rs582757,tumor
TNFAIP3,Rs582757,celiac disease
TNFAIP3,Rs582757,autoimmune diseases
TNFAIP3,Rs582757,systemic lupus erythematosus
TNFAIP3,Rs582757,rheumatoid arthritis
TNFAIP3,Rs2230926,rheumatoid arthritis
TNFAIP3,Rs582757,systemic sclerosis
TNFAIP3,Rs582757,psoriasis
TNFAIP3,Rs2230926,psoriasis
TNFAIP3,Rs2230926,lupus nephritis
TNFAIP3,Rs2230926,systemic lupus erythematosus
TNFAIP3,Rs2230926,autoimmune rheumatic conditions
TNFAIP3,Rs2230926,hematologic manifestations
TNFAIP3,Rs2230926,psoriasis
TNFAIP3,Rs2230926,Sjögren's syndrome
TNFAIP3,Rs2230926,systemic lupus erythematosus
TNFAIP3,Rs2230926,Non-Hodgkin Lymphoma
TNFAIP3,Rs2230926,Sjogren's Syndrome
TNFAIP3,Rs2230926, Synd
TNFAIP3,Rs2230926,systemic lupus erythematosus (SLE)
TNFAIP3,Rs2230926,Systemic lupus erythematosus (SLE)
TNFAIP3,Rs2230926,rheumatoid arthritis
TNFAIP3,Rs2230926,autoimmune diseases
TNFRSF1A,Rs4149584,odds
TNFRSF1A,Rs4149584,s f
TNFRSF1A,Rs4149584, two SN
TNFRSF1A,Rs4149584,"gene that each (independently) increase risk for multiple sclerosis,"
TNFRSF1A,Rs4149579,tumor necrosis
TNFRSF1A,Rs4149577,ankylosing spondylitis
TNFRSF1A,Rs104895217,dominantly inherited autoinflammatory syndromes
TNFRSF1A,Rs4149579,tumor necrosis
TNFSF15,Rs6478109,Strategies and issues in the detection of pathway enrichment in genome-wide association studies.
TNFSF15,Rs6478109,associated with spondyloarthritis
TNFSF15,Rs6478109,irritable bowel syndrome
TNMD,Rs1155974,T2D
TNMD,Rs1155974,plasma glucose levels
TNNI3,Rs104894729,"familial restrictive cardiomyopathy, type 1"
TNNI3,Rs104894729,familial hypertrophic cardiomyopathy (HCM)
TNNI3,Rs121917761,familial restrictive cardiomyopathy
TNNI3,Rs267607127, familial hypertrophic cardiomyopathy
TNNI3,Rs267607127,hypertrophic 
TNNI3,Rs267607127,cardiomyopathy
TNNI3,Rs267607127,mutation 
TNNI3,Rs397516347,sudden cardiac death patient
TNNI3,Rs397516347,pathogenic/likely pathogenic
TNNI3,Rs397516347,familial hypertrophic cardiomyopathy
TNNI3,Rs104894729, familial hypertrophic cardiomyopathy (HCM)
TNNI3,Rs397516347,hypertrophic cardiomyopathy
TNNI3,Rs397516347,HCM
TNNI3,Rs397516347,sudden cardiac death
TNNI3,Rs397516347,hypertrophic cardiomyopathy
TNNI3,Rs397516347,familial hypertrophic cardiomyopathy
TNNI3,Rs104894729,"familial restrictive cardiomyopathy, type 1"
TNNI3,Rs104894727,familial hypertrophic cardiomyopathy
TNNI3,Rs104894728,cardiomyopathy
TNNI3,I5007729,familial hypertrophic cardiomyopathy
TNNI3,I5007729,hypertrophic cardiomyopathy
TNNI3,I5007733,familial restrictive cardiomyopathy
TNNI3,I5007733,"familial restrictive cardiomyopathy, type 1"
TNNI3,I5007735,restrictive cardiomyopathy
TNNI3,Rs104894728,familial hypertrophic cardiomyopathy
TNNI3,I5048706,dilated cardiomyopathy
TNNI3,I5007736,dilated cardiomyopathy
TNNI3,Rs104894724,amilial hypertrophic cardiomyopathy
TNNI3,Rs104894724,familial retrictive cardiomyopathy
TNNI3,Rs104894724,familial hypertrophic cardiomyopathy (HCM)
TNNI3,Rs104894727,TNNI3 gene
TNNI3,Rs104894727,"hypertrophic cardiomyopathy,"
TNNI3,Rs104894728,hypertrophic 
TNNI3,Rs104894724,724(T) allele is reported to lead to familial retrictive cardiomyopathy
TNXB,Rs12198173,HIV-1 infection
TNXB,Rs12198173,HIV-1 infection
TNXB,Rs12198173,HIV-DNA
TNXB,Rs12198173,HIV-RNA
TNXB,Rs12198173,Distinct genetic loci
TNXB,Rs12198173,HIV-DNA levels
TOMM40,Rs2075650,associated with the rarer rs2075650(G) allele
TOMM40,Rs2075650,Alzheimer's disease
TOMM40,Rs157580,late-onset Alzheimer's disease
TOMM40,Rs157580,late-onset Alzheimer's disease
TOMM40,Rs157580,Alzheimer's disease
TOMM40,Rs157580,Alzheimer's disease
TOMM40,Rs157580,carotid artery disease
TOMM40,Rs157580,late-onset Alzheimer's disease 
TOMM40,Rs157580,metabolic-syndrome
TOMM40,Rs157580,bstructive sleep apnea in children.
TOMM40,Rs157580,late-onset Alzheimer's disease
TOMM40,Rs157580,Alzheimer's disease
TOMM40,Rs10524523,Alzheimer's disease
TOMM40,Rs157580,Hippocampal atrophy
TOR1A,Rs2296793,SNP
TOR1A,Rs80358233,autosomal dominant torsion dystonia
TOR1A,Rs80358233,Ashkenazi Jews
TOR1A,Rs80358233,torsion dystonia
TOR1A,Rs2296793,torsion dystonia.
TOR1A,Rs2296793,torsion dystonia
TOR1A,Rs2296793,dystonia
TOR1A,Rs13283584,sex
TOR1A,Rs1801968,torsion dystonia
TOR1A,Rs13283584,dystonia
TOR1A,Rs13283584,age
TOR1A,I4000446,deltaE302
TOR1A,I4000446,torsion dystonia
TOR1A,Rs1801968,developing torsion dystonia
TPD52,Rs1042638,leucine 
TPD52,Rs1042638,breast 
TPD52,Rs1042638,cancer
TPD52,Rs1042638,breast cancer.
TPH1,Rs1799913,Tryptophan hydroxylase gene 1
TPH1,Rs211105,Polymorphism
TPH1,Rs211105,schizophrenia
TPH1,Rs1800532,schizophrenia
TPH1,Rs1800532,related to schizophrenia
TPH1,Rs1799913,heroin addiction
TPH1,Rs1800532,schizophrenia
TPH1,Rs1799913,cerebrospinal fluid 5-hydroxyindole acetic acid
TPH1,Rs1799913,heroin addiction
TPH1,Rs1799913,heroin addiction
TPH1,Rs1799913,homovanillic acid concentrations
TPH1,Rs1799913,Tryptophan hydroxylase gene 1 (TPH1)
TPH1,Rs1799913,neuroleptics:
TPH2,Rs1386494, Malaysians
TPH2,Rs1386494,schizophrenic patients
TPH2,Rs1386494,low occurrence of suicidality 
TPH2,Rs1386494, panic disorder
TPH2,Rs1386494,gender-specific effect
TPH2,Rs1386494,female
TPH2,Rs1487276,bipolar affective disorder
TPH2,Rs1487276,suicide attempts.
TPH2,Rs1386494,schizophrenia in Asian populations
TPH2,Rs4290270,heroin addiction
TPH2,Rs4565946,early-onset
TPH2,Rs4565946,obsessive compulsive disorder
TPH2,Rs4565946,Tourette's Syndrome
TPH2,Rs7305115,susceptibility to suicide.
TPH2,Rs7954758,bipolar I disorder
TPH2,Rs1487276,tryptophan hydroxylase II
TPH2,Rs1843809,attention-deficit/hyperactivity disorder
TPH2,Rs1386494,alcohol-related suicide behavior
TPH2,Rs1386494,alcohol-dependent patients
TPH2,Rs1007023,bipolar affective disorder
TPH2,Rs1007023,suicide attempts.
TPH2,Rs1007023,tryptophan hydroxylase II
TPH2,Rs120074176,Norwegian female
TPH2,Rs120074176,ADHD
TPH2,Rs1386494, Caucasian populations
TPH2,Rs1386494,mental health disorders
TPH2,Rs120074176,major depression.
TPH2,Rs1386494,psychiatric disorders
TPH2,Rs1386494, major depression
TPH2,Rs1386494, Caucasian patients
TPH2,Rs1386494,Finnish population 
TPH2,Rs1386494,major depression
TPH2,Rs1386494,suicide attempts
TPH2,Rs1386494,completed suicide
TPH2,Rs1386494,"suicidality, alcoholism and depression."
TPM1,Rs104894505,alpha-tropomyosin
TPM1,Rs104894505,dilated cardiomyopathy.
TPM1,Rs104894505,Mutations
TPM1,Rs104894505,dilated cardiomyopathy.
TPP1,Rs56144125,CLN2 disease (neuronal ceroid lipofuscinosis)
TPP1,Rs28940573,neuronal ceroid lipofuscinosis
TRAF1,Rs10818488,rheumatoid arthritis
TRAF1,Rs10818488,rheumatoid arthritis
TRAF1,Rs10818488,rheumatoid factor-negative polyarthritis
TRAF1,Rs10818488,juvenile idiopathic arthritis
TRAF1,Rs1930780,polymorphism that increases susceptibility to Rheumatoid Arthritis
TRAF1,Rs1930780,Rheumatoid Arthritis
TREM2,Rs75932628,poorer cognitive function
TREM2,Rs75932628,Alzheimer's 
TREM2,Rs75932628,Alzheimer's 
TREM2,Rs75932628,European 
TREM2,Rs75932628,AD 
TREM2,Rs75932628,Alzheimer's disease
TREM2,Rs75932628,Caucasian 
TREM2,Rs75932628,Alzheimer
TREM2,Rs75932628,frontotemporal dementia–like syndrome
TREM2,Rs75932628,AD 
TREM2,Rs75932628,Japanese 
TREM2,Rs75932628,Alzheimer 
TREM2,Rs75932628,AD 
TREM2,Rs75932628,late-onset AD
TREM2,Rs75932628,Alzheimer's disease
TREM2,Rs75932628,increased AD risk
TREM2,Rs75932628,Alzheimer cases
TREM2,Rs75932628,frontotemporal dementia–like syndrome
TREM2,Rs75932628,Alzheimer's disease 
TREM2,Rs75932628,Alzheimer's disease
TREM2,Rs75932628,poorer cognitive function
TREM2,Rs75932628,Alzheimer's disease
TREM2,Rs143332484,immune system
TREM2,Rs143332484,Alzheimer's disease
TREM2,Rs75932628,Alzheimer's disease
TRPC6,Rs121434392,Focal segmental glomerulosclerosis
TRPC6,Rs121434392,Focal segmental glomerulosclerosis
TRPC6,Rs121434391,segmental glomerulosclerosis
TRPC6,Rs121434394,Focal segmental glomerulosclerosis
TRPC6,Rs121434391,Focal segmental glomerulosclerosis
TRPC6,Rs121434393,Focal segmental glomerulosclerosis
TRPC6,Rs121434391,Focal segmental glomerulosclerosis
TRPC6,Rs121434390,segmental glomerulosclerosis
TRPC6,I6019089,Focal segmental glomerulosclerosis
TRPC6,I6019082,Focal segmental glomerulosclerosis
TRPC6,I6019080,Focal segmental glomerulosclerosis
TRPC6,I5005222,Focal segmental glomerulosclerosis
TRPC6,I5005220,Focal segmental glomerulosclerosis
TRPC6,I5005218,Focal segmental glomerulosclerosis
TRPM4,Rs387907216,progressive familial heart block type 1B
TRPM4,Rs267607142,familial heart block type 1B
TRPM4,Rs200038418,progressive familial heart block type 1B
TRPM4,Rs172151858,progressive familial heart block type 1B
TRPM4,Rs172149856,progressive familial heart block type 1B
TRPM4,Rs200038418,progressive familial heart block
TRPM8,Rs10166942,migraines
TRPV1,Rs222747,Meniere's disease
TRPV1,Rs222747,Meniere's disease
TSHR,Rs12101255,Graves' disease
TSHR,Rs4704397,A separate study of 970 pregnant women at 28 weeks of gestation found that serum TSH was highest for rs4704397
TSLP,Rs1837253,reduce the risk of developing late-onset (adult) asthma
TSLP,Rs1837253,certain types of asthma
TSLP,Rs1837253,asthma
TSLP,Rs1837253,inflammation of cells in the trachea and alveoli
TSLP,Rs1837253,asthma
TTC12,Rs10502172,associated with smoking during adolescence
TTC26,Rs13225917,"e gene prevented normal development of photoreceptor sensory and other cilia. The protein is necessary for assembly of full length cilia, although the effect (if any) of rs13225917 on its functioning has not been determined. One publication speculates that this protein may play a role in Inherited Retinal Degeneration and so screening for TTC26 mutations in human ciliopathy|ciliopathies could be warranted, but to date there is no evidence supporting rs13225917 as a mutation of any consequence. TTC26/DYF13 is an intraflagellar transport protein required for transport of motility-related proteins into flagella. Knockdown of ttc26 disrupts ciliogenesis of the photoreceptor cells and the pronephros in zebrafish. The tetratricopeptide repeat: a structural motif mediating protein-protein interactions."
TTC26,Rs13225917,"ozygous A-allele carriers exist in HapMap, OpenSNP or 1000 "
TTC29,Rs76715876,male infertility
TTC29,Rs763399136,Asthenozoospermia
TTC29,Rs766352190,"Axonemal Protein,"
TTC29,Rs766352190,Asthenozoospermia
TTC29,Rs76715876,Asthenozoospermia and Male Infertility.
TTC6,Rs1998359,Allergies
TTC6,Rs1998359,Allergies
TTN,Rs1060500435,dilated cardiomyopathy
TTN,Rs1060500435,very early-onset atrial fibrillation
TTR,Rs76992529,risk of developing cardiac amyloidosis
TTR,Rs76992529,heart failure
TTR,Rs267607161,transthyretin familial amyloid polyneuropathy
TTR,Rs76992529,neuronal ceroid lipofuscinosis
TTR,Rs1800458,Alzheimer
TTR,Rs76992529,cardiomyopathy
TTR,Rs76992529,amyloidosis
TTR,Rs76992529,hereditary amyloidoses
TTR,Rs76992529,Cardiac amyloidosis
TTR,Rs1800458,schizophrenia
TTR,Rs121918070,heart-related symptoms
TTR,Rs121918070,familial amyloid polyneuropathy
TTR,I3002758,myloid PolyneuropathyFamilial
TTR,I3002758,amyloid polyneuropathies
TTR,I3002759,cardiac amyloidosisrs
TTR,I5004213,myloid PolyneuropathyFamilial
TTR,I3002759,cardiac amyloidosis
TTR,I6019130,cardiac amyloidosis
TTR,I6019130,cardiac amyloidosisrs
TTR,Rs121918070,TTR-related familial amyloid polyneuropathy
TTR,Rs121918070,heart-related symptoms
TTR,I5004213,amyloid polyneuropathies
TUBB8,Rs869025609,Human Oocyte Meiotic Arrest
TUBB8,Rs869025612,Human Oocyte Meiotic Arrest
TUBB8,Rs869025612,Mutations in TUBB8
TUBB8,Rs869025610,Human Oocyte Meiotic Arrest
TUBB8,Rs869025610,Mutations in TUBB8
TUBB8,Rs869025609,Mutations in TUBB8
TUBB8,Rs869025611,Human Oocyte Meiotic Arrest
TUBB8,Rs869025273,Human Oocyte Meiotic Arrest
TUBB8,Rs869025272,Human Oocyte Meiotic Arrest
TUBB8,Rs869025272,Mutations in TUBB8
TUBB8,Rs869025271,Human Oocyte Meiotic Arrest
TUBB8,Rs869025271,Mutations
TUBB8,Rs869025273,R2K Mutations in TUBB8 
TXNRD1,Rs4630362,sporadic amyotrophic lateral sclerosis
TXNRD1,Rs4630362,familial
TXNRD1,Rs4630362,sporadic amyotrophic lateral sclerosis
TXNRD1,Rs4630362,familial amyotrophic lateral sclerosis
TXNRD1,Rs4630362,amyotrophic lateral sclerosis
TXNRD1,Rs10861192,sporadic amyotrophic lateral sclerosis (ALS).
TXNRD1,Rs10861192,familial amyotrophic lateral sclerosis (FALS)
TXNRD1,Rs4630362,amyotrophic lateral sclerosis (ALS)
TXNRD1,Rs4630362,amyotrophic lateral sclerosis (FALS)
TXNRD2,Rs4485648,gastric cancer.
TXNRD2,Rs4485648,Polymorphisms
TXNRD2,Rs4485648,gastric cancer
TYK2,Rs12720356,chronic hepatitis C
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs2304256,myeloid leukemia
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs2304256,discoid and subacute cutaneous lupus erythematosus
TYK2,Rs12720356,systemic lupus erythematosus
TYK2,Rs2304256,SLE
TYK2,Rs2304256,acute myeloid leukemia
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs2304256,sclerosis 
TYK2,Rs2304256,lupus erythematosus
TYK2,Rs12720356,susceptibility to Crohn's disease
TYK2,Rs2304256,SLE 
TYK2,Rs12720356, Crohn Disease
TYK2,Rs12720270,systemic lupus erythematosus
TYK2,Rs12720356,systemic lupus erythematosus
TYK2,Rs12720270,systemic lupus erythematosus
TYK2,Rs12720356,de novo acute myeloid leukemia
TYK2,Rs12720270,Japanese
TYK2,Rs12720270,systemic lupus erythematosus
TYK2,Rs12720270,systemic lupus erythematosus
TYK2,Rs12720356,de novo acute myeloid leukemia
TYK2,Rs12720356,Crohn Disease
TYK2,Rs12720270,SLE
TYK2,Rs12720356,hepatitis C
TYK2,Rs12720356,cirrhosis
TYK2,Rs12720356,Irish
TYK2,Rs12720356,multiple sclerosis
TYK2,Rs12720356,Crohn's disease
TYK2,Rs12720356,Japanese population
TYK2,Rs12720356,chronic hepatitis C virus infection
TYMS,Rs502396,endometrial cancer
TYMS,Rs502396,renal cancer
TYR,Rs1393350,risk of skin cancer in Caucasians.
TYR,Rs1393350,hair color and skin pigmentation
TYR,Rs1393350,Skin sensitivity to sun
TYR,Rs1393350,Blue rather than green eyes
TYR,Rs1393350,Blond rather than brown
TYR,Rs1393350,Blond
TYR,Rs1393350,skin cancer
TYR,Rs1393350,brown 
TYR,Rs1042602,absence of freckles
TYR,Rs1393350,human eye color
TYR,Rs1393350,Caucasians
TYR,Rs1847134,eye color
TYRP1,Rs387907171,dark-skinned
TYRP1,Rs387907171,blond hair
TYRP1,Rs387907171,Melanesians
TYRP1,Rs387907171,blond hair
TYRP1,Rs2733832,skin pigmentation
TYRP1,Rs387907171,dark-skinned
UBA5,Rs540839115,recessive spinocerebellar
UBA5,Rs114925667,pathogenic
UBA5,Rs114925667,early infantile epileptic encephalopathy
UBA5,Rs114925667,early infantile epileptic encephalopathy-44
UGT1A1,Rs887829,coronary artery disease..
UGT1A1,Rs887829,coronary artery disease
UGT1A1,Rs887829,coronary artery disease
UGT1A1,Rs887829,higher levels of serum bilirubin
UGT1A1,Rs887829,coronary artery disease
UGT1A1,Rs6742078,ARDS
UGT1A1,Rs6742078,prostate cancer
UGT1A1,Rs6742078,mortality
UGT1A1,Rs6742078,sepsis
UGT1A1,Rs6742078,Serum bilirubin levels
UGT1A1,Rs6742078,prostate cancer
UGT1A1,Rs4148325,prostate 
UGT1A1,Rs4148325,cancer
UGT1A1,Rs4148325,metabolizing 
UGT1A1,Rs4148325,Xenobiotic 
UGT1A1,Rs3755319,hyperbilirubinemia
UGT1A1,Rs6742078,ARDS
UGT1A10,Rs4124874,colorectal cancers
UGT1A10,Rs4124874,breast cancer
UGT1A10,Rs4124874,benzene poisoning
UGT1A10,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A10,Rs4148325,prostate 
UGT1A10,Rs4148325,metabolizing 
UGT1A10,Rs4148325,cancer
UGT1A10,Rs4124874,increased Bilirubin
UGT1A10,Rs4148325,Xenobiotic 
UGT1A10,Rs4124874,Gilbert's syndrome
UGT1A10,Rs4124874,Gilbert's syndrome
UGT1A10,Rs4124874,ARDS
UGT1A10,Rs4124874,colorectal cancer
UGT1A10,Rs4124874,chronic benzene poisoning
UGT1A10,Rs4124874,breast cancer
UGT1A10,Rs4124874,Bilirubin
UGT1A10,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A10,Rs3755319,hyperbilirubinemia
UGT1A10,Rs11892031,urinary bladder cancer
UGT1A10,Rs11692021,Clinically relevant UGT1A10 variant
UGT1A10,Rs4124874,sepsis
UGT1A3,Rs4148325,Xenobiotic 
UGT1A3,Rs4148325,metabolizing 
UGT1A3,Rs4148325,cancer
UGT1A3,Rs4148325,prostate 
UGT1A3,Rs6742078,prostate cancer
UGT1A3,Rs6742078,sepsis
UGT1A3,Rs6742078,ARDS
UGT1A3,Rs6742078,mortality
UGT1A3,Rs4124874,Gilbert's syndrome
UGT1A3,Rs6742078,prostate cancer
UGT1A3,Rs6742078,ARDS
UGT1A3,Rs6742078,Serum bilirubin levels
UGT1A3,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A3,Rs4124874,breast cancer
UGT1A3,Rs4124874,benzene poisoning
UGT1A3,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A3,Rs3755319,hyperbilirubinemia
UGT1A3,Rs4124874,colorectal cancers
UGT1A3,Rs4124874,breast cancer
UGT1A3,Rs4124874,chronic benzene poisoning
UGT1A3,Rs4124874,Bilirubin
UGT1A3,Rs4124874,ARDS
UGT1A3,Rs4124874,sepsis
UGT1A3,Rs4124874,Gilbert's syndrome
UGT1A3,Rs4124874,increased Bilirubin
UGT1A3,Rs4124874,colorectal cancer
UGT1A4,Rs4148325,Xenobiotic 
UGT1A4,Rs4148325,metabolizing 
UGT1A4,Rs4148325,prostate 
UGT1A4,Rs4148325,cancer
UGT1A4,Rs6742078,prostate cancer
UGT1A4,Rs6742078,prostate cancer
UGT1A4,Rs6742078,ARDS
UGT1A4,Rs6742078,mortality
UGT1A4,Rs6742078,sepsis
UGT1A4,Rs6742078,ARDS
UGT1A4,Rs4124874,Gilbert's syndrome
UGT1A4,Rs6742078,Serum bilirubin levels
UGT1A4,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A4,Rs4124874,colorectal cancers
UGT1A4,Rs4124874,benzene poisoning
UGT1A4,Rs3755319,hyperbilirubinemia
UGT1A4,Rs4124874,Bilirubin
UGT1A4,Rs4124874,breast cancer
UGT1A4,Rs4124874,chronic benzene poisoning
UGT1A4,Rs4124874,colorectal cancer
UGT1A4,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A4,Rs4124874,sepsis
UGT1A4,Rs4124874,Gilbert's syndrome
UGT1A4,Rs4124874,increased Bilirubin
UGT1A4,Rs4124874,breast cancer
UGT1A4,Rs4124874,ARDS
UGT1A5,Rs4148325,metabolizing 
UGT1A5,Rs4148325,cancer
UGT1A5,Rs4148325,prostate 
UGT1A5,Rs6742078,prostate cancer
UGT1A5,Rs6742078,Serum bilirubin levels
UGT1A5,Rs6742078,mortality
UGT1A5,Rs6742078,sepsis
UGT1A5,Rs6742078,prostate cancer
UGT1A5,Rs6742078,ARDS
UGT1A5,Rs4148325,Xenobiotic 
UGT1A5,Rs6742078,ARDS
UGT1A5,Rs4124874,Gilbert's syndrome
UGT1A5,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A5,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A5,Rs4124874,colorectal cancers
UGT1A5,Rs3755319,hyperbilirubinemia
UGT1A5,Rs4124874,Bilirubin
UGT1A5,Rs4124874,breast cancer
UGT1A5,Rs4124874,colorectal cancer
UGT1A5,Rs4124874,chronic benzene poisoning
UGT1A5,Rs4124874,sepsis
UGT1A5,Rs4124874,Gilbert's syndrome
UGT1A5,Rs4124874,increased Bilirubin
UGT1A5,Rs4124874,breast cancer
UGT1A5,Rs4124874,benzene poisoning
UGT1A5,Rs4124874,ARDS
UGT1A6,Rs4148325,prostate 
UGT1A6,Rs4148325,Xenobiotic 
UGT1A6,Rs4148325,metabolizing 
UGT1A6,Rs4148325,cancer
UGT1A6,Rs6742078,prostate cancer
UGT1A6,Rs4124874,Gilbert's syndrome
UGT1A6,Rs6742078,ARDS
UGT1A6,Rs6742078,mortality
UGT1A6,Rs6742078,sepsis
UGT1A6,Rs6742078,prostate cancer
UGT1A6,Rs6742078,ARDS
UGT1A6,Rs6742078,Serum bilirubin levels
UGT1A6,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A6,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A6,Rs4124874,benzene poisoning
UGT1A6,Rs4124874,colorectal cancers
UGT1A6,Rs3755319,hyperbilirubinemia
UGT1A6,Rs4124874,Bilirubin
UGT1A6,Rs4124874,chronic benzene poisoning
UGT1A6,Rs4124874,colorectal cancer
UGT1A6,Rs4124874,breast cancer
UGT1A6,Rs4124874,sepsis
UGT1A6,Rs4124874,Gilbert's syndrome
UGT1A6,Rs4124874,increased Bilirubin
UGT1A6,Rs4124874,breast cancer
UGT1A6,Rs4124874,ARDS
UGT1A7,Rs4148325,prostate 
UGT1A7,Rs4148325,Xenobiotic 
UGT1A7,Rs4148325,metabolizing 
UGT1A7,Rs4148325,cancer
UGT1A7,Rs6742078,prostate cancer
UGT1A7,Rs6742078,ARDS
UGT1A7,Rs6742078,ARDS
UGT1A7,Rs6742078,mortality
UGT1A7,Rs6742078,sepsis
UGT1A7,Rs6742078,prostate cancer
UGT1A7,Rs4124874,Gilbert's syndrome
UGT1A7,Rs6742078,Serum bilirubin levels
UGT1A7,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A7,Rs4124874,increased Bilirubin
UGT1A7,Rs4124874,benzene poisoning
UGT1A7,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A7,Rs4124874,colorectal cancers
UGT1A7,Rs3755319,hyperbilirubinemia
UGT1A7,Rs4124874,Bilirubin
UGT1A7,Rs4124874,breast cancer
UGT1A7,Rs4124874,chronic benzene poisoning
UGT1A7,Rs11692021,Clinically relevant UGT1A10 variant
UGT1A7,Rs4124874,ARDS
UGT1A7,Rs4124874,sepsis
UGT1A7,Rs4124874,Gilbert's syndrome
UGT1A7,Rs4124874,breast cancer
UGT1A7,Rs4124874,colorectal cancer
UGT1A8,Rs4148325,prostate 
UGT1A8,Rs4148325,cancer
UGT1A8,Rs4148325,metabolizing 
UGT1A8,Rs4148325,Xenobiotic 
UGT1A8,Rs4124874,Gilbert's syndrome
UGT1A8,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A8,Rs4124874,breast cancer
UGT1A8,Rs4124874,colorectal cancers
UGT1A8,Rs4124874,benzene poisoning
UGT1A8,Rs4124874,increased Bilirubin
UGT1A8,Rs4124874,breast cancer
UGT1A8,Rs4124874,sepsis
UGT1A8,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A8,Rs11692021,Clinically relevant UGT1A10 variant
UGT1A8,Rs11892031,urinary bladder cancer
UGT1A8,Rs3755319,hyperbilirubinemia
UGT1A8,Rs4124874,Gilbert's syndrome
UGT1A8,Rs4124874,chronic benzene poisoning
UGT1A8,Rs4124874,colorectal cancer
UGT1A8,Rs4124874,ARDS
UGT1A8,Rs4124874,Bilirubin
UGT1A9,Rs4148325,metabolizing 
UGT1A9,Rs4148325,Xenobiotic 
UGT1A9,Rs4124874,Gilbert's syndrome
UGT1A9,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A9,Rs4124874,colorectal cancers
UGT1A9,Rs4124874,benzene poisoning
UGT1A9,Rs4124874,breast cancer
UGT1A9,Rs4124874,increased Bilirubin
UGT1A9,Rs4124874,Gilbert's syndrome
UGT1A9,Rs4124874,ARDS
UGT1A9,Rs4148325,cancer
UGT1A9,Rs4124874,colorectal cancer
UGT1A9,Rs4124874,chronic benzene poisoning
UGT1A9,Rs4124874,breast cancer
UGT1A9,Rs4124874,Bilirubin
UGT1A9,Rs3755319,hyperbilirubinemia
UGT1A9,Rs11692021,Clinically relevant UGT1A10 variant
UGT1A9,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A9,Rs4124874,sepsis
UGT1A9,Rs4148325,prostate 
UGT2B17,Rs6552182,Deletion of both copies of this gene alters testosterone metabolism making steroid use undetectable.
UNC13D,Rs121434352,familial hemophagocytic lymphohistiocytosis
UNC13D,Rs796065026,familial hemophagocytic lymphohistiocytosis
UNC13D,Rs796065026,amilial hemophagocytic lymphohistiocytosis
UNC13D,Rs796065024,familial hemophagocytic lymphohistiocytosis
UNC13D,Rs764196809,familial hemophagocytic lymphohistiocytosis
UNC13D,Rs121434354,familial hemophagocytic lymphohistiocytosis (HLH)
UNC13D,Rs747169857,familial hemophagocytic lymphohistiocytosis (HLH)
UNC13D,Rs121434354,cytosis
UNC13D,Rs121434354,pathogenic
UNC13D,Rs764196809,familial hemophagocytic lymphohistiocytosis
UROS,Rs121908012,congenital erythropoietic porphyria
USH1C,Rs55843567,syndromic and non-syndromic deafness
USH1G,Rs397517925,pathogenic
USH1G,Rs397517925,Usher syndrome
USH1G,Rs397517925, Usher syndrome (type 1G)
USH2A,Rs111033367,Usher syndrome
USH2A,Rs111033367,Usher syndrome
USH2A,Rs111033367,Usher syndrome
USH2A,Rs111033367,syndrome type 2 in Canadians of French origin and confirms comm
USH2A,Rs111033367,"on of novel mutations in usherin, the gene responsible for Usher syndro"
USH2A,Rs111033334,non-Ashkenazi Jews
USH2A,Rs111033334,Usher syndrome type 2
USH2A,Rs111033273,USH2A mutations
USH2A,Rs111033334,retinitis pigmentosa
USH2A,Rs111033334,retinitis pigmentosa
USH2A,Rs111033273,Usher syndrome 2a
USH2A,Rs111033273,Usher syndrome 1b
USH2A,Rs111033334,Usher syndrome type 2
USH2A,Rs111033273,visual impairment
USP9Y,Rs2032598,association with schizophrenia
USP9Y,Rs3212292,protective lipid
USP9Y,Rs2032598,schizophrenia
USP9Y,Rs2032597,HIV
USP9Y,Rs2032597,HIV
USP9Y,Rs2032598,schizophrenia
UTY,Rs2032658,"Association of Y chromosome haplogroup I with HIV progression, and HAART outcome."
VARS,Rs150882285,Arg947His
VARS,Rs150882285,R947H
VCAN,Rs80356555,Erosive vitreoretinopathy
VCAN,Rs80356555,Wagner syndrome
VCAN,Rs80356555,intronic mutations
VCAN,Rs80356555,wagner disease
VCAN,Rs80356555,Erosive vitreoretinopathy
VCAN,Rs80356555,Wagner syndrome
VCAN,Rs80356555,imbalance of splice variants
VCAN,Rs80356555,wagner disease
VCAN,Rs80356555,Japanese
VCAN,Rs80356555,Wagner syndrome
VCAN,Rs80356554,wagner disease
VCAN,Rs80356554,Erosive vitreoretinopathy
VCAN,Rs251124,intracranial aneurysms
VCAN,Rs251124,disruption of the extracellular matrix (ECM) of the arterial wall
VCAN,Rs173686,intracranial aneurysm
VCAN,Rs173686,Intracranial Aneurysm
VCAN,Rs80356555,Erosive vitreoretinopathy
VDR,Rs2228570,Central and Eastern Europe
VDR,Rs2228570,osteonecrosis in children with acute lymphoblastic leukemia
VDR,Rs2228570,type 1 diabetes mellitus in the Portuguese population
VDR,Rs2228570,postmenopausal breast cancer
VDR,Rs2228570,breast cancer risk in the Polish population
VDR,Rs2228570,Hispanic and African Americans.
VDR,Rs2228570,adiposity and colon cancer
VDR,Rs2228570,twins with multiple sclerosis.
VDR,Rs2228570,advanced non-small-cell lung cancer
VDR,Rs2228570,dietary vitamin D intake and colorectal cancer
VDR,Rs2228570,human height
VDR,Rs2228570,Colon tumor
VDR,Rs2228570,breast cancer
VDR,Rs2228570,ischemic stroke
VDR,Rs2228570,multiple sclerosis
VDR,Rs2228570,ovarian cancer
VDR,Rs2228570,renal cancer
VDR,Rs2228570,prostate cancer
VDR,Rs2228570,HIV-1 infection in injection drug users
VDR,Rs2228570,olon and rectal cancer
VDR,Rs2228570,type 1 diabetes
VDR,Rs2228570,recurrent venous thromboembolism
VDR,Rs2228570,Graves' disease in German and Polish but not in Serbian patients
VDR,Rs2228570,Asthma
VDR,Rs2228570,schizophrenia and selected anthropometric measures
VDR,Rs2228570,generalized aggressive periodontitis
VDR,Rs2228570,postmenopausal breast cancer
VDR,Rs2228570,fracture
VDR,Rs2228570,older women
VDR,Rs2228570,South Croatia.
VDR,Rs2228570,"acute lymphoblastic leukemia cases in Churchill County, Nevada"
VDR,Rs2228570,cancer
VDR,Rs2228570,bone mass and geometry
VDR,Rs2228570,hyroid autoimmune disorders
VDR,Rs2228570,colon cancer
VDR,Rs2228570,salmonellosis or campylobacteriosis and chronic illness
VDR,Rs2228570,ovarian cancer
VDR,Rs2228570,ovarian cancer
VDR,Rs2228570,colorectal cancer
VDR,Rs2228570,respiratory syncytial virus bronchiolitis
VDR,Rs2228570,Brazilian individuals with type 1 diabetes
VDR,Rs2228570,asthma
VDR,Rs2228570,sun exposure
VDR,Rs2228570,African Americans
VDR,Rs2228570,multiple sclerosis in Canadians.
VDR,Rs3847987,COPD
VDR,Rs2228570,breast cancer risk among Caucasian women in Ontario
VDR,Rs2228570,active calcium stone disease.
VDR,Rs2228570,inflammatory bowel
VDR,Rs2228570,Irish
VDR,Rs2228570,breast cancer risk among Chinese women
VDR,Rs2228570,Prostate cancer
VDR,Rs2228570,respiratory syncytial virus
VDR,Rs2228570,tuberculosis
VDR,Rs2228570,East India.
VDR,Rs2228570,prostate cancer
VDR,Rs2228570,Parkinson's diseas
VDR,Rs2228570,HIV Patients
VDR,Rs2228570,Mycobacterium tuberculosis
VDR,Rs2228570,Turkish postmenopausal women.
VDR,Rs3847987,COPD
VDR,Rs2228570,South African children
VDR,Rs2228570,blood pressure progression and incident hypertension
VDR,Rs2228570,periodontitis
VDR,Rs2228570,colorectal cancer.
VDR,Rs2228570,multiple sclerosis
VDR,Rs2228570,prostate cancer
VDR,Rs2228570,differentiated thyroid carcinoma
VDR,Rs2228570,diabetic retinopathy
VDR,Rs2228570,melanoma
VDR,Rs2228570,UK
VDR,Rs2228570,asthma
VDR,Rs2228570,Chinese Han
VDR,Rs2228570,hepatocellular carcinoma in alcoholic cirrhosis.
VDR,Rs2228570,malignant melanoma
VDR,Rs2228570,multiple sclerosis.
VDR,Rs2228570,diabetic nephropathy
VDR,Rs2228570,Asthma
VDR,Rs2228570,families with type I diabetes
VDR,Rs2228570,type I diabetes
VDR,Rs2228570,Type I Diabetes
VDR,Rs2228570,extrapulmonary tuberculosis
VDR,Rs2228570,rectal tumors
VDR,Rs2228570,"type 1 diabetes in Crete, Greece"
VDR,Rs2228570,obesity and osteoporosis
VDR,Rs2228570, FokI polymorphism
VDR,Rs2228570,periodontitis
VDR,Rs2228570,colon and rectal cancer
VDR,Rs2228570,syncytial virus bronchiolitis
VDR,Rs2228570,thyroid autoimmune disorders
VDR,Rs2228570,colon cancer
VDR,Rs2228570,campylobacteriosis
VDR,Rs2228570,chronic illness
VDR,Rs2228570,ovarian cancer
VDR,Rs2228570,ovarian cancer
VDR,Rs2228570,colorectal cancer
VDR,Rs2228570,polymorphism
VDR,Rs2228570,type 1 diabetes
VDR,Rs2228570,HIV-1 infection
VDR,Rs2228570,renal cancer
VDR,Rs2228570,osteonecrosis
VDR,Rs2228570,type 1 diabetes
VDR,Rs2228570,postmenopausal breast cancer
VDR,Rs2228570,breast cancer
VDR,Rs2228570,lymphoblastic leukemia
VDR,Rs2228570,breast cancer
VDR,Rs2228570,schizophrenia
VDR,Rs2228570,Graves' disease
VDR,Rs2228570,Chinese
VDR,Rs10735810,Idiopathic short stature
VDR,Rs10735810,Osteonecrosis
VDR,Rs10735810,acute lymphoblastic leukemia
VDR,Rs10735810,breast cancer
VDR,Rs10735810,ymphoblastic leukemia
VDR,Rs10735810,breast cancer
VDR,Rs1544410,low BMD
VDR,Rs2228570,colon cancer
VDR,Rs1544410,osteoporosis
VDR,Rs2107301,prostate cancer
VDR,Rs2107301,~2.5x higher risk of prostate cancer
VDR,Rs2107301,prostate cancer
VDR,Rs2107301,Caucasian patients
VDR,Rs2228570,FokI polymorphism
VDR,Rs2228570, breast cancer
VDR,Rs2228570,obesity
VDR,Rs2228570,osteoporosis
VDR,Rs1544410,Shorter stature
VDR,Rs2228570,adiposity
VDR,Rs2228570,Graves' disease
VDR,Rs2228570,human height
VDR,Rs2228570, asthma 
VDR,Rs2228570, type 1 diabetes
VDR,Rs2228570,sclerosis
VDR,Rs2228570,diabetic
VDR,Rs2228570,type I diabetes
VDR,Rs2228570, type I diabetes 
VDR,Rs2228570, Type I Diabetes
VDR,Rs2228570, Type I Diabetes
VDR,Rs2228570, polymorphisms
VDR,Rs2228570,rectal tumors
VDR,Rs2228570, cirrhosis
VDR,Rs2228570,polymorphisms
VDR,Rs2228570,Prostate cancer
VDR,Rs2228570,breast cancer 
VDR,Rs2228570,inflammatory bowel disease
VDR,Rs2228570,breast cancer
VDR,Rs2228570,race and ethnicity
VDR,Rs2228570,colorectal cancer
VDR,Rs2228570,hepatocellular carcinoma
VDR,Rs2228570,diabetic retinopathy
VDR,Rs2228570,colorectal cancer
VDR,Rs2228570,prostate cancer
VDR,Rs2228570,lung cancer
VDR,Rs2228570,thyroid carcinoma
VDR,Rs2228570,Colon tumor 
VDR,Rs2228570,breast cancer
VDR,Rs2228570,nonhypertensive
VDR,Rs2228570,lymphotoxin-alpha
VDR,Rs2228570,prostate cancer
VDR,Rs2228570,venous thromboembolism
VDR,Rs2228570,type 1 diabetes
VDR,Rs2228570,ovarian cancer
VDR,Rs2228570,hypertension
VDR,Rs2228570,postmenopausal women
VDR,Rs2228570,HIV
VDR,Rs2228570,Mycobacterium tuberculosis
VDR,Rs2228570,prostate cancer
VDR,Rs2228570,respiratory syncytial virus
VDR,Rs2228570,blood pressure
VDR,Rs2228570, tuberculosis
VDR,Rs2228570,multiple sclerosis
VEGFA,Rs2010963,non-small cell lung cancer
VEGFA,Rs2010963,myocardial infarction
VEGFA,Rs2010963,heumatoid arthritis
VEGFA,Rs2010963,cardiovascular disease
VEGFA,Rs2010963,rheumatoid arthritis
VEGFA,Rs2010963,age-related macular degeneration
VEGFA,Rs2010963,multiple myeloma
VEGFA,Rs2010963,severe radiation pneumonitis
VEGFA,Rs2010963,highly myopic eyes
VEGFA,Rs2010963,ischemic heart disease
VEGFA,Rs2010963,efficacy of thalidomide
VEGFA,Rs2010963,rheumatoid arthritis
VEGFA,Rs2010963,diabetic retinopathy.
VEGFA,Rs2010963,coronary artery disease.
VEGFA,Rs2010963,diabetes:
VEGFA,Rs2010963,nonproliferative and proliferative diabetic retinopathy
VEGFA,Rs2010963,Gilbert's syndrome
VEGFA,Rs2010963,Pazopanib-induced hyperbilirubinemia
VEGFA,Rs2010963,gastric cancer
VEGFA,Rs2010963,major solid tumors.
VEGFA,Rs2010963,renal cancer
VEGFA,Rs2010963,diabetic retinopathy.
VEGFA,Rs2010963,rheumatoid arthritis
VEGFA,Rs2010963,esophageal cancer
VEGFA,Rs2010963,ovarian cancer
VEGFA,Rs3025039,increased risk
VEGFA,Rs833061,breast cancer 
VEGFA,Rs3025039,bladder cancer risk
VEGFA,Rs2010963,acute myocardial infarction
VEGFA,Rs833069,rheumatoid arthritis
VEGFA,Rs833068,ovarian cancer
VEGFA,Rs833068,neovascular age-related macular degeneration
VEGFA,Rs833068,bladder cancer risk
VEGFA,Rs833061,cardiovascular malformation
VEGFA,Rs833061,graft-versus-host disease
VEGFA,Rs833061,Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy.
VEGFA,Rs833061,Gene polymorphism of vascular endothelial growth factor -1154 G>A is associated with hypertensive nephropathy in a Hispanic population.
VEGFA,Rs833061,polymorphisms and esophageal cancer prognosis. The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors.
VEGFA,Rs833061,Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformation.
VEGFA,Rs833061,"Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk."
VEGFA,Rs833061,VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.
VEGFA,Rs833061,identifies
VEGFA,Rs833061,cancer risk
VEGFA,Rs833061,Large-scale evaluation of candidate genes
VEGFA,Rs833061,Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort.
VEGFA,Rs699947,lymph node metastasis
VEGFA,Rs699947,thyroid cancer
VEGFA,Rs3025039,heumatoid arthritis
VEGFA,Rs3025039,multiple myeloma
VEGFA,Rs3025039,neovascular age-related macular degeneration
VEGFA,Rs3025039,peptic ulcer diseases
VEGFA,Rs3025039,gastric cancer
VEGFA,Rs3025039,non-small-cell lung cancer
VEGFA,Rs3025039,macular degeneration
VEGFA,Rs2010963,acute graft-versus-host disease
VEGFA,Rs2010963,carotid intima-media thickness
VEGFA,Rs2010963,age-related macular degeneration
VEGFA,Rs1570360,Gilbert's syndrome
VEGFA,Rs1570360,microdeletion syndrome
VEGFA,Rs1570360,Alzheimer's disease
VEGFA,Rs1570360,renal cancer
VEGFA,Rs1570360,diabetic retinopathy
VEGFA,Rs1570360,sporadic renal cell carcinoma
VEGFA,Rs1570360,diabetic retinopathy
VEGFA,Rs1570360,polymorphisms
VEGFA,Rs1570360,ventricular septal defect
VEGFA,Rs1570360,bladder cancer risk
VEGFA,Rs1570360,polymorphisms 
VEGFA,Rs1570360, psoriatic arthritis
VEGFA,Rs1570360,gene polymorphisms
VEGFA,Rs1570360,type 2 diabetes
VEGFA,Rs1570360,breast cancer
VEGFA,Rs1570360,Polymorphisms
VEGFA,Rs1570360,Henoch-Schonlein purpura
VEGFA,Rs1570360,rheumatoid arthritis
VEGFA,Rs1570360,vascular endothelial growth factor (VEGF)
VEGFA,Rs1570360,giant cell arteritis
VEGFA,Rs1570360,ischemic complications
VEGFA,Rs1570360,Sudden Infant Death Syndrome
VEGFA,Rs13207351,polymorphisms
VEGFA,Rs13207351,iabetic retinopathy
VEGFA,Rs2010963,acute graft-versus-host disease
VEGFA,Rs1570360,Pazopanib-induced hyperbilirubinemia
VEGFA,Rs1570360,polymorphism
VEGFA,Rs1570360,polymorphism
VEGFA,Rs1570360,diabetic retinopathy
VEGFA,Rs1570360,nonproliferative and proliferative diabetic retinopathy
VEGFA,Rs2010963,esophageal adenocarcinoma risk
VEGFA,Rs2010963,familial endometriosis
VEGFA,Rs2010963,non-small-cell lung cancer
VEGFA,Rs2010963,acute myeloid leukaemia
VEGFA,Rs2010963,cognitive ageing
VEGFA,Rs2010963,cognitive ability
VEGFA,Rs2010963,bladder cancer
VEGFA,Rs2010963,psoriatic arthritis
VEGFA,Rs2010963,Kawasaki disease
VEGFA,Rs2010963,breast cancer
VEGFA,Rs2010963,renal complications
VEGFA,Rs2010963,Henoch-Schonlein purpura
VEGFA,Rs2010963,endometriosis
VEGFA,Rs2010963,giant cell arteritis
VEGFA,Rs2010963,rheumatoid arthritis
VEGFA,Rs1570360,rheumatoid arthritis
VEGFA,Rs2010963,rheumatoid arthritis
VEGFA,Rs2010963,breast cancer
VEGFA,Rs2010963,Kawasaki disease
VEGFA,Rs1570360,hypertensive nephropathy
VEGFA,Rs2010963,"growth, differentiation and apoptosis"
VEGFA,Rs2010963,diabetes
VEGFA,Rs2010963,coronary artery disease
VEGFA,Rs2010963,severe ischemic complications
VEGFA,Rs2010963,renal cancer
VHL,Rs28940298,congenital Chuvash polycythemia
VHL,Rs28940298,human cancer
VHL,Rs28940298,Renal cell carcinomas
VHL,Rs28940298,Congenital disorder of oxygen sensing
VHL,Rs28940298,von Hippel-Lindau disease
VHL,Rs28940298,human cancer
VHL,Rs28940298,tumors
VHL,Rs28940298,thrombosis and vascular abnormalities
VHL,Rs28940298,polycythemia VHL mutation
VHL,Rs28940298,thrombosis and vascular abnormalities
VHL,Rs28940298,acute mountain sickness
VHL,Rs28940298,human cancer.
VHL,Rs28940298,Renal cell carcinomas
VHL,Rs28940298,Sherpas
VHL,Rs28940298,hypoxia
VHL,Rs28940298,fenestration of the vertebral artery
VHL,Rs28940298,on Hippel-Lindau disease
VHL,Rs28940298,von Hippel-Lindau
VHL,Rs28940298,Chuvash polycythemia
VHL,Rs28940298,Congenital disorder of oxygen sensing
VHL,Rs28940298,thrombosis
VHL,Rs28940298,vascular abnormalities
VHL,Rs28940298,tumors
VHL,Rs28940298,congenital Chuvash polycythemia
VHL,Rs28940298,acute mountain sickness
VHL,Rs28940298,von Hippel-Lindau disease
VHL,Rs28940298,fenestration of the vertebral artery
VHL,Rs28940298,human cancer
VHL,Rs193922613,Congenital polycythemia
VHL,Rs193922613,Von Hippel-Lindau-dependent polycythemia
VHL,Rs193922613,paraneoplastic polycythemia.
VHL,Rs28940298,acute mountain sickness
VHL,Rs28940298,fenestration of the vertebral artery
VHL,Rs28940298,von Hippel-Lindau disease
VHL,Rs28940298,Renal cell carcinomas
VHL,Rs28940298,von Hippel-Lindau (VHL) tumour
VHL,Rs28940298,congenital Chuvash polycythemia
VHL,Rs28940298,Congenital disorder of oxygen sensing
VHL,Rs28940298,Chuvash polycythemia
VHL,Rs28940298,fenestration of the vertebral artery
VHL,Rs28940298,thrombosis and vascular abnormalities
VHL,Rs28940298,human cancer
VHL,Rs28940298,symptoms of acute mountain sickness
VHL,Rs28940298,von Hippel-Lindau
VHL,Rs28940298,Renal cell carcinomas
VHL,Rs28940298,von Hippel-Lindau (VHL) tumour
VHL,Rs28940298,congenital Chuvash polycythemia
VHL,Rs28940298,Congenital disorder of oxygen
VHL,Rs28940298,huvash polycythemia
VHL,Rs28940298,thrombosis
VHL,Rs28940298,vascular abnormalities
VHL,Rs28940298,tumors
VHL,Rs28940298,tumors
VKORC1,Rs9934438,calcification of the aortic far wall
VKORC1,Rs9934438,increase of calcification of the aortic
VKORC1,Rs9934438,aortic calcification
VKORC1,Rs9934438,calcification of the aortic far wall 
VKORC1,Rs9934438,aortic calcification
VKORC1,Rs9934438,aortic calcification
VLDLR,Rs1454626,"carotid artery disease,"
VLDLR,Rs1454626,"BMI,"
VLDLR,Rs1454626,LDL-associated apolipoprotein B
VPS35,Rs797044948,autosomal dominant
VPS35,Rs797044948,"inborn genetic disease"""
VPS35,Rs146795505,recessively inherited
VPS35,Rs797044948,inborn genetic disease
VPS35,Rs146795505,recessively inherited
VPS35,Rs146795505,Meier-Gorlin syndrome 3
VPS35,Rs146795505,Meier-Gorlin syndrome 3
VPS53,Rs587777466,Pontocerebellar hypoplasia
VPS53,Rs587777466,leading to Pontocerebellar hypoplasia
VWF,I5049282,Von Willebrand disease
VWF,Rs33978901,Von Willebrand disease
VWF,I5049208,Von Willebrand disease
VWF,I5049208,Von Willebrand disease
VWF,I5049266,Von Willebrand disease
VWF,I5049282,Willebrand disease
VWF,I5049282,Willebrand disease
VWF,Rs267607326,"Von Willebrand disease, type 2A"
VWF,I5049344,Von Willebrand disease
VWF,Rs121964894,"Von Willebrand disease, type 2N"
VWF,Rs121964895,Von Willebrand disease
VWF,Rs1800386,Von Willebrand disease
VWF,Rs1800386,Caucasians
VWF,Rs1800386,blood group type O
VWF,I5049192,Willebrand disease
VWF,I5049344, Willebrand disease
VWF,I5049192,Von Willebrand disease
VWF,I5049161,Von Willebrand disease
VWF,I5049165,Von Willebrand disease
VWF,I5049165,Willebrand
VWF,I5039448,Von Willebrand disease
VWF,I5039483,Willebrand disease
VWF,I5049057,Willebrand
VWF,I5049057,Willebrand disease
VWF,I5049057,Willebrand disease
VWF,I5049076,Von Willebrand disease
VWF,I3002797,Von Willebrand disease
VWF,I5049104,Willebrand disease
VWF,I5049117,Willebrand disease
VWF,I5049145,Willebrand disease
VWF,I5049145,Von Willebrand disease
VWF,I5049157,Willebrand disease
VWF,I5049157,Von Willebrand disease
VWF,I5049076,Willebrand disease
WDR66,Rs7961894,cerebral infarction
WDR66,Rs7961894,postevent morbidity
WFS1,Rs28937895,deafness
WFS1,Rs28937895,deafness
WFS1,Rs28937894,deafness
WFS1,Rs28937893,deafness
WFS1,Rs28937893,deafness
WFS1,Rs28937894,deafness
WISP3,Rs1230345,schizophrenia
WRN,Rs1801195,scan for cleft lip and cleft palate
WRN,Rs1801195,polymorphisms
WRN,Rs1801195,Colorectal cancer
WRN,Rs1801195,benzene hematotoxicity
WRN,Rs1801195,non-Hodgkin lymphoma
WRN,Rs17847577,Caucasians
WRN,Rs17847577,non-Japanese populations
WRN,Rs113993961,Werner Syndrome
WRN,Rs113993961,change in a splice donor sequence
WRN,Rs113993961,frameshift of codons
WRN,Rs17847577,Werner Syndrome
WT1,Rs28941779,Denys-Drash syndrome
WT1,Rs28941779,Denys-Drash syndrome
WT1,Rs28941779,Frasier syndrome
WT1,Rs28941778,"nephrotic syndrome, type IV"
WT1,Rs28941779,Frasier syndrome
WT1,Rs16754,Wilms' tumor
WT1,Rs16754,acute myeloid leukemia
WT1,Rs16754,Wilms' tumor gene
WT1,Rs28941778,Denys-Drash syndrome
WWC1,Rs749318706,Tourette syndrome
WWC1,Rs17070145,gene polymorphisms
WWC1,Rs17070145,hippocampal activations during memory retrieval
WWC1,Rs17070145,Alzheimer's disease
WWC1,Rs17070145,Alzheimer's disease
WWC1,Rs17070145,Alzheimer's disease
WWC1,Rs17070145,Alzheimer's disease
WWC1,Rs17070145,mild cognitive impairment
WWC1,Rs17070145,Alzheimer's disease
WWC1,Rs17070145,Alzheimer's disease
WWC1,Rs749318706,Tourette syndrome
WWOX,Rs2548861,coronary artery disease
WWOX,Rs2548861,Low serum HDL-cholesterol
XIAP,Rs387907301,inflammatory bowel disease
XIAP,Rs387907301,lymphoproliferative syndrome
XPC,Rs2470353,bladder cancer
XPC,Rs2470353,vitro functional effects
XPC,Rs2228000,cancer.
XPC,Rs2228000,cancer 
XPC,Rs2470353,XPC gene
XPC,Rs2228000,cancer
XPC,Rs2228000,bladder cancer
XPC,Rs2228000,cancer
XPC,Rs2228000,cancer
XPC,Rs2228000,bladder cancer.
XRCC1,Rs25487,myeloid or lymphocytic leukemia
XRCC1,Rs25487,"Caucasians,"
XRCC1,Rs25487, squamous cell cancer
XRCC1,Rs25487,basal cell BCC
XRCC1,Rs25487, Koreans
XRCC1,Rs25487,basal cell cance
XRCC1,Rs25487,increased childhood risk of acute lymphoblastic leukemia among Asians 
XRCC1,Rs25487,No association was found in Caucasians
XRCC1,Rs25487,Hispanics with non-small cell lung cancer
XRCC1,Rs25487,melanoma
XRCC1,Rs25487,biliary tract cancer and biliary stones
XRCC1,Rs25487,China
XRCC1,Rs25487, early onset lung cancer
XRCC1,Rs25487, Central-South Italian population
XRCC1,Rs25487,melanoma risk
XRCC1,Rs25487,Lynch syndrome
XRCC1,Rs25487, Polish population
XRCC1,Rs25487,head and neck squamous cell cancer survival
XRCC1,Rs25487,Bladder cancer
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,systemic lupus erythematosus
XRCC1,Rs25487,head and neck squamous cell cancer survival
XRCC1,Rs25487,glioblastoma
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,neutropenia
XRCC1,Rs25487,bladder cancer
XRCC1,Rs25487,lung adenocarcinoma
XRCC1,Rs25487,Locally Advanced Head and Neck Cancer
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,Breast Cancer
XRCC1,Rs25487,cell lung cancer
XRCC1,Rs25487,cancer
XRCC1,Rs25487,metastatic gastric cancer
XRCC1,Rs25487,radiation pneumonitis
XRCC1,Rs25487,non-small cell lung cancer
XRCC1,Rs25487,larynx cancer
XRCC1,Rs25487,colorectal cancer risk
XRCC1,Rs25487,Turkish population
XRCC1,Rs25487,ral precancer and cancer
XRCC1,Rs25487,carcinogen vinyl chloride
XRCC1,Rs25487, cancer in Lynch syndrome
XRCC1,Rs25487,carcinogen metabolism
XRCC1,Rs25487,colorectal cancer risk
XRCC1,Rs25489,pancreatic adenocarcinoma risk
XRCC1,Rs25487,metastatic gastric cancer 
XRCC1,Rs25489,prostate cancer
XRCC1,Rs25489,erectile dysfunction
XRCC1,Rs25489,gastric cancer
XRCC1,Rs25489,breast cancer risk
XRCC1,Rs25489,bladder cancer risk
XRCC1,Rs25489,biliary tract cancer and biliary stones
XRCC1,Rs25489,lung cancer
XRCC1,Rs25489,lung cancer
XRCC1,Rs25487,head and neck squamous cell carcinoma
XRCC1,Rs25489,cancer
XRCC1,Rs25489,human breast cancer risk
XRCC1,Rs25489,Lung Cancer
XRCC1,Rs25489,lung cancer
XRCC1,Rs25489,HPV16-negative head and neck squamous cell carcinoma
XRCC1,Rs25489,breast cancer
XRCC1,Rs25489,breast cancer risk
XRCC1,Rs25489,risk of radiation pneumonitis
XRCC1,Rs25489,non-small cell lung cancer
XRCC1,Rs25489,melanoma risk
XRCC1,Rs25489,ncreased risk for breast cancer
XRCC1,Rs25489,lung cancer
XRCC1,Rs25489,prostate cancer
XRCC1,Rs25489,breast cancer
XRCC1,Rs25487,pneumonitis 
XRCC1,Rs25487,female
XRCC1,Rs25487,lung adenocarcinoma
XRCC1,Rs25487, Breast Cancer
XRCC1,Rs25487, Maharashtrian population of central India.
XRCC1,Rs25487,non-small cell lung cancer risk.
XRCC1,Rs25487,Gallbladder cancer predisposition
XRCC1,Rs25487,breast cancer risk
XRCC1,Rs25487,bladder cancer.
XRCC1,Rs25487,non-small cell lung cancer
XRCC1,Rs25487,bladder cancer
XRCC1,Rs25487,head and neck squamous cell carcinoma
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,non-small cell lung cancer in women
XRCC1,Rs25487,Lung Cancer
XRCC1,Rs25487,Japanese population
XRCC1,Rs25487,North Indian women
XRCC1,Rs25487, breast cancer risk.
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,pancreatic adenocarcinoma
XRCC1,Rs25487,neutropenia in cancer patients
XRCC1,Rs25487,cell lung cancer
XRCC1,Rs25487,acute lymphoblastic leukemia
XRCC1,Rs25487,Lung Cancer
XRCC1,Rs25487,increased childhood risk of acute lymphoblastic leukemia
XRCC1,Rs25487,risk of either myeloid or lymphocytic leukemia
XRCC1,Rs25487,non-small cell lung cancer
XRCC1,Rs25487,Hodgkin disease
XRCC1,Rs25487,risk of gastric cancer
XRCC1,Rs25487,Bladder cancer
XRCC1,Rs25487,adult glioma
XRCC1,Rs25487,bladder cancer risk
XRCC1,Rs25487,basal cell cancer
XRCC1,Rs25487,lung cancer risk
XRCC1,Rs25487,risk of breast cancer
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,pancreatic adenocarcinoma risk
XRCC1,Rs25487,cancer
XRCC1,Rs25487,risk of breast cancer
XRCC1,Rs25487,human breast cancer risk
XRCC1,Rs25487,colorectal cancer
XRCC1,Rs25487,biliary tract cancer and biliary stones
XRCC1,Rs25487,squamous cell cancer (SCC
XRCC1,Rs25487,risk of both basal cell BCC
XRCC1,Rs25487,colorectal cancer in Lynch syndrome
XRCC1,Rs25487,both basal cell BCC
XRCC1,Rs25487,squamous cell cancer
XRCC1,Rs25487,acute lymphoblastic leukemia
XRCC1,Rs25487,myeloid or lymphocytic leukemia
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,Hodgkin disease
XRCC1,Rs25487,Bladder cancer 
XRCC1,Rs25487,gastric cancer
XRCC1,Rs25487,Hodgkin lymphoma (NHL)
XRCC1,Rs25487,biliary tract cancer and biliary stones
XRCC1,Rs25487,pancreatic adenocarcinoma risk
XRCC1,Rs25487,non-small cell lung cancer
XRCC1,Rs25487,neck squamous cell carcinoma
XRCC1,Rs25487,glioblastoma
XRCC1,Rs25487,neutropenia
XRCC1,Rs25487,Locally Advanced Head and Neck Cancer
XRCC1,Rs25487,breast cancer risk
XRCC1,Rs25487,Gallbladder cancer 
XRCC1,Rs25487,modulate oral precancer and cancer risk
XRCC1,Rs25487,adult glioma
XRCC1,Rs25487,risk of non-small cell lung cancer in women.
XRCC1,Rs25487,Risk of non-Hodgkin lymphoma (NHL)
XRCC1,Rs25487,glioblastoma
XRCC1,Rs25487,SCC
XRCC1,Rs25487,lymphocytic leukemia
XRCC1,Rs25487,cell lung cancer
XRCC1,Rs25487,Hodgkin disease
XRCC1,Rs25487,Bladder cancer predisposition
XRCC1,Rs25487,non-Hodgkin lymphoma 
XRCC1,Rs25487,NHL)
XRCC1,Rs25487, cancer cells
XRCC1,Rs25487,bladder cancer risk
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,biliary tract cancer
XRCC1,Rs25487,biliary stones
XRCC1,Rs25487,HPV16-negative head and neck squamous cell carcinoma
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,pancreatic adenocarcinoma risk
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,colorectal cancer
XRCC1,Rs25487,basal cell BCC
XRCC1,Rs25487,basal cell cancer
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,melanoma risk
XRCC1,Rs25487,squamous cell cancer
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,bladder cancer risk
XRCC1,Rs25487,bladder cancer
XRCC1,Rs25487,Locally Advanced Head and Neck Cancer
XRCC1,Rs25487,Breast Cancer
XRCC1,Rs25487,risk factor for pterygium
XRCC1,Rs25487,non-small cell lung cancer risk
XRCC1,Rs25487,Gallbladder cancer
XRCC1,Rs25487,lung adenocarcinoma
XRCC1,Rs25487,radiation pneumonitis
XRCC1,Rs25487,non-small cell lung cancer
XRCC1,Rs25487,larynx cancer
XRCC1,Rs25487,colorectal cancer risk
XRCC1,Rs25487,risk of systemic lupus erythematosus
XRCC1,Rs25487,lung cancer risk
XRCC1,Rs25487,oral precancer and cancer risk
XRCC1,Rs25487,risk of early onset colorectal cancer in Lynch syndrome
XRCC1,Rs25487,early-stage head and neck squamous cell cancer survival
XRCC1,Rs25487,metastatic gastric cancer
XRCC2,Rs3218536,epithelial ovarian cancer
ZBTB40,Rs7524102,osteoporosis
ZBTB40,Rs7524102,gothenburg osteoporosis
ZBTB40,Rs7524102,obesity
ZBTB40,Rs7524102,obesity
ZBTB40,Rs7524102,osteoporosis
ZBTB40,Rs7524102,Osteoporotic fractures
ZBTB40,Rs7524102,Bone mineral density variations
ZBTB40,Rs7524102,osteoporosis
ZBTB40,Rs7524102,osteoporosis
ZBTB40,Rs7524102,Han Chinese women
ZBTB40,Rs7524102,osteoporosis
ZBTB40,Rs7524102,bone mineral density
ZBTB40,Rs7524102,Bone mineral density variations
ZBTB40,Rs7524102,osteoporosis susceptibility
ZBTB40,Rs7524102,obesity determinants
ZBTB40,Rs7524102,gothenburg osteoporosis
ZBTB40,Rs7524102,cortical bone mineral density
ZBTB40,Rs7524102,osteoporosis
ZBTB40,Rs7524102,growth
ZBTB40,Rs7524102,Osteoporotic fractures
ZBTB40,Rs7524102,Bone mineral density variations
ZBTB40,Rs7524102,Osteoporotic fractures
ZNF365,Rs7089814,breast size
ZNF804A,Rs7597593,schizophrenia.
ZNRF3,Rs16986825,Pancreatic cancer
ZNRF3,Rs16986825,Pancreatic cancer
ZNRF3,Rs16986825,pancreatic cancer
ZNRF3,Rs2269577,Vitiligo
